Académique Documents
Professionnel Documents
Culture Documents
NICOLAOU, E. J. SORENSEN
CLASSICS IN
TOTAL
SYNTHESIS
TARGETS, STRATEGIES,METHODS
VCH
Classics in Total Synthesis \320\272.\321\201.Nicolaou and
E. J. Sorensen
VCH
Other successful books in organic chemistry from VCH:
J.M. Lehn
Supramolecular Chemistry
Concepts and Perspectives
1995. X, 271pages with 51 figures.
Hardcover. ISBN 3-527-29312-4.
Softcover. ISBN 3-527-29311-6.
J. Fuhrhop, G. Penzlin
Organic Synthesis - Concepts,Methods, StartingMaterials
Second, Revised and Enlarged Edition
With a Foreword by E. J. Corey
1994. XVI, 432 pages with 16 figures and 37 tables.
Hardcover. ISBN 3-527-29086-9.
Softcover. ISBN 3-527-29074-5.
M. Nogradi
Stereoselective Synthesis - A Practical Approach
Second, Thoroughly Revised and Updated Edition
With a Foreword by A. I. Meyers
1994.XVI, 452 pages with 171 figures and 23 tables.
Hardcover. ISBN 3-527-29242-X.
Softcover. ISBN 3-527-29243-8.
H. Waldmann (Ed.)
Organic Synthesis Highlights II
1995. XIII, 407 page'swith 318 figures and 3 tables.
Hardcover. ISBN 3-527-29200-4.
Distribution:
VCH, P.O. Box 101161,D-69451 Weinheim, Federal Republic of Germany
VCH, P.O. Box, CH-4020
Switzerland: Basel, Switzerland
United Kingdom and Ireland: VCH, 8 Wellington Court, Cambridge CB1 1HZ,
United Kingdom
USA and Canada: VCH, 220 East 23rd Street,New York, NY 10010-4606, USA
Japan: VCH, Eikow Building, 10-9Hongo 1-chome, Bunkyo-ku, Tokyo 113, Japan
Synthesis
With a Foreword by
E. J. Corey
Weinheim
New York
Basel
Cambridge
VCH Tokyo
\320\232.
\320\241.
Nicolaou, Ph. D.
Erik J. Sorensen, Ph. D.
This book was carefully produced. Nevertheless, authors and publisher do not warrant the information contained therein to be free
of errors. Readers are advised to keep in mind that statements, data, illustrations, procedural details or other items may inadver-
be inaccurate.
inadvertently
Published jointly by
VCH Verlagsgesellschaft mbH, Weinheim (Federal Republic of Germany)
VCH Publishers, Inc., New York, NY (USA)
VCH
\302\251 Verlagsgesellschaft mbH, D-69451 Weinheim (Federal Republic of Germany), 1996
Printed on acid-free and chlorine-free paper.
All rights reserved(including those of translation in other languages). No part of this book may be reproduced in any form - by photo-
printing, microfilm, or any other means - nor transmitted or translated into machine language without written permission from the
publishers. Registerednames, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered
unprotected by law.
Composition: Fa. Hagedornsatz GmbH, D-68519 Viernheim.
Printing: Zechnersche Buchdruckerei, D-67346Speyer.
Bookbinding: Wilhelm Osswald & Co, D-67433 Neustadt.
Printed in the Federal Republic of Germany.
Foreword
chemistry,
but also with biology and medicine; relevance,at a very fun-
fundamental level to human well-being, health, and education.
As I read a prepublicationdraft of \"Classics in Total Synthesis\",
all of these general characteristicsof synthetic research assumed a
reality and sharpness that I had not expected, partly because I was
E. J. Corey
Harvard University
30 October 1995
Abbreviations, GC gas chromatography
HETE hydroxyeicosatetraenoic.
hfc 3-(heptafluoropropylhydroxymethylenci
Ac acetyl camphorato
acac acetylacetonyl HMPA hexamethyrphosphoramide
AD asymmetric dihydroxylation HMG hydroxymethylglutaryl
AIBN 2,2'-azobisisobutyroriitrile HPLC high-pressure liquid chromatography
BBEDA jV,jV'-bis(benzylidene)ethylenediamine HWE Homer- Wadsworth-Emmons
9-BBN 9-bOrabicyclo[3.3.1]nonane Im (imid.) imidazole
BINAL-H 2,2'-dihydroxy-l,r-binaphthylaluminum IND indoline
hydride Ipc isopinocampheyl
BIN AP 2,2'-bis(diphenylphosphino)-1,1 '-binaphthyl KHMDS potassium bis(trirQethylsilyl)amide
Bn benzyl LDA lithium diisopropylamide
BOC (f-BOC) ferf-butoxycarbonyl LHMDS lithium bis(trimethylsilyl)amide
BOM benzyloxymethyl raCPBA 3-chloroperoxybenzoic acid
BTMSA bis(trimethylsilyl)acetylene MEM 2-methoxyethoxymethyl
Bz benzoyl MOM methoxymethyl
18-C-6 18-crown-6 Ms methanesulfqnyl
Cbz benzyloxycarbonyl NaHMDS sodium bis(trimethylsilyl)amide
CHD coronary heart disease NB 2-nitrobenzyl
. CoA coenzyme A pNB 4-nitrobenzyl
COD 1,5-cyclooctadiene NBS /V-bromosuccinimide
Guy, John I. Trujillo, and Eddy W. Yue for their assistance and for
checking the references. We thank Professors Charlie L. Perrin, Jay
S. Siegel, and Emmanuel A. Theodorakis for useful discussions and
\320\232. Nicolaou
\320\241 was born in
1946 in Cyprus. He studied
chemistry at the University of
London (B.Sc, 1969;Ph.D.,
1972), Columbia University
(postdoctoral research) and
Harvard University (postdoc-
(postdoctoral
research). Between 1976
and 1989 he was a faculty
member at the University of
Pennsylvania. He currently
holds joint appointments at The
Scripps Research Institute,
where he is the Darlene Shiley
Professor of Chemistry and
Chairman of the Department of
Chemistry, and at the Univer-
of
University California, San Diego,
where he is Professorof Chem-
K. B. Sharpless)
20. Asteltoxiri (S.L. Schreiber) A983)
21. Periplanone \320\222 (S.L Schreiber) A984)
22. Menthol (Takasago) A984)
23. Hirsutene and A9A2)-Capnellene (D. P. Curran) A986)
24. Amphoteronolide and
\320\222 \320\241
(\320\232. Nicolaou) A987)
\320\222
Amphotericin
25. Ginkgolide \320\222 (E. J. Corey) A988)
26. Methyl Homosecodaphniphyllate \320\235.
(\320\241. Heathcock) A988)
27. Indolizomycin (S. J. Danishefsky) A990)
28. Cytovaricin (D. A. Evans) A990)
Chapter 1
Chapter 2
Strychnine
R. B. Woodward A954)
2.1 Introduction 21
2.2 Retrosynthetic Analysis and Strategy 22
2.3 Total Synthesis 27
2.4 Conclusion 40
Chapter 3
Penicillin V
J. C. Sheehan A957)
3.1 Introduction 41
3.2 Retrosynthetic Analysis and Strategy 44
3.3 Total Synthesis 45
3.4 Conclusion 50
XIV Table of Contents
Chapter 4
Reserpine
R.B. Woodward A958)
4.1 . Introduction 55
\"
4.2 Retrosynthetic Analysis and Strategy 56
4.3 Total Synthesis 57
4.4 Conclusion 63
Chapter 5
5.1 Introduction 65
5.2 Retrosynthetic Analysis and Strategy -. 67
5.3 Total Synthesis 71
5.4 Conclusion 81
Chapter 6
Progesterone
W. S. Johnson A971)
6.1 Introduction 83
6.2 Retrosynthetic Analysis and Strategy 85
6.3 Total Synthesis 88
6.4 Conclusion 92
Chapter 7
Carpanone
O.L Chapman A971)
7.1 Introduction 95
Chapter 8
Vitamin En
R.B. Woodward and A. Eschenmoser A973)
8.1 Introduction 99
8.2 Retrosynthetic Analysis and Strategy 100
8.3 Total Synthesis 105
8.3.1 The Woodward Synthesis of Cyanobromide 6 105
8.3.2 TheEschenmoserSynthesis of \320\222-Ring Intermediate 8 . 113
8.3.3 The Woodward Synthesis of C-Ring Intermediate 9 ... 115
8.3.4 The EschenmoserSynthesis of C-Ring Intermediate 9 . 115
8.3.5 The Eschenmoser Synthesis of Thiodextrolin G) 117
8.3.6 The Woodward-Eschenmoser Macrocyclization
Strategy 121
8.3.7 The EschenmoserSynthesis of A-Ring Intermediate 24
and D-Ring Intermediate25 123
8.3.8 The Eschenmoser Cyclization Strategy 126
8.3.9 Completion of the Woodward-Eschenmoser Total
Synthesis of Cobyric Acid and Vitamin Bi2 . 130
\342\200\242
8.4 Conclusion 134
Chapter 9
Prostaglandin A2 (PGA2)
and Prostaglandin F2a (PGF2a)
G. Stork A976, 1978)
Chapter 10
Estrone
\320\240.
\320\232. Vollhardt
\320\241 A977)
Chapter 11
Erythronolide \320\222
Chapter 12
Monensin
Y. Kishi A979)
Chapter 13
\320\222
Periplanone
W. C. Still A979)
Chapter 14
Isocomene
M. C. Pirrung A979)
Chapter 15
Monensin
W. C. Still A980)
Chapter 16
Thienamycin
Merck A980)
Chapter 17
Chapter 18
Biotin
Hoffmann-La Roche A982)
Chapter 19
L-Hexoses
S. and
Masamune \320\232.
\320\222.
Sharpless A983)
Chapter 20
Asteltoxin
S. L SchreiberA983)
Chapter 21
Periplanone \320\222
S. L. Schreiber A984)
Chapter 22
Menthol
Takasago A984)
Chapter 23
Hirsutene and
A9A2)-Capnellene
D.P. CurranA986)
Chapter 24
Amphoteronolide and
\320\222
\320\222
Amphotericin
\320\232. Nicolaou
\320\241. A987)
Chapter 25
Ginkgolide \320\222
Chapter 26
Methyl
Homosecodaphniphyllate
\320\241. Heathcock
\320\235. A988)
Chapter 27
Indolizomycin
S. J. Danishefsky A990)
Chapter 28
Cytovaricin
D.A. EvansA990)
Chapter 29
Gilvocarcin M and
Gilvocarcin V
Chapter 30
Calicheamicin y]
\320\232. Nicolaou
\320\241 A992)
Chapter 31
Rapamycin
\320\232. Nicolaou
\320\241 A993)
Chapter 32
Paeoniflorigenin and
Paeoniflorin
E.J. Corey A993)
Chapter 33
Strychnine
L E. Overman A993)
Chapter 34
Taxol
\320\232. Nicolaou
\320\241 A994)
Chapter 35
Zaragozic Acid A/
Squalestatin SI
\320\232. Nicolaou
\320\241 A994)
Chapter 36
Palytoxin
Y. Kishi A994)
Chapter 37
Brevetoxin \320\222
\320\232. Nicolaou
\320\241. A995)
\321\201
Oxepane Systems 737
37.2 Retrosynthetic Analysis and Strategy 748
37.2.1 The Triply Convergent Approach:
The First-Generation Strategy
750
particular, and to the other sciences in general, lies not only in its
ORGANIC SYNTHESIS
Target Oriented
Methods Oriented
(Total Synthesis)
Me
\320\236 \320\276
I
x
Me\"'^OH
Me Me
N...
camphor tropinone
(Fischer, 1929)
Me,?
MeO.
HO
\342\200\242HCI
Figure 2. Selected landmark total syntheses of natural products from 1828 to 1944.
6 1 Introduction: Constructing the Moleculesof Nature
1955 Vincent du Vigneaud work on biochemically important sulfur compounds, especially for
the first synthesis of a polypeptide hormone
1963 Karl Ziegler and Giulio Natta discoveries in the field of the chemistry and technology of high
polymers
1965 Robert Burns Woodward achievements in the art of organic synthesis
1968 H. Gobind Khorana (medicine) interpretations of the genetic code and its function in protein
synthesis
1969 Derek H.R. Barton and development of the concept of conformation and its application
Odd Hassel in chemistry
1975 Vladimir Prelog and (V P.) stereochemistry of organic molecules and reactions,
John W. Cornforth (J. C.) stereochemistry of enzyme-catalyzed reactions
1979 Herbert Brown
\320\241 and development of boron (H. \320\241. and
\320\222.) phosphorus (G. W.) com-
Georg Wittig compounds into important reagents in organic synthesis
1981 Roald Hoffmann and development of theories concerning the course of chemical
Kenichi Fukui reactions
It
was, however, after World War II that
organic synthesis and
the total synthesis of natural products, in particular, flourished, and
many impressive achievements were recordedin rapid succession.
With the arrival of R. B. Woodward and his foresight, complex
structures fell one after another, total synthesis progressed enorm-
enormously, and the discipline enjoyed unparalleled respect among the
strategies and methods and new chemical entities. In other words, the
target molecule defines to a large extent the research program that
lies ahead and the opportunities to be encountered and exploited.
Depending on the setting and
specific goals of the synthetic
chemist,different criteria are used for selecting target molecules.
Thus, in academically oriented laboratories where the quest for
basic science,competitiveness in the pursuit of excellence, and
peer recognition are of primary concern, the target molecules are
often selected for their potential to offer opportunities for the
development of new synthetic technologies and strategies, to
explore and probe biologicalquestions, and to deliver interesting
and impressive substances. In industrial laboratories, on the other
hand, where emphasis is on commercial exploitation, the target
molecules are selected for their potential to lead to practical and
profitable applications.Synthetic targets are usually either natural
S. J. Danishefsky products or designed molecules.
1.6 Natural Products as Synthetic Targets
B.M. Trost
1.6 Natural Products as Synthetic Targets 11
H2N
NH,
I HO f
Me
H^SJ
OH MeO
VOH
calicheamicinYi'A992)
vitamin B12 A973)
OH
,\320\276\320\275
\320\276\320\275
\320\276\320\275
palytoxin A994)
OH
cytovaricin A990)
CHO
I \320\220<\320\256
\320\276
Ptv^NH \320\276
H H Me
OBz OAC y
Taxol\342\204\242
A994) brevetoxin \320\222
A995)
The heart and the beauty of chemistry lies in its creative nature. On
the basis of simple structural principles, the organic chemist is free
to imagine and design unlimited numbers of new moleculesnever
seen before either or in the laboratory. This molecular
in nature
design process guided is by the particular interests of the
often
chemist and can be aided by computer or manual molecular model-
modelingstudies. Depending on the area, the designed moleculescan be
of theoretical,physical, materials science, or biological interest.
J.-M. Lehn These designedmolecules
then become for the
potential targets
synthetic chemist, and although some may look deceptively simple,
they regularly present formidable challenges. Examples of designed
moleculesof theoretical interest (which may eventually attract a
more practical interest depending on their properties) that have
been synthesized in the laboratory are: tetrahedrane, prismane,
cubane, dodecahedrane,[18]-annulene, heptahelicene, and various
other 'aesthetically pleasing molecular constructs. Undoubtedly,
however, the most fertile area of molecular design for the organic
chemist is that of biologically interesting molecules. The fascina-
fascinationof
biological action and of how living systems work, coupled
with the potential for biomedical breakthroughs has prompted an
avalanche of molecular designin academia and in the pharmaceuti-
1.8 SyntheticStrategy 13
connectivities, this
question presents a challengerequiring logical
analysis and intellectual input of the highest order. In the early
days
of the science, when relatively simple targets were considered,the
chemist would try to connect potential starting materials with the
target molecule by known reactions. The starting materials were
often closelyrelated to the final products. As the target molecules
became more complex,this process became impractical. Higher
levels of intellectual planning and skill in execution were
demanded. Synthetic chemists rose to the challenge by devising a
new armory of methods and novel strategies. As the field of total
synthesis developed and its intellectual demands were recognized,
the science was received with much excitement and euphoria. The
contributions of R.B. Woodward and the developments in the elec-
electronic theory and mechanisms of organic reactions, conformational
analysis, analytical and chromatographic techniques, crystallo-
graphic and spectroscopic methods, and new synthetic technology
that took place after World War II greatly facilitated this outburst of
14 1 Introduction: Constructingthe Molecules
of Nature
with formidable targets falling one after the other, and each new
., accomplishment pushing the envelope further and further in terms
of complexity and efficiency. syntheses Landmark such as strych-
strychnine (Woodward, reserpine (Woodward, 1956),26 penicillin V
1954),25
(Sheehan, 1957),27 colchicine (Eschenmoser, 1959),28 and chloro-
chlorophyll (Woodward, I960J9 are monuments to the ingenuity and
characterof the chemists of this era. Thinking about synthetic strat-
in
chemistry 1990. become routine to think about a tar-
Nowadays, it has
target molecule
of its retrosynthetic analysis. Furthermore, it
in terms
is hard to imagine how chemists developed synthetic strategies
Ithaca
One of the most difficult tasks we facedin writing this book was the
selection of what we considered to be \"classics\" in the art of total
synthesis, particularly under the pressure of space and time. With so
much wealth and so many brilliant accomplishments it was hard to
come to the inevitable close.We sincerely apologize to those whose
elegant work could not be included owing to the limitations of this
undertaking; and we can offer the hope, that in the event of a second
offered, which are not found in the original papers and are, there-
therefore, speculations on our part. These are solely our responsibility,
and we apologize in advance to the original authors for any misin-
misinterpretations of their results.
We will now begin our journey in total synthesis from the 1950s
to the 1990s. As you read through hope your jour-
these pages we
journey to \"Ithaca\" will be as adventurous, educational, and enjoyable
as was our odyssey of putting together this book on \"Classics in
Total Synthesis\".
This forty-year exposition of the state of the art should serve to
put total synthesis in perspective as the 20th century draws to a
close.
References
1. Sarton, G. In Ancient Science Through the Golden 13.Harris, S.A.; Stiller, E.T.; Folkers, K. J. Am. Chem.
Age of Greece, Dover Publications: New York, 1980, Soc. 1939, 61, 1242; Harris, S.A.; Folkers, K. ibid.
p. 253. 1939, 61, 1245;Harris, S.A.; Folkers, K. ibid. 1939,
2. Corey, Cheng, X.-M. The Logic of Chemical
E.J.; 61, 3307.
Synthesis, John Wiley & Sons: New York, 1989. 14.(a) Woodward, R.B.; Doering, W.E. J. Am. Chem.
3. Woodward, R. B. In Perspectives in Organic Chem- Soc. 1944, 66, 849; (b) Woodward, R.B.; Doering,
Chemistry,Todd, A. R., Ed., Interscience:New York, 1956, W. E. ibid. 1945, 67, 860.
pp. 155-184. 15. See brochure of Nobel Committees for Physics and
4. Corey, E. J. Pure & Appl. Chem. 1967, 14, 19. Chemistry,The Royal Swedish Academy of Sciences,
5. Wohler, Phys. Chem. 1828, 12, 253.
F. Ann. List of the Nobel Prize Laureates 1901-1994, Alm-
6. Kolbe, Chem. Pharm. 1845, 54, 145.
H. Ann. quist & Wiksell Tryckeri: Uppsala, Sweden, 1995.
7. Fischer, E. Ber. Dtsch. Chem. Ges. 1890,23, 799. 16. Danishefsky, S. J. Aldrichimica Ada 1986, 19, 59.
8. (a) Perkin, W. H. J. Chem. Soc. 1904,654; (b) See 17. Woodward, R. B. In Perspectives in Organic Chem-
also, Fleming, I. Selected OrganicSyntheses, John Chemistry,Todd, A.R., Ed., Interscience: New York, 1956,
Wiley & Sons: New York, 1973. p. 155.
9. See, Thomas, A.F, In The Total Synthesis of Natural 18. Corey, E.J. In Bindra, J. S.; Bindra, R. Creativity in
Products, ApSimon, J.. Ed., John Wiley & Sons: Organic Synthesis, Academic Press: San Francisco,
New York, 1973, Vol. 2, pp. 149-154. 1975, Vol. 1, vii.
10. Robinson, R. J. Chem. Soc. 1917, 762. 19. Eschenmoser,A.; Wintner, C.E. Science (Washing-
11.(a) Fischer, H.; Kirstahlcr, A. Justus Liebigs Ann. D.C.)
(Washington, 196, 1410.
1977,
Chem. 1928, 466, 178;(b) Fischer, H.; Zeile, K. ibid. 20. Barton, D.H.R. Chem. Br. 1973, 9, 149.
1929, 468, 98. 21. Sharpless, Proc.
\320\222.
\320\232. Robert A. Welch Foundation
12.Bachmann, W.E.; Cole, W.; Wilds, A.L. J. Am. Conf. Chem. Res. 1983, 27, 59.
Chem. Soc. 1939, 61, 974. 22. Trost, B.M.Science(Washington, D.C.) 1985, 227,
908.
References 19
23. Lehn, J.-M. Angew. Chem. Int. Ed. Engl. 1990, 29, 28. Schreiber, J.; Leimgruber, W,; Pesaro, M.; Schudel,
1304; Lehn, J.-M. Supramolecular Chemistry, VCH: P.; Threlfall, Eschenmoser,
\320\242.; A. Helv. Chim. Acta
Weinheim, 1995. 1961, 44, 540.
24. Nicolaou, K.C.; Xiao, X.-Y.; Parandoosh, Z.; Senyei, 29. (a) Woodward, R.B. Pure & Appl. Chem. 1961, 2,
A.; Nova, M.P. Angew. Chem. Int. Ed. Engl. 1995, 383; (b) Woodward, R.B.; Ayer, W.A.; Beaton, J.M.;
34, 2289 and references cited therein. Bickelhaupt, F; Bonnett, R.; Buchschacher, P.; Closs,
25. (a) Woodward, R.B.; Cava, M.P.; Ollis, W.D.; Hun- G.L.;Dutler, H.; Hannah, J.; Hauck, F.P.; Ito, S.;
Hunger, A.; Daeniker, H.U.; Schenker, K. J. Am. Chem. Langemann, A.; LeGoff, E.; Leimgruber, W.;
Soc. 1954, 76, 4749; (b) Woodward, R.B.; Cava, Lwowski, W.; Sauer, J.; Valenta, Z.; Volz, H. / Am.
M.P; Ollis, W.D.; Hunger, A.; Daeniker, H.U.; Chem. Soc. 1960, 82, 3800; (c) Woodward, R.B.;
Schenker, K. Tetrahedron 1963, 19, 247. Aycr, J.M.; Bickelhaupt,
W. A.; Beaton, F.; Bonnet,
26. (a) Woodward, R.B.; Bader, F.E.; Bickel, H.; Frey, R.; Buchschacher, P.; Le Goff, E.; Leimgruber, W.;
A.J.; Kierstead, R.W. / Am. Chem. Soc. 1956, 78, Lwowski, W.; Sauer, J.; Valenta, Z.; Volz, H.
2023, 2657; (b) Woodward, R.B.; Bader, RE.; Tetrahedron 1990, 46, 7599.
Bickel, H.; Frey, A.J.; Kierstead, R.W. Tetrahedron 30. Reference 2, p. 6.
1958,2, 1. 31.Woodward, R.B. Proc. Robert A.Welch Foundation
27. Sheehan, J.C.; Henery-Logan, K.R. J. Am. Chem. Conf. Chem. Res. 1969, 12, 3.
Soc. 1957, 79, 1262; (b) Sheehan, J.C.; Henery- 32.Cavafy, \320\241. In The Complete
\320\240. Poems of Cavafy,
Logan, K.R. ibid. 1959, 81, 3089. Translated by Rae Dalven, Harcourt, Brace & World:
New York, 1961,p. 36.
2
R.B.WoodwardA954)
Strychnine
2.1 Introduction
C-12- \320\236
cleavage
Conjugate addition
1: strychnine
allylic
rearrangement
\320\275\320\276
HO-
3: isostrychnine I
Lactam
formation
\320\275 \320\276
Organometallic
addition
6: dehydrostrychninone
c/s-glyoxal7
NAc
CO2H
\321\214 Dieckmann
NAc condensation
H
C-16 epimerization
CO2Me
11
NSO2Ar
13a
Lactam
Ar = C6H4-p-Me
formation
OMe
\320\272\320\263\320\276\320\274\320\265
16
C-C bond
formation
OMe
sOMe
18b
Ar = C6H4-p-Me
\320\236
x
\320\225\320\232\320\223\320\245\320\235\320\236
Imine formation 21: ethyl glyoxylate
OMe
20: 2-veratryltryptamine
C-C bond
formation
OMe
OMe
23: 2-veratrylindole
Fischer indole
synthesis
OMe
NHNH2
bond.
The recognition array of atoms in 16 (see num-
that the reactive
numbered atoms) from a very stable, substituted aromatic
could evolve
ring demonstrates great insight. It was anticipated that oxidative
stage, in a manner that will permit the elaboration of rings III, IV,
and VI of strychnine. 2-Veratrylindole B3) thus provides a logical
starting point for the synthesis and it could be prepared from simple
building blocks (intermediates 24 and 25) through a Fischer indole
synthesis.9
polyphosphoric
OMe id
NHNH2
OMe
Fischer indole
OMe
synthesis
24: phenylhydrazine 25: acetoveratrone OMe
OMe
OMe
OMe
23: 2-veratrylindole
CH2O, Me2NH,
H2O-dioxane, (92%)
AcOH
1. Mel NMe2
OMe
2. NaCN, DMF
OMe
(97% overall)
22
\320\236
x
EtO'^
21: ethyl glyoxylate
OMe
PhH (92%)
\"\342\200\242OMe \320\276\320\274\320\265
20: 19
2-veratryltryptamine
2. Ac2O, pyr.
13a
v NSO2Ar
at C-16 H
epimerization
'CO2Et
CO2Me
13a Ar = C6H4-p-Me 13b
NSO2Ar
\320\224
G2%)
CO2Me CO2H
13a 27
1. AC2O,pyr.
2. CH2N2, MeOH
NaOMe,
MeOH, A
OMe
0O
CO2Me CO2Me
11 12
NaOMe (88%)
NAc
CO2Me
CO2Me
OTs
p-TsCI, pyr.
NaSCH2Ph,
MeOH, 25 \320\241
G7%)
Raney Ni,
\320\233
\320\225\320\256\320\235,
(84%)
H2, Pd-C
CO2Me G3%) CO2Me
c/s-31
KOH,
H2O-MeOH,
reflux (87%)
CH2N2,
''CO2Me
21 Et2O
frans-31
With the C-16 nitrogen atom (Nb) and a carboxylgroup four car-
carbon atoms removed, intermediate 9 would appear to be well suited
for the elaboration of ring VI of strychnine. The constructionof
ring VI would require inversion of the stereogenic center at C-14
and installation of a methylene bridge between Nb and C-21. Treat-
Treatment of iV-acetyl acid 9 with acetic anhydride and pyridine at reflux
provides enol acetate 35 in 42 % yield (see Scheme 6). This inter-
interesting transformation undoubtedly involves the initial formation of
mixed anhydride 32. Flanked by the electron-withdrawing pyridone
ring and the C-21 carbonyl group, the C14-H bond is labile and,
Ac2O, pyr.,
reflux D2%)
-CO2
OAc
CHO
\320\276\320\275
c/s-glyoxal 7 frans-glyoxal 36
cyclization
oxidation
37 6: dehydrostrychninone
3: Isoetrychnine I
1: (-)-strychnine
Lindlar
catalyst
(86%)
6: dehydrostrychninone 38
path to strychnine from this substance had already been laid down
in 1948.10
In order to achieve the goal of synthesizing isostrychnine I C)
6: dehydrostrychninone from dehydrostrychninone F), the C-20 lactam carbonyl and the
aromatic a-pyridone ring must both be reduced, and the C-21
ketone must be homologated (seeScheme 8b). With respect to the
latter objective, it was found that treatment of a solution of 6 in
LiAIH4
XO
UAIH4,
Et2O, A
HO
C0%)
39
1. HBr, AcOH,
120\302\260C A3%
2. H2SO4, H2O, overall)
KOH,EtOH
3: Isostrychnine I
complete.
40 2 Strychnine
2.4 Conclusion
References
1. (a) Pelletier, P.J.; Caventou, J.B. Ann. Chim. Phys. 7. Since the report of the first total synthesis of strych-
1818, 8, 323; (b) ibid. 1819,10, 142. strychnine by Woodward et al. in 1954, the following
2. (a) Briggs, L.H.; Openshaw, H.T.; Robinson, R. syntheses have been disclosed:(a) Magnus, P.; Giles,
J. Chem. Soc. 1946, 903; (b) Robinson, R. Ex- M.; Bonnert, R.; Kim, C.S.; McQuire, L.; Merritt,
perientia 1946, 2, 28; (c) For a comprehensive survey, A.; Vicker, N. J. Am. Chem. Soc. 1992, 114, 4403;
see: Smith, G.F. Alkaloids (Academic Press) 1965, 8 (b) Stork, G. Disclosed at the Ischia Advanced
591. School of Organic Chemistry, Ischia Porto, Italy, Sep-
3. (a) Bokhoven, C; Schoone, J.C.; Bijvoet, J.M. September 12, 1992; (c) Kuehne, M.E.; Xu, F. Abstracts
Proc.K.Ned. Akad. Wet. 1948, 51, 990; (b) ibid. of Papers, 205th National Meeting of the American
1949, 52, 120;(c) Ada Crystallogr. 1951, 4, 275; Chemical Society, Denver, CO, March 28 - April 2,
(d) Robertson, J.H.; Beevers, A. Nature
\320\241 (London) 1993; American Chemical Society: Washington, DC,
1950, 165, 690;(e)Acta Crystallogr. 1951, 4, 270. 1993, ORGN 187; (d) Knight, S.D.; Overman, L.E.;
4. Peerdeman, A. F. Acta Crystallogr. 1956, 9, 824. Pairaudeau, G. J. Am. Chem. Soc. 1993, 115, 9293;
5. Robinson, Prog. Org. Chem. 1952, 1,
R. 2. (e) Kuehne, M.E.; Xu, F. J. Org. Chem. 1993,58,
6. (a) Woodward, R.B.; Cava, MR; Ollis, W.D.; Hun- 7490; (f) Rawal, V.H.; Iwasa, S.; J. Org. Chem.
Hunger, A.; Daeniker, H.U.; Schenker, K. J. Am. Chem. 1994, 59, 2685; see also, (g) Beifuss, U. Angew.
Soc. 1954, 76, 4749; (b) Woodward, R.B.; Cava, Chem. Int. Ed. Eng. 1994, 33, 1144.
M.P.; Ollis, W.D.; Hunger, A.; Daeniker, H.U.; 8. Schaefer, J. P; Bloomfield, J.J. Org. React. (N.Y.)
Schenker, K. Tetrahedron 1963, 19, 247. 1967,/5, 1.
9. Robinson, B. Chem. Rev. 1969, 69, 227.
10.Prelog, V.; Battegay, J.; Taylor, W.I. Helv. Chim.
Acta 1948, 31, 2244.
11.Woodward, R.B. Nature (London) 1948, 162, 155.
1: penicillin V
/. \320\241.Sheehan
A957)
Penicillin V
3.1 Introduction
The fascinating history of antibiotics began in the late
the /Mactam
1920s with Sir Alexander discovery of a sub-
Fleming's historic
substance capable of destroying pathogenic bacteria. This substanceis
produced in nature by the mold Penicillium notatum and it was
aptly named penicillin.1 Approximately ten years after Fleming's
discovery, Chain, Florey and coworkers reported that penicillin
\320\233? V
to the acyl grouping attached to the nitrogen atom that is a to the
lactam carbonyl. Thus, unless we refer to a particular member of
the penicillin family, the word \"penicillin\" actually includes each
member.
CO2H Before Professor Crowfoot-Hodgkin's major contribution in
penicillin G 1945, few chemists had faith in the proposal that
penicillin's
structure is distinguishedby a /?-lactam ring even though consider-
considerableevidence had been during the Anglo-American
accumulated
penicillinproject that was consistent with the /Mactam structure.
Of courseit is now well known that the /Mactam moiety is respon-
responsible for penicillin's chemical lability and biological activity.
Destruction of penicillin's /2-lactam ring, a feat that can be easily
achieved, deprives penicillin of its potent antibacterialproperties.
By virtue of penicillin's marked lability, and given the limitations
of organicsynthesis methodology in the 1940s, it is certainly not
surprising that successes in its synthesis were few and far between.
do
a^N'
\"b
all, consistent
the failures of traditional lactamization strategies
were well documented during the wartime penicillin project.Suf-
Suffice it to say, a new and mild lactamization method would have to
be developed before the attractive and direct conversion of 5 to 1
couldbe achieved;the lactamization protocols available at the out-
outset of Sheehan's penicillin studies were simply too harsh for this
objective.
\320\275\320\275
PhO
\320\275\320\2762\321\201
Lactamization
CO2H CO2H
1: penicillin V
Ring
formation
CHO
\"CO2H
Me Me Me
CO2H \321\201\320\276\320\263\320\275
\320\220\320\2412\302\260;
Me Me
60 \302\260\320\241
G2-80% yield)
NH2 \302\260
G5% yield)
9: (+)-vaiine 10 Cl
Me O0
Me
Me
C|
J -Cl -Cl
Me Me Me
isomerizatlon H2S, NaOMe,
S\302\273
MeOH
4 Me G5% yield)
\320\272
Me
11
Michael
addition
\302\251OMe
Meo
Me
,\"\320\247/\"'
T-.. Me
HS
COjMe
Me
12
A00% I 1. HCI, H2O, reflux
overall) I 2. (CH3JCO
Me Me 1. brucine Me
e s / HCO2H, Me 2. resolution Mev s
' \"\"\"Me -Me \"Me
X 3. cone.HCI, Me'
COaH
CHO CHO
13: isopropylldene-DL- 14: Af-formyl isopropylidene-
15
penlclllamine DL-peniclllamlne Me
HS. 2 N HCI
Me
(99% yield)
HCI-H2N *'CO2H
7: D-peniclllamlne
hydrochloride
1. f-BuONa
CHO
2. tBuOCHO
Me
Me
\321\201\320\275\320\276
HCI\302\253H2N \"CO2H
NaOAc,
H2O
\320\225\320\256\320\235,
H H H H
Sv Me
CO2H CO2H
D-a-6
H H \302\273
N
HCI-H2N^f
PhOCH2COCI,
*-
f-BuO2C HN / \"Me
Et3N G0% yield) f-BuO2C \"Me
CO2H CO2H
D-a-18 19
1. HCI, CH2CI2,0 \302\260C
OPh
2. pyr., (CH3JCO, H2O
H H
OPh
VH 1.
H H
KOHAequiv.)
\"Me
2. VH
V-N=C=N\342\200\224/ \"Me
CO2K
^ J
\302\251H^ D equiv.), dioxane, CO2H
20 H2O, 25 \302\260C
A0-12% yield)
1955, the facility with which the amino group of one amino acid
derivative can be coupledwith the free carboxyl group of another
using DCC as a dehydrating agent. The overall process involving
initial in situ activation of a carboxyl group with DCC followed by
subsequent reaction with an amine to give an amide can be con-
conducted under very mild conditions (i.e. room temperature, neutral
pH) and, usually, in excellent yield.19 For these reasons,it was
anticipated that DCC might permit the construction of the reactive
/Mactam ring of the penicillin V molecule. In the event, addition of
four equivalents of DCC to a dilute solution of the monopotassium
salt of 5 in dioxane-water at 25 \302\260Cresults in the formation of peni-
penicillin V potassium salt in 10-12% yield. Although the mechanism
for this step could conceivablyinvolve the intramolecular attack of
the thiazolidine nitrogen atom upon a symmetrical anhydride, the
proximity of the reacting groups and more recent mechanistic stud-
studies20 favor the intramolecular addition of the thiazolidine nitrogen
to the activated carbonyl of an O-acylisourea (see intermediate 20,
Scheme 5). In spite of the low yield for the crucial lactamization
50 3 Penicillin
3.4 Conclusion
a
\320\235 \320\235
OPh
H H
S 1. KOHAequiv.) PhO
\320\274\320\265
\320\234\320\265
\320\276
\320\241\320\2362\320\235
22
\320\275\320\275 H H
f
j
Ph3CCI,
\320\235\320\2362\320\241
HN^/ \"Me Et2NH
CO2Bn CO2Bn
23 24
Me ; Me
\\\342\200\224
N=C=N\342\200\224/ F7% yield)
Me' Me ,
H H H H
1
1. H2, Pd
(
Me 2. HCI, H2O -N^y \"Me
CO2H \320\241\320\2362\320\222\320\277
26: 6-aminopenicillanic 25
acid
References
1. Fleming, A. Brit.J. Exp. Path. 1929, 10, 226. 7. Bachmann, W. E.; Cronyn, M. W. In The Chemistry
2. Chain, E.; Florey, H. W.; Gardner, A.D.; Heatley, of Penicillin, Clarke, H.T.;Johnson, J.R.; Robinson,
N. G.; Jennings, M. A.; Orr-Ewing, J.; Sanders, A. G. R., Eds., Princeton University Press: Princeton, New
Lancet 1940, 239, 226. Jersey, 1949,Ch. 22, p. 861.
3. Sheehan, J. \320\241
The Enchanted Ring: The Untold Story 8. (a) Johnson, J. R.; Woodward, R. \320\222.;Robinson, R. in
of Penicillin, The MIT Press: Cambridge, The Chemistry of Penicillin, Clarke, H.T.; Johnson,
Massachusetts, 1982. J.R.; Robinson, R., Eds., Princeton University Press:
4. (a) For a detailed account of the British-American Princeton, New Jersey, 1949, Ch. 15, p. 443-449;
penicillin project, see: The Chemistry of Penicillin, (b) Woodward, R.B. Special Publication No. 28, the
Clarke, H.T.; Johnson, J. R.; Robinson, R., Eds., Prin- Chemical Society, London, 1977, Ch. 18, p. 167; (c)
Princeton University Press: Princeton, New Jersey, 1949; Woodward, R.B. Science 1966, /53, 487.
(b) For a review, see: Cook, A. H. Quart. Rev. 1948, 9. (a) Sheehan, J.C.; Henery-Logan, K.R. / Am.
2, 203. Chem. Soc. 1957, 79, 1262; (b) Sheehan, J.C.; Hen-
5. During the course of the prodigious wartime effort to Henery-Logan, K.R. ibid. 1959, 81, 3089.
synthesize penicillin, a Merck group succeeded in 10. For summaries of Sheehan's penicillin synthesis and
synthesizing minute quantities of penicillin G, see: (a) related work, see: (a) Fleming, I. Selected Organic
Folkers, K. In Perspectives in Organic Chemistry, Syntheses: A Guidebook for Organic Chemists,
Todd, A., Ed., IntersciencePublishers: New York, John Wiley & Sons: New York, 1973, p. 80; (b)
N.Y., 1956, p. 409; (b) duVigneaud, V.; Carpenter, Johnson, F. In The Total Synthesis of Natural Prod-
F.H.; Holley, R. W.; Livermore, A.H.; Rachele, J.R. Products, Vol. 1, ApSimon, J., Ed., Wiley-Interscience:
Science 1946, 104, 431; (c) duVigneaud, V.; Wood, New York, 1973, p. 331; (c) Holden, K.G. In Chem-
J. L.; Wright, M. E. In The Chemistry of Penicillin, Chemistry and Biology of fi-Lactam Antibiotics, Morin,
Clarke, H.T.; Johnson, J.R.; Robinson, R., Eds., Prin- R. \320\222.;
Gorman, M., Eds., Academic Press: New York,
Princeton University Press: Princeton, New Jersey, 1949, 1982, Ch. 2, p. 99.
Ch. 23, p. 893-894. 11.Sheehan, J. \320\241The Enchanted Ring: The Untold
6. Crowfoot, D.; Bunn, C.W.; Rogers-Low, B.W.; Story of Penicillin, The MIT Press: Cambridge,
Turner-Jones, A. In The Chemistry of Penicillin, Massachusetts, 1982, p. 7.
Clarke, H. \320\242.;
Johnson, J.R.; Robinson, R., Eds., Prin- 12. Woodward, R.B. In Perspectives in Organic Chem-
Princeton University Press: Princeton, New Jersey, 1949, Chemistry, Todd, A., Ed., Interscience Publishers: New
Ch. 11, p. 310. York, 1956, p. 160.
References 53
13. (a) Sheehan, J.C.; Izzo, P.T. J. Am. Chem. Soc. 17. Sheehan, J.C.; Corey, E.J. J. Am. Chem. Soc. 1952,
1948, 70, 1985; (b) Sheehan, J.C.; Izzo, P.T. ibid. 74, 4555.
1949, 71, 4059; (c) Sheehan, 1\320\241; Bose, A.K. ibid. 18. (a) J.C.;
Sheehan, Hess, G.P. J. Am. Chem. Soc.
1950, 72, 5158; (d) Sheehan, J.C.; Buhle, E.L.; 77, 1067; (b) Sheehan, J.C.; Goodman,
1955, M.;
Corey, E.J.; Laubach, G.D.; Ryan, J.J. ibid. 1950, Hess, G.P. ibid. 1956, 78, 1367.
72, 3828; (e) Sheehan, J.C.; Laubach, G.D.; ibid. 19.(a) Khorana, H.G. Chem. Rev. 1953, 53, 145;(b)
1951, 73, 4376; (f) Sheehan, J.C.; Hoff, D. R. \320\263\320\250. Khorana, H.G. Chem. Ind. (London) 1955,1087;(c)
1957, 79, 237; (g) Sheehan, J.C.; Corey, E.J. ibid. Albertson, N.F.; Org. React. (N.Y.) 1962, 12, 157;
1951,73, 4756. (d) Kurzer, F.; Douraghi-Zadeh, K. Chem. Rev. 1967,
14. (a) Leach, B.E.; Hunter, J.H. Biochem. Preps. 1953, 67, 107; (e) Klausner, Y. S.; Bodansky, M. Synthesis
J, 111;(b) Crooks,H.M.,Jr., In The Chemistry of 1972, 453.
Penicillin, Clarke, H. \320\242.; Johnson, J.R.; Robinson, 20. (a) Rebek, J.; Feitler, D. J. Am. Chem. Soc. 1973,95,
R., Eds., Princeton University Press: Princeton, New 4052;(b) Rebek, J.; Feitler, D. ibid. 1974, 96, 1606.
Jersey, 1949,Ch. 16,455. 21. Bachmann, W. E.; Cronyn, M.W. In The Chemistry
15.Sheehan, J. C; Johnson, D. A. /. Am. Chem. Soc. of Penicillin, Clarke, H.T.;Johnson, J. R.;Robinson,
1954, 76, 158. R., Eds., Princeton University Press: Princeton, New
16. Sheehan, J.C.; Laubach, G.D. / Am. Chem. Soc. Jersey, 1949,Ch. 22, p. 851.
1951, 73, 4752. 22. Sheehan, J. C; Henery-Logan, K. R. /. Am. Chem.
Soc. 1962,54,2983.
MeO
\320\236\320\234\320\265
1: reserpine R. \320\222.Woodward
A958)
Reserpine
4.1 Introduction
Lactamization /mine
formation
A
Meo\342\200\224<C
\321\211
C-Cbond |H %.....
formation H |? MeO2C ,.T c
OAc
OMe MeOjC^Y'^OAc
OMe
1: reserpine
Diels-Alder
MeO2C\"^ >
+ k<^
OAc MeO
\320\234\320\265\320\2362\320\241\320\223:
Yi: \320\237
= H
MeO2C OMe
CO2Me
7: p-benzo- 8 4: 6-methoxytryptamine
quinone
\302\260
CO2Me
7: p-benzo- 8
quinone
i T = OH
\320\235\320\236\320\263\320\241\320\223
H i H
^*> 1. CH2N2
2. Ac2O
MeO
1. PhH (Schlff base
formation, see 3,
Scheme1)
MeO
^ OAc 2. NaBH4, MeOH
: \320\277
OMe
OAc
4: 6-methoxytryptamine
MeO MeO
20: (\302\261)-methyl-O-acetyl-
isoreserpate
and it adopts the familiar chair conformation wherein four of its five
substituents can be orientedequatorially (see Scheme 3). The asym-
asymmetric carbon atom next to the aldehyde carbonyl in 5 is thus config-
urationally stable.
When a solution intermediate
of 5 in benzene is treated with
rings and all six stereocenters. With the exception of the 3,4,5-tri-
methoxybenzoate grouping, 20 differs from reserpine A) in one
very important respect: the orientation of the ring methine
\320\241 hydro-
hydrogen at C-3 in 20 with respect to the molecular plane is oppositeto
that found in reserpine. Intermediate 20 is a reserpatestereoisomer,
MeO2C
epimeric position
a t 3, and its identity was secured by comparison OMe
of its infrared spectrum with that of a sample of (-)-methyl-O- 20: (\302\261)-methyl-O-acetyl-
acetyl-isoreserpate, a derivative of reserpine itself.9 Intermediate 20 isoreserpate
is produced by the addition of hydride to the more accessiblecon-
convex face of 19, and it rests comfortably in a conformation that
allows all of the large groups attached to the D/E ring skeleton to
be equatorially disposed.
One requirement for the completion of the synthesisof reserpine
is that the
newly stereocenter (C-3) at the junction between
created
rings and
\320\241 D be inverted (Scheme 4). This task could conceivably
be achieved simply by treating 20 with acid (see plausible mechan-
mechanismin Scheme 5). However, at equilibrium, conformer 20a is
expected to be heavily favored over 20b. In 20a, the ring E substi-
substituents and the large indolyl nucleus are all oriented equatorially,
and the prospects for epimerizing the errant stereocenterat position
3 withacid seem grim. If, on the other hand, intermediate 20 could
somehow be induced to adopt the less stable
alternative and much
conformation, 20b, then there ought to be a substantial thermody-
namic driving force for epimerization at position 3; in 20b, the
large indolyl nucleus is axial, and it interacts unfavorably with the
two axial substituents (X and Y) in ring E. Thus, if 20 could be
locked into conformer 20b, or one very analogous to it, then in the
presence of acid it should undergo, through the cascade of events
62 4 Reserpine
1. \320\232\320\236\320\235,
MeOH
2. DCC,
\321\200\321\203\320\263.
MeO
MeO
OMe
22: (\302\261)-reserpic acid lactone 21: (i)-isoreserpic acid lactone
1. MeOH/CHCI3 C/1),
(+)-CSA
2. resolution
3. 1 N NaOH
MeO,C^ i ^T i \"o
i \320\275
\320\275
OMe
1: (-)-reserpine
MeO MeO
4.4 Conclusion
References
1. Miiller, J.M.; Schlittler, E.; Bein, H.J. Experientia 6. (a) For an excellent review, see: Oppolzer,W. In
1952, 8, 338. Comprehensive Organic Synthesis; Trost, B.M.,
2. Scriabine, A. In Pharmacology of Antihypertensive Fleming, I., Eds., Pergamon Press: New York, 1991,
Drugs; Scriabine, A., Ed., Raven Press: New York, Vol. 5, p. 315; (b) Sauer, J. Angew. Chem. Int. Ed.
1980, p. 119. Engl. 1967, 6, 16;(c)
Carruthers, W. In Tetrahedron
3. (a) Dorfman, L.; Huebner, C.F.; MacPhillamy, H.B.; Organic Chemistry Series: Cycloaddition Reactions
Schlittler, E.; St. Andre, A.F. Experientia 1953, 9, in Organic Synthesis; Pergamon Press: New York,
368; (b) Dorfman, L.; Furlenmeier, A.; Huebner, C.F.; 1990, Vol. 8, p. 7.
Lucas, R.; MacPhillamy, H.\320\222.;Mueller, J.M.; Schlitt- 7. Wild, A.L. Org. Y.) 1944, 2, 178.
React. (TV.
E.;
Schlittler, Schwyzer, R.; St. Andre, A.F. Helv. Chim. 8. (a) Barton, Chem. Soc. 1953, 1027;(b)
D.H.R. J.
Acta 1954, 37, 59. Nace, H.R.; O'Conner, G.L. J. Am. Chem. Soc.
4. (a) Huebner, C.F.; MacPhillamy, H.B.; Schlittler, E.; 1951, 73, 5824; (c) Umland, J.B.; Jefraim, M.I. ibid.
St. Andre, A.F. Experientia 1955, //, 303; (b) Wen- 1956, 78, 2788.
kert, E.; Liu, L.H. ibid. 1955, 11, 302; (c) Huebner, 9. MacPhillamy, H.B.; Huebner, C.F.; Schlittler, E.;
C.F.; Wenkert, E. J. Am. Chem. Soc. 1955, 77, 4180; St. Andre, A.F.; Ulshafer, P.R. J. Am. Chem. Soc.
(d) Diassi, P.A.; Weisenborn, F.L.; Dylion, \320\241\320\234.; 1955, 77, 4335.
Winterseiner, O. ibid. 1955, 77, 4687;(e) Van Tame- 10.For other total syntheses of reserpine, see: (a) Pearl-
len, E.E.; Hance, P.D. ibid. 1955, 77, 4692. man, B.A. J. Am. Chem. Soc. 1979, 101, 6398,
5. (a) Woodward, R.B.; Bader, F.E.; Bickel, H.; Frey, 6404; (b) Wender, P. A.; Schaus, J.M.; White, A.W.
A.J.; Kierstead, R.W. J. Am. Chem. Soc. 1956, ibid. 1980, 102, 6157; Heterocycles1987,25, 263;
78, 2023, 2657; (b) Woodward, R.B.; Bader, F.E.; (c) Martin, S.F.; Rueger, H.; Williamson, S.A.;
Bickel, H.; Frey, A.J.; Kierstead, R.W. Tetrahedron Grzejszczak, S. J. Am. Chem. Soc.1987, 109, 6124;
1958,2, 1. (d) Stork, G. Pure & Appl. Chem. 1989,61,439.
\320\275\320\276
\320\241\320\2362\320\235 \320\241\320\2362\320\235
Me Me
\320\275\320\276 \320\235\320\236
\320\235\320\236
\320\275 \320\275\320\276'
\320\275
1: PGF2a 2: PGE2
E.J.Corey A969)
Prostaglandin
and Prostaglandin E2 (PGE2)
5.1 Introduction
Using unsaturated fatty acids such as arachidonic acid as biosyn-
thetic building blocks, prostaglandin synthetase assembles a num-
number of structurally homologous hydroxylated compounds which are
ubiquitous in mammalian tissues.Collectivelyknown as the prosta-
...Ra
HO HO
\320\235\320\236*
RM HO\" Rm
F-
pilot-plant production.
In this chapter, we present Corey'sstrategy for the synthesis of
PGF2a A) and PGE2B). Because a thorough and concise summary
of Corey's prostaglandin synthesis including the numerous
improvements disclosed up to the mid-1970s has already been pub-
published,63 we have opted to address here the original strategy and the
more recent refinements which have been reported up to 1992.
.CD
Wittig
. reaction
Horner-Wadsworth-
Emmons reaction
AcO
lodolactonization
OMe OMe
i
AcO HO
10
9: Corey lactone
MeO
OMe
12 HO
11
Baeyer-Villiger
oxidation
Diels-Alder reaction
MeO
MeO
CN
13 14 15 16
7 and
intermediates 8 with concomitant formation of the requisite trans
C13-C14 olefin. Retrosynthetic simplification of aldehyde 7 pro-
provides intermediate 9, a molecular assembly commonly known as
the Corey lactone.
The maneuvers
retrosynthetic that we have addressed thus far
have only resulted in simplification of the vicinal side-chain substi-
tuents appended to carbons 8 and 12; we have yet to address the
marked stereochemical complexity of the cyclopentane nucleus of
70 5 Prostaglandin F2a (PGF2a) and ProstaglandinE2 (PGE2)
lation of cyclopentadienylsodium,
derived from the action of sodium
hydride on cyclopentadieneA7), with chloromethyl methyl ether
(M0MC1) in THF at -55\302\260C to give 5-methoxymethyl-l,3-cyclo-
pentadiene A5) (see Scheme 3). Intermediate 15 is itself a
rather
unstable substance.Under acidicor basic conditions and even at
temperatures as low as 0\302\260C, 15 readily undergoes a 1,5-hydrogen 1,5-hydrogen
shift
shift to give isomeric 1- and 2-substituted cyclopentadienes.To
compensate for. the instability of 15, it was found necessary .OMe
to remove the solvent below 0 \302\260C
and to use crude 15 immediately.
Intermediate 15 is to serve as the 4n component in a Diels-
MeO
NaH, THF;
MeOCH2CI,
THF, -55 \302\260C
17
MeO
NaOH, H2O,
f
0 \302\260C;
then CO2
HO
11 12
Kl3, NaHCO3,
(80%) H2O, 0 \302\260C
\320\276
1. BBr3,CH2CI2,
1. Ac2O, pyr. 0 \302\260C
(>90%)
^> a
2.
\342\200\236OMen-Bu3SnH, .OMe 2. CrO3\302\2532pyr.,
AIBN, PhH, A CH2CI2, 0 \302\260C
13
. A H
H\302\260 Ac\302\260 AcO
(99% overall)
10 9: Corey lactone
\320\233
Zn(BH4J, DME
Me
(>97%ofa1:1
mixture of C-15
eplmers)
AcO
DMSO
\342\200\242
\320\277 .\320\233
(-80% from 18) H
\320\242\320\235\320\240\320\236
HTHPtf\" \320\275
THp(j
thpo \320\275
20 1. H2Cr207, PhH/H2O 4
AcOH, 2. AcOH,H2O,37 \302\260C
H2O, 37 \302\260C G0% for 2 steps)
(90%)
HO H
r 4CO2H
VX
H
HO \320\275\320\276'
\320\275
(-1: (+)-PGF2a
V\342\200\224
Me.
AiCi3, CH2Ci2,
1
-55 \302\260C
AiCi,
(89%)
26
1. BnO
LDAA.1 equiv.)
-78 -*0\302\260C
t
2. O2, THF, (EtOKP
B equiv.), -78\302\260C
28 (90%)
27
B:1 mixture of (diastereoseiectivity: 97:3)
diastereoisomers)
BnO
NaiO4, H2O/f-BuOH,
\320\276\320\275
pH 7 (97%)
\320\236
\320\276\320\275
29 30
e
H2O2, OH
\321\216-\"\\
HO HO
32 31
[a]f-33.3
reactions.19d>f
5.3 Total Synthesis 79
Ph Ph
\320\222\320\237\320\236.
\320\232
CF3O2SN NSO2CF3 1
Al \302\260
I
1 \\J \302\246^\320\243
CH2Ci2, -78 \302\260C
Me
26 34
33 (93% yieid; >95% \320\265\320\265)
base-labiie bond
BnO
1. H2O2)
1. LDA LiOH,H2O
2. MeSSMe 2. EtOH,
A00%) (EtOKCH,
CH3SO3H
(95%2 steps)
HC(OMeK,
MeOH,23 C, BnO
Bn(MeKN\302\251MeO\302\251;
CO2
-Ci 9
then NCS,
CH3CN, 0 \302\260C \302\251S-Me
40
MeOH
\320\270
1. mCPBA, CH2Ci2,
0 \302\260C,
NaHCO3
2. 2 N KOH, 23 \302\260C;
then CO2
OBn OMe
i JNHCI.
Hd' 3. i2, Kl, K2CO3, 0 \302\260C o\302\260c
OMe
OBn
E 1
Br -78
CH2CI2, \302\260\320\241
1
(83%) BnO\342\200\224'\"
43
5 moi%
NH2OH*HCi, CH0
aq. AgNO3
THF/H2O,
Br
pH4,
-5 -> 5 \302\260C v exo-44
(95%; 92% \320\265\320\265)
aq. NaOH
1 \320\234
(92% \320\265\320\265)
prostaglandin synthesis.
5.4 Conclusion
It was in 1969 when Corey disclosed his elegant and versatile bicy-
cloheptaneprostaglandin strategy.
synthetic Over the course of the
ensuing two and a half decades, Corey's original strategy has
References
1. (a) Bergstrom, S. Science(Washington, D.C.) 1967, 5. (a) Andersen, N.H. J. Lipid Res. 1969, 10, 320;
157, 382; (b) Horton, E.W. Chem. Soc. Rev. 1975, 4, (b) Andersen, N. Ann.N. Y. Acad. 180, 14.
Sci. 1971,
589; (c) Horton, E.W. Prostaglandins, Monographs 6. (a) Bindra, Bindra, R. Prostaglandin
J. S.; Synthesis,
on Endrocrinology, Vol. 7, Springer-Verlag: Heidel- Academic Press: New York, 1977; (b) Mitra, A. The
Heidelberg,1972; (d) Chemistry, Biochemistry and Pharma- Synthesis of Prostaglandins, Wiley-Interscience:New
Pharmacological Activity of Prostanoids, Roberts, S.M.; York, 1977; (c) New Synthetic Routes to Prostaglan-
Scheinmann, F., Eds., Pergamon Press: Oxford, 1979; and
Prostaglandins Thromboxanes, Roberts, S. M.; Scheinmann,
(e) Prostaglandins Research, Crabbe, P., Ed., Organic F., Eds., Academic Press: San Diego, 1982; (d) Caton,
Chemistry: A Series of Monographs 36, Academic M.P.L. Tetrahedron 1979, 35, 2705; (e) Nicolaou,
Press: New York, 1977; (f) Prostaglandins:Biology K.C.; Gasic, G.P.; Barnette, W.E. Angew. Chem. Int.
and Chemistry of Prostaglandins and Related Eico- Ed. Engl. 1978, 17, 293; (f) Newton, R.F.; Roberts,
sanoids, Curtis-Prior, P. \320\222.,Ed., Churchill Living- S.M. Tetrahedron 1980, 36, 2163; (g) Noyori, R.
Livingstone:New York, 1988. Suzuki, M. Angew. Chem. Int. Ed. Engl. 1984, 23,
2. Collins, P.W.; Djuric, S.W. Chem. Rev. 1993, 93, 847.
1533. 7. (a) Corey, E.J.; Weinshenker, N.M.; Schaaf, \320\242.\320\232.;
3. For an informative discussion and a compilation of Huber, W. J. Am. Chem. Soc. 1969, 5675; 91, (b)
leading references, see: Bindra, J.S.; Bindra, R. Pros- Corey, E.J.; Schaaf, Huber,
\320\242.\320\232.; W.; Koelliker, U.;
Prostaglandin Synthesis, Academic Press: New York, Weinshenker, N.M. ibid. 1970, 92, 397; (c) Corey,
1977, p. 7. E.J.; Noyori, R.; Schaaf, ibid.
\320\242.\320\232. 1970, 92, 2586;
4. (a) Bergstrom, S.; Sjovall, J. Acta Chem. Scand. 1957, (d) Corey, E.J. Ann. N. Y. Acad. Sci. 1971, 180, 24;
11, 1086; (b) Bergstrom, S.; Sjovall, J. ibid. 1960, 14, (e) Corey, E.J.; Cheng, X.-M. The Logic of Chemical
1693;(c) Bergstrom, S. Sjovall, J. ibid. 1960, 14, Synthesis, John Wiley & Sons: New York, 1989,
1701;(d) Bergstrom, S.; Ryhage, R.; Samuelsson,\320\222.; p. 250-266.
Sjovall, J. ibid. 1962, 16, 501; (e) Bergstrom, S.; 8. (a) Trippett, S. Q. Rev. Chem. Soc. 1963,17,406; (b)
Ryhage, R.; Samuelsson, \320\222.;
Sjovall, J. J. Biol. Chem. Maercker, A. Org. React. (N.
1965, 14, 270; (c) Y)
1963,238, 3555. Schlosser,M. Top. Stereochem. 1970, J, 1; (d) Mary-
anoff, B.E.; Reitz, A.B. Chem. Rev. 1989, 89, 863.
82 5 Prostaglandin F2a (PGF2a) and Prostaglandin E2 (PGE2)
9. (a) Corey, E.J.; Albonico, S.M.; Koelliker, U.; 19.(a) Corey, Imwinkelried,
E.J.; R.; Pikul, S.; Xiang,
Schaaf, \320\242.\320\232.;
Varma, R.K. J. Am. Chem. Soc. 1971, Y.B. J. Am. Soc. 1989, 111, 5493; (b) Corey,
Chem.
93, 1491;
(b) Corey, E.J.; Becker, K.B.; Varma, R.K. E.J.; Imai, N.; Pikul, S. Tetrahedron Lett 1991, 32,
ibid. 1972, 94, 8616. 7517; (c) Corey, E.J.; Imai, N.; Zhang, H.Y. J. Am.
10.(a) Wadsworth, W.S., Jr. Org. React. (N.Y.) 1977, Chem. Soc. 1991, 113, 728; (d) Corey, E.J.; Loh,
25, 73; (b) Walker, B.J. In
Organophosphorous T.P. ibid. 1991, 113, 8966; (e) Corey, E.J.; Sarshar,
Reagents in Organic Synthesis, Cadogan, J. I.G., S.; Bordner, J. ibid. 1992,114,7938; (f) Corey, E.J.;
Ed., Academic Press: New York, 1979, p. 155;(c) Loh, T.P; Roper, T.D.; Azimioara, M.D.; Noe, M.C.
Wadsworth, W.S., Jr.; Emmons, W.D. J. Am. Chem. ibid. 1992,114,8290.
Soc. 1961, 83, 1733. 20.Corey, E.J.; Imwinkelried, R.; Pikul, S.; Xiang, Y.B.
11.Corey, E. J.; Cheng, X.-M. The Logic of Chemical J. Am. Chem. Soc. 1989,111,5493.
Synthesis, John Wiley & Sons, Inc.:New York, 1989. 21. Corey, E.J.; Yu, \320\241\320\234.;
Kim, S.S. J. Am. Chem. Soc.
12. (a) Mulzer, J. In Organic Synthesis Highlights, Mul- 1989,111,5495.
zer, J.; Altenbach, H.-J.; Braun, M.; Krohn, K.; Reis- 22. Corey, E. J.; Lee, D.H. J. Am. Chem. Soc. 1991, 113,
sig, H.-U., VCH Publishers: Weinheim, New York, 4026.
1991, p. 158;(b) Dowle, M.D.; Davies, D.I. Chem. 23. Corey, E.J.; Ensley, H. E. J. Am. Chem. Soc. 1975,
Soc. Rev. 1979, 171; (c) Bartlett, PA. In Asymmetric 97, 6908.
Synthesis, Morrison, J. D., Ed., Academic Press: New 24. For excellent reviews of asymmetric Diels-Alder
York, 1984, Vol. 3B, p. 411; (d) Bartlett, PA. reactions and insightful discussions, see: (a) Helm-
Tetrahedron 1980, 36, 2. chen, G.; Karge, R.; Weetman, J. In Modern Syn-
13.Danishefsky, S. J. Aldrichimica Acta 1986, 19, 56. Synthetic Methods, Scheffold, R., Ed., Springer-Verlag:
14.(a) Hassall, C.H. Org. React. (N. Y.) 1957, 9, 73; (b) Berlin, Heidelberg, 1986,
Vol. 4, p. 262-306; (b)
Krow, G. R. In Comprehensive Organic Synthesis, Oppolzer, W. Angew. Chem. Int. Ed. Engl. 1984, 23,
Trost, B.M.; Fleming, I., Eds., Pergamon Press: New 876; (c) Paquette, L. A. In Asymmetric Synthesis,
York, 1991, Vol. 7, 671; (c) House, H.O. Modern Morrison, J.D., Ed., Academic Press: New York,
Synthetic Reactions, Second edition, W. A. Benjamin: 1984, Vol. 3, p. 455; (d) Masamune, S.; Choy, W.;
Menlo Park, CA, 1972, p. 325. Petersen, J. S.; Sita, L. R. Angew. Chem. Int. Ed.
15. (a) For a review of ketene equivalents, see: Ranga- Engl. 1985, 24, 1; (e) Charlton, J.L.; Alauddin,
nathan, S.; Ranganathan, D.; Mehrota, A.K. M.M. Tetrahedron 1987, 43, 2873; (f) Narasaka, K.;
Synthesis 1977, 289; (b) Oppolzer, W. In Compre- Inouye, M.; Okada,N. Chem. Lett. 1986, 1109; (g)
Comprehensive Organic Synthesis, Trost, B.M.; Fleming, I., Evans, D.A.; Chapman, \320\232. Bisaha,
\320\242.; J. J. Am.
Eds., Pergamon Press: New York, 1991, Vol. 5, Chem. Soc. 1988,110,1238; (h) For a review of cat-
p. 315; (c) Carruthers, W. In Tetrahedron Organic catalytic asymmetric Diels-Alder reactions, see: Kagan,
Chemistry Series: Cycloaddition Reactions in H.B.; Riant,O. Chem. Rev. 1992, 92, 1007.
Organic Synthesis; Pergamon Press: New York, 1990, 25.Evans, D.A.; Britton, T.C.; Ellman, J.A. Tetrahe-
Vol. 8. Lett.
Tetrahedron 1987, 28, 6141.
16. Shiner, C. S.; Fisher, A.M.; Yacoby, F. Tetrahedron 26. (a) Trost, B.M.; Tamura, Y. J. Am. Chem. Soc. 1975,
Lett. 1983, 24, 5687. 97,3528;(b) 1977, 99, 3101.
17.Corey, E. J. Pure & Appl. Chem. 1990, 62, 1209. 27. Corey, E.J. Abstracts, 33rd National Organic Sym-
18. (a) Corey, E.J.; Bakshi, R.K.; Shibata, S. J. Am. Symposium, June 13-17, Bozeman, Montana, ACS Divi-
Chem. 1987, 109, 5551; (b) Corey,E.J.; Bakshi,
Soc. Division of Organic Chemistry, 1993, p. 30.
R.K.; S.; Chen, \320\241\320\240.;
Shibata, Singh, V.K. ibid.
1987, 109, 7925;(c) Corey, E.J.; Shibata, S.; Bakshi,
R.K. J. Org. Chem. 1988, 53, 2861; (d) Corey, E.J.;
Bakshi, R.K. Tetrahedron Lett. 1990, 31, 611.
\320\276'
1: progesterone
W.S.Johnson A971)
Progesterone
6.1 Introduction
A popular to the synthesis of the linearly
approach fused cyclohex-
anoid frameworks characteristic of the ubiquitous steroids and poly-
cyclic triterpenoids has involved multistep annulations wherein
each new six-membered ring is built onto a preexisting ring in a
stepwise fashion.1 The Robinson annulation and the successful
annulation methods developedby G. Stork and his group at Colum-
Columbiahave figured prominently in the application of this strategy to
the synthesis of numerous polycyclic natural products. In marked
contrast to this controlled, stepwise approach to the synthesis of
polycyclic natural products, the biomimetic approach can fashion a
complex polycyclic array in a single step through a stereospecific
2: squaiene oxide
*~ \320\275\320\276
4: dammaradienoi
2: squaiene oxide
trans-anti-paralleladdition of
C-2 and C-11 across the A6>7oiefin
produces trans ring fusion stereo-
stereochemistry. The stereochemical
course of the conversion of 2 to 4
is consistent with a concerted cycli-
zation event
4: dammaradienoi
Scheme 1. Enzyme-induced cyclizations of squaiene oxideB) (a) and the Stork-Eschenmoser hypo-
hypothesis (b).
6.2 Retrosynthetic Analysis and Strategy 85
courseof
stereochemical the biochemical cyclization of squalene
oxide on stereoelectronicgrounds.In 1955, Stork and Eschenmoser
independently proposed that polyunsaturated molecules with trans
olefinic linkages, such as squalene oxide B), should exhibit an
inherent preference for cyclizing in a stereospecific fashion to give
a polycyclic molecule which possesses trans,anti,transring fusion
stereochemistry. The important features of the Stork-Eschenmoser
hypothesis can be illustrated by using the cyclization of squalene
oxide B) to dammaradienol D) as an example (see Scheme lb).
We will assume that protonation of the oxygen of squaleneoxide
induces opening of the oxirane ring to give a transient tertiary car-
bonium ion at C-2. Once formed, this electrophilic species would
find itself in proximity to the C6-C7 trans olefinic linkage and, in
such a setting, it is conceivable that this cation could initiate an
4 \302\260
-^\342\200\224Intramolecular
aldol/dehydration
1: progesterone
5 ^^> Intramolecular
o aldol/ Me' OH
9 dehydration 8
10 13
moiety. As it turns out, the Johnson ortho ester variant of the Clai-
sen rearrangement is an excellent method for the synthesis of y,d-
unsaturated esters.11 In fact, the Claisen rearrangement, its many
variants included, is particularly valuable in organic synthesis as a
method for the stereocontrolled construction of trans di- and tri-
substituted carbon-carbon double bonds.12'13 Thus, it is conceiva-
that
conceivable intermediate 18 could be fashioned in one step from allylic
alcohol 20 through a Johnson ortho ester Claisen rearrangement. In
88 6 Progesterone
PPh3
Johnson
Me Me
ortho ester
Claisen
Me \320\222 Me rearrangement
EtO2C
13 18
Me
Me Carbonyl
VMe \"\342\200\224\342\200\224
addition
Y
CHO BrMg,
22 21
Me
Me
CH3C(OEtK,
C2H5CO2H @.3%),
+ 1
Y\"* HO
CHO BrMg,
138\302\260CE5%for2
Me steps)
22 21 20
Me
Me
Me
EtO
Johnson-
EtO2C Claisen Me
19
18
1. LiAIH4, Et2O, Me
G7% for 0\302\260C
2 steps) Me
2. CrO3*2pyr.,
CH2CI2, 23 \302\260C
13
Me 1. \320\236 \320\276
n-BuLi,THF, C.2 equiv.),
\320\235\320\236(\320\241\320\2352J\320\236\320\235 Br
-30 ~> -20 \302\260C p-TsOH @.026 equiv.),
Br hydroquinone (trace),
PhH, reflux [- H2O] \320\236 \320\236
16 17 15 G1%) 14
B.9 equiv.),
-20 -\302\27323\302\260C Nal A.4 equiv.),
G5%)
MgO (trace), (99%)
80 \302\260C
\320\241\320\263\320\2355\320\241\320\236\320\241\320\2353,
\320\223\320\233 \320\223\320\233
\302\251'
\320\276. \320\276 o ^oo
PPh3
Ph3P A.4 equiv.), 4
Me
i
PhH, 80 \302\260C
(94%)
\320\236 \320\236
24 23
\320\263\320\273 \320\223\320\233
\320\276.\320\276 \302\251 \320\276.\320\276
i
PPh3
Et2O)
Me
0 0 Me
24 1.
12
13
-70-\302\273
-30 \302\260\320\241
2. PhLi A equiv.);
then excess
MeOH, -30 \320\241
\320\2363,
\320\234\320\265\320\236\320\235/\320\241\320\2352\320\24112,
-70 then Zn,
\302\260\320\241; AcOH,
\320\2352\320\236,-15^23 \302\260\320\241
E1%)
6.4 Conclusion
References
1. (a) reviews
For of annulation methods, see: Jung, Schlosser,M. Top. Stereochem. 1970, 5, 1; (d) Mar-
M.E. Tetrahedron 1976, 32, 3; (b) Akhrem, A. A.; yanoff, B.E.; Reitz, A.B. Chem. Rev. 1989, 89, 863.
Titov, Y. A. Total Steroid Synthesis, Plenum Press: 9. (a) Schlosser,M.; Christmann, K. F. Angew. Chem.
New York, 1970; (c) The Total Synthesis of Natural Int. Ed. Engl. 1966,(b) Schlosser,M.;Christ-
5, 126;
Products, ApSimon, J., Ed., John Wiley & Sons: New Christmann, K.F. Liebigs Ann. Chem. 1967, 708, 35;
York, 1973, Vol. 2, p. 641; (d) Blickenstaff, R.T.; (c) Schlosser, M.; Christmann, F.K.; Piskala, A.; Cof-
Ghosh, A.C.; Wolf, G.C. Total Synthesis of Steroids, finet, D. Synthesis 1971, 29.
Academic Press: New York, 1974; (e) Stork, G. Pure 10. For example, see: Biichi, G.; Wuest, H. J. Org. Chem.
& Appl. Chem. 1964, 9, 131; (f) Stork, G.; 1966, 31, 977.
Danishefsky, S.; Ohashi, M. J. Am. Chem. Soc. 1967, 11.Johnson, W. S.; Werthemann, L.; Bartlett, W. R.;
89, 5459; (g) Stork, G.; McMurry, J. E. ibid. 1967, 89, Brocksom, T. J.; Li, \320\242. Faulkner,
\320\242.; D.J.; Petersen,
5463; (h) Stork, G.; McMurry, J.E. ibid. 1967, 89, M.R. J. Am. Chem.Soc. 1970, 92, 741.
5464. (i) Woodward, R. \320\222.;
Sondheimer, F.; Taub, D.; 12.Faulkner, D. J. Synthesis 1971, 175.
Heusler, K.; McLamore,W.M. ibid. 1952, 74, 4223. 13.For some excellent reviews of the Claisen rearrange-
2. (a) Johnson, W.S. Ace. Chem. Res. 1968, /, 1; (b) see:
rearrangement, (a) Rhoads, S.J.; Raulins, N. R. Org.
Johnson, W. S. Angew. Chem. Int. Ed. Engl. 1976, /5, React. (N.Y.) 1975, 22, 1; (b) Ziegler, F.A. Ace.
9; (c) Johnson, W.S. Bioorg. Chem. 1976, 5, 51; (d) Chem. Res. 1977, 10, 227; (c) Bennett, G.B.
Van E.E. Ace. Chem. Res. 1975,8, 152;(e)
Tamelen, Synthesis 1977, 589; (d) Hill, R.K. In Asymmetric
Van Tamelen, E. E.; Milne, G. M.; Suffness, M.I.; Synthesis; Morrison, J.D., Ed., Vol. 3, Academic
Rudler Chauvin, M.C; Anderson, R.J.; Achini, R.S. Press: New York, 1984, p. 503; (e) Ziegler, F.A.
J. Am. Chem. Soc. 1970, 92, 7202; (f) Van Tamelen, Chem. Rev. 1988, 88, 1423; (f) Kallmerten, J.; Witt-
E.E.; Freed, J.H. ibid. 1970,92, 7206; (g) Van Tame- man, M.D. Stud. Nat. Prod. Chem. 1989, 3, 233;
Tamelen,E.E.; Anderson, R.J. ibid. 1972, 94, 8225; (h) (g) In Comprehensive
Wipf, P. Organic Synthesis;
Van Tamelen, E.E.; Holton, R. A.; Hopla, R.E.; Konz, Trost, Fleming, I., Eds., Pergamon
B.M.; Press: New
W.E. ibid. 1972, 94, 8228; (i) Van Tamelen, E.E.; Sei- York, 1991, Vol. 5, p. 827.
ler, M.P.; Wierenga, W. ibid. 1972, 94, 8229; (j) 14. March, J. Advanced Organic Chemistry; John Wiley
Sharpless, K.B. ibid. 1970, 92, 6999; (k) Bartlett, & Sons: New York, 1985, 3rd Ed., p. 381.
P. A. In Asymmetric Synthesis; Morrison, J.D., Ed., 15. For some important mechanistic studies and insight-
Academic Press: New York, 1984, Vol. 3, p. 341. insightful
discussions, see: (a) Vedejs, E.; Snoble, K. A.J.
3. (a) Clayton, R.B. Q. Rev. Chem. Soc. 1965, 19,168; J. Am. Soc. 1973, 95, 5778; (b) Vedejs,
Chem. E.;
(b) Woodward, R.B.; Bloch, K. J. Am. Chem. Soc. Snoble, K. A.J.; Fuchs, PL. J. Org. Chem. 1973, 38,
1953, 75, 2023; (c) Van Tamelen, E.E.; Willet, J.D.; 1178;(c) Vedejs, E.; Fuchs, PL. J. Am. Chem. Soc.
Clayton, R.B.; Lord, K.E. ibid. 1966, 88, 4752; (d) 1973, 95, 822; (d) Vedejs, E.; Meier, G.P.; Snoble,
Van Tamelen, E.E. ibid. 1982, 104, 6480; (e) Corey, K.A.J. ibid. 1981, 103, 2823; (e) Vedejs, E.; Marth,
E.J.; Russey, W.E.; Ortiz de Montellano, PR. ibid. C.F.; Ruggeri, R. ibid. 1988, 110,3940; (f) Vedejs,
1966, 88, 4750; (f) Corey, E.J.; Virgil, S.C. ibid. E.; Marth, C.F., ibid. 1988,110,3948.
1991, 113, 4025; (g) Corey,E.J.; Virgil, S.C; Sarshar, 16. For some noteworthy recent achievements by W.S.
S. ibid. 1991, 113,8171;(h) Corey, E.J.; Virgil, S.C; Johnson et al., see: (a) Johnson, W.S.; Telfer, S.J.;
Liu, D.R.; Sarshar, S. ibid. 1992, 114,1524. Cheng, S.; Schubert, U. J. Am. Chem. Soc. 1987,
4. (a) Stork, G.; Burgstahler, A.W. J. Am. Chem. Soc. 109, 2517; (b) Johnson, W.S.; Lindell, S.D.; Steele,
1955, 77, 5068; (b) Eschenmoser, A.; Ruzicka, L.; J. ibid. 1987,109,5852; (c) Johnson, W.S.; Chenera,
Jeger, O.; Arigoni, D. Helv. Chim. Ada 1955, 38, Tham,
\320\222.; F.S.; Kullnig, R.K. ibid. 1993, 115, 493;
1890; (c) Stadler, P. A.; Eschenmoser, A.; Schinz, H.; (d) Johnson, W. S.; Fletcher, V.R.; Chenera, \320\222.; Bart-
Stork, G. Helv. Chim. Ada 1957, 40,2191. Bartlett, W.R.; Tham, F.S.; Kullnig, R.K. ibid. 1993,
5. (a) Johnson, W.S.; Bailey, D.M.; Owyang, R.; Bell, 115, 497 (e) Johnson, W.S.; Buchanan, R.A.; Bart-
R.A.; Jaques, \320\222.;
Crandall, J.K. J. Am. Chem. Soc. Bartlett, W.R.; Tham, F.S.; Kullnig, R.K. ibid. 1993,
1964, 86, 1959; (b) Johnson, W.S.; Crandall, J.K. 115, 504; (f) Johnson, W.S.; Plummer, M.S.; Reddy,
J. Org. Chem. 1965, 30, 1785. S.P.; Bartlett, W.R. ibid. 1993, 115, 515.
6. (a) Johnson, W.S.; Gravestock, M.\320\222.; McCarry, B.E. 17. (a) Burke, S.D.; Saunders, J.O.; Oplinger, J. A.; Mur-
J. Am. Chem. Soc. 1971,93, 4332; (b) Gravestock, tiashaw, C.W. Tetrahedron Lett. 1985, 26, 1131;(b)
M. \320\222.;Johnson, W.S.; McCarry, B.E.; Parry, R. J.; Burke, S.D.; Takeuchi, K.; Murtiashaw, C.W.; Liang,
Ratcliffe, B.E. ibid. 1978, 100, 4274. D.W.M. ibid. 1989, 30, 6299; (c) Burke, S.D.;
7. Corey, E.J.; Cheng, X.-M. The Logic of Chemical Strickland, S.M. S.; Organ, H.M.; Silks, L.A., III.,
Synthesis; John Wiley & Sons: New York, 1989. ibid. 1989, 30, 6303; (d) Burke, S.D.; Deaton, D.N.
8. (a) Trippett, S. Q. Rev. Chem. Soc. 1963, 17, 406; (b) ibid. 1991,32, 4651;(e)Burke, S.D.; Shankaran, K.;
Maercker, A. Org. React. (TV. Y.) 1965, 14, 270; (c) Jones Helber, M. ibid. 1991, 32, 4655.
94 6 Progesterone
18.Johnson, W.S.; Gravestock, M.B.; Parry, R.J.; 21. Johnson, W.S.; Daub, G.W.; Lyle, T.A.; Niwa, M.
Myers, R.F.; Bryson, T.A.; Miles, D.H. J. Am. J. Am. Chem. Soc. 1980,102,7800.
Chem. Soc. 1971, 93, 4330. 22.For reviews of electrophilic substitutions of vinyl-
19.(a) Johnson, W.S.; Yarnell, T.M.; Myers, R.R; Mor- silanes, see: (a) Blumenkopf, T. A.; Overman, L. E.
Morton, D.R. Tetrahedron Lett. 1978, 2549; (b) Johnson, Chem. Rev. 1986, 86, 857; (b) Fleming, I.; Duno-
W.S.; Yarnell, T.M.; Myers, R.R; Morton, D.R.; gues, J.; Smithers, R. Org. React. (N. Y.) 1989, 37,
Boots, S.G. J. Org. Chem. 1980,45, 1254. 57.
20.Johnson, W.S.; Chen, Y.Q.; Kellogg, M.S. J. Am.
Chem. Soc. 1983, 105, 6653.
Me..
\320\236.L.
Chapman A971)
Carpanone
7.1 Introduction
Me
Me
Intramolecular \\
Diels-Alder
1: carpanone 2
C-C bond
rotation
7.3 Total Synthesis
bis(quinodimethide) 2.
Palladium dichloride (PdCh) was carefully chosen to effect the
desired oxidative coupling reaction.Although phenolic couplings
have traditionally been achieved with one-electron oxidants, it was
anticipated that PdCb, containing as it does a divalent metal, could
facilitate the crucial oxidative coupling step by bringing two pheno-
phenolicunits together (see intermediate 5). By rendering the phenolic
7.4 Conclusion
References
1. Brophy, G.C.; Mohandas, J.; Slaytor, M.; Sternhell, 5. (a) Tietze, L.F.; Beifuss, U. Angew. Chem. Int. Ed.
S.; Watson, T. R.; Wilson, L.A. Tetrahedron Lett. Engl. 1993, 32, 131;(b) Hoffmann, H.M.R. ibid.
1969,5159. 1992, 31, 1332;(\321\201) T.-L.
\320\235\320\276, Tandem Organic Reac-
2. Chapman, O.L.; Engel, M.R.; Springer, J.P.; Clardy, Reactions, John Wiley & Sons: New York, 1992.
J.C. J. Am. Chem. Soc. 1971, 93, 6696. 6. Braun, M. In Organic Synthesis Highlights, Mulzer,
3. Alexander, B.H.; Gertler, S.I.; Brown, R.T.; Oda, J.; Altenbach, H.-J.; Braun, M.; Krohn, K.; Reissig,
T. A.; Beroza, M. J. Org. Chem. 1959, 24, 1504. H.-U.,VCH Publishers: Weinheim, New York, 1991,
4. (a) Oppolzer,W. Angew. Chem. Int. Ed. Engl. 1977, p. 232.
16, 10; (b) Oppolzer, W. Synthesis 1978, 793; (c) 7. Corey, E.J.; Cheng, X.-M. The Logic of Chemical
Ciganek, E. Org. React. (TV. Y.) 1984, 32, 1; (d) Fallis, Synthesis, John Wiley & Sons: New York, 1989.
A.G. Can.]. Chem. 1984, 62, 183.
1: vitamin \320\222,2
Vitamin \320\22212
8.1 Introduction
the blood pigment heme B), and the leaf pigment chlorophyll a C).
Each moleculepossessesa macrocyclic nucleus comprising four five-
membered heterocyclic rings A, B, C, and D, and organized around a
central metal atom. As we shall seelater,the binding of a metal atom
by the corrin nucleusof vitamin is a very useful property shared
\320\22212
H2NOC
*in9 closure
\320\275\320\263\320\274\320\276\321\201
Me MeO2C Me
I
\342\200\224v Me /\342\200\224CONH-,
H I M^CONMe2
10: (+)-camphor-
quinone
12
15.
A sequence of straightforward functional group interconversions
leads from 17 back to compound 20 via 18 and 19. In the synthetic
direction, a base-induced intramolecular Michael addition reaction
could createa new six-membered ring and two stereogenic centers.
The transformation of intermediate 20 to 19 would likely be stereo-
selective; substrate structural features inherent in 20 should control
the stereochemical course of the intramolecular Michael addition
reaction.Retrosynthetic disassembly of 20 by cleavage of the indi-
H2NOC
CONH'
4: cobyric acid
MeO2C
MeO2C
MeO2C
X, i
Me
12 11 (\-27
Me
OMe OMe
O=C=N\342\200\224p-Ph
Me
1. separation H
O'\"^/ Me
2. pyrolysis 31: a-phenyiethyl-
\302\253-22 Me | isocyanate \320\276
+ 54.4 NH
[a]D
m.p. 93-94 \302\260C Me
32 + Ph (\302\261)-22
+ diastereomer
\320\223 CONH2
(-)-camphor NOH
N2 I
NO
COCI
CO2Me Me CHO CO2Me Me f
Me
1. LiAIH4 1. ph,P= -Me
2. CrO3 2. OH\302\251
Me Me 3. SOCI2 M e
21
OMe
Me
! 1. NaOMe,dry MeOH
2. PhCH3, \320\224
Me OMe Me .OMe Me
OMe
f-BuOH
Me
18: pentacyclenone
Me
HO.
oxime formation \320\276
17 37 36
CO2Me
Me
HO.
1. O3, MeOH,-80 \302\260C
2. HIO4
0 3.
CH2N2
17
CO2Me CO2Me
Me
MsO 1. mesylation HO
2. O3,MeOAc, H2O
3. \320\235\320\2564
4. CH2N2
MeO2C
CO2Me
CO2Me CO2Me
Me
CO2Me CO2Me
CO2Me CO2Me
Me ,
NaOMe, MeOH
CO2Me CO2Me
42: a - corrnorsterone 14: p
- corrnorsterone
(desired)
\302\251o,c
43 44
MeOH CO2Me
CO2Me
PhSH, HCI
reactive
Me
i.\" H
carbonyl group
14: C - corrnorsterone
MeO2C MeO2C
O3,MeOH, \"^\320\234\320\265'-\320\247-\320\234\320\235
NH3(I)
Me\"
MeO2C -90 \302\260C
H\302\253
X^\021*1
\320\234\320\265\320\2362(\320\223
CHO CHO
H2NOC
SPh
46 13
1.
2.
NaBH4
CO2Me
\320\236
\302\260C
Ms2O, \321\200\321\203\320\263.,
3. LiBr, DMF
racifirc / =
\320\275
I
\320\274\320\265
carbonyl group \321\201\320\2762\320\274\320\265
14: - corrnorsterone
p
HS(CH2JOH,
CO2Me \342\200\242hSI CO2Me
CO2Me CO2Me
IX = 388 nm in UV spectrum]
48 47
ozonolysis reaction proceed cleanly and in the desired way to give the
formyl thioester (i. e. 45).
Contained within 45 is one side chain that terminates in a phe-
nylthioester group. It was known, at the time, that whereas oxygen-
based nucleophilesreact with esters and thioesters with roughly
reactmorereadily
equal facility, nitrogen-basednucleophiles with
thioesters. Thus, treatment of 45 with liquid ammonia results in the
completely selective replacement of the thiophenol grouping by
ammonia to give formyl amide 46 in nearly quantitative yield.
Although the inherently reactive aldehyde grouping in 45 is
remarkably impervious to the action of liquid ammonia, it is readily
reduced by sodium borohydride to the corresponding primary alco-
alcohol. Treatment of this substance with methanesulfonic anhydride
and pyridine, followed by displacement of the resulting mesylate
with bromide ion, completes the synthesis of cyanobromide 6, a
suitably differentiated left-wing building block. It is important to
note that the employment of methanesulfonic anhydride in this
sequence is not arbitrary; the use of the more conventional metha-
nesulfonyl chloride or bromide to achieve the desired mesylation is
attended by the production of significant amounts of a halide by-
byproduct. This complicating path can be easily circumvented through
the use of methanesulfonic anhydride. It will also be noted that the
terminal nitrile function in 6 is formed through dehydration of the
primary amide grouping with methanesulfonic anhydride.
Me
PhH, SnCI4 G3% yield)
COjH
12 11:1,3-butadiene (\302\261)-27
a - phenylethyiamine I
CO2H CrO3,
Me-
,CO2H H2SO4,
(CH3JCO
CO2H
G5% yield)
Me-)\342\200\224b-Me \302\273-
Me--)\342\200\224( Me
\320\236.
\320\233. E5% yield) HN
CO2Me
10: (+)-camphorquinone
8.3.3 The Woodward Synthesis of C-Ring Intermediate9
OAc
It was known from the work of Manasse and Samuel that a tri-
Me
methylcyclohexanone carboxylic acid is formed when camphorqui-
none A0, Scheme 9) is exposedto acidic reagents. Subsequent
studies by Simonsen and Chakravarti revealed the structure of the
trimethylcyclohexanone carboxylic acid, and it was Cornforth12
who recognized the structural relationship between this substance
52
and ring of
\320\241 vitamin \320\22212. In the face of such precedent, the
approach to the C-ring building block logically begins with an
acid-induced conversion of (+)-camphorquinone A0) into enantio-
\320\234\320\261
\320\234\320\261.
BF3\302\253OEt2,
,
\320\220\321\2012\320\236
10: (+)-camphorquinone
52 R = F or OAc '\302\251
(COCIJ
NH3
I*
OAc
\302\251o_n\302\256
^,Me O3
^\342\200\242\342\200\242\302\246\302\246Me
H-T ^Me
CONH2
53
CO2Me
55 54
1
HN -4
J \321\201
\\ Me
pyrolysis 0
Me
H
V
\320\273
\\
9 CO2Me
MeO2C MeO2C
CH2N2, Et2O,
MeOH,NaOMe(cat.)
MeO2C
(92% yield)
MeO2C
Br
base
M >
\320\270 60
59 61
R3P
- [R3P=S]
RNH, R3OBF4
YY YY - YY-
OR \320\236
^NH
64 63 62
benzoyl ,8-
peroxide
Ts +
YLv- /
Y V \320\276
59 65 66
X = oxygen
S R3P
YY II yV
PR,
\320\236
67
Me
HN
\320\276
Me ...\302\246Me benzoyl peroxide,
Me
Me
HCI, CH2CI2 H\302\251
Me 68
CO2Me
CO2Me
...Me ...Me
CO2Me
H CO2Me
Me-'T
N
MeO2C MeO2C
Me Me
H CO2Me
MeO2C
t-BuOK,
' CO2Me
f-BuOH
MeO2C MeO2Cr ,.
Me
CO2Me NC
NC CO2Me
6: cyanobromide 7: thiodextrolin 71: thloether type I
MeO2C
MeO2C
MeO2
CO2Me
CO2Me
TFA, CH3NO2
NC CO2Me
CN CO2Me
MeO2C MeO2C
O2Me
MeO2C
1. PZS5, ^plcoline,
toluene CO2Me
2. Me3OBF4 MeO2C
Me'
CO2Me CO2Me
MeO2C MeO2C
Me
MeO2C MeO2C
DBN,
CO2Me CO2Me
CH3CON(CH3J,
MeOjC 60 \302\260C
DBN
CO2Me \302\246\321\201\320\276 CO2Me
Me
0
MeO2C
MeO2C
x
0 } I
1. KCN, MeOH, 25 ^ .H P2S5, THF, 25 \302\260C
\302\260C,
2. CH2N 2. Et2O, , MeOH (f
y\342\200\224\302\261
E7% after A
MeO2C
A/
.C-NH
kV-NH separation)
\"C02 Me NC Me
NC : Me
24
51 76
(>95% as diastereoisomers,
epimericat , in
\320\241 favor of 76.)
Scheme 15. The Eschenmosersynthesis of A-ring intermediate 24.
1. NH3, MeOH,
CrO3, H2SO4, 25 \302\260C
Me > \302\273
*CO2H
(CH3JCO,25 \302\260C 2. CH2N2, Et2O,
MeOH
Me G5% yield) \320\275
\320\2765 \321\201\320\2762\320\275
F4% overall)
KCN, MeOH,
MeO2C
25 \302\260C
G2%)
79 78
. (CH2OHfe, CH(OMeK, /\302\273-TsOH,
MeOH, 80 \320\241
G6%)
2. P2S5,THF,25\302\260C(81%)
Me CO2Me
, Me CO2Me
'.\342\200\236H 1. Ra-Ni, MeOH, 25 \302\260C p~-
2. Ac2O, pyr., 25 \302\260C
(86%)
H
\321\201 1. HCI, MeOH, 65 \302\260C
3. 40% AcOH, 60 \302\260C N 2. NH2OH*HCI, NaOAc, ^-T~n
4. Ac2O, pyr., 25 \302\260C
(94%)
\\
Ac MeOH, 65 \302\260C
(>95%) n'/ I H
Me
\320\236 HON Me
81 82 83
1. HCI(g),CHCI3
2. SOCI2, 25 \320\241
G4%
3. piperidinomethyl- overall)
polystyrene, CHCI3,
25 \302\260C
MeO2C
MeO2C the active methylene group of the newly formed methyl propionate
side chain condensesintramolecularly onto the cyano group. To be
H2N
more precise, the propionate ester, in its enolic form, attacks the
B4), \320\222
(8), \320\241
(9), and D B5) can be synthesizedfrom the two
enantiomers of a single starting compound is most impressive, and
it seems to reflect underlying regularities in the biosynthesis of the
MeO2C
natural corrinoids.7d Schemes 17 and 18 present the synthetic
details of this approach.
The EschenmoserA-D variant
begins with the conversion of
intermediate 70, the precursor thiodextrolinof G), into the corre-
corresponding thiolactam thiolactone 85 with P2S5. The sulfur atom of
the thiolactam in 85 is to serve as a nucleophilein a coupling reac-
reaction with building
D-ring block 25. This reaction is analogous to CO,M.'
the of cyanobromide
coupling 6 with thiodextrolin G) (see Scheme
a
13), key operation in the Woodward/Eschenmoser A-B variant.
Treatment of 85 with ?err-butoxide produces a thiolate ion which
subsequently the displaces
ring D-bromide to give a sulfur-bridged CO,Me
intermediate.As we have already seen in analogous systems, the
sulfur atomserves as a disposabletether; it forces rings \320\241
and D
into regions of space and facilitates
neighboring the key carbon-
carbon bond forming event by making it intramolecular. After it
has served its purpose, the sulfur atom is smoothly excised by the
phosphine thiophile. In the presence of dimethylamine, intermedi-
CO2Me
86
intermediate is converted into exocyclic enamine 87. This intermediate is
not isolated; it with AModosuccinimide to give
is treated directly
vinyl iodide 88. modified sulfide contraction
By employing a pro-
MeO2C
cadmium, key intermediate 23. The stage is now set for the crucial
xylene,130\302\260C
(84%)
CO2Me CO2Me
85
1. f-BuOK, f-BuOH,
THF, 25 \302\260C
F4% overall'
2.
[25| yield)
3. [NC(CH2J]3P,
TFA, sulfolane,
60 \302\260C
MeO2C
Me'
CO2Me
AModosuccin-
imide, CH2CI2,
0\302\260C
I
CONMe2
MeO2C
...\302\246Me
H CO2Me
,CO2Me
|, NaHMDS,
H
MeO2C
^ PhH, 25 \320\241 coupling)
(\320\220/\320\222
CN
CO2Me
88
MeO2C
CONMe2
. Ph3P,TFA,
phH 80 oC MeO2C
(sulfide contraction) Me-\"
__ ^ Me-yi
co2Me
2. Cd(CIO4J,*-Pr2NEt,
PhH, MeOH, 25 \302\260C; MeOjC
then NaCI workup \320\275
(recompiexation) Me'
D6% overall from 86)
CO2Me
MeO2C
CONMe2
H cOjMe
1. hv (visible), 60 \302\260C MeO2C
2. CoCI2,58\302\260C
3. KCN.air, H2O,
CH2CI2,\320\236
\320\241 MeO2C
C02Me CO2Me _
75: blsnorcobyrlnlc acid 23
abdeg pentamethyl ester
\321\201
dlmethylamlde f nltrlle
91 92 93
places the D-ring methylene group beneath (or above) the A-ring
methylidene n system and guides the stereochemicalcourseof the
cycloisomerization event. Provided that the central metal ion is
inert with respect to the quenchingof the excitation of the chromo-
phore, the photo-induced cycloisomerization proceeds very
smoothly and provides corrin complexes possessing the necessary
trans configuration between rings A and D. The trans A-D config-
configuration found in cobyric acid D) is thermodynamically more stable
than the alternative trans configuration. The macrocyclization
event described in Scheme 18 provides the natural stereochemical
arrangement almost exclusively. You will note that both paths to
cobyric acid D) have now converged on a common intermediate.
From bisnorcobyrinicacid abdeg pentamethylester \321\201
dimethylamide
f nitrile G5), the journey to cobyric acid D) was completed collab-
oratively by both groups.
MeO2C MeO2C
Me
MeO2C Me\302\2602CM\302\273.-
AcOH
CO2Me CO2Me
MeO2C ..
\320\234\320\265\320\2362\320\241
sterlc
...\342\200\242*** shielding
MeOfC-10.
Me'
CO2Me CO2Me
75: bisnorcobyrinic acid 94
abdeg pentamethyl ester
1.
\321\201
dimethylamlde f nitrile CICH2OCH2Ph
sulfolane, 75 \320\241
2. PhSH
MeO2C MeOX
MeO2C
CO2Me CO2Me
CO2Me CO2Me
96: cobyrinic acid abcdeg 95
hexamethyiester f nitrile
noteworthy. This new substance,intermediate 97, is identified as 97: cobyrinic acid abcdeg
amide
cobyrinic acid
f
abcdeg hexamethyiester f amide and it is produced hexamethyiester
MeO2C MeO2C
MeO2C MeO2C
cone. H2SO4
CO2Me CO2Me
MeO2(T ..
H'\"
Me'
N2O4, \320\241\320\241\320\246,
NaOAc
MeO2C
NH2
Me Me
MeO2C
CO2Me
MeO2C ..-
H'*
Me'
CO2H CO2Me
Bernhauer et al.
[ref. 5]
V
\320\275\320\276
Me-% -0 ^ H
7\320\2764
\320\276\320\275
OH
1: (-)-vitamin B12
structure of 97. Arranged around its periphery are six side chains
which terminate in methoxycarbonyl groups and one side chain
which terminates in a primary amide group. One problem requiring
a solution is the selective hydrolysis of the primary amide grouping
in this compound. At first glance, this problem may seem insur-
insurmountable by virtue of the fact that an amide is inherently less elec-
trophilic and, therefore, less susceptible to attack by nucleophilic
reagents than esters. Nevertheless, deaminations of amides using
nitrous acid or some other nitrous derivative were well known, and
both the Woodward and Eschenmoser camps were certainly mindful
of these precedents. Although initial model experiments were uni-
uniformly unsuccessful, the Cambridge group eventually discovered
that when a solution of 97 in carbon tetrachloride is treated with
\321\207~
MeO2C pn H3O\302\251(mild)
MeO2C z\342\200\224-
LA
H2N.> (i) H
I
\302\260\302\251
MeO2C
MeO2C ... Me \\
/o\302\251
NMe2
8.4 Conclusion
References
1.(a) Woodward, R.B. Pure & Appl. Chem. 1968,17, 3. (a) Woodward, R.B. Spec. Publ. Chem. Soc. 1967,
519; (b) Woodward, R.B. ibid. 1971, 25, 283; (c) 21, 217;(b) Woodward, R.B.; Hoffmann, R. Angew.
Woodward, R.B. ibid. 1973, 33, 145; (d) Eschenmo- Chem. Int. Ed. Engl. 1969, 8, 781.
ser, Wintrier, C.E. Science (Washington,
A.; D.C.) 4. (a) Crowfoot-Hodgkin, D.; Johnson, A.W.; Todd,
1977, 196, 1410; (e) Woodward, R.B. In Vitamin Bl2, A.R. Spec. Publ. Chem. 1955, 3, 109; (b)
Soc.
Proceed. 3rd European Symposium on Vitamin B12 Crowfoot-Hodgkin, D.; Kamper, J.; MacKay, M.;
and Intrinsic Factor, Zagalak, Friedrich,
\320\222.; W., Eds., Pickworth, J.; Trueblood, K.N.; White, J.G. Nature
Walter de Grayter: Berlin, 1979, p. 37; (f) Eschenmo- (London) 1956, 178, 64; (c) Crowfoot-Hodgkin, D.;
ser, A. Pure & Appl. Chem. 1963, 7, 297; (g) Eschen- Kamper, J.; Lindsey, J.; MacKay, M.; Pickworth, J.;
moser, A. ibid. 1971, Suppl. Special Lectures XXIII. Robertson, J.H.; Shoemaker, White,
\320\241\320\222.; J.G.; Pro-
IUPAC Int. Congress, Boston, Vol. 2, p. 69; sen, R. J.; Trueblood, K.N. Proc. R. Soc. London A
(h) Eschenmoser, A. Naturwissenschaften 1974, 61, 1957, 242, 228; (d) Bonnett, R. Chem. Rev. 1963, 63,
513. 573.
2. Eschenmoser, A. Angew. Chem. Int. Ed. Engl. 1988, 5. Friedrich, W.; Gross, G.; Bernhauer, K.; Zeller, P.
27,5. Helv. Chim. Ada 1960, 43, 704.
136 8 Vitamin B12
6. (a) Bertele, E.; Boos, H.; Dunitz, J.D.; Elsinger, R; 10. (a) Kaiser,E.M. Synthesis 1972, 391; (b) Harvey,
Eschenmoser, A.; Felner, I.; Gribi, Gschwend,
H.P.; R.G. 1970, 161; (c) Birch,
ibid. A. J.; Subba Rao, G.
H.; Meyer, E.F.; Pesaro, M.; Scheffold, R. Angew. Adv. Org. Chem. 1972, 8, 1; (d) Caine, D. Org.
Chem. Ed. Engl. 1964, 3, 490; (b) Yamada,
Int. Y.; React. (N.Y.) 1976, 23, 1.
Miljkovic, D.; Wehrli, P.; Golding, \320\222.;Loliger, P.; 11. Bachmann, W.E.; Strave, W.S. Org. React. (N.Y.)
Keese, R.; Miiller, K.; Eschenmoser, A. ibid. 1969, 8, 1942,1, 38.
343. 12. (a) de la Mare, P.B.D. Nature (London) 1962, 195,
7. (a) Dubs, P.; Gotschi, E.; Roth, M.; Eschenmoser, A. 441; (b) For a review of this work, see: Jackson,
Chimia 1970, 24, 34; (b) Roth, M.; Dubs, P.; Gotschi, A.H.; Smith, K.M. In The Total Synthesis of Nat-
E.; Eschenmoser, A. Helv. Chim. Ada 1971, 54, 710; Natural Products, ApSimon, J., Ed., Wiley-Interscience:
(c) Gotschi, E.; Hunkeler, W.; Wild, H.J.; Schneider, New York, 1973, Vol. 1, p. 261.
P.; Fuhrer, W.; Gleason, J.; Eschenmoser, A. Angew. 13.(a) Grobel, B.T.; Seebach, D. Synthesis 1977, 357;
Chem. Int. Ed. Engl. 1973, 12, 910;(d) Eschenmoser, (b) Seebach, D. Angew. Chem. Int. Ed. Engl. 1979,
A. Q. Rev. 1970, 24, 366;(e) Eschenmoser, & A. Pure 18, 239.
Appl. Chem. 1969,20, 1. 14.Woodward, R.B. Pure & Appl. Chem. 1968, 17,
8. For reviews of the Diels-Alder reaction, see: (a) Sauer, 529.
J. Angew. Chem. Int. Ed. Engl. 1966, 5, 211; (b) 15.(a) Gotschi, E.; Hunkeler, W.; Wild, H.J.; Schneider,
Sauer, J. ibid. 1967, 6, 16;(c) Martin, J. G.; Hill, R. K. P.; Fuhrer, W.; Gleason,J.; Eschenmoser, A. Angew.
Chem. Rev. 1961, 61, 537; (d) Oppolzer, W. In Com- Chem. Int. Ed. Engl. 1973, 12, 911; (b) Fischli, A.;
Comprehensive Organic Synthesis, Trost, B.M.; Fleming, Eschenmoser,A. ibid. 1967, 6, 866.
I., Eds., Pergamon Press: New York, 1991, Vol. 5, 16. In March 1976, M.A. Wuonola and R.B. Woodward
p. 315; (e) Carruthers, W. Tetrahedron Organic accomplished the conversion of cobyric acid D) to
Chemistry: Cycloaddition Reactions in Organic vitamin B12 A). The total synthesis of vitamin B12
Synthesis, Pergamon Press: New York, 1990, Vol. 8; can thus be claimed, see: reference Id, footnote 11,
(f) Kahn, S.D.; Pau, C.F.; Overman, L.E.; Hehre, p. 1420. The formal total synthesis of 1 had been
W.J. J. Am. Chem. Soc. 1986, 108, 7381. accomplished in 1973.
9. (a) Donarama, L.G.; Heldt, W.Z. Org. React. (N.Y.) 17. We are grateful to Prof. A. Eschenmoserfor helpful
1960,11,1; (b) Gawley, R.E. ibid. 35, 1. comments on this chapter.
CO2H
Me
\320\275\320\276
PGA2
9.1 Introduction
The Claisen many variants constitute a group
rearrangement and its
of pericyclicreactionsthat extremely valuable in organic synthe-
is
synthesis.1 In its most basic form, the Claisen rearrangement is the [3,3]
sigmatropic rearrangement of allyl vinyl ether C) to give 4-pente-
nal D) (see Scheme la); it accomplishes the homologation of an
allylic system through a process that creates a new carbon-carbon
bond and, in substituted cases, it can create vicinal stereochemical
relationships in an extremely efficient and controlled fashion by
virtue of its highly organized transition state geometry. In this chap-
chapter, we address the total syntheses of PGA2 A) and PGF2a B) by
Gilbert Stork and his group at Columbia.2 These two syntheses
0\302\260
CH3C{OCH3K,
1
HO H CH3CH2CO2H,
\320\224
mixed-ketene
acetal
[3,3]
Johnson ortho
ester Claisen
rearrangement
Scheme 1. Parent Claisen rearrangement (a) and the Johnson ortho ester variant (b).
Dieckmann
condensation
*> MeO2C
Me Me
1: PGA2
MeO2C MeO2C
formation
MeO2C
Mlxed-ketene acetal
formation
MeO2C
Johnson ortho
ester Clalsen
rearrangement
C-C bond
formation
\320\275\320\276.
\320\276
Carbonatebond
formation V
Me Me
13 14: 2,3-isopropylidene-
L-erythrose
analysis, a strategy for the total synthesis of PGA2 and PGF2a was
thus evolved.
MeAMe
14: 2,3-isopropylidene- 15
L-erythrose A0 equiv.), Johnson ortho
CH3C(OCH3K
CH3CH2CO2H@.1 equiv.),
rearrangement
MeO2C
.. \\
\320\243 15
1. 25%AcOH,
H2O,120X
2. Et3N A equiv.),
CH2CI2,25\302\260C
MeO2C
B equiv.),
\320\2460|
C02Me
(\320\234\320\265\320\236\320\254\320\241
Johnson ortho ester
Claisen rearrangement
CO2Me CO2Me
MeO2C. j. =
K2CO3 @.1 equiv.),
\342\200\242
MeO2C MeOH, 25 \320\241 MeO2C
OH \"
E9% from 11)
h:h
1. H2, 5% Pd-BaSO4,
MeOH, quinoilne
G9% 2. p-TsCiA.1equiv.),
overail) pyr., -20 \302\260C
CO2Me n-Bu2CuLi,
MeO2C Me
THF, 25 \302\260C
\320\225\320\225\320\236\320\223
\320\275
5
0.5 N NaOH, reflux; I
mo.
. .
then phosphate buffer I G7% from 6)
PhSe
PhSeCI C equiv.)
18
NaiO4, H2O/MeOH,
25 \302\260C
\320\276
H
1/
\\, ^\\z\"m\"
H
HO'\" H
1: (+)-PGA2
\302\261>
TsO'
C-C bond
OSiPh2f-Bu formation
<=
\320\275\320\276 EEO
C-C bond
23 formation 22
[3,3]
Johnson ortho
ester Claisen
rearrangement
\320\276\320\275
12
HO'
HO-
13 OH |
OH
28: a-D-glucose
2. (\320\241\320\2353J\320\241\320\236,
\320\276\320\275) '
\320\275\320\276
\320\254\320\275
\320\276\320\275
0.1NH2SO4,
\320\276\320\275 Me
25\302\260C;thenNH3
Me Me
F8% overall)
28: a-D-glucose 29 30
1. NaBH4, MeOH,
10\302\260C
2. Ac2O, pyr.,
CHCI3,-7\302\260C
HC(OMeJNMe2,
\302\246* \320\276
from Me OAc
D0%
29)
32
1. OH\302\251
2. CICO2MeA.5equlv.),
\320\236
\302\260\320\241
\321\200\321\203\321\202.,
1. CuSO4,MeOH,H2O,reflux
2. (CH3JCO, H2SO4, 25 \320\241
OMe
E4% from 33) Me 27
\320\241\320\2353\320\241(\320\236\320\241\320\2353K,
\320\241\320\2353\320\241\320\2352\320\241\320\2362\320\235
Me
Me Johnson ortho ester
Claisen rearrangement
t
(80%) 12 16
OMe l14
\320\275
26
1. NaOMe
2. p-TsCI, pyr.
1. n-Bu2CuLi A0 equiv.),
Et2O, -40 \302\260C
,OTs ______ ^
the newly formed stereogenic center at C-12 and the trans \320\24113\342\200\224
C14 double bond are both expressed in the natural product. Cleav-
Cleavageof the cyclic carbonate in 25 with sodium methoxide, followed
sequentially by selectivetosylation of the primary hydroxyl group
and protection of the C-15 secondary hydroxyl group, provides 35,
an intermediate that is properly functionalized for the introduction
of the saturated four-carbon chain encompassingcarbons 17-20.
The selection of methoxide ion to cleave the cyclic carbonate in 25
Me
is not arbitrary; although a host of other metal alkoxides would
Me\\L /CO*MeOEE
\342\200\236 probably perform the task of cleaving the cyclic carbonate in 25
\342\200\242V-o/' OTs with the same facility that sodium methoxide does, it is also very
probable that transesterification at C-9 would also occur to give a
mixture of esters.
Replacement of the tosylate group in 35 with a saturated butyl
chain is achieved with an excess of lithium di-n-butylcuprate and,
after hydrolytic cleavage of the isopropylidene and ethoxyethyl
(\320\225\320\225)
protecting groups, lactone 23 is obtained in an overall yield of
35 % from 25. Acid-catalyzed hydrolysis of the isopropylidene fur-
furnishes a free hydroxyl group at C-ll, which subsequently initiates
lactonization by attacking the proximal methyl ester. After simulta-
simultaneous protection of the two hydroxyl groups in 23 in the form of
ethoxyethyl acetals (seeScheme7), advantage is taken of the labi-
lability of the C-H bonds adjacent to the lactone carbonyl.In the pre-
presence of lithium bis(trimethylsilyl)amide (LHMDS), one of the two
a-methylene hydrogens is removed as a proton to afford a lactone
9.5 Total Synthesis of PGF2a 149
Q H
1. Dibal-H
2. HCN, EtOH
2. p-TsCI,
TsO \320\225\320\225\320\236'
\320\275
\321\200\321\203\320\263. \320\264
\320\235\320\236 EEO H
C7% from 22)
36
EEO.
OSiPh2f-Bu
KHMDS, PhH,
reflux G2%)
TsO
EEO \" EEO H EEO
EEO' H H
21 38
1. F0,THF
2. CrO3\302\2532pyr. (Collins's reagent) (83% overall)
3. AgNO3, H2O, EtOH, KOH
CN.
HO. EEO.
CO2H
50% AcOH-THF, 40 \302\260C
Me
HO H \320\235\320\236
EEO H
\320\275
40
L-Selectrfde,
THF, -78 \302\260C
G3% from 39)
9.6 Conclusion
References
1. For some excellentreviews, see: (a) Rhoads, S.J.; 4. Schaefer,J.P.; Bloomfield, J.J. Org. React. (N.Y.)
Raulins, N.R. Org. React. (N.Y.) 1975, 22, 1; (b) 1967, 15, 1.
Ziegler, F.E. Ace. Chem. Res. 1977,10,227; (c) Ben- 5. Corey, Cheng, X.-M. The Logic of Chemical
E. J.;
Bennett, G.B. Synthesis1977, 589; (d) Hill, R. K. In Synthesis, Wiley & Sons: New York, 1989.
John
Asymmetric Synthesis, Morrison, J. D., Ed., Academic 6. (a) Vittorelli, P.; Hansen, H.J.; Schmid, H. Helv.
Press: New York, 1984, Vol. 3, p. 503; (e) Ziegler, Chim. Ada 1975,58, 1293;(b) Vittorelli, P.; Wink-
F.E. Chem. Rev. 1988, 88, 1423;(f) Kallmerten, J.; ler, \320\242.; Hansen, H.J.; Schmid, H. ibid. 1968, 57,
Wittman, M.D. Stud. Nat. Prod. Chem. 1989, 3, 233; 1457.
(g) Wipf, P. In Comprehensive Organic Synthesis, 7. Bartlett, P. A. Tetrahedron 1980, 36, 2.
Trost,.B.M.; Fleming, I., Eds., Pergamon Press: New 8. Mislow, K. Introduction to Stereochemistry, Benja-
York, 1991, Vol. 5, p. 827. Benjamin Press: New York, 1965, p. 131.
2. (a) Stork, G.; Raucher, S. J. Am. Chem. Soc. 1976, 9. Stork, G.; Maldonado, L. J. Am. Chem. Soc. 1971,
98, 1583; (b) Stork, G.; Takahashi, Kawamoto,
\320\242.; I.; 93, 5286.
Suzuki, T. ibid. 1978, 100, 8272. 10.Seebach, D. Angew. Chem. Int. Ed. Engl. 1979, 18,
3. (a) Johnson, W.S.; Werthemann, L.; Bartlett, W. R.; 239.
Brocksom, T.J.; Li, T.T.; Faulkner, D.J.; Petersen, 11. Eastwood, F. W.; K.J.; Josan, J. S.; \320\240\320\270\320\263\
Harrington,
M.R.J. Am. Chem. Soc. 1970, 92, 741; (b) Faulkner, J. L. Tetrahedron Lett. 1970, 5223.
D.J. Synthesis 1971, 175. 12.Stork, G.; Takahashi, T. J. Am. Chem. Soc. 1977,99,
1275.
\320\275\320\276
1: estrone
K.P.C.VollhardtA977)
Estrone
10.1 Introduction
intermolecular
Diels-Alder
\320\241 a,
intramolecular
Diels-Alder
\022
5 6
components are part of the same molecule. In such a setting, the probabil-
that
probability the two unsaturated moieties will react with each other can
be enhanced, and the structural change that attends the intramolecu-
intramolecular
[4+2] cycloaddition event is impressive.2 In a single operation,
a rather complex bicyclic framework can be fashioned from a com-
comparatively simple polyunsaturated acyclic molecule. The Diels-
Alder cycloadditionis indeeda most productive process because it
involves a simple summation of the reaction partners; all of the
R R1
R R1
R2 R2 R2 R
R R R1
/
R
y 4
R2 R2
R R1 R R1
/t
/ 4
R
R R2 V
R R1 R R1
Ri
R
/ \\,
\\
R1 /
R2\342\200\224= R2 r2
\320\250\320\234\320\2653
SiMe3
(cat.), \320\224
200 \302\260C
SiMe,
(Diels-Alder) SiMe3
(ca. 100%yield)
o-quinodimethane
10
cyclobutene 9.
CpCo(COJ CpCoCO + CO
CpCoCO(BTMSA) CpCo(BTMSA) 4- CO
Me3Si,
CpCo(BTMSA) 4- 'SiMe3
Me3Si
SiMe3
1. Diels-Alder
2. demetalation
-
\"CpCo\"
BnO
BnO
o-xylene,
i
120 \302\260C
G3% yield)
' intramolecular
Diels-Alder
Me
\024
(\302\261)-cheiidonine
E mol%),
CpCo(COJ
BTMSA, reflux
F0% yield)
CpCo(COJ E Me3Si
BTMSA, reflux
MeaSi OMe
D5% yield)
BTMSA, reflux
Me3Si
(90% yield)
BTMSA, refiux
Me3Si
(80% yield)
Me3Si
Me3Si
1: estrone
Intramolecular Diels-Alder 14
Alkylation
SiMe3 Cycioollgomerization
. Me3Si
=\302\246
+
SiMe3 Me3Si
8: bis(trlmethylsilyl)- 16 15
acetylene (BTMSA)
OTMS
Alkylation
Me Me
/t 19: 2-methylcyclo-
Michael addition
17 18 pentenone
anticipated that
cleavage of the trimethylsilyl enol ether in 18 using
the procedure of Binkley and Heathcock18 would regiospecifically
furnish the thermodynamic (more substituted) cyclopentanone eno-
enolate, a nucleophilic species that could then be alkylated with iodo-
OTMS
Me
1. , Cul Me LiNH2, NH3(I),
\302\273
2. Me3SiCi THF
(89% yield) H
19:2-methylcyclo-
pentenone 18
Me3Si =\342\200\224SiMe3
8: BTMSA
4
decane, CpCo(COJ E mol%)
\342\200\224-
\302\246
\320\270
\320\275
reflux
G1% yield)
15 16
intramolecular Dieis-Alder
Me3Si
Me3S
14 13
1. TFA, \302\260C
\320\241\320\241\320\246,-30
2. Pb(OCOCF3L
(ca. 90%overall
yield)
Me,Si
should undergo conversion to the same orrto-quinodimethane14
by a conrotatory opening of the four-membered ring. Gratifyingly,
15
cocyclization of diyne 16 with BTMSA (8) in the presence of
E mol %) under oxygen-free conditions furnishes
\320\241\321\200\320\241\320\276(\320\241\320\236)\320\263 a
Me
of the 2-position in 13 can, in fact, be exploited to achieve the total
,?
synthesis of the estrone molecule. Under carefully controlled condi-
conditions, exposure of 2,3-bis(trimethylsilyl)estratrienone 13 to the
action of trifluoroacetic acid (TFA) in CC14 at -30 results
\302\260C in the
formation of a 9:1 mixture of regioisomeric monotrimethylsilylated
HO
compounds in favor of the desired C-3 silylated steroid (90%
1: (\302\261)-estrone yield). A regioselective protodesilylation of 13 was thus achieved.
10.4 Conclusion 165
10.4 Conclusion
products.
References
1. For reviews of the Diels-Alder reaction, see: (a) 2, For reviews of the intramolecular Diels-Alder reac-
Sauer, J. Angew. Chem. Int. Ed. Engl. 1966, 5, 211; reaction, see: (a) Carlson, R.G. Annu. Rep. Med. Chem.
(b) Sauer, J. ibid. 1967, 6, 16;(c) Martin, J.G.; Hill, 1974, 9, 270;(b) Oppolzer, W. Angew. Chem. Int. Ed.
R.K. Chem. Rev. 1961, (d) Oppolzer,W. In
61, 537; Engl. 1977, 16, 10; (c) Brieger, G.; Bennett, J.N.
Comprehensive Organic Synthesis, Trost, B.M.; Chem. Rev. 1980, 80, 63; (d) Ciganek.E. Org.React.
Fleming, I., Eds., Pergamon Press: New York, 1991, (N.Y.) 1984, 32, 1; (e) Fallis, A.G. Can.]. Chem.
Vol. 5, p. 315; (e) Carruthers, W. Tetrahedron Organ- 1984, 62, 183;(f) Taber, D. F. Intramolecular Diels-
OrganicChemistry Series: Cycloaddition Reactions in Alder and Alder Ene Reactions, Springer-Verlag:
Organic Synthesis, Pergamon Press: New York, 1990, Berlin, 1984; (g) Craig, D. Chem. Soc. Rev. 1987, 16,
Vol. 8; (f) Kahn, S.D.; Pau, C.F.; Overman, L.E.; 187; (h) Roush, W. R. In Advances in Cycloaddition,
Hehre, W. J. J. Am. Chem. Soc. 1986,108, 7381. Curran, D. P., Ed., Jai Press: Greenwich, Connecticut,
1990, Vol. 2, p. 91.
166 10 Estrone
3. For excellent discussions economy, see: (a)
of atom 11.Colvin, E.W. Silicon in Organic Synthesis, Butter-
Trost, B.M. Science(Washington, D. C.) 1991, 254, worths: London, 1981.
1471; (b) Trost, B.M. Pure & Appl. Chem. 1992, 64, 12. Vollhardt, K.P.C. In Strategies and Tactics in
315;(c) Trost, B.M. ibid. 1994, 66, 2007; (d) Trost, Organic Synthesis, Lindberg, Ed.,
\320\242., Academic
B.M. Angew. Chem. Int. Ed. Engl. 1995, 34, 259. Press: San Diego, 1984,Vol. 1, p. 299.
4. (a) Vollhardt, K.P.C. Ace. Chem. Res. 1977, 10, 1; 13. (a) Oppolzer, W. J. Am. Chem. Soc. 1971, 93, 3833;
(b) Vollhardt, K.P.C. Angew. Chem. Int. Ed. Engl. (b) Oppolzer, W. ibid. 1971, 93, 3834; (c) Oppolzer,
1984, 23, 539. W.; Keller, K. ibid. 1971,93, 3836.
5. (a) Berthelot, M.C.R. Hebd. Seances Acad. Sci. 14.(a) Funk, R.L.; Vollhardt, K.P.C. J. Am. Chem. Soc.
1866,62,905;(b) Nieuwland, J.A.; Vogt, R.R. The 1976, 98, 6755; (b) Funk, R.L.; Vollhardt, K.P.C.
Chemistry of Acetylene, Reinhold: New York, 1945; ibid. 1980, 102,5245.
(c) Badger, G.M.; Lewis, G.E.; Napier, I. M. 15.(a) Tietze, L. F.; Beifuss, U. Angew. Chem. Int. Ed.
J. Chem. Soc. 1960,2825. Engl. 1993, 32, 131;(b) Ho, T.-L. Tandem Organic
6. Reppe, W.; Schlichting, O.; Klager, K.; Toepel,T. Reactions, John Wiley & Sons: New York, 1992; (c)
Justus Liebigs Ann. Chem. 1948, 560, 1. Hoffmann, H. M.R. Angew. Chem. Int. Ed. Engl.
7. (a) Bird, C.W. Transition Metal Intermediates in 1992,31, 1332.
Organic Synthesis, Logos Press: London, 1967; (b) 16.(a) Fieser, L.F.; Fieser, M. Steroids, Reinhold: New
Bowden, F. L.; Lever, A. B.P. Organomet. Chem. York, 1959; (b) Wiechert, R. Angew. Chem. Int. Ed.
Rev. 1968, 3, 227; (c) Hiibel, W. In Organic Synthe- Engl. 1970, 9, 321; (c) Akhrem, A. A.; Titov, Y.A.
via Metal
Synthesis Carbonyls, Wender, I.; Pino, P., Eds., Total Steroid Synthesis, Plenum Press: New York,
John Wiley & Sons: New York, 1968, Vol. 1, p. 273; 1970; (d) Blickenstaff, R.T.; Ghosh, A.C.; Wolf,
(d) Yur'eva, L.P. Chem.
\320\233\320\270\320\262. Rev. (Engl. Transl.) G.C. Total Synthesis of Steroids, Academic Press:
1974, 43, 48; (e) Dickson, R.S.; Fraser, P.J. Adv. New York, 1974; (e) Quinkert, G.; Stark, H. Angew.
Organomet. Chem. 1974,12,323. Chem. Int. Ed. Engl. 1983, 22, 637.
8. (Tollman, J.P.; Hegedus, L.S.; Norton, J.R.; Finke, 17. (a) Funk, R.L.; Vollhardt, K.P.C. J. Am. Chem. Soc.
R. G. Principles and Applications of Organotransi- 1980, 102, 5253; (b) Funk, R. L.; Vollhardt, K.P.C.
tion Metal Chemistry, University Science Books: ibid. 1977, 99, 5483; (c) Funk, R.L.; Vollhardt,
Mill Valley, California, 1987, p. 870. K.P.C. ibid. 1979,101,215.
9. (a) Aalbersberg, W.G.L.; Barkovich, A.J.; Funk, 18. Binkley, E.S.; Heathcock, C.H. J. Org. Chem. 1975,
R.L.; Hillard, R.L., III; Vollhardt, K.P.C. J. Am. 40, 2156.
Chem. Soc. 1975, 97, 5600; (b) Hillard, R.L., III; 19. (a) Partch, J. Am. Chem. Soc. 1967,89, 3662;
R.E.
Vollhardt, K.P.C. ibid. 1977, 99, 4058. (b) Kalman, J.R.; Pinhey, J.T.; Sternhell, S. Tetrahe-
10.(a) Oppolzer, W. Synthesis 1978, 793; (b) Kametani, Lett.
Tetrahedron 1972, 5369; (c) Bell, H.C.; Kalman, J.R.;
T. Pure & Appl. Chem. 1979, 5/, 747; (c) Funk, Pinhey, J.T.; Sternhell, S. ibid. 1974,853; (d) West-
R.L.; Vollhardt, K.P.C. Chem. Soc. Rev. 1980, 9, 41; phal, D.; Zbiral, E. Justus Liebigs Ann. Chem. 1975,
(d) Vollhardt, K.P.C. Ann. N.Y. Acad. Sci. 1980, 2038.
333, 241;(e) Oppolzer, W. Heterocycles 1980, 14,
1615; (f) Kametani, Fukumoto,
\320\242.; K. ibid. 1977, 8,
465; (g) Kametani, Nemoto,
\320\242.; H. Tetrahedron
1981, 37, 3; (h) Charlton, J.L.; Alauddin, M.M. ibid.
1987, 43, 2873.
Me
11
Me
1: erythronolide \320\222
E.J.Corey A978)
Erythronolide \320\222
11.1 Introduction
Thus, even if one could cope with the wealth of asymmetric carbon
atoms contained within erythronolide B, the state of the art in
organic synthesis methodology was not equal to the task of con-
constructing large-ring lactones before the mid 1970s.
Challengedand inspired by the complex structures of the eryth-
a &
\342\200\236A
(CH2)n
OH 0O
4
2-pyridinethione
Me
Me Me
Me
1: erythronolide \320\222
OBz
Me
BzO- E
Me\342\200\224^\342\200\224O
\320\276
Me
11
\320\237
Baeyer- C-C bond formation
WHiger \302\246'OTBS
Jl
OBz Me OBz
Me Me 12
\"\320\236
\320\233
Me X 14 15
Alkylation
13
Br
Me Me^lJ Me
V \302\246\342\200\242Me
lactonization
x
Me'
\320\223\320\222\320\263\320\276\321\202\320\276-
\320\273 17
1\320\252
lactonlzation
16
Me Me
II
J
- *
Me Me- / C-aliylatlon
\302\246r
CO2H
19 20
methylphenol B1).
\320\276\320\275
Me 1.
BH3\302\273THF, 0\302\260C;
\302\260
H2O2, NaOH, 0
NaOMe, PhH,
2. CrO3, H2SO4,
Me Me
Me
(CH3JCO
F0%)
G2% overall) CO2H
21 19
20
Br2,
KBr, (96%)
H2O
Br\"
Br
Me, Me
Me Me
KOH, H2O, M(
CM THF (98%) o-
Me'i
4,/\320\241\320\236\320\263\320\235 j Me
co2(
.\302\251
18
1. {\320\257>(+)-1-a-naphthylethylamine:
2. recrystallization H2n
3. CH3SO3H, Et2O
Br
Me, Me Me.
'\342\200\224Me
o:;'
. 'O
=
\342\200\242MeT
handful of steps, all of the carbon atoms that constitute the planar
aromatic ring in 21 are converted into unsymmetrically substituted
tetrahedral carbon atoms in a manner that secures correct relative
stereochemical relationships for an eventual synthesis of erythrono-
\320\222
erythronolide A).
An important task remaining is the stereocontrolled introduction
of a methyl group at C-8. When a cold (-78 \302\260C)solution of 14 in
THF is treated successivelywith LDA and methyl iodide and then
warmed to \342\200\22445 intermediate
\302\260C, 24 admixed with minor amounts of
the C-8 epimer is formed in a yield of 95 %. The action of LDA on
14 generates a lactone enolate which is alkylated on carbon in a
diastereoselective fashion with methyl iodide to give 24. It is of no
consequence that 24 is contaminated with small amounts of the
unwanted C-8 epimer because hydrolysis of the mixture with
lithium hydroxide affords, after Jones oxidation of the secondary
alcohol, a single keto acid A3) in an overall yield of 80%. Appar-
Apparently, the undesired diastereoisomer is epimerized to the desired
oneunder the basic conditions of the saponification step.
To complete the synthesis of key intermediate 11, the ?-lactone
ring must be formed and the carboxyl group must be converted into
11.3 Total Synthesis 175
Br
Me. Me.
Me
Br2, KBr, ...Me n-Bu3SnH, AIBN,
H2O(91%)' PhH, 75 \302\260C
(93%)
Me
,CO2H
17 16
(87:13 mixture at C-2)
Al/Hg, THF-H2O,
0 ->-10\302\260C G6%)
OBz OH
14 23 22
Me
G0%)
Me (80% overall) Me Me
24 13 25
OBz
Me QUO
.Me
THF
BzO- < Ph3P,
Me\"
F5%)
J
S
Me
11
H2O2, Na2WO4,
\321\217
pH 5, 55 \320\241 2. recrystallization
3. CH3SO3H, Et2O
1. SO2CI G6%overall)
A.05eq.)
1. =\342\200\224L>H2N(CH2JNH2,
pyr., -20 \302\260C DMSO
2. Me2CuLi,
'\342\200\242\342\200\242\320\276\320\275 Et2O, -15 \302\260C \"OH 2. Amberlite IRC-50,
MeOH
Me OH
G5% overall) (90%overall)
30 29
1. f-BuMe2SiCI, imidazole,
DMF
2. LDA, THF,-78 \302\260C;
Mel, -78 -> 25 \302\260C
(88% overall)
Me
1. Cp2ZrHCI, PhH, 43 \302\260C
2. l2, CCI4
(84% overall)
t-BuLi, pentane,
-78 ->-50\302\260C;
I, -20 \302\260C
(90%)
OBz
Zn(BH4J,
DME/Et2O, 5 \320\241
G0%)
Me Me Me
9
1. AcOH, THF/H2O,
55 \302\260C
G8%) '
2. 1 N LiOH
,, 30% H2O2,THF
Me
1. KOH, DME/H2O,
45 \302\260C
2. CH2N2, Et2O
(86%)
Me
Me
Me,..
0.1 N KOH,
Me
MeOH/H2O Me
(95%)
Me Me
f-Bu f-Bu
N S\342\200\224S N
i-Pr i-Pr
Ph3P, PhCH3
Me
Me
MnO2, CH2CI2
\320\236
\320\276' '\342\200\242\320\276\320\275
V I Me 1
Me Me
41 1: erythronolide \320\222
OH
OBz \342\200\236Me
OBz
Me. 9 Me cycll- Mev>4>^.Me
1 N LiOH, Me zatlon un
loB;
\320\235\320\236 OH T.OBzT
\320\275\320\276
zL
OH
\320\276' 30%H2O2, I
OBz
THF
\320\233\320\265
V^
1 'OBz
Me Me Me
39
11.4 Conclusion
Corey's synthesis of erythronolide \320\222
A) is a beautiful illustration
of the traditional approach to the creation of consecutive arrays of
stereogeniccenters.Through a short sequence of reactions in which
the bromolactonization reaction plays a commanding role, a simple,
symmetrical aromatic ring is moldedinto a saturated six-membered
ring which is laden with six contiguous asymmetric carbon atoms
(see intermediate 14). In addition, the formation of the oxygenated
stereogenic center at C-6 through a regioselective and stereospecific
Baeyer-Villiger oxidation, and the efficient coupling of intermedi-
11
intermediates and 12, an exercise in stereochemical correlation,20 are
both noteworthy transformations in this synthesis.
Natural product total syntheses are particularly valuable when
they are attended by the development of general utility methods of
synthesis. In some instances, the successful completion of a natural
References
1. (a) Corey, E.J.; Trybulski, E.J.; Melvin, L.S., Jr.; Gerzon, K.; Flynn, E.H.; Sigal, M.V., Jr.; Weaver, O.;
Nicolaou, K.C.; Secrist, J.A.; Lett, R.; Sheldrake, Quarck, U.C; Chauvette, R.R.; Monahan, R. ibid.
P.W.; Falck, J.R.; Branelle, D.J.; Haslanger, M.F.; 1957, 79, 6062;(f) Wiley, P.P.; Sigal, M. V., Jr.; Wea-
Kim, S.; Yoo, S. J. Am. 4618;
Chem. Soc. 1978, 100, Weaver, O.; Monahan, R.; Gerzon, K. ibid. 1957, 79,
(b) Corey, E.J.; Kim, S.; Yoo, S.; Nicolaou, K.C.; 6070; (g) Harris, D.R.; McGeachin, S;G.; Mills, H.H.
Melvin, L.S., Jr.; Branelle, D.J.; Falck, J.R.; Try- Tetrahedron Lett. 1965, 679; (h) Djerassi,C; Halpern,
Trybulski, E.J.; Lett, R.; Sheldrake, P.W.ibid. 1978,100, O.; Wilkinson, D.I.; Eisenbraun, E. J. Tetrahedron
4620. 1958, 4, 369.
2. Woodward, R.B. In Perspectives in Organic Chemis- 4. Corey,E.J.; Nicolaou, K.C J. Am. Chem. Soc. 1974,
Todd,
Chemistry, A., Ed., Interscience Publishers; New York 96, 5614.
1956, p. 155 (seep. 160). 5. (a) Corey, E.J.; Nicolaou, K.C; Melvin, L. S., Jr.
3. (a) Perun, T. J. In Drug Action and Drug Resistance J. Am. Chem. Soc. 1975,97, 653; Corey, E.J.; Nico-
in Bacteria, Vol. /, Mitsuhashi, S., Ed., University of Nicolaou, K.C; Melvin, L.S., Jr. ibid. 1975, 97, 654; (b)
Tokyo Press: Tokyo, 1971, pp. 123-152;(b) Flynn, Nicolaou, \320\232. Tetrahedron
\320\241 1977, 33, 683; (c) Masa-
E.H.; Sigal, M. V., Jr.; Wiley, P.P.; Gerzon, K. J. Am. mune, S.; Bates, G. S.; Corcoran,J. W Angew. Chem.
Chem. Soc. 1954, 76, 3121; (c) Gerzon, K.; Flynn, Int. Ed. Engl. 1977, 16, 585; (d) Paterson, I., Mansuri,
E.H.; Sigal, M.V., Jr.; Wiley, P.P.; Monahan, R.; M.M. Tetrahedron 1985, 41, 3569.
Quarck, U.C. ibid. 1956, 78, 6396; (d) Sigal, M.V.. 6. Corey, E.J.; Branelle, D.J.; Stork, P.J. Tetrahedron
Jr.; Wiley, P.F.; Gerzon, K.; Flynn, E.H.; Quarck. Lett. 1976, 3405.
U.C; Weaver, O. ibid. 1956,78, 388; (e) Wiley, PR:
184 11 Erythronolide \320\222
Y.KishiA979)
Monensin
12.1 Introduction
arise when these optically active fragments are joined must neces-
necessarily be the desired ones. On the other hand, when addressing the
synthesis of a molecule that contains multiple stereocenters in
proximity, it is often possible to exploit preexisting asymmetry for
the purpose of establishing new asymmetry. Stereochemical control
in this sense is referred to as relative asymmetric induction1*
because a stereocenter(s)already present in the substrate molecule
guides the introduction of a new stereocenter(s); the newly intro- Spiroketalization
expect that exposure of the keto triol resulting from the hydrogen-
olysis of the C-5 benzyl ether in 2 to an acidic medium could,
under equilibrating conditions, result in the formation of the spiro-
spiroketal in 1. This proposition was based on the reasonable assump-
that
assumption the configuration of the spiroketal carbon (C-9) in monen-
monensin
corresponds to the thermodynamically most stable form, as is
the case for most spiroketal-containing natural products.19 Spiro-
ketals found in nature usually adopt conformations in which steric
effects are minimized and anomeric effects are maximized.
188 12 Monensin
10 11 14 15
7)\342\200\224\320\273 .Et
I\342\200\224V I\342\200\224V Me
Spiroketalization
Me
1: monensin
Ho
Aldol condensation
OMe OH
i \320\223\320\276'; ri
\320\223\320\276'1
MeH Et H H H OMe
13
Me
OH
H It H H H OMe
14
\302\2534 Me Me
.\320\236\320\235
H Et H
\320\275 H \320\275
H
\320\275 I \320\236\320\234\320\265
|
-1 14 I
= Ring closure
\320\220\320\263 \320\233\342\200\224
\320\236\320\234\320\265
-?-^
\320\264
Horner-Wadsworth-
Mev Me.
Emmons reaction
Me Me CO2Me ^\320\242\320\276\320\242\320\242\320\276-\320\223\320\232\320\276^^^\"\"
\320\235 Et \320\235 \320\235
\320\235
9 <1
7 J^
\320\236
15
\320\236\320\234\320\265
Bromide
displacement
Bromoetherification
OBn
Ar\342\200\224
= \320\236
i \342\200\242
H Et H
Wltti9 reaction 17 ^ Wittig reaction
Hydroxy epoxide
cyclization | Me
^CN
Ar\".
Carbonyl
addition 21
16. Et
EtO2C 17
OBn OBn
23 22
OBn
25
the retron for the aldol condensation transform.21 Thus, retrosyn- 7\321\201\320\275\320\276
enolate derived from methyl ketone 4 and aldehyde 3 could accom- )\342\200\224OMe
accomplish the simultaneous creation of the C7-C8 bond and the hydrox- Me\342\200\224/
The stereocontrolled
synthesis Kishi et al. designed for monensin's
left wing, intermediate 3, is detailed in Schemes 3. 2-Furyl-
2 and
acetonitrile A2), a known substance, can be conveniently converted
to 2-B-furyl)propionaldehyde A1) in four straightforward steps.
Thus, methylation of the nitrile-stabilized anion derived from 12,
followed by basic hydrolysis of the nitrile function, provides car-
boxylicacid 27. Although the (R) enantiomer of 27 is illustrated in
Ph3P; CO2Et
Y
Me
\320\263
\320\240\320\277\320\235,\320\224G0%)
BH3 \342\200\224N
OBn B2H6, THF, BnO LIAIH4,
0 C; then 25 \302\260C
\342\200\242 // V
Me
/
1. Ph\342\200\224\320\241
NCO
1|fu
\302\246
rVrlj
Mai
Hid, OMe OH fSK-)-a-methyI-
DMF-THF, 0 \302\260C benzyiisocyanate,
\302\273-
2. H2,10% Pd-C, Et3N, 50 \302\260C
MeOH, 25 \320\241
2. resolution
3. LiAIH4
(88% overall)
(8:1 mixture of
diastereoisomers PCC, CH2CI2,
in favor of 28) 25 \302\260C
(88%)
Me
allylic
destabilizing 1,3-strain,27 the C-4 methyl group in 9a resides in a
common plane with the C-2 hydrogen, not with the bulkier methyl
or furanyl groups. The hydroboration reaction then takes place
across the sterically less hindered a-face to give 28. The single
stereogeniccenter in 9 imparts facial selectivity to the
hydrobora-
hydroboration
reaction, while C3-C4 relative stereorelationship
the anti in 28
arises naturally from the trans olefm geometry in 9. This impres-
impressive transformation thus proceeds with both relative and internal
asymmetric induction.18It should be noted here that although this
steric model adequately rationalizes the observed stereochemical
196 12 Monensin
// V
alcohol (\302\261)-29. With a free primary hydroxyl group, compound (\302\261)-29
provides a convenient opportunity for optical resolution at this
Me Me
stage. Indeed, separation of the equimolar mixture of diastereo-
meric urethanes (carbamates) resulting from the action of (S)-(\342\200\224)-a-
methylbenzylisocyanate on (\302\261)-29, followed by lithium aluminum
OMe \320\236 hydride reduction of the separated urethanes, provides both enantio-
mers of 29 in optically active form. Oxidation of the levorotatory
alcohol (-)-29 with PCC furnishes enantiomerically pure aldehyde
8 (88% yield).
Extensive studies of the Wittig and the related Horner-Wads-
worth-Emmons reaction have shown that the structural features of
the component
carbonyl and/or the ylide component, the solvent,
OMe and the reaction temperature can all significantly influence the
stereochemical outcome of the olefination event.28 Interestingly,
when aldehyde 8 is condensed with the stabilized anion derived
Me Me CO2Me from (MeOJP(O)CH(CH3)CO2Me in THF at -78->-50\302\260C, \321\201\320\274
\302\260
OMe B2H6,THF, 0 OMe OH OH
then H2O2,
(80%)
diastereoisomers
in favor of 5)
I I 2. PCC, ll 2. CH2N2 I I
Me Me Me CH2CI2 Me Me Me Me Me Me
E5% overall)
3 31 30
(89%overali)
MOM = CH2OCH3
tute for a carboxyl group.25-26 Gratifyingly, the furan ring has been
impervious to all of the reactions described thus far, it has even
and
served as a stereocontrollinggroup in a crucial transformation (see
9\342\200\224>28,Scheme 2). Nonetheless, it is now time to effect the oxida-
tive cleavage of the furan ring. As an electron-rich entity, a furan
4N=c=O
(S>(+)-1-A-naphthyl)
ethyl isocyanate,
Et3N, 25 \302\260C
2. resolution
Et 3. LiAIH4
24 25
CH3C(OEtK,
CH3CH2CO2H,
140 \302\260C
[3,3] rtEt
OBn EtO2C OBn
Johnson ortho ester
Claisenrearrangement
23 22
1. MeO MgBr
Et2O, 0 \302\260C
OHC 17
OBn
2. CrO3, H2SO4,
H2O-(CH3JCO
3. BCI3
21
[31%fromfSH-)-33]
\320\220\320\223: -OMe
mCPBA,
CH2CI2,
^~
aq.
\320\276\320\275 NaHCO3,
25 \302\260C
[OH-directed
21b epoxidation] 35
[destabilized by
allylic 1,3-strain] 1. p-TsCI, pyr., 0 \302\260C
2. UAIH4, Et2O, 0 \302\260C
Et
\320\276
Me Me
mCPBA, aq. KOH
CH2CI2
U
37 (Baeyer-Villiger 38 (\302\261)-39
oxidation)
1. (+)-a-methylbenzylamine
2. resolution
1. LiAIH4, Et2O
2. MsCI, 1. \320\225\320\256\320\235,
Me Me pyr., \302\246 Me
Me \302\246 Me Me
o\302\260c H2SO4, \320\224
CO2Et CO2H
SPh 2. BrCH2OCH3,
3. PhSNa,
\320\236\320\234\320\236\320\234 DMF \320\236\320\234\320\236\320\234 PhNMe2, \320\276\320\275
CH2CI2, 25 \320\241
41 40 W-39
1. CH3CO3H,NaOAc,
0 \302\260C
AcOH-CH2Ci2,
2. \320\224, decalin
\320\241\320\260\320\241\320\236\320\267,
Me Me 1. HCI, \320\225\320\256\320\235.\320\224 Me Me
2. MsCI, pyr., 0 \320\241
rvPh *-
3. LiBr, DMF, 100 \302\260C
\320\275 o \320\276\320\274\320\276\320\274
\320\276\320\274\320\276\320\274 4. Ph3P, DMF, 120 \302\260C
alternative diastereomer.
Although the action of electrophilicbromine on 17 effects the
desired cyclization reaction, the bromine atom in the product must
Me Me
CH3S(O)CH2Na,
\302\273
DMSO, 25 \302\260C
\302\251PPh3
Br\302\251
43
C13-C16
C13-C16
45
\\bromoetherification
Me. Me.
KO2,18-crown-6, DMSO
1. CI3CCOCI,\321\200\321\203\320\263.,
\320\236
\320\241
2. OsO4, pyr., THF, 25 \302\260C
3. PhCOCi, pyr., CH2Ci2,25 \302\260C
4. CrO3, H2SO4, \320\2352\320\236-(\320\241\320\235\320\267J\320\241\320\236
Me Me. Me.
.Me 1. NaOMe,
OH
MeOH, 25 \302\260C
Ar
2. (CH3OKCH, \320\223\320\276'=
\320\223\320\276'1
/\\ 0-
H Et H H H OMe H Et H H H
MeOH, CSA,
14 CH2CI2, 25 \302\260C
E3% overall) 15
Me. .Me
Li, \320\225\320\256\320\235,
MeO- MeO
=J Toi Pol \320\223\320\276^-\321\207
Nh3(i) \320\223\320\276'=
\320\223\320\276'|
I o\\
i
H Et H H H MeO \\..
\320\227\320\232>
H Et H H H MeO '
OH OH
14 47
1. (CH3OKCH, MeOH,CSA,
CH2CI2,25 \302\260C
2. O3, MeOH, -78 \302\260C
3. MgBr2, CH2CI2-H2O,
25 \302\260C
MeMgBr,
\302\260\320\235 Et
\302\260
\320\236\320\235\320\241 \320\235 \320\235
\320\220
25 X \342\200\236\320\265\320\276
\320\276\320\275
Me
48
Re face addition
\320\236\320\235
\320\274\320\265
B2% from 14)
49 13
\321\201\320\275\320\276
Nu
OBn \\
H Me *Pr2NMgBr, W^Me
OMe H-+
THF, -78 \302\260C
B1% yield; 92% yield T
based on recovered 4) C5-C,
Med Me
3
aldol condensation
H Me
1. 10%Pd-C,
\320\2352,
MeOH-AcOH A00:5), 25 \302\260C
2. CSA, H2O,
CH2CI2-Et20C:1), 25 \302\260C CO2Me
1
H Me
1N NaOH-MeOHA:5),
60 \302\260C
12.4 Conclusion
relationships
- stereochemical communication and stereochemical
correlation.Kishi's elegant synthesis of monensin also provides an
instructive demonstration of allylic 1,3-strain as an element for
References
1. (a) Dobler, M. Ionophores and Their Structures, R. E.; Anderson, R.C.; Badoud, R.; Fitzsimmons,
John Wiley & Sons: New York, 1981; (b) Westley, B.J.; McGarvey, G.J.; Thaisrivongs, S.; Wilcox, C. S.
J.W. Adv. Appl. Microbiol.177; (c) Press-
1977, 22, J. Am. Chem. Soc. 1983, 105, 1988; (c) Ireland,
Pressman, B.C. Annu. Rev. Biochem. 1976, 45, 501;(d) R.E.; Norbeck, D.W. ibid. 1985, 107, 3279; (d) Ire-
Westley, J.W. Annu. Rep. Med. Chem. 1975, 10, Ireland, R.E.; Norbeck, D.W.; Mandel, G.S.; Mandel,
246. N.S. ibid. 1985, 107, 3285; (e) Ireland, R.E. Aldri-
2. Polyether Antibiotics: Naturally Occurring Acid Aldrichimica Acta 1988, 21, 59; (f) Kallmerten, J.; Witt-
Ionophores, Westley, J. W., Ed., Marcel Dekker: New man, M.D. Stud. Nat. Prod. Chem. 1989, 3, 233.
York, 1982, Vol. 1-2. 9. (a) Nakata, T; Kishi, Y Tetrahedron Lett. 1978,
3. Agtarap, A.; Chamberlin, J. W.; Pinkerton, M.; Stein- 2745;(b) Still, W.C.; McDonald, J.H., III ibid. 1980,
rauf, L. J. Am. Chem. Soc. 1967, 89, 5737. 21, 1031;(c) Still, W.C.; Schneider, J.A. ibid. 1980,
4. Stark, W. M. In Fermentation Advances, Perlman, 21, 1035; (d) Reetz, M.T. Angew. Chem. Int. Ed.
D., Ed., Academic Press: New York, 1969, 517. Engl. 1984, 23, 556.
5. Kishi, Y. Aldrichimica Acta 1980, 13, 23. 10. (a) Evans, D.A.; Nelson, J.V.; Taber, T.R. Top.
6. (a) Fukuyama, Vranesic,
\320\242.; \320\222.;
Negri, D.P.; Kishi, Y. 1;
Stereochem.1982,13, (b) Evans, D.A. Aldrichi-
Tetrahedron Lett. 1978, 2741; (b) Johnson, M.R.; Acta
Aldrichimica 1982, 75, 23; (c) Heathcock, C.H. In
Nakata, Kishi,
\320\242.; Y. ibid. 1979, 4343; (c) Johnson, Asymmetric Synthesis, Morrison, J. D., Ed., Aca-
M.R.; Kishi, Y ibid. 1979, 4347;(d) Hasan, I; Kishi, Academic Press: New York, 1984, Vol. 3, p. Ill; (d)
Y. ibid. 1980, 21, 4229. Heathcock,\320\241. Aldrichimica
\320\235. Acta 1990, 23, 99.
7. (a) Rychnovsky, S.D.; Bartlett, PA. J. Am. Chem. 11. Evans, D.A.; Bender, S.L.; Morris, J. J. Am. Chem.
Soc. 1981, 103, 3963; (b) Bartlett, PA. In Asym- Soc. 1988, 110, 2506.
Asymmetric Synthesis, Morrison, J. D., Ed., Academic 12.Nakata, Schmid,
\320\242.; G.; Vranesic, \320\222.;
Okigawa, M;
Press: New York, 1984, Vol. 3, p. 411. Smith-Palmer, \320\242.; Kishi, Y J. Am. Chem. Soc. 1978,
8. (a) Ireland, R.E.; Thaisrivongs, S.; Vanier, N.; Wil- 100,2933.
cox, S.
\320\241 J. Org. Chem. 1980, 45, 48; (b) Ireland,
References 209
13. For reviews of synthetic achievements in the poly- 24. Reference 16, p. 521.
ether field, see: (a) Kishi, Y. In Polyether Antibiot- 25. (a) Danishefsky, S.J.; Kerwin, J.F.; Kobayashi, S.
Antibiotics:
Naturally Occurring Acid lonophores, Westley, J. Am. Chem. Soc. 1982, 104, 358; (b) Larson, E.R.;
J. W., Ed., Marcel Dekker: New York, 1982, Vol. 2, Danishefsky, S.J. ibid. 1983, 705, 6715; (c)
Ch. 1; (b) Wierenga, W. In The Total Synthesis of Danishefsky, S.J.; Pearson, W.H.; Segmuller, B.E.
Natural Products, ApSimon, J., Ed., Wiley-Inter- ibid. 1985,107,1280;(d) Danishefsky, S. J.; Harvey,
science: New York, 1981, Vol. 4, p. 263; (c) Seealso, D.F. ibid. 1985, 107,6647; (e) Danishefsky, S.J.;
Walba, D.M.; Thurmes, W.N.; Haltiwanger, R.C. Maring, \320\241 ibid. 1985, 107, 7762; (f) Mukaiyama, \320\242.;
J. Org. Chem. 1988, 53, 1046,and references cited Tsuzuki, R.; Kato, J. Chem.Lett. 1985,837; (g) Carl-
therein. sen, P.H.J.; Katsuki, Martin,
\320\242.; V.S.; Sharpless,
14. (a) Schmid, G.; Fukuyama, Akasaka,
\320\242.; K.; Kishi, Y. K.B. J. Org. Chem. 1981, 46, 3936.
J. Am. Chem. Soc. 1979, 101, 259; (b) Fukuyama, 26. Lipshutz, B.H. Chem. Rev. 1986, 86, 795.
\320\242.;
Wang, C.-L.J.; Kishi, Y. ibid. 1979, 101,260; (c) 27. (a) Johnson, F. Chem. Rev. 1968, 68, 375;(b) Hoff-
Fukuyama, Akasaka,
\320\242.; K.; Karanewsky, D. S.; Hoffmann, R.W Chem. Rev. 1989, 89, 1841.
Wang, C.-L. J.; Schmid, G.; Kishi, Y. ibid. 1979, 28. For an excellent review of the Wittig and related
101, 262. reactions, see: Maryanoff, B.E.; Reitz, A. B. Chem.
15.For other total syntheses of monensin, see: (a) Col- Rev. 1989, 89, 863.
McDonald, J.H., III; Still,
lum, D.B.; WC. J. Am. 29. For an excellent review of substrate-directed chemical
Chem. Soc. 1980, 102, 2117;(b) Collum, D.B.; reactions, see: Hoveyda, A. H.; Evans, D.A.; Fu,
McDonald, J.H., \320\250.;Still, ibid. 1980,
W.C. 102, G.C. Chem. Rev. 1993, 93, 1307.
2118;(c) Collum, D.B.; McDonald, J.H., HI.; Still, 30. Johnson, W.S.; Werthemann, L.; Bartlett, W.R.;
W.C. 1980, 102, 2120; (d) Ireland,
ibid. R.E.; Arm- Brocksom, T.J.; Li, T.T.; Faulkner, D.J.; Petersen,
Armstrong, III.; Lebreton, J.; Meissner,R. S.; Rizza-
J.D., M.R. J. Am. Chem. Soc. 1970, 92, 741.
casa, M.A. ibid. 1993, 115, 7152;(e) Ireland, R.E.; 31. (a) Faulkner, D.J. Synthesis 1971, 175;(b) Hill, R.K.
Meissner, R. S.; Rizzacasa, M.A. ibid. 1993, 115, In Asymmetric Synthesis, Morrison, J. D., Ed., Aca-
7166. Academic Press: New York, 1984, Vol. 3, p. 503.
16. Woodward, R.B. Pure & Appl. Chem. 1968,17, 519 32. (a) Kilb, R.W.; Lin, C.C.; Wilson, E.B., Jr. J. Chem.
(see pp. 520-521). Phys. 1957, 26, 1695; (b) Herschbach,D.R.; Krisher,
17. Danishefsky, S. J. Aldrichimica
Acta. 1986, 19, 59. L.C. ibid. 1958, 28, 728; (c) Bothner-By, A.A.;
18. Bartlett, Tetrahedron 1980, 36, 2.
P. A. Naar-Colin, C; Giinther, H. J. Am. Chem. Soc. 1962,
19.For a review of the chemistry of spiroketals, see: 84, 2748.
Perron, F.; Albizati, K.F. Chem. Rev. 1989, 89, 1617. 33. (a) M.N.; Rondan, N.G.; Houk,
Paddon-Row, K.N.
20. Ireland, R.E.; Habich, D.; Norbeck, D.W J. Am. J. Am. Chem. Soc. 1982,104,7162; (b) Houk, K.N.;
Chem. Soc. 1985, 107, 3271. Rondan, N. G.; Wu, Y.-D.; Metz, J.T.; Paddon-Row,
21. Corey, E.J.; Cheng, X.-M. The Logic of Chemical M.N. Tetrahedron 1984, 40, 2257.
Synthesis, John Wiley and Sons: New York, 1989. 34. Krow, G. R. In
Comprehensive Organic Synthesis,
22. (a) Cram, D.J,; Abd Elhafez, F. A. J. Am. Chem. Soc. Trost, B.M.; Fleming, I., Eds., Pergamon Press: New
1952,74, 5828; (b) Cherest, M.; Felkin, H.; Prudent, York, 1991, Vol. 7, p. 671.
N. Tetrahedron Lett. 1968, 2199; (c) Anh, N.T.; 35. (a) Valters, R. Russ. Chem. Rev. (Engl. Transl.)
Eisenstein, O. Nouv. J. Chim. 1977,1, (d) Anh, 61; 1974,43, 665; (b) Valter, R.E. ibid. 1973, 42, 464.
N.T. Top. Curr. Chem. 1980, 88, 145. 36. Corey, E. J.; Nicolaou, K.C.; Shibasaki, M.; Machida,
23. For some informative discussions, see: (a) Morrison, Y; Shiner, C.S. Tetrahedron Lett. 1975, 3183.
J. D.; Mosher, H. S. Asymmetric Organic Reactions, 37. (a) Kaiser, E.M. Synthesis 1972, 391; (b) Harvey,
Prentice-Hall: Englewood Cliffs, New Jersey, 1971, R.G. ibid. 1970, 161; (c) Caine, D. Org. React.
Ch. 3; (b) Eliel, E.L. In Asymmetric Synthesis, Mor- (N Y.) 1976, 23, 1.
Morrison, J.D., Ed., Academic Press: New York, 1983, 38. (a) Cram, D.J.; Kopecky, K.R. J. Am. Chem. Soc.
Vol. 2, p. 125; (c) reference 18, p. 15-16; (d) Mul- 1959, 81, 2748; (b) Cram, D.J.; Wilson, D.R. ibid.
zer, J. In Organic Synthesis Highlights, Mulzer, J.; 1963, 85, 1245.
Altenbach, H.-J.; Braun, M.; Krohn, K.; Reissig, 39.Evans, D.A.; Sacks, C.E.; Whitney, R.A.; Mandel,
H.-U., VCH Publishers: Weinheim, New York, 1991, N. G. Tetrahedron Lett. 1978, 727.
p. 3.
Me
1: periplanone \320\222
W. \320\241Still A979)
\320\222
Periplanone
13.1 Introduction
periplanone and
\320\222
conclusively established that 1 correctly depictsthe
gross structure and relative stereochemistry of this molecule.5 From
the standpoint of strategy and synthetic design, Still's periplanone
\320\222
synthesis provides a striking demonstration of the power of the
anionic oxy-Cope rearrangement for the synthesis of cyclodecanoid
frameworks6 and, equally noteworthy, it demonstrates how insights
212 13 Periplanone\320\222
selective
Me
P
functionalization
Me
\320\225\320\225\320\236
1: periplanone \320\222 = '
\320\225\320\225 \320\276 anionic
oxy-Cope
rearrangement
selective appendage
'
introduction
\320\225\320\225\320\236 \320\225\320\225\320\236
220 \302\260C
OH
220 3 h
\302\260C, enol
tautomerization
H (90%yield)
III IV
KH, THF,
18-crown-6,
18 h, 25 \302\260C
Scheme 2. Representative Cope (a), oxy-Cope (b), and anionic oxy-Cope (c) rearrangements.
214 13 Periplanone\320\222
ment6a,e,8,i] js a particularly valuable tool in synthesis because, in
this case, the Cope rearrangement is driven thermodynamically by
product isomerization to an unsaturated ketone (see conversion of
III to IV, Scheme 2bI2; the formation of the carbonyl through enol
tautomerization provides a thermodynamic impetus for the oxy-
Cope rearrangement and rendersthe [3,3] sigmatropic process irre-
irreversible.
.0 Me3Sn OTMS
1. LDA,THF,O\302\260C
2. crotonaldehyde, -78 \320\241 Me 1. LiSnMe3 Me
THF, 70 \302\260C
Et2O
Me
EEO' 8 EEO EEO
E7% from 7)
EEO' 9 EEO
OTMS scopic data and the known preference for a chair-like transition state
geometry for the oxy-Cope rearrangement.6b>c
Me
The expedient synthesis of intermediate 2 marked the achieve-
achievementof the first synthetic objective. The recognition that it should
i I
be possible to functionalize the periphery of intermediate 2 in a
^\" Me
9
controlled and selective fashion by taking advantage of conforma-
tional preferences of cyclodecanoidintermediates is an elegant and
central feature of Still's strategy. To minimize destabilizing transan-
nular interactions, 1,4- and 1,5-cyclodecadienes adopt well-defined
and predictable conformations wherein the planes of the olefinic
groups and the plane of the ring are perpendicular.73 This confor-
mational preferencerendersthe exterior face of a medium-ring dou-
double bond much more accessible and enforces a peripheral attack by
reagents (see Figure 1). The synthesisof the first diastereomer of 1
EEO 2 commences with the conversion of the secondary alcohol in 2 to
the corresponding teTt-butyldimethylsilyl ether in the conventional
way (see Scheme 4). As expected, the protected C-5 hydroxymethyl
substituent in 11 adopts an equatorial orientation preferentially,
defines the local conformation76'8 of the ten-membered ring (see
structure 11a), and enforces a stereoselective, peripheral epoxida-
Peripheral attack
OTBS \320\275
\320\275
\320\275
Me
f-BuMe2SiCi,
Me Me
imidazole, DMF EEO
\320\276 OTBS
Me 11\320\260
EEO EEO'' 11
f-BuOOH,
TBS = Sif-BuMe2 Triton B,
Triton \320\222
= /V-benzyltrimethyl- THF
ammonium hydroxide F6% from 2)
1. 25 \302\260\320\241
\320\220\321\201\320\236\320\235-\320\2352\320\236, 0 \302\251
OTBS
2. o-NO2C6H4SeCN, Y CH2SMe2,
THF, \320\236\302\260\320\241
\320\277-\320\222\320\2703\320\240, DMSO-THF
4. />-Bu4NF, THF
5. CrO3\302\2732pyr., EEO EEO' 12
CH2CI2
OTBS OH
1. Me3SiCH2MgCI, Et2O 9...
2. KH, THF F2% overall)
3. />-Bu4NF,THF
EEO' 12 EEO
f-BllOOH,
VO(acacJ,
PhH
(95% overall)
1. CrO3*2pyr., CH2CI2
2. AcOH-H2O
3. o-NO2C6H4SeCN,
/>-Bu3P, THF
4. H2O2, THF
3. H2O2,THF Me
\320\225\320\225\320\241\320\223
11
E4% overall)
OTBS 0 \302\251
CH2SMe2)
DMSO-THF
F9%)
18a
D:1 mixture of epoxide
diastereomers)
1. n-Bu4NF,
THF
2. CrO3\302\2732pyr.,
CH2CI2
(81% overall)
13.4 Conclusion
References
1. Roth, L.M.; Willis, E.R. Am. Midi. Nat. 1952, 47, 65. 9. Cope, A.C; Hardy, E.M. J. Am. Chem. Soc. 1940,
2. (a) Persoons, C.J.; Verwiel, P.E.J.; Ritter, F.J.; Tal- 62,441.
man, F. E.; Nooijen, P. F. J.; Nooijen, W. J, Tetrahedron 10. Vogel, E.; Grimme, W.; Dinne, E. Angew. Chem. Int.
Lett. 1976, 2055; (b) Talman, E.; Verwiel, J.; Ritter, Ed. Engl. 1963, 2, 739.
F.J.; Persoons,C.J. hr. Chem. J. 1978, 17, 227; (c) 11.Berson, J. A.; Jones, M., Jr. J. Am. Chem. Soc. 1964,
Persoons, C.J.; Verwiel, P.E.J.; Talman, E.; Ritter, 86, 5019.
F. J. J. Chem. Ecol. 1979, 5, 219. 12.Marveii, E.N.; Whalley, W. Tetrahedron Lett. 1970,
3. Still, W.C. J. Am. Chem. Soc. 1979,101,2493. 7, 509.
4. For some insightful discussions, see: (a) Eschenmoser, 13. Evans, D.A.; Golob, A.M. J. Am. Chem. Soc. 1975,
A.; Wintner, C.E. Science (Washington DC.) 1977, 97, 4765.
196, 1410;(b) Woodward, R.B. In Perspectives in 14.Still, W.C. J. Am. Chem. Soc. 1977,99, 4186.
Organic Chemistry, Todd, A., Ed., Interscience Pub- 15. (a) Evans, D.A.; Baillargeon, D.J. Tetrahedron Lett.
Publishers: New York,'1956, p. 155. 1978, 36, 3315; (b) Evans, D.A.; Baillargeon, D.J.
5. The absolute configuration of periplanone \320\222 was also ibid. 1978, 36, 3319;(c) Steigerwald, M.L.; God-
determined, see: Adams, M.A.; Nakanishi, K,; Stiii, dard, W. A., Ill; Evans, D.A. ibid. 1979, 101, 1994.
W.C; Arnold, E.Y.; Clardy, J.; Persoons, C.J. J. Am. 16.For some insightful discussions, see: (a) Overman,
Chem. Soc. 1979, 101, 2495. L.E. Ace. Chem. Res. 1992, 25, 352; (b) Overman,
6. (a) Hill, R. K. In Asymmetric Synthesis, Morrison, L. E. Abstracts, 33rd National Organic Symposium,
J.D., Ed., Academic Press: New York, 1984, Vol. 3, June 13-17, Bozeman, Montana, ACS Division of
p. 503; (b) Paquette, L.A. Synlett 1990, 67; (c) Organic Chemistry, 1993, 96.
Paquette, L. A. Angew. Chem. Int. Ed. Engl. 1990, 29, 17.(a) Still, W.C. J. Am. Chem. Soc. 1977,99, 4836;
609; (d) Wilson, S.R. Org. React. (N.Y.) 1993, 43, (b) Still, W.C. ibid. 1977, 99, 418&.
93; (e) Hill, R. K. In Comprehensive Organic Synth- 18. (a) Magid, R. M. Tetrahedron 1980, 36, 1901; (b)
Synthesis, Trost, B.M.; Fleming, I., Eds., Pergamon Press: Paquette, L.A.; Stirling, C.J.M. ibid. 1992, 48,
New York, 1991, Vol. 5, p. 785; (f) Hesse, M. Ring 7383.
Enlargement in Organic Chemistry, VCH Publishers: 19. (a) Rubottom, G.M.; Gruber, J. M.; Juve, H.D., Jr.
Weinheim, New York, 1991. Org. Synth. 1985,64, 118.
7. (a) Still, W.C; Galynker, I. Tetrahedron 1981, 37, 20. Grieco, P.A.; Nishizawa, M.; Oguri, Burke,
\320\242.; S.D.;
3981; (b) Still, W.C; MacPherson, L.J.; Harada, \320\242.; Marinovic, N. J. Am. Chem. Soc. 1977, 99, 5773.
Cailahan, J.F.; Rheingold, A.L. ibid. 1984, 40, 2275; 21. (a) Corey, E.J.; Chaykovsky, M. J. Am. Chem. Soc.
(c) Still, W. \320\241 In Selectivity - A Goal for Synthetic 1965, 87, 1353; (b) Trost, B.M.; Melvin, L.S., Jr.
Efficiency, Bartmann, W.; Trost, B.M., Eds., Verlag Sulfur Ylides, Academic Press: New York, 1975; (c)
Chemie: Weinheim, 1984, p. 263; (d) Still, W.C. In Block, E. Reactions of Organosulfur Compounds,
Current Trends in Organic Synthesis, Nozaki, H., Academic Press: New York, 1978.
Ed., Pergamon Press: Elmsford, New York, 1983, 233; 22. (a) Grieco,P. A.; Gilman, S.; Nishizawa, M. J. Org.
(e) Vedejs, E.; Dolphin, J.M.; Gapinski, D.M.; Masta- Chem. 1976, 41, 1485.
lerz, H. In Current Trends in Organic Synthesis, 23. (a) Peterson, D.J. J. Org. Chem. 1968, 33, 780; (b)
Nozaki, H., Ed., Pergamon Press: Elmsford, New Peterson, D.J.; Chan, \320\242.\320\235.; Chang, E.; Vinokur, E.
York, 1983, p. 221;(f) Vedejs, E.; Dent, W.H., III; Tetrahedron Lett. 1970, 1139; (c) Ager, D.J. Org.
Gapinski, D.M.; McClure, C.K. J. Am. Chem. Soc. React. (N. Y.) 1990, 38, 1.
1987, 109, 5437; (g) Vedejs, E.; Gapinski, D.M. ibid. 24. (a) Sharpless, K.B.; Michaelson, R.C J. Am. Chem.
1983, /05, 5058. Soc. 1973,95, 6136;(b) Sharpless, K.B.; Verhoeven,
8. Rhoads, S.J.; Raulins, N.R. Org. React. (N Y.) 1975, T.R. Aldrichimica Acta 1979, 12, 63.
22, 1. 25. Hoveyda, A.H. Evans, D.A.; Fu, G.C Chem. Rev.
1993, 93, 1307.
14
\320\274\321\221
1: isocomene
M.C.PirrungA979)
Isocomene
14.1 Introduction
Me skeletal Me
Me / rearrange-
rearrangement
1: isocomene
[2*2]
Photocycloaddltlon
BrMg
Me
Ph3P=CH2,
DMSO,70 \302\260C
G7%)
Bond b migration
Bond a migration
4\302\256
14.4 Conclusion
In this synthesis, we have witnessed the dramatic productivity of
References
1. Zalkow, L.H.; Harris, R.N.; Van Derveer, D.; Ber- Fetizon, M.; Flament, J.P. ibid. 1975, 31, 1897;
trand, J. /. Chem. Soc, Chem.Commun. 1977, 456. (d) Ohfune, Y; Shirahama, H.; Matsumoto, T.
2. (a) Pirrung, M.C. J. Am.
Chem. Soc. 1979, 101, 7130; Tetrahedron Lett. 1976, 2869.
(b) Pirrung, ibid. 1981, 103, 82.
M.C. 5. For reviews of methodology for the construction of
3. (a) Crimmins, M.T. Chem. Rev. 1988, 88, 1453;(b) quaternary carbon centers, see: (a) Martin, S.F.
Crimmins, M.T. In Comprehensive Organic Synth- Tetrahedron 1980, 36, 419; (b) Fuji, K. Chem. Rev.
Synthesis;Trost, B.M.; Fleming, I.; Eds., Pergamon Press: 1993, 93,2037.
New York, 1991, Vol. 5, p. 123; (c) Crimmins, M.T.; 6. (a) Trippett, S. Q. Rev. Chem. Soc. 1963, 17, 406; (b)
Reinhold, T.L. Org. React. (N. Y.) 1993, 44, 297. Maercker, A. Org. React. (N. Y.) 1965, 14, 270; (c)
4. (a) Hayano, K.; Ohfune, Y; Shirahama, H.; Matsumo- Maryanoff, B.E.; Reitz, A.B. Chem. Rev. 1989, 89,
to, T. Chem. Lett. 1978, 1301; (b) Due, K.; Fetizon, M.; 863.
Tetrahedron
\320\234.
\320\232\320\276\320\277\320\265, 1978, 34, 3513; (c) Mahn, D.;
Et
Me
H Me-
W. \320\241Still A980)
Monensin
15.1 Introduction
ffe\342\200\224 / -S,
1\" EtMgBr Et ft\302\273
+
HO..
.E
2. workup Me^H
/
\342\204\226
/ IVa IVb
ill: acetaidehyde
Me \320\276 1. LiAIH4 Me OH Me H
HJ, fJA H<
^S r J-
+
/\\
Ph Me 2. Ph Me Me
H3O+
V: 3-phenyi-2- VI Vii
butanone (Vi:Vii/2.5:1)
M OH
R'M
Viii iX
L>M>S
in order of decreasing
steric bulk
x p x .\320\276\320\275
R'MY
-Hr\"
Xi XII XIII
X = heteroatom function
L = largesubstituent
S = small substituent
H Me
H Me
\"Me
?Hi5
\320\273-BuMgBr^ H
7 MEMO. .0
THF.-78X MEMO 'OH
Mg
(>95% yield) L/NL XV
diastereoseiectivity: >99:1
MEM = \320\241\320\2352\320\236(\320\241\320\2352J\320\236\320\241\320\235\320\267
\342\200\224Aldol
10 14
\342\200\236 15
,Et Me
Spiroketalization
Me
1: monensin
Carbonyl addition
CHO
C-C bond
formation Me.
Lactonization 11
Me-'
5 / \320\223i
Carbonyl
S
OMe
\320\233
OMe
Me
PyrS
Me Me
\320\236\320\234\320\265
OHC. 4 1 2 .CO2Me
\320\273
\320\267
CHO
V Me
OBn
Me Me
10 13 17
Lactonization H
OH \320\223
\320\276 \320\254
Me Me CHO Me
< Me
OBn
11:(+)-p-hydroxy- 14 18 19
isobuiyric acid
\320\233
\320\236\320\235
-CO2H
\320\275\320\2762\321\201\342\200\224
\\ \320\241\320\2362\320\235
\320\276\320\275
\320\234\320\262
\320\265^\320\234\320\262
Carbonyl addition
possibility of C2-C3 syn stereochemical relationship
creating the
through an aldol condensation with
intermolecular a propionate
Et Me
enolate or some equivalent. In turn, intermediate 10 can be traced
to (+)-/Miydroxyisobutyricacid A1), and it was anticipated that
a /?-chelation-controlled addition process (see 21+10\342\200\224> 22 in
Scheme 3) could guide the formation of the C-3 stereocenter in 9.
Since the geometry of the enolate derived from 21 would determine
Ring closure BnO. i-.\\2_/24 the configuration of the C-2 stereocenter in 9, it is imperative that
21 be converted into a Z enolate.14
Still's synthesis of intermediate 3, the right wing of monensin,
was designedto be highly convergent (Scheme 2). Retrosynthetic
C-C bond
formation
cleavage of the indicated bonds in 3 provides keto lactone 6 as a
Me viable precursor. The constitution of intermediate 6 is such that it
11 \\ 15 Me
13/ ought to permit an a-chelation-controlled addition10of ethylmagne-
sium bromide to the C-16 ketone carbonyl (see in
6\342\200\224>38\342\200\224>39
and, in this
particular application, a 5:1 mixture of syn aldol OTMS
diastereoisomers is formed in favor of the desired aldol adduct 22 Me
Me Me Me
(85% yield). The action of lithium diisopropylamide (LDA) and
magnesium(n) bromide on 21 affords a (Z) magnesium enolate that 22
236 15 Monensin
OBn
1. LDA, THF;
Nu
then MgBr2,
L
OH 0
-110 \302\260C
Me .OTMS .OTMS
JO 2. OBn
Me Me \320\276 Me Me
;'\320\2421^\320\234\320\265
Me Me
21 22
\321\201\320\275\320\276
E:1 mixture of C2-C3
syn aldol dlastereomers
10 in favor of 22)
(85% yield)
1. H5IO6, MeOH
2. KN(SiMe3J; E0%
th overall)
then (CH)
(CH3JSO4
OBn
Me
-AlEtj OMe \320\236 OMe
1. H2,10%Pd-C
OHC CO2Me CO2Me
THF, -78 \302\260C
Me Me
2. CrO3*2pyr.,
CH2CI2
? Me Me
Nu
1. silica gel
chromatography
TESO OMe
7
2. LiOH, THF, H2O;
then CH2N2
OHC
V
Y\302\253
: 1
3. Et3SiOCIO3,
Me Me Me
CH3CN>Pyr. Me-4T2
2 4. O3,MeOH,-78\302\260C; 0Me
Me2S, pyr.
4
(>95%yield from 4) C-i)
1- BH3.THF;
\321\201\320\2762\320\275
/\342\200\224CO2H (CH3JC(OCH3Jl thenH3O\302\251
\320\270
\320\275\320\2762\321\201\342\200\224s\342\200\224 \342\200\242>
\\ p-TsOH
oo 2. BnOCH2CI, \320\276 \320\276
f-Pr2NEt
G5-85%yield) \320\234\320\265'\320\274\320\265
15:(S>(-)-malicacld 26 14
OTBS
/-pen \342\200\236A-
MgBr Me
\320\275\320\276
\320\234\320\265\320\276\320\275
12 27
6
p-TsOH,CuSO4
2. NBS, Ph3P
JL Me Me
then CrO3, H2SO4, H2O,
-78^0\302\260\320\241 1. KOH, MeOH, H2O
\321\200] 1^
\320\241\302\2602\320\222\320\237
*
\\
2. Pb(OAcL, Cu(OAcJ, \\\\ 2. I2,CH3CN,-15X
|] \320\2410>\320\222\"
I PhH,80\302\273C
(89% overall yield)
(\320\271
Me
1. LIAIH4,Et20
2. Me
(\320\241\320\235\320\267\320\254\320\241\320\236,
CuSO4, p-TsOH H2,10%Pd/C,
-* \320\275\320\276
3-
J-\320\275\320\277 CrO3\302\273pyr..HCI, Et2O (84% from 30) CO2Bn
CHC'
Me
(80% overall yield)
18 32 31
1- CH3CH2CO2Et,
H2,5%Rh/AI2O3,
\320\223 *~
2. p-TsOH(excess), Et2O, -10 \302\260C
PhH'reflUX
33 34 A00% yield) 35
E0% overall yield)
Ph3PA.2equiv.)
i
130 3h
\302\260\320\241,
19 36
You will note that the configuration of the newly created oxy-
oxygen-bearing stereocenter at C-17 (monensin numbering) in 30 is
opposite to the corresponding stereocenter in intermediate 18.
Therefore, at some stage during the course of the conversion of 30
to 18, an inversion of stereochemistry at position 17 must be
a Me
\302\251|
Me
Ph,\302\256 JL NaH,DMSO,25\302\260C;
then b*15811 21
\320\270
\320\2462|G0% \320\274! Kl3, NaHCO3,
on 18) \320\275\320\276
Me
H2O
19 (87% yield)
17b 17a
\302\260C
[destabilized by
AgCO2CF3, CH2CI2,25
, allylic 1,3-strain]
E0% yield)
Me
\\ 1\320\257 Me
PyrS \320\275
) \320\273 1
1. CrO3, H2SO4,H2O 20^
/is : \321\207\320\276
\320\276' \320\275'
2. 2-pyrSH, COCI2, Et3N H \321\205\320\276
\320\236
0
37 8
Me
Me e Me
NBS, p-TsOH, Me
CH2CI2, 0 \302\260C
Br
Me 1. BnOCH2Li, 8 Me
THF, -78 \302\260C Me
2. HC(OCH3K,
Br Me p-TsOH Br
Bn0\342\200\224*\320\252\320\274\320\265 overail
(80% yield)
42
1. Zn(Cu),Nal, DMF, 60 \302\260C
(85%overall
yield)
2. Et3SiOCIO3, pyr., CH3CN,25 \320\241
3. O3, CH2CI2, -78 \302\260C;
then Me2S, pyr.
Et Me
1. LDA.THF,
-78 \302\260C;
MgBr2
\" 2. |2|(i.2equiv.)
4\342\200\224 Me
0 )
G5% yield)
26 / \\
MeO Me
References
1. (a) Blomberg, C; Mosher, H.S. J. Organomet. 10. Reetz, M.T. Angew. Chem. Int. Ed. Engl. 1984, 23,
Chem. 1968, 13, 519; (b) Ashby, E.C.; Laemmle, J.; 556.
Neumann, H. M. Ace. Chem. Res. 1974, 7, 272; (c) 11.(a) Still, W.C.; McDonald, J.H., III Tetrahedron
Ashby, E.C. Pure & Appl. Chem. 1980, 52, 545; (d) Lett. 1980, 21, 1031; (b) Still, W.C.; Schneider, J.A.
Holm, T. Ada Chem. Scand., Ser.\320\222 1983, B37, 567; ibid. 1980,27, 1035.
(e) Ashby, E.C. Ace. Chem. Res. 1988, 21, 414;(f) 12. (a) Schmid, G.; Fukuyama, \320\242.; Akasaka, K., Kishi, Y.
Walling, J. Am. Chem. Soc. 1988, 110,6846;
\320\241 (g) J. Am. Chem. Soc. 1979, 101, 259; (b) Fukuyama,
Han, R.; Looney, A.; Parkin, G. ibid. 1989, 111, \320\242.;
Wang, C.L.J.; Kishi, Y. ibid. 1979, 101, 260; (c)
7276. Fukuyama, Akasaka,
\320\242.; K.; Karanewsky, D. S.;
2. Cram, D.J.; Abd Elhafez, F.A. J. Am. Chem. Soc. Wang, C.L.J.; Schmid, G.; Kishi, Y. ibid. 1979, 101,
1952, 74, 5828. 262; (d) Kishi, Y. In Polyether Antibiotics: Natu-
3. Seefootnote 13 in reference 2. Naturally Occurring Acid lonophores, Westley, J. W.,
4. For some informative discussions, see: (a) Morrison, Ed., Marcel Dekker: New York, 1983, Vol. 2, p. 1
J.D.; Mosher, H.S. Asymmetric Organic Reactions 13. (a) Collum, D.B.; McDonald, J.H., III; Still, W.C.
Prentice-Hall: Englewood Cliffs, 1971; (b) Eliel, J. Am. Chem. Soc. 1980, 102, 2117; (b) Collum,
E.L. In Asymmetric Synthesis, Morrison, J. D., Ed., D.B.; McDonald, J.H., III; Still, W.C. ibid. 1980,
Academic Press: New York, 1983, Vol. 2, p. 125; (c) 102, 2118; (c) Collum, D.B.; McDonald, J.H., III;
Bartlett, P. A. Tetrahedron 1980, 36, 2; (d) Mulzer, J. Still, W.C. ibid. 1980, 102, 2120.
In Organic Synthesis Highlights, Mulzer, J.; Alten- 14.For some excellent discussions of stereoselective
bach, H.-J.; Braun, M.; Krohn, K.; Reissig, H.-U., aldol reactions, see: (a) Evans, D.A.; Nelson, J.V.;
VCH Publishers: Weinheim, New York, 1991,p. 3. Taber, T.R. Top. Stereochem.1982,13, (b) Heath- 1;
5. Cornforth, J.W.; Cornforth, R.H.; Matthew, \320\232.
\320\232. cock, C.H. In Asymmetric Synthesis, Morrison, J.D.,
J. Chem. Soc. 1959, 112. Ed., Academic Press:New York, 1984, Vol. 3,p. 111.
6. Karabatsos, G.J. J. Am. Chem. Soc. 1967,89, 1367. 15. Corey, E.J.; Cheng, X.-M. The Logic of Chemical
7. Cherest, M.; Felkin, H.; Prudent, N. Tetrahedron Synthesis, John Wiley & Sons: New York, 1989.
Lett. 1968, 2199. 16.(a) Dowle, M.D.; Davies, D.I. Chem. Soc. Rev.
8. (a) Anh, N.T.; Eisenstein, O. Nouv. J. Chim. 1977, i, 1979, 171; (b) Bartlett, PA. Tetrahedron 1980, 36,
61;(b) Anh, N.T. Top. Curr. Chem. 1980, 88, 145; 2; (c) Bartlett, P. A. In Asymmetric Synthesis, Morri-
(c) Biirgi, H.B.; Lehn, J.M.; Wipff, G. J. Am. Chem. Morrison,J. D., Ed., Academic Press: New York, 1984,
Soc. 1974,96, 1956; (d) Biirgi, H.; Dunitz, J.D.; Vol. 3, p. 411; (d) Mulzer, J. In Organic Synthesis
Lehn, J.M.; Wipff, G. Tetrahedron 1974, 30, 1563. Highlights, Mulzer, J.; Altenbach, H.-J.; Braun, M.;
9. (a) Cram, D.J.; Kopecky, K.R. J. Am. Chem. Soc. Krohn, K.; Reissig, H.-U., VCH Publishers: Wein-
1959, 81, 2748; (b) Cram, D.J.; Wilson, D.R. ibid. Weinheim, New York, 1991, p. 158.
1963, 85, 1245.
248 15 Monensin
17. (a) Trippett, S. Q. Rev. Chem. Soc. 1963, 17; 406; 23. Barton, T.J.; Tully, C.R. J. Org. Chem. 1978, 43,
(b) Maercker, A. Org. React. (TV. Y.) 1965, 14, 270; 3049.
(c) Schlosser,M. Top. Stereochem. 1970, 5, 1; (d) 24. Bartlett, P. A.; Myerson, J. J. Am. Chem. Soc. 1978,
Maryanoff, B.E.; Reitz, A.B. Chem. Rev. 1989, 89, 100, 3950.
863. 25. (a) Johnson, F. Chem. Rev. 1968, 68, 375;(b) Hoff-
18. Scott, J. W. In Asymmetric Synthesis, Morrison, J. D.; Hoffmann, R.W. ibid. 1989, 89, 1841.
Scott, J. W., Eds., Academic Press: New York, 1984, 26. Corey, E.J.; Clark, D.A. Tetrahedron Lett. 1979,
Vol. 4, p. 1. 2875.
19.(a) Danishefsky, S.J. Aldrichimica Acta 1986, 19, 27. Voss, J. In Comprehensive Organic Synthesis, Trost,
59; (b) Woodward, R.B. Pure & Appl. Chem. 1968, B.M.; Fleming, I., Eds., Pergamon Press: New York,
17,(see pp. 520-521). 1991, Vol. 6, p. 435.
20. Goodhue, Schaeffer,
\320\241\320\242.; J.R. Biotechnol. Bioeng. 28. Mukaiyama, Araki,
\320\242.; M.; Takei, H. /. Am. Chem.
1971, 13,203. Soc. 1973, 95, 4763.
21.Buse, Heathcock,
\320\241\320\242.; C.H. J. Am. Chem. Soc. 29. Still, W.C. /. Am. Chem. Soc. 1978,100, 1481.
1977,99, 8109. 30. Perron, F.; Albizati, K.F. Chem. Rev. 1989, 89, 1617.
22. Still, W. C; Kahn, M.; Mitra, A. /. Org. Chem. 1978,
43, 2923.
\302\251
\320\275\320\276
N
\320\275
Me'
0' x f
co2
1: thienamycin
Merck A980)
Thienamycin
16.1 Introduction
\320\275\320\276 \320\275\320\276
H
\320\275
-N
rv5\027 4 1\\ \342\200\242\342\200\224\342\200\224Conjugate
addition-
0 14 '
C03Q COjpNB
elimination
1: thienamycin 2 Carbene insertion
pNB a CH2C6H4-p-NO2
C-Cbond
formation
vC-Cbond
6: acetaldehyde \320\275\320\276 HO formation
i H H
T'H H
Aidoi --
condensation \302\260
R a SiMe2f-Bu
Diazo
group
Insertion
n
bXOjBn
\320\223\320\242
BnO2C NHSIMe,
i Lactam
10 formation 12: L-aspartic acid
Merck's
thienamycin synthesis commences with mono iV-silylation
CO2Bn
of dibenzyl aspartate A3, Scheme 2), the bis(benzyl) ester of aspar-
\320\263\320\223
tic acid A2). Thus, treatment of a cooled @\302\260C) solution of 13 in
BnO2C NH2
ether with trimethylsilyl chloride and triethylamine, followed by fil-
13
filtration to remove hydrochloride by-product, pro-
the triethylamine
provides 11. When the action of one equivalent
11 is exposed to of
Me3SiCI, \"
CO,Bn g(
Et2O,0->25\302\260C
I\342\200\224\321\203
\320\263\320\241 NH
NH2
\320\222\320\277\320\2362\320\241 Et20,0 \302\260CBnOzC
2. 2 N HCI, NH4CI
MeOH
\342\204\226BH4,
1. CH3SO2CI,Et3N,
M3uMe2SiCI,Et3N, DMF CHCC
\302\253
NR 2. Nal, (CH3JCO,
yield from
\320\224
E0% overall
L-asparticacid A2))
8 15 14
R = Sif-BuMe2
u
G0-80% yield)
then [\320\262\\(97%yield)
\320\236
16 17
A6:17 ca. 1:1)
LDA, THF, 6: acetaldehyde
-78\302\260C;
then
\320\236
(82% yield)
K-Selectride,Kl,
1
It was recognized
DMSO/triethylamine.10 that a potential solution
to the problem of
establishing (R) configuration
the at C-8 of thien-
thienamycin would be the diastereoselective reduction of a trigonal
carbonyl group at C-8. Gratifyingly, the action of excess potassium
tri-sec-butylborohydride (K-Selectride)and potassium iodide on
intermediate 18 results in the formation of a 9:1 mixture of C-8 epi-
mersin favor of the desired C-8 /?-OH isomer 16. The undesired
C-8 epimer 17 could be recovered and converted back to 18 by
oxidation. This two-stepreaction sequenceG\342\200\224\320\2308\342\200\224H6) provides
an adequate and simple solution to the challenge presented by the
C-6 side chain of thienamycin, and the contiguous stereocenters at
C-6 and C-8. It shouldbe noted at this point that the task of secur-
17 correct absolute at positions 5, 6, and 8 of
securing the configurations
thienamycin has been accomplished.
We are now in a position to address the elaboration of the C-5
side chain in 16 into a form suitable for the crucial cyclization
event. Exposure of intermediate 16 to HgCb and HgO in aqueous
methanol results in hydrolysis of the dithiane moiety and furnishes
\320\275\320\276 HO HO
H H \320\275
\320\275 \320\2352\320\2362,
HgCI2, HgO, >0 \320\234\320\265\320\236\320\235,
Me** Me
\320\236 \320\270*
\320\234\320\265\320\236\320\235,\320\23529,\320\224 SIMe3 H2O 0H
(93% yield)
G6% yield)
16 19
R = Slf-BuMe2
lm2CO,
THF, 25 \302\260C
HO
H H Mg(O2CCH2CO2pNBJ, THF, 25 \302\260C
Me 21
\302\253c
22
pNB = CH2C6H4-p-NO2
HO HO
H H \320\275
\320\275
Rh(OAcJ (cat),
Me Me
NH PhH or \342\200\242
PhCH3, \\
80 \302\260C
A00% yield) \320\275
N-H insertion
1. HO
NHCOapNB KJ
CIP(OKOPhJ,4-DMAP (cat.),
Et, CH3CN,0 \"C H H
2-
,NHCO2pNB
:, CH3CN, -5 \302\260C
Bn
\320\276 NHBn
24 25 26
NaCNBH3, AcOH
F1% from 24)
A reflux
BnOH,
AcOH (cat.), 70 \302\260C,
16 h, C0:29/3:1)
HO HO 1. f-BuMe2SICI,
; \320\275\320\275 ; H H : H H
DCC, Et3N,
CO2Bn \342\200\242>
Me CO,Bn *\" M
CH3CN, 2. Pd/C,H2D0psi),
NH
N
HO2C NH2*HCI 60 \302\260C MeOH
30 (92% yield) 31 32
R = Slf-BuMe2
O. lm2CO,
CH2CI2
Me RO
! H \320\275
4-DMAP
F0-72% from31)
RO
H H
-CO2
-(CH3JCO CO2pNB
36
pNB = CH2C6H4-p-NO2
31 (92% yield). In this step, DCC reacts with the free carboxyl group
in 30 to give an activated ester which subsequently suffers an intra-
[-BuMe2SiO intramolecular attack by the primary amino group four atoms removed.
32
terr-butyldimethylsilyl chloride, followed by hydrogenolysis of the
benzyl ester, provides protected carboxylic acid 32.
To set the stage for the crucial carbene insertion reaction, the
acetic acid side chain in 32 must be homologated. To this end,
treatment of 32 with 1,1 '-carbonyldiimidazole furnishes imidazo-
lide 33, a competent acylating agent, which subsequently reacts
with the conjugate base of Meldrum's acid C4) to give 35. Solvo-
Solvolysis of this substance with para-nitrobenzyl alcohol in acetonitrile
at reflux provides \320\224-keto ester 36 after loss of one moleculeof ace-
16.3 Total Synthesis 259
RO
1. HCI, MeOH, H20 HO
? H H 2. Ph3P, DIAD, H H
HCO2H, THF, 25 \302\260C
36 37
R = Sif-BuMe2 DIAD = >-PrO2CN=NCO2/-Pr
P-CH3-C6H4SO2N3, I ,
Et,N. EtOAc
Et3N,
F5% from 36>
HO HO
H H H H
Rh2(OAcL (cat),
t Me
NH
PhCH3,80 \302\260C
N-H insertion
\320\275\320\276
H H
CIP(O)(OPhb, *-Pr2NEt,
OPO(OPhJ
-N
CH3CN,0 \302\260C
CO2pNB
H2,Pt02,THF, '
\321\201
H2O, pH 7.0
(90% yield)
EtO2C
\320\235\320\236
HCI, CH2CI2,25'
EtOjC,
Me1\"' T \"NHBn
H Me\"\"
CO2Et CO2Et
CO2Et
(\302\261)-27 38
NaHCO3
H2O
00 HO2C
HO HO Ph3P, H0
DEAD,
/ Me\"
THF
CO2Et CO2Et CO2Et
39
N\342\200\224NHCOjEt
NHCO2Et
'pN\342\200\224
Ph3P\302\251
-Ph3P=O \320\276
N Me
Go \".\320\276
CO2Et
Me Us
PO
40
CO2Et CO2Et
cone,.HCI, 1
reflux
NHBn-HCI
CO2H
41
E3% yield from 38)
Scheme 6. Intramolecular Mitsunobu strategy for the inversion of the C-8 stereocenter
C9->41).
262 16 Thienamycin
16.4 Conclusion
1. (a) Tally, F.P.; Jacobus, N.V.; Gorbach, S.L. Antimi- 16. Mitsunobu, O.; Kimura, J.; Iiizumi, K.; Yanagida, N.
crob. Agents Chemother. 1978, 14, 436; (b) Weaver, Bull. Chem.Soc.Jpn. 1976, 49, 510.
S.S.; Bodey, G.P.; LeBlanc, B.M. ibid. 1979, 15, 17. Melillo, D.G.; Liu, \320\242.; Ryan, K.; Sletzinger, M.;
518; (c) Kahan, J.S.; Kahan, F.M.; Goegelman, R.; Shinkai, I. Tetrahedron Lett. 1981, 22, 913.
Currie, S.A.; Jackson, M.; Stapley, E. O.; Miller, 18.Sletzinger, M.; Liu, \320\242.;
Reamer, R. A.; Shinkai, I.
T.W.; Miller, A.K.; Hendlin, D.; Mochales,S.; Her- Tetrahedron Lett. 1980, 21, 4221.
Hernandez, S.; Woodruff, H. \320\222.;
Birnbaum, J. /. Antibiot. 19. For additional syntheses of thienamycin in both opti-
1979,32, 1. optically active and racemic forms, see: (a) Ponsford,
2. Albers-Schonberg, G.; Arison, B.H.; Hensens, O.D.; R.J.; Southgate, R. /. Chem. Soc, Chem. Commun.
Hirshfield, J.; Hoogsteen, K.; Kaczka, E.A.; Rhodes, 1979, 846; (b) Hiraoka, T. Tetrahedron
Shiozaki, M.;
R.E.; Kahan, J.S.; Kahan, F.M.; Ratcliffe, R.W.; Lett. 1980, 21, 4473; (c) Kametani, \320\242.;
Huang, S.-P;
Walton, E.; Ruswinkle, L.J.; Morin, R.B.; Christen- Yokohama, S.; Suzuki, Y.; Ihara, M. /. Am. Chem.
sen, B.G.J. Am. Chem. Soc. 1978,100,6491. Soc. 1980, 102, 2060; (d) Shibasaki, M.; Nishida, A.;
3. Salzmann, T.N.; Ratcliffe, R.W.; Christensen, B.G.; Ikegami, S. /. Chem. Soc, Chem. Commun. 1980,
Bouffard, F. A. /. Am. Chem. Soc. 1980,102,6163. 1324; (e) Hanessian, S.; Desilets, D.; Rancourt, G.;
4. Johnston, D.B.R.; Schmitt, S.M.; Bouffard, F.A.; Fortin, R. J. Chem. 1982, 60, 2292;
Can. (f) Shiba-
Christensen, B.G. /. Am. Chem. Soc. 1978, 100, Shibasaki,M.; Nishida, A.; Ikegami, S. Tetrahedron Lett.
313. 1982, 23, 2875; (g) Miyashita, M.; Chida, N.; Yoshi-
5. Corey, E.J.; Cheng, X.-M. The Logic of Chemical kohsi, A. /. Chem. Soc, Chem. Commun. 1982,
Synthesis, John Wiley & Sons: New York, 1989. 1354; (h) Ikota, N.; Yoshino, O.; Koga, K. Chem.
6. Greene, T.W.; Wuts, P. G.M. Protective Groups in Pharm. Bull. 1982, 30, 1929;(i) Grieco, PA.; Flynn,
Organic Synthesis, Second Edition, John Wiley & D.L.; Zelle, R.E. /. Am. Chem. Soc. 1984, 106,
Sons: New York, 1991. 6414; (j) Hodgson, S.T.; Hollinshead, D.M.; Ley,
7. Bernardi, F.; Csizmadia, I.G.; Mangini, A.; Schlegel, S.V. Tetrahedron 1985, 41, 5871; (k) Iimori, \320\242.;
H.B.;Whangbo, M.-H.; Wolfe, S. /. Am. Chem. Soc. Shibasaki, M. Tetrahedron Lett. 1985, 26, 1523;
1975, 97, 2209. A) Hart, D.J.; Ha, D.-C. Tetrahedron Lett. 1985,
8. (a) Seebach, D. Angew. Chem. Int. Ed. Engl. 1979, 26, 5493; (m) Maruyama, H.; Hiraoka, T. J. Org.
18, 239; (b) Grobel, B.T.; Seebach, D. Synthesis Chem. 1986,57, 399; (n) Buynak, J.D.; Mathew, J.;
1977, 357. Narayana Rao, M. /. Chem. Soc, Chem. Commun.
9. (a) Brook, A.G.;Duff, P.F.; Davis, N.R.
J.M.; Jones, 1986, 941 (o) Evans, D.A.; Sjogren, E.B. Tetrahe-
/. Am. Chem. Soc. (b) Corey, E.J.;
1967, 431;
\302\2539, Lett.
Tetrahedron 1986, 27, 4961; (p) Fleming, I.; Kilburn,
Seebach,D.; Freedman, R. ibid. 1967, 89, 434. J.D. / Chem. Soc, Chem. Commun. 1986, 1198; (q)
10.Tidwell, T.T. Org. React. (N. Y.) 1990, 39, 297. Georg, G.I.; Kant, J.; Gill, H.S. /. Am. Chem. Soc.
11. Brooks, D.W.; Lu, L.D.-L.; Masamune, S. Angew. 1987, 109, 1129;(r) Hatanaka, M.; Nitta, H. Tetrahe-
Chem.Int. Ed. Engl. 1979, 18, 72. Lett.
Tetrahedron 1987, 28, 69; (s) Kaga, H.; Kobayashi, S.;
12.Ratcliffe, R.W.; Salzmann, T.N.; Christensen, B.G. Ohno, M. Tetrahedron Lett. 1988, 29, 1057.
Tetrahedron Lett. 1980, 21, 31. 20. For reviews of synthetic work, see: (a) Kametani, T.
13. Melillo, D.G.; Shinkai, I.; Liu, \320\242.;
Ryan, K.; Sletzin- Heterocycles 1982, 17, 463; (b) Labia, R.; Morin, C.
ger, M. Tetrahedron Lett. 1980, 21, 2783. /. Antibiot. 1984, 37, 1103; (c) Ratcliffe, R.W.;
14. Oikawa, Y.; Sugano, K.; Yonemitsu, O. /. Org. Albers-Schonberg, G. In Chemistry and Biology of
Chem. 1978, 43, 2087. P-Lactam Antibiotics, Morin, R. \320\222.;Gorman, M.,
15. (a) Mitsunobu, O. Synthesis 1981, 1; (b) Hughes, D. Eds., Academic Press:San Diego,1982,Vol. 2, p. 227.
L; Reamer, R.A.; Bergan, J. J.; Grabowski, E. J.J. 21. Burke, S.D.; Grieco, PA. Org. React. (N.Y.) 1979,
/. Am. Chem. Soc. 1988, 110, 6487; (c) Varasi, M.; 26, 361.
Walker, K.A.M.; Maddox, M.L. J. Org. Chem. 22. Cama, L.D.; Christensen, B.G. Tetrahedron Lett.
1987, 52, 4235; (d) Camp, D.; Jenkins, I.D. ibid. 1978, 4233.
1989,54, 3045.
CO2H \320\241\320\2362\320\235
2:
1: endiandric acid A endiandric acid \320\222
17
17.1 Introduction
The endiandric acids comprise a most notable class of secondary
metabolites. Isolated 1980s from the Australian
in the early plant
Endiandra introrsa (Lauraceae) by D.St.C. Black'sgroup,1 these
natural products are striking for their novel molecular architecture
and their intricate structural interrelationships. Endiandric acids A
A), \320\222
B), and contain
\320\241
C) four fused carbocyclic rings, a phenyl
substituent and a carboxyl group. Despite containing eight stereo-
genie centers, the endiandric acids are found in nature as racemates,
which is very 'unusual for chiral natural products. To explain this
rather curious observation, Black proposed an intriguing hypothesis
for the \"biosynthesis\" of these moleculesfrom achiral polyunsatu-
rated precursors through a series of nonenzymatic electrocycliza-
tions,(see Schemes1 and 2). The Black hypothesis postulates the
cascade of reactionsshown in Scheme 1 as the pathway by which
endiandric acids A-D are formed in nature. Thus endiandric acids
E E), F F), and G G) were proposed as immediate precursorsto
tetracyclic endiandric acids A A), \320\222
B), and \320\241
C) respectively; the
conversion being effected by an intramolecular Diels-Alder reac-
reaction. Endiandric D) cannot undergo an intramolecular
acid D
Diels-Alder and so it does not form a corresponding tetra-
reaction,
cycle. An additional striking feature of the hypothesis of Black and
coworkers is that endiandric acids D-G D-7) could arise from
sequential electrocyclizations of achiral polyenes I\342\200\224IV
through the
intermediacy of 1,2-frans-disubstituted cyclooctatrienes (Scheme1).
The molecular frameworks of the endiandric acids were unprece-
unprecedented at the time of their discovery. Intrigued by these unique
structures and Black's hypothesis for their biogenetic origin, the
\320\276
\321\204
\320\260
\321\216'
\320\260.
\320\276' Ph
\320\222
\320\236
\320\260.
\321\210
13
\320\277 CO2R
X
\321\204
\320\241\320\2362\320\235
\320\235\320\2362\320\241
\320\275
a: conrotatory 8 electron
\320\272
electrocycllzation
to: disrotatory 6 n electron
electrocyciization CO2H
\321\201\320\2762\320\275
or
X Y
conrotatory 8 electron
\320\266 ss
electrocyclizatlon ^^
^
dlsrotatory 6 n electron
electrocyclization
conformational switch
dlsrotatory 6 electron
\320\272
electrocyclizatlon
synthesis.2
Wittig
I
H ^Wittig
Dlels-Alder Dlels-Alder
HO2C
RO2C
5: endiandric acid E, n = 0
6: endiandric acid F, = 1
\320\273 7: endiandric acid G
6 \320\272
electron
disrotatory
electro-
side-chain x x\342\200\224\"
differentiation H cyclization
10 11
8 \320\272
electron
conrotatory
electro-
cyclization
Acetylene
coupling
14 13
H2, Llndlar
catalyst,
^-
qulnollne,
CH2CI2-Me0H,
25 \302\260C
D5-55%)
(90%)
\320\275
12, \320\2322\320\241\320\236\320\267,
\320\275
\320\276\320\275i \320\235
\320\237\320\235
CH2CI2, \320\2750
-20-\302\2730\302\260\320\241
A00%)
1. t-BuPh2SICi, imld.,
DMF, 25 \302\260\320\241
2. Zn, AcOH, 25 \302\260\320\241
G0-80% overall)
1. Ph3P,
CBr4,
/=\\
\320\241\320\2352\320\24112,
0\302\260\320\241 4, >\342\200\224\320\235 Dibal-H, <\\
\321\207\321\207
*. ,OSifrBuPh2
\\-\320\224-\320\275 \342\200\236 ,OSi(-BuPh2
2. NaCN, CHzClz,
\"
\320\235\320\234\320\240\320\220, -78 \"\320\241
25 \302\260\320\241
21 22 (95%) 23
(93% overall)
\320\240\320\230'^:^/\320\247\321\207\320\240\320\236(\320\236\320\235\320\254
PhCH3>
.OSif-BuPh2
H OSi(-BuPh2
25 OSifrBuPhj
\320\275
and the resulting alcohol is converted to the corresponding bromide
and then to the nitrile 26 (95 % overall yield). Finally, hydrolysis of
\321\201\320\2762\320\275
the nitrile grouping in 26 with basic hydrogen peroxide at 25-50 \302\260C
1: endiandric acid A
furnishes, in 95 % yield, endiandric acid A A). For the synthesis of
endiandric acid \320\222
B), nitrile 26 is taken through a different route.
Ph First, it is reduced with Dibal-H to afford the aldehyde which is
H then treated with to afford the methyl
\320\240\320\254\320\267\320\240=\320\241\320\235\320\241\320\2362\320\234\320\265 ester of
endiandricacid \320\222
in 81 % overall yield. Finally, endiandric acid \320\222
(95% overall)
OSif-BuPh2
1. Dlbal-H, CH2CI2,
KOH, H2O2, -78 \302\260C
EtOH, H2O
(95%) (81% 2. Ph3P=CHCO2Me,
overall) PhH, 25 \302\260C
3. LiOH, THF, H2O
bc H OSi*-BuPh2
(MeOJP(O)CH2CO2Me,
' H .OSiJ-BuPh2
NaH, THF, 25 \302\260C
(80%)
3^\\x4H
23
PhCH3,110\302\260C(92%)
1. n-Bu4NF, THF,
25 \302\260C
(98%)
s r-
,OSif-BuPh2
2. Ph3P, CBr4,
CH2CI2,0 \302\260C
(90%)
G5%)
1. KOH, H20o,
THF, H2O,
n-Bu4NF, 25 \302\260C
(95%)
22 32
. Ph3P,CBr4,
CH2CI2,0 \302\260C
2. NaCN, HMPA,
25 \302\260C
overall)
3. LiOH.THF,
H2O, 25 \302\260C
G5% overall)
24
Ag2O, NaOH,
,\321\201\320\275\320\276
(90%)
1. (MeObP(O)CH2CO2Me,
NaH, THF, 25 \302\260C
(85%)
\320\236\320\275
s . CH2N2, Et2O, 0 \302\260C
\342\200\242
HO2C. MeO2C
(98%)
4: endiandric acid D
1. Dlbal-H, CH2CI2>
-78 DC
2. (MeOJP(O)CH2CO2Me,
NaH, THF, 25 \302\260C E9% overall)
3. LiOH, THF, H20,25 \302\260C
precursorsto the
required polyolefinic substances upon mild hydro-
genation Lindlar
over catalyst. Scheme 7 outlines, in retrosyn-
thetic format, the general features of the strategy for the synthesis
of these polyunsaturated molecules. Thus, disconnection of the car-
carbon-carbon bond between the two acetylenic groups in 37 and 38
and functional group interchange by converting the two adjacent
double bonds to single bonds carrying phenylthio groups leads to
the terminal acetylenes 39-41. In the synthetic direction, oxidation
of sulfur to the corresponding sulfoxide followed by .ryn-elimina-
tion is expected to generate the desired E doublebond in each com-
compound. Two important reactions for carbon-carbon bond formation
are then called upon to allow tracing of these intermediates C9-41)
to simple starting materials as shown in Scheme 7. The use of
heteroatoms (sulfur and phosphorus) synthesis is amply
in organic
demonstrated in these Alkylations of sulfur-stabilized
constructions.
anions and sulfoxide s}>n-eliminations are used to form, sequen-
sequentially, single and double carbon-carbon bonds; phosphonate-alde-
hyde condensationsareused to form olefinic bonds.
Scheme 8 summarizes the construction of the requisite building
blocks 40, 41, and 50. Alkylation of the lithio derivative of l-(tri-
methylsilyl)-3-phenylthio-l-propyne D2) with 3-iodo-l-(tert-butyl-
dimethylsilyloxy)propane in the presence of HMPA affords com-
compound 43 in 90% yield. Selective desilylation of the protected
alcohol is achieved by warming 43 to 40 \302\260C
in AcOH-THF-H2O
Acetylene coupling
* 37:n = 0 CO2Me
38: n =1
PhS V sph
Alkylation
/(\"'(\\342\200\236
Phosphonate co2i
39 condensation 40, \320\273
= \320\236
41,n=1
PhS
(EtOfeP(O)CH2
^(MeOfcP(O)CH2CO2Me
1. CrO3,H2SO4, SPh
(CH3JCO,-10\302\260C
Me3Si\342\200\224=
2. CH2N2, Et2O, 0 \302\260C
3. KF, 18-crown-6, DMF,
25 \302\260C
F8% overall)
PCC, CH2CI2, 25 \302\260C
G6%)
or SO3*pyr., Et3N, DMSO,
25\302\260C(80%)
PhS
SPh
=\342\200\224SIMe3
Me3SI
LDA, THF,
-78 -\302\273
25 \302\260C
47
G8%)
SPh
^\342\200\224SlMe3
Me3SI\342\200\224^
49
AgNO3, KF,
KCN, 18-crown-6,
(98%) EtOH-H2O, DMF,
25 \302\260C
\302\251
PCC = 0 CiCrO30
1
H
SPh
C:2:2), affording alcohol 44 in 75 % yield. Jones oxidation of 44
Me3Si\342\200\224^ to the corresponding carboxylic acid is possible under carefully
controlled conditions leading, after esterification (CH2N2) and
deprotection the acetylene (KF/18-crown-6), to terminal
of acety-
acetylene methyl 40 in 68 % overall yield. Taken
ester in a slightly dif-
SPh different direction, primary alcohol 44 can be oxidized with pyridi-
Me3Si\342\200\224= nium chlorochromate (PCC) in methylene chloride G6%) or
alternatively with SO3\302\273pyr/Et3N in DMSO (80%) to the corre-
corresponding aldehyde 45, a common precursor to both key intermedi-
41
intermediates and 50. Thus, standard olefination of 45 with the appropri-
appropriate
phosphonate reagent furnishes the E a,/?-unsaturated methyl
Me3S
ester 46 stereoselectively and in 76 % yield. Finally, removal of the
SPh
SPh
Ph 50
40 41 CO2Me
Cu(OAcb B.0 equiv.), Cu(OAcJ B.0 equiv.),
pyr., MeOHA:1),25\302\260C pyr., MeOHA:1),25\302\260C
G0% based on 50) G2% based on 50)
SPh SPh
CO2Me
CO2Me
51 Ph
53
mCPBA, CH2CI2,
(85%) -78\302\260C
\\\\
SPh SPh
f/
CO2Me
CO2Me
52 Ph 54
PhCH3,50\302\260C, PhCH3,50\302\260C,
e>ZA1:1) I G5%;?;Z/1:1)
G8%;
CO2Me
CO2Me
37 38
CO2Me
COjMe
Ph 38
cataiyst, quinoiine,
catalyst, quinoiine,
CH2Ci2,25 \302\260C CH2CI2,25 \302\260C
2. 2. PhCH3,100 \302\260C
PhCH3,1(\320\256\302\260\320\241
\320\275
CO2Me CO2Me
55: endiandric acid A 57: endiandric acid \320\222 58: endiandric acid \320\241
CO2Me
MeO2C
CO2Me
Meo2c.
(Figure la). Eventually, all the material is transformed, and en- 55: endiandric acid A
endiandric acid A methyl ester E5) is formed in high yield. Similar methyl ester
observations were made with endiandric acid D methyl ester C6)
as shown in Figure lb. Its half-life at 70 \302\260C was determined to be
ca. 3.8 h, endiandric acid A being formed essentially in quantitative
yield. This finding explains the absence of endiandric acid D
methyl ester C6) in the hydrogenation-thermolysis experiment dis-
discussed above.
The thermally induced reactions of endiandric acids F and G
methyl esters E9 and 60) were followed in a similar fashion
282 17 Endiandric Acids A-D
Figure 1. Thermolysis of the methyl esters of endiandric acids E E6) (a), D C6) (b), F E9) (c), and G F0)
(d) at 70\302\260Cin [D8]toluene. Data obtained by 1H NMR spectroscopy (COOCH3) at 250 MHz. (from ref. 2d)
58: endiandric acid \320\241 eluded by extrapolation of these results, that these chemical phe-
methyi ester nomena could take place in nature, albeit at slower rates.
17.4 Conclusion 283
17.4 Conclusion
References
1.(a) Bandaranayake, W.M.; Banfield, J.E.; Black, 3. For reviews of intramolecular Diels-Alder reactions,
D.St.C; Fallon, G.D.; Gatehouse, B.M. J. Chem. see: (a) Carlson, R.G. Annu. Rep. Med. Chem. 1974,
Soc, Chem. Commun. 1980, 162; (b) Bandaranayake, 9, 270; (b) Oppolzer, W. Angew. Chem.Int. Ed. Engl.
W.M.; Banfield, J.E.; Black, D.St.C. ibid. 1980, 902; 1977, 16, 10; (c) Oppolzer, W. Synthesis 1978, 793;
(c) Bandaranayake, W.M.; Banfield, J.E.; Black, (d) Brieger, G.; Bennett, J.N. Chem. Rev. 1980, 80,
D.St.C; Fallon, G.D.; Gatehouse, B.M. Aust.J. 63; (e) Ciganek,E. Org. React. (N. Y.) 1984, 32, 1; (f)
Chem. 1981, 34, 1655; (d) Bandaranayake, W.M.; Funk, R.L.; Vollhardt, K.P.C Chem. Soc.Rev. 1980,
Banfield, J.E.; Black, D.St.C. ibid. 1982, 35, 557; (e) 9, 41; (g) Fallis, A.G. Can. J. Chem. 1984, 62, 183;
Bandaranayake, W.M.; Banfield, J.E.; Black, D.St.C; (h) Taber, D. F. Intramolecular Diels-Alder and Alder
Fallon, G.D.; Gatehouse, B.M. ibid. 1982, 55, 567; Ene Reactions, Springer-Verlag; Berlin, 1984; (i)
(f) Banfield, J.E.; Black, D.St.C; Johns, S.R.; Wil- Craig, D. Chem. Soc. Rev. 1987, 16, 187; (j) Kame-
Willing, R.I. ibid. 1982, 55, 2247. tani, Nemoto,
\320\242.; H. Tetrahedron 1981, 37, 3; (k)
2. (a) Nicolaou, K.C.; Petasis, N.A.; Zipkin, R.E.; Oppolzer, W. Heterocycles 1980, 14, 1615; A) Roush,
Uenishi, J. J. Am. Chem. Soc. 1982, 104, 5555; (b) W.R. In Advances in Cycloaddition, Curran, D.P.,
Nicolaou, \320\232. Petasis,
\320\241; N. A.; Uenishi, J.; Zipkin, Ed., JAI Press: Greenwich, Connecticut, 1990, Vol. 2,
R.E. ibid. 1982, 104, 5557; (c) Nicolaou, K.C.; Zip~ p. 91.
kin, R.E.; Petasis, N.A. ibid. 1982, 104, 5558; (d) 4. (a) Woodward, R.B. Spec. Publ. Chem. Soc. 1967,
Nicolaou, K.C.; Petasis, N.A.; Zipkin, R.E. ibid. 21, 217;(b) R. Angew.
Woodward, R.B.; Hoffmann,
1982, 104, 5560; (e) Nicolaou, K.C; Petasis, N.A. In Chem. Engl. 1969, 8, 781.
Int. Ed.
Strategies and Tactics In Organic Synthesis, Lind- 5.(a) Haynes, L.J.; Heilbron, I.; Jones, E.R.H.; Sond-
Ed., Academic
berg, \320\242., Press; San Diego, 1984,Vol. heimer, F. J. Chem. Soc. 1947, 1583;(b) Heilbron, I.;
l,p. 155. Jones, E.R.H.; Sondheimer, F. ibid. 1947, 1586.
Hoffmann-La Roche A982)
Biotin
18.1 Introduction
In 1982, scientists at Hoffmann-La Roche disclosed an elegant,
enantiospecific total synthesis of biotin A).1 Biotin A) is an essen-
essentialvitamin that functions as an indispensable coenzyme in a range
of biocarboxylation reactions related to crucial physiological pro-
processessuch as gluconeogenesisand fatty acid biosynthesis. Today,
biotin is widely used in human nutrition and therapy, and in animal
health. Although the biotin molecule is relatively small, its struc-
structure is interesting. Biotin A) possesses three contiguous stereocen-
ters, and its unusual tetrahydrothiophene ring accomodates a cyclic
urea and a five-carbon-atom side chain terminating in a carboxyl
group. The cyclic urea and the carboxylic side chain are oriented
on the same side of the tetrahydrothiophene nucleus.
Severalelegant synthetic have been devised for biotin
strategies
A); this
chapter of the
describes total one
syntheses developed at
Hoffmann-La Roche. This insightful synthesis employs a derivative
of L-cysteine, a readily available member of the chiral pool,2 as the
starting material, and showcases the powerful intramolecular
nitrone-olefin [3+2] cycloaddition reaction.
The class of 1,3-dipolarcycloadditions embraces a variety of
reactions that can accomplish synthesis of a diverse array
the of
Ph,
[3+2] Y
\320\234\320\262\320\236\320\263\320\241\320\235\320\235.
H3N* CO,\"
Ph-
25 \302\260C
(s>...
2: L-cysteine
Ph
-CHO
MeOj.CHN,
BnNHOH MeO2CHN..
Ph
MeO2CHN 1
[3+2] \\
25 \302\260C
Nitrone-olefln
cycloaddition
reductive \\ \320\275
\\HV
HN N
deoxygenatlon cleavage \302\2604^
=>
CO2H
MeO2C
NH2
13: L-cystine
dimethyl ester A
12
Amide bond Nitrons
formation formation
**
MeO2C
X J .NH
9:1,65%) A\"~^lf
\320\236
13: L-cystlne 12 15
dimethyl ester 1. Dibal-H, PhCH3,-78 \302\260C
2. BnNH(OH)*HCI, CH2CI2
F8% overall yield)
NH 2. CICO2Me,THF,
Na2CO3,0 \320\241
F5% overall)
16
Ba(OHJ
(87%)
dioxane-H2O,
A
II
\320\276
1
SOCI2, Et2O
coci -civ
COCI
CO2H o>
OH cr
\320\276
MeOH
\320\236 \320\236
\320\276
\320\233
HN NH
,nh lie sulfide has played a crucial, but temporary, role in this synthesis.
After having served its purpose of controlling the stereochemical
(+)-biotin methyl ester were identical with those of the methyl ester
prepared from natural biotin.
18.4 Conclusion
References
1.Baggiolini, Lee, H.L.; Pizzolato, G.; Uskokovic,
E.G.; 7. LeBel, N. A. Trans.
N. Y. Acad. Sci. 1965, 27. 858.
M.R. Chem. Soc. 1982,104,6460.
J. Am. 8. (a) Tufariello, Ace. Chem. Res. 1979.12.396:
J.J.
2. Scott, J.W. In Asymmetric Synthesis, Morrison, J. D.; (b) Padwa, A, Angew. Chem. Int. Ed. Engl. 1*7*.
Scott, J. W., Eds., Academic Press: San Diego, 1984, /5, 123; (c) Oppolzer, W. ibid. 1977, 16. 10; \302\253d\30
Vol. 4, p. 1. Padwa, A.; Schoffstall, A.M. In Advances in
3. Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry, Cycloaddition, Curran D. P., Ed., JAI Press: Green-
Padwa, A., Ed., John Wiley & Sons: New York, 1984, Greenwich,Connecticut, 1990, Vol. 2, pp. 1-89.
pp. 1-176. 9. Corey, E.J.; Cheng, X.-M. The Logic of Chemical
4. Beckmann, E. Ber. Dtsch. Chem. Ges. 1890, 23, Synthesis, John Wiley & Sons: New York, 1989.
1680,3331. 10. The intermediacy of an episulfonium cation was
5. (a) Grashey, R.; Huisgen, R.; Leitermann, H. Tetra- invoked to explain the facility of a Beckmann frag-
Lett.
Tetrahedron 1960, 9; (b) Brown, C.W.; Marsden, K.; fragmentation during the course of another elegant
Rogers, M.A.T.; Tylor, \320\241\320\234.\320\222.;
Wright, R. Proc. nitrone-olefin [3+2] cycloaddition based approach to
Chem. Soc. (London) 1960, 254; (c) LeBel, N.A.; the synthesis of biotin, see: Confalone, P. N.; Pizzo-
Whang, J.J. J. Am. Chem. Soc. 1959,81, 6334; (d) Pizzolato,G.; Confalone, D.L.; Uskokovic, M.R. J. Am.
Cope, A.C.; LeBel, N. A. ibid. 1960,82, 4656. Chem. Soc. 1980, 102, 1954, For a review, see
6. (a) Huisgen, R. Angew. Chem. Int. Ed. Engl. 1968, 7, Capon, B. Q. Rev. Chem. Soc. 1964, 18, 45.
321; (b) Huisgen, R. J. Org. Chem. 1968,33, 2291;
(c) Huisgen, R. In Advances in Cycloaddition,
Curran, D.P., Ed., JAI Press: Greenwich, Connecticut,
1988, Vol. 7, p. 1-31.
\320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
2: L-altrose 3: L-mannose
\320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275
\320\276\320\275
\320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275 \320\276\320\275
\320\276\320\275 S. Masamune and
5: L-gulose 6: L-ldose 7: L-talose 8: L-galactose
\320\232.\320\222.
Sharpless A983)
L-Hexoses
19.1 Introduction
\320\276
\320\241\320\2353\320\234\320\264\320\245
[encto-10:exo-11
i
| Ph3P=CH2 LIAIH4
mCPBA
\321\201\320\2752
(substrate-stereocontrolled epoxidation)
diastereoselection.
Scheme 1. Substrate-controlled
19.1 Introduction 295
Ti(OAPrL,
\320\234\320\227\320\270\320\236\320\236\320\235,
*
CH2CI2, - 20 \302\260\320\241
70-90% yield;
> 90% \320\265\320\265
TI(Of-PrLl
OH
f-BuOOH
Ti(Of-PrL,
\320\276\320\275
\320\276
(matched)
\320\260-13
\321\200-14
\321\201\320\260.
(\320\260-13\321\204-14 90:1)
SAE = Sharpless asymmetric epoxidation
OR OR
I I
R CH\342\200\224CH\342\200\224CH=CH
\342\200\224CHjOH
reiterate
\"\"\302\253.
R\342\200\224CH=CH \342\200\224CH2OH
ii
OR1 OR1 I
I I
R CH\342\200\224CH\342\200\224CHO R\342\200\224CHO
\320\276
/\\
R CH\342\200\224CH\342\200\224CH2OH
IV
OR1 OR'
I I
R CH\342\200\224CH\342\200\224CH2OH
aldehyde, thereby setting the stage for another cycle. This concise
and flexible strategy thus provides several opportunities for control-
controlling stereochemical relationships. With to stage I of the
respect
cycle, it ought to be possible to define the
geometry of the allylic
alcohol via ah E- or Z-selective Wittig reaction.12 In stage II, the
stereo-directing influence of the appropriate tartrate ligand deter-
determines which enantioface of the allylic alcohol is epoxidized.
But
one at C-2, and the other at C-3. But in addition, C-l of a 2,3-
epoxy alcohol also has latent electrophilic reactivity. For example,
exposure of 14 to aqueous sodium hydroxide solution results in the
formation of triol 19 in 79% yield (see Scheme 5). In this interest-
transformation,
interesting hydroxide ion induces the establishment of an ^\342\200\224
\320\236\320\235
\320\241\320\236\320\2
equilibrium between 2,3-epoxy-l-ol 14 and the isomeric 1,2-
epoxy-3-ol 18. This reversible, base-induced epoxide migration 18
,\302\251OH
NaOH,
(Payne rearrangement)
14 18 19
(erythro)
[2,3-anti]
process forward.
/ NaOH, PhSH, / /
-/-\320\236 H2O/f-BuOH,A ~\320\243~\320\236 9
Ok T~\302\260t
SPh
(Payne rearrangement)
14
C-l hydroxyl group. In this manner, the C-l oxygen atom can
direct the regiochemical course of the subsequent epoxide ring
opening reaction. The reaction types presented in Scheme 8 are, in 2,3-epoxy
from intramolecular alcohol
fact, highly regioselective, affording products
nucleophilic attack at C-2.
With respect to the total synthesis of the hexoses, the transforma-
transformation
presented in Scheme 6 is particularly promising. In contrast to
OH
17
NaOH, f-BuSH,
H20/t-BuOH, \320\224
Sf-Bu
OH
21
I Me3OBF4, CH2CI2
HO
OH f-Bu
22
I NaH, CH2CI2
T
OH
''\320\236 OTHP
LiAIH4, 23
EtjO, 0 \302\260C
(83%) Et2O, -40 25 \302\260C
-\302\273 F3%)
OH OH
Me2CuLi,
Et2O, G4%)
-40 \302\260C
OH
24
OTHP
OH
OH
25
1. ROC@)Clor
RNCO
2. acid
\320\276\320\275
1. RNCO
2. base
2,3-epoxy \320\276\320\275
alcohol
Red-AI
Red-AI = NaAIH2(OCH2CH2OCH3J OH
.\320\276\320\275
V-
12-E 12-Z
Ti(O/-PrL, I I
rnCPBA, CH2CI,
f-BuOOH, (+)-DET I
(91%)
OH
14 27
(diastereoselectlvity: ca. 22:1) (diastereoselectivity: ca. 1.1:1)
\320\276\320\275 0H
\"-\342\200\242/-\320\276 \320\223~
\302\260
\302\260\320\2334
\320\236\320\235 \320\236\320\235
20 28
OMe
II
1.
SPh POCI3 \320\232\320\275 ac2o,
'\320\247 ,\320\275
zl--
\302\246*- \320\276.\320\233:\" \302\273-
2. fflCPBA NaOAc
H'\"
(Pummerer H'\"
rearrangement)
\302\251 Ph
AcO
2l--r
7\320\265-
K2CO3,MeOH 99 Dibal-H, -78 \320\241
(98%) ^^ _(86%)
30
\"\302\246 CHO
\302\2464-0
\320\236
.\342\200\242\320\233
\"V
31 30
C0:32/99:1)
CHO
32 32 30
C2:30/95:5) 2,3-threo 2,3-erythro
[2,3-syn ] [2,3-anti]
p-eiimination
H-.
R CHO
CHO pylidene ketal) thus serves several important functions in the reac-
reaction sequence presented in Scheme 10; in addition to its obvious
i role as a protecting group, the C2-C3 ketal in compound 30
cyclic
createsan ideal setting for the desired epimerization at C-2.
At first glance, it may seem surprising that enolate 31, produced
on deprotonation of the a carbon (C-2) in 30, does not initiate a /?-
elimination of the C-3 alkoxy substituent. After all, enolates con-
containing alkoxy groups or other heteroatom functions in the /? posi-
position are, in many instances, prone to a destructive ^-elimination
pathway. In the context of 31, however, the C2-C3 cyclic ketal pre-
prevents a destructive ^-elimination by maintaining orthogonality
between the enolate n system and the C3-0 bond
\321\201 (see
Figure 2).13c-16 To summarize, the threo 2,3-diol problem is solved
simply by conducting the cleavage of the acetoxythioacetal func-
function in a sufficiently basic medium, so that epimerization at C-2
can also take place.
But how susceptible is erythro aldehyde 30 to epimerization at
C-2? Can the conversion of acetoxythioacetal 29 to erythro alde-
RCHO
SAE SAE
[(+)-tartrate] [(-)-tartrate]
HO HO
OH \320\236\320\235
RS^rSPh
OAc
Scheme 11. General strategy for the achievement of stereochemical control in the synthesis of the
hexoses 1-8.
308 19 L-Hexoses
4Y2
\321\201\320\275\320\276 dotted line are diastereomeric. As a result, the success of a reaction
\320\276\320\275
\320\276\320\275 to the right of the dotted line does not guarantee the success of the
corresponding reaction to the left of the line or vice versa.
1: L-allose The Masamune-Sharplesssynthesis of L-allose A) is outlined
retrosynthetically in Scheme 12. Through a straightforward se-
sequence of deprotections, L-allose A) could be derived from com-
OH OH OH
CHO
\320\276\320\275
\320\276\320\275
1: L-allose
SPh
39 40
Ti(o;-PrL, HO
(+J-DIPT, PhSH, NaOH,
\320\247\320\236\320\235
f-BuOOH
4SPh
2 OH \320\224
H2O/f-BuOH,
(92% yield) OH
G1%)
40
(>95% \320\265\320\265) 39 41
D:1 mixture of
R = CHPh2 regloisomers
in favor of 41)
1. 2,2-dimethoxypropane,
POCi3 (cat.)
2. mCPBA,-78\302\260C
<M% overall>
3. AC2O, NaOAc, \320\224
RO
43
(threo)
ligand
in subsequent asymmetric epoxidations, and the employment
of the appropriate acetoxythioacetal cleavage protocol could then
secure the requisite diastereomeric relationships.
2,3-Epoxy alcohol 39 is produced with >95 % \320\265\320\265
by SAE of 40,
and is poised for a Payne rearrangement/epoxide opening reaction.
In the event, exposure of 39 to thiophenol in a basic medium
results in the formation of a 4:1 mixture of regioisomeric diol sul-
fides in favor of the desired C-l opened product 41. Recrystalliza-
tion of the 4:1 mixture furnishes compound 41 in 71 % yield. As
we have seen in Schemes 5 and 6, the action of hydroxide ion on a
L-gulose E), L-idose F), L-talose G), and L-galactose (8). The syn-
synthesis of intermediates 37 and 43 marked the completion of the first
turn of the cycle and set the stage for the second turn. Independent
treatment of compounds 37 and 43 with formylmethylenetriphenyl-
phosphorane smoothly achieves the desired two-carbon extension,
furnishing the corresponding E a,p-unsaturated aldehydes in excel- R = CHPh2
excellent yields and with >20:l stereoselectivity in each case (see Scheme
14). It is noteworthy that epimerization at C-2 does not occur during RO
the course of these Wittig reactions. As expected, sodium boro-
hydride reduction of the two-carbon extended aldehydes, derived
respectively from 37 and 43, proceeds uneventfully and gives the \320\276\",
5 J.
Scheme14.
Syntheses of the i-hexoses A-8).
19.4 Conclusion 313
19.4 Conclusion
References
1. Seebach, D.; Weidmann, Wilder,
\320\222.; L. In Modern 5. Sharpless, K.B. Chem. Scr.1985,25,71.
Synthetic Methods 1983, Scheffold, R., Ed., Otto 6. (a) Masamune, S.; Choy, W.; Petersen, J.S.; Sita, L.R.
SalleVerlag: Frankfurt, 1983, p. 324. Angew. Chem. Int. Ed. Engl. 1985, 24, 1; (b) Masa-
2. For reviews concernedwith the synthesis and reactions Masamune, S. Heterocycles 1984, 21, 107.
of epoxides,see:(a) Rao, A.S.; Paknikar, S.K.; Kir- 7. Katsuki, \320\242.;
Sharpless, K.B. J. Am. Chem. Soc. 1980,
tane, J. G.Tetrahedron 1983, 39, 2323; (b) Sharpless, 102,5974.
K.B.; Verhoeven, T.R. Aldrichimica Acta 1979, 12, 8. For excellent reviews of the Sharpless asymmetric
63; (c) Berti, G. Top. Stereochem. 1973, 7, 93; (d) epoxidation reaction, see: (a) Rossiter, B.E. In Asym-
Buchanan, J.G.; Sable, H.Z. In Selective Organic Asymmetric Synthesis, Morrison, J.D., Ed.; Academic
Transformations, Thyagarajan, B.S., Ed., John Wiley Press:New York, 1985, Vol. 5, 193; (b) Finn, M.G.;
& Sons: New York, 1972, Vol. 2, p. 1; (e) Yandovskii, Sharpless, K.B. In Asymmetric Synthesis, Morrison,
V.N.; Ershov, B.A. Russ. Chem. Rev. (Engl. Transl.) J.D., Ed., Academic Press: New York, 1985, Vol. 5,
1972, 41, 403; (f) Swern, D. In Organic Peroxides, 247; (c) Pfenniger, A. Synthesis (d) Johnson,
1986, 89;
Swern, D., Ed., Wiley-Interscience: New York, 1971, R.A.; Sharpless, K.B. In Comprehensive Organic
Vol. 2, Ch. 5; (g) Parker, R.E.; Isaacs, N.S. Chem. Synthesis, Trost, B.M.; Fleming, I., Eds., Pergamon
Rev. 1959, 59,1\320\2521. Press: New York, 1991, Vol. 7, p. 389; (e) Johnson,
3. For excellent discussions, see: Bartlett, P. A. Tetra- R. A.; Sharpless, K.B. In Catalytic Asymmetric Syn-
Tetrahedron 1980, 36, 2. Synthesis, Ojima, I., Ed., VCH: Weinheim, New York,
4. Eliel, E.L.; Wilen, S.H.; Mander, L.N. Stereochem- 1993, 103; (f) Katsuki, Martin,
\320\242.; V.S. Org. React.
of
Stereochemistry Organic Compounds, John Wiley & Sons: (N. Y.), in press.
New York, 1994, pp. 736, 789, 838-839.
References 315
S.LSchreiberA983)
Asteltoxin
20.1 Introduction
sunlight (hv),
ons yesr
A
I: carvone II: carvonecamphor
Me
hv
III: benzaldehyde IV
hv
VI
IX X: cubane
OEt
\342\200\242 0Et hv
hv
\320\275 /0Et ?f
A.+
A
\342\200\236A.
r ii^r \320\247\320\235
Me Me
XI: acetone XII: ethyl vinyl XIII XIV
ether
[XllhXIV ca. 3:7]
H2O, 25 \302\260C
\320\236\320\235
\320\275
\320\276
Me
XV XIV
OH
\320\275
\320\275 H H
H2, 5% Rh/AI2O3 ....Ph
\302\246\302\26001NHC'' Me
THFA:4)
Me Me
(88-92%)
XVIII XVII IXX
(head-to-head,
exo photoadduct) wet
Celite
concave
face Ph
OH
\\ Me
HO \342\200\236\342\200\242^h\302\273
Me
XX
XVII \\
convex
face
HO H
H H 1 H
....Ph NaOH
BH3\302\253THF; H2O2, Ph
Me Me
(82%)
Me
XVII XXI
BH3\302\253THF H2O2) T
NaOH
\" R^ / Ph
\320\230
\320\235 4 H !
Me
Me\342\200\224\\jZo\302\251
'Me
Me A
Me
Me. Me H mCPBA, \302\253
\320\235\320\236,.
NaHCO3,
CH2CI2,25 \302\260C
H (80-84%) H
XXII XXIII
C-C bond
H9 Me PH ^ formation
Me-l I J /
Intermolecular aldol/dehydratlon
1: asteltoxin Me OMe
**\"
Me\"'
Pummerer
rearrangement
\320\236 \320\236
Me'AX Me
\320\276\320\275
OH
Me-i
OBn
OH Me
OBn
Ring X* Carbonyl NNMe2 NNMe2
closure addition
11 12 13
Me
Me
Me
OBn
benzene, Et2O,
hv, 6h F3%)
HO HO Me
\320\236
OBn Me...
3 N HCI,
H-PC^B
.Me
\302\253\302\253 ArCO2-
THFC:1)
H-O^^^OBn
15
lactol formation
HO
, MgSO4, I
Me^l/* OH
^H CH2Cl2 Me- .
Me-H-H
. G2% from
'\302\246\342\200\224\321\207 16) {.
''\342\200\242-
Nu
Nu L
HO Me H 0H
Me
MO,
Mevbf0H h\342\200\224\320\235\321\201\320\267=\320\276'
h^y^oh
R R
XXIV
^
\320\234\320\265\320\223 ^ ^\302\260\320\222\320\237
MeH\302\260 -?
(\320\241\320\235\320\267\320\254\320\241\320\236,
OH
CuSO4, CSA Me.
Lactol OBn
formation
OBn OBn
14
Hydrazone
formation
OBn
ArCO2-
Paterno-Buchl
19: 3,4-dimethyl- 18: p-(benzyloxy)-
reaction
furan propanal
Me Me H
Me
Me H dimethylhydrazine 16
on dioxabicyclo[3.2.0]heptane would result
HO.. f in the formation of lactol 13 via intermediates 15 and
/... .Ph /... .Ph hydrazone
OBn SeAr
HO
O3,CH2CI2,
MeOH,Me2S
Me'
(92%)
1. Mel, K2CO3,
\320\236 \320\236 1. lm2CO,THF
p. P
\320\224\320\220
*
Me'XX Me 2, NaNH2 (excess), Me 2. Me2SO4, OMe
NH3) EtzO, CO2 Me
K2CO3,
(CH3JCO
8: 2,4-pentanedione 7
\320\275\320\276
Me \320\223
2 (88%) 22
aq. NH4CI,
25 \302\260C
SPh
HO.
[2,3] sigmatropic
i
rearrangement
24 23
/2,3/sigmatropic
rearrangement
HQ \320\276\320\275
\342\200\236\342\200\236
SOPh
25
HO \320\276\320\275
Me
H0
Me ?H
HgCl2, CaCO3,
^.
,OAc CH3CN/H2OC:1) Me
CHO
F0% overall
lSPh from 26)
\320\275\320\276\321\200\320\275
\320\234\320\265 It is instructive, at this stage, to draw attention to the sulfoxide
grouping in intermediate 26. As we have already witnessed, the
versatile sulfoxide functional group permitted the conversion of
intermediate 5 into a resonance-stabilized carbanion which was
used to form a key carbon-carbon bond, and it permitted the ela-
SOPh
26 elaboration of a significant portion of asteltoxin's unsaturated side
chain through sequential [2,3] sigmatropic rearrangements. In addi-
addition, the sulfoxide function is a viable precursorfor an electrophilic
carbonyl group. Acetylation of the sulfoxide oxygen in 26, under
the conditionsillustrated in Scheme 7, initiates a Pummerer rearran-
rearrangement24 and to the formation of acetoxy sulfide
leads 27, a sub-
5: frans-1-phenylsulfinyl-
substance which was taken forward in crude form. The combined
methyl-1,3-butadiene
action of mercury(n) chloride and calcium carbonate on a solution
of 27 in aqueous acetonitrile unveils the reactive dienal moiety
(see 28) and sets the stage for the crucial intermolecular aldol con-
condensation with substituted pyrone 4. Deprotonation of the indicated
methyl group (C*) in 4 with lithium diisopropylamide (LDA) fur-
furnishes a delocalized anion, an extended enolate, which reacts
SPh
smoothly
with aldehyde 28 to give aldol adduct 29 in a yield of
80% (see Scheme
8). Tosylation of less
the hindered secondary
allylic hydroxyl group in 29 with concomitant elimination com-
completes Schreiber's elegant synthesis of (\302\261)-asteltoxin [(\302\261)-1].
HO OH
\342\200\236_
4 HO 29
Me OMe
j3642
4-DMAP, Et3N, CH2CI2
(82%)
20.4 Conclusion
commanding role.
332 20 Asteltoxin
References
1. (a) Dilling, W.L. Chem. Rev. 1966, 66, 373; (b) 12. Schreiber, S.L.; Hoveyda, A.H.; Wu, H.-J. J. Am.
Bauslaugh, P.G. Synthesis 1970, 287; (c) Sammes, Chem. Soc. 1983,105, 660.
P.G. ibid. 1970, 636; (d) Sammes, P.G. Q. Rev. 13. For insightful discussions, see: Woodward, R. \320\222.;
Chem. Soc. 1970,24, 37; (e) Kossanyi, J. Pure & Bader, F.E.; Bickel, H.; Frey, A.J.; Kierstead, R.W.
Appl. Chem. 1979, 51, 181;(f) Baldwin, S.W Org. Tetrahedron 1958,2, 1.
Photochem. 1981, 5, 123; (g) Wender, P. A. In 14.Zweifel, G.; Plamondon, J. J. Org. Chem. 1970,35,
Photochemistry in Organic Synthesis, Coyle, J. D., 898.
Ed., Royal Society of Chemistry: London, 1986, 15.For review of substrate-directed
an excellent chemical
1964, 86, 962; (b) Eaton, P.E.; Cole, T.W., Jr. ibid. York, 1983, Vol. 2, p. 125; (e) For a review, see:
1964, 86, 3157. Reetz, M.T. Angew. Chem. Int. Ed. Engl. 1984, 23,
8. For reviews of the Paterno-Buchi reaction, see: (a) 556; (f) Mulzer, J. In Organic Synthesis Highlights,
Arnold, D.R. Adv. Photochem. 1968, 6, 301; (b) Mulzer, J.; Altenbach, H.J., Braun, M.; Krohn, K.;
Jones,G.,II Org. Photochem. 1981, 5, 1; (c) Carless, Reissig, H.U., VCH Publishers, Weinheim, New
H.A.J. Synthetic Organic Photochemistry, Hors- York, 1991, p. 3; (g) Still, W.C.; McDonald, J.H., III
Horspool, W.M., Ed., Plenum Press: New York, 1984, Tetrahedron Lett. 1980, 21, 1031;(h) Still, W.C.;
p. 425; (d) Braun, M. Nachr. Chem. Tech. Lab. Schneider, J. A. ibid. 1980, 21, 1035.
1985,33, 213;(e)Porco, J. A., Jr.; Schreiber, S.L. In 22. Grieco, P.A.; Gilman, S.; Nishizawa, M. J. Org.
Comprehensive Organic Synthesis, Trost, B.M.; Chem. 1976,41, 1485.
Fleming, I., Press: New York, 1991,
Eds., Pergamon 23.Corey, E.J.; Hoover, D.J. Tetrahedron Lett. 1982,
Vol. 5, p. 151; (f) Braun, M. In Organic Synthesis 23, 3463.
Highlights, Mulzer, J.; Altenbach, H.-J.; Braun, M.; 24. (a) De Lucchi, O.; Miotti, U.; Modena, G. Org.
Krohn, K.; Reissig, H.-U.; VCH Publishers: Wein- React. (N. Y.) 1991, 40, 157; (b) Moiseenkov, A.M.;
heim, New York 1991, p. 105. Dragan, V. A.; Veselovskii, V. V. Russ. Chem. Rev.
9. (a) Schroeter, S.H.; Orlando, \320\241\320\234.,
Jr. /. Org. Chem. (Engl. Transl.) 1991,60, 643.
1969, 34, 1181;(b) Schroeter, S.H. ibid. 1969, 34, 25.Evans, D.A.; Andrews, G.C. Ace Chem. Res. 1974,
1188. 7, 147.
10.Schreiber, S.L. Science (Washington, D.C.) 1985, 26. Whipple, E.B.; Evanega, G.R. Tetrahedron 1968,
227, 857. 24, 1299.
11.(a) Toki, S.; Shima, K.; Sakurai, H. Bull. Chem. Soc.
Jpn. 1965,38, 760; (b) Shima, K.; Sakurai, H. ibid.
1966, 39, 1806.
Me
1: perlplanone \320\222
S.LSchreiberA984)
\320\222
Periplanone
21.1 Introduction
X)
KH, 18-crown-6,
25 \302\260C
G1%)
(95%)
oxy-Cope
\342\200\236
\320\275
rearrangement)
electrocyclic
ring opening
hv
\302\273
(81%)
enol
tautomerization
10 (90% yield) 11
14
\320\275
2: allene hotocycloaddltlon
ThermolysisA75 of
\302\260C) 13 induces electrocyclic ring opening and fur-
furnishes a mixture of the desired trans diene and the undesired 12
cis diene isomer. Although these substances can be isolated in pure
form, irradiation of the mixture of isomeric dienes establishes a
in the trans isomer. In this way, the desired trans diene 12 can be
obtained in a yield approaching 75 %. PhS
From intermediate 12, the path to periplanone \320\222
A) is short but
interesting. Enolization of 12 with lithium bis(trimethylsilyl)amide
at -78 followed
\302\260C, by sulfenylation using Trost's reagent,12affords
a 16:1 mixture of regioisomeric monosulfenylated ketonesfavoring
intermediate 17. The regioselectivity displayed in this reaction is
338 21 Periplanone \320\222
F3%)
HO
[3,3] KH, 18-crown-6,
Me
(anlonic 60 \302\260C
G5%)
, oxy-Cope
Me
Me rearrangement)
13 14
175 \302\260C,
PhCH3 G7%)
/iv, PhH (82%)
PhS
1. NalO4, H2O, MeOH 2
1. LiN(SiMe3J G1%from 12)
\302\273
2. PhSSO2Ph 2. PhCH3,110 \302\260C
D5%)
f-BuOOH,
KH, THF (83%)
\342\200\242
[peripheral
attack]
18a
1. LiN(SiMe3J
2. PhSeBr(83%)
PhSe
\320\236
\\
Me
K2CO3,
MeOH,
H2O
F0% from 20)
9. \320\276
\302\251\302\251
CH2SMe2,
DMSO-THF
[peripheral
Me
attack]
F2%)
21.4 Conclusion
Itis incumbent upon us to emphasize that the most productive and
impressive transformations in
(\302\261)-periplanone
\302\261)-1: \320\222
Schreiber's periplanone \320\222
synthesis
are initiated simply by light and heat. The model study and the
total synthesis discussed in this chapter reaffirm the utility of the
anionic oxy-Cope ring-expansion process for the construction of
5-cyclodecen-l-one frameworks. The carbon-carbondouble bond
and keto functions of such frameworks provide convenient opportu-
opportunities for further functionalization, thereby allowing the elaboration
of a variety of complex cyclodecanoid systems. In only two steps,
15\320\260 bicyclic /?,y-unsaturated ketone 15a, the product of a completely
regioselective[2+2] photocycloaddition reaction between simple
starting materials, is converted into cyclodecenone 13. The position
of the carbon-carbon doublebond in the cyclobutene a13 permits
thermally allowedelectrocyclic
conrotatory ring opening15 to give
the conjugated moiety. Of course, this conjugated
1,3-diene diene
unit is not only expressed in the natural product, but it also imposes
a marked influence on the conformation of the ten-membered ring
in which it is contained. As we have seen, this feature was master-
masterfully exploited by Schreiber and Santini to control the stereochemi-
cal courseof a crucial oxidation step. We have now witnessed two
independent and elegant total syntheses89 of periplanone B, the
potent sex pheromone of the American cockroach, and both illus-
illustrate the preparative value of synthetic organic chemistry. The utili-
utilization of synthetic periplanone for
\320\222 the control of the population
of the American cockroach has been explored.
References 341
References
1. Schreiber, S.L.; Santini, Tetrahedron
\320\241 Lett. 1981, React. (N.Y.) 1993, 43, 93; (e) Hill, R.K. In
22,4651, Comprehensive Organic Synthesis, Trost, B.M.;
2. For reviews, see: (a) Dilling, W.L. Chem. Rev. 1966, Fleming, I., Eds., Pergamon Press: New York, 1991,
66, 373; (b) Bauslaugh, P.G. Synthesis 1970, 287; (c) Vol. 5, p. 785; (f) Hesse, M. Ring Enlargement in
Sammes, P.G. ibid. 1970, 636; (d) Sammes, P.G. Organic Chemistry, VCH Publishers: Weinheim,
Q. Rev. Chem. Soc. 1970,24, 37; (e) Baldwin, S.W. New York, 1991.
In Organic Photochemistry, Padwa, A., Ed., Marcel 8. (a) Schreiber, S.L.; Santini, C. J. Am. Chem. Soc.
Dekker: New York, 1981, p. 123; (f) Wender, P. A. In 1984, 706, 4038; (b) Schreiber, S.L. Science
Photochemistry in Organic Synthesis, Coyle, J.D., (Washington D. C.) 1985, 227, 857.
Ed., Royal Society of Chemistry: London, 1986, 9. Still, W.C. J. Am. Chem. Soc. 1979,101,2493.
p. 163; (g) Horspool, W. M. In Photochemistry in 10. (a) Still, W.C; Galynker, I. Tetrahedron 1981, 37,
Organic Synthesis, Coyle, J.D., Ed., Royal Society of 3981; (b) Still, W.C; MacPherson, L.J.; Harada, \320\242.;
Chemistry: London, 1986, p. 210; (h) Crimmins, Callahan, J.F.; Rheingold, A.L. ibid. 1984, 40, 2275;
M.T.; Reinhold, T.L. Org. React. (N.Y.) 1993, 44, (c) Still, W. \320\241
In Selectivity - A Goal for Synthetic
297. Efficiency, Bartmann, W.; Trost, B.M., Eds., Verlag
3. (a) Corey,E.J.;Bass,J.D.;LeMahieu, R.; Mitra, R.B. Chemie: Weinheim, 1984, p. 263. (d) Still, W.C. In
J. Am. Chem. Soc. 1964, 86, 5570; (b) Eaton, P.E. Current Trends in Organic Synthesis, Nozaki, H.,
Tetrahedron Lett. 1964, 3695. Ed., Pergamon Press: Elmsford, New York, 1983,
4. For insightful discussions, see: Woodward, R. \320\222.; p. 233.
Bader, F.A.; Bickel, H.; Frey, A.J.; Kierstead, R.W. 11.Corey, E.J.;Cheng, X.-M. The Logic of Chemical
Tetrahedron 1958, 2, 1. Synthesis, John Wiley & Sons: New York^ 1989.
5. Marvell, E.N.; Whalley, W. Tetrahedron Lett. 1970, 12. Trost, B.M.; Salzmann, T.N.; Hiroi, K. J. Am.
509. Chem. Soc. 1976,98, 4887.
6. Evans, D.A.; Golob, A.M. J. Am. Chem. Soc. 1975, 13 (a) Nicolaou, \320\232. Petasis,
\320\241; N. A. Selenium in Nat-
97, 4765. Natural Products Synthesis, CIS: Philadelphia, 1984;(b)
7. For some excellent reviews of the anionic oxy-Cope Organoselenium Chemistry, Liotta, D., Ed., John
rearrangement, see: (a) Hill, R. K. In Asymmetric Wiley & Sons: New York, 1987.
Synthesis, Morrison, J.D., Ed., Academic Press: New 14.Marshall, J.A.; Royce, R.D. Jr. J. Org. Chem. 1982,
York, 1984, Vol. 3, p. 503; (b) Paquette, L.A. Synlett 47, 693.
1990, 67; (c) Paquette, L.A. Angew. Chem. Int. 15. Woodward, R.B.; Hoffmann, R. Angew. Chem. Int.
Ed. Engl. 1990, 29, 609; (d) Wilson, S.R. Org. Ed. Engl. 1969, 8, 781.
1: menthol
Takasago A984)
Menthol
22.1 Introduction
\302\251
[Rh((fl,fl>DiPAMP)COD] BF40(cat.),
'
AcO
NHAc H2 A00%) \320\224\321\201\320\236
\302\251
\320\2353\320\236
4: L-DOPA
1. (R,R>PNNP-Rh(l) (cat.),
H2, EtOH (83% \320\265\320\265)
(catalytic aaymmetric
CO2Me
hydrogenation)
\302\253
2. MeOH H NHAc
H\302\251,
6: E>phenylalanlne
methyl ester (97% \320\265\320\265
after recrystalllzatlon)
\320\275\320\276'
\320\235
'NH2
aspartic acid
MeO2C 0
~\321\201\320\2762\320\275
^ \321\203.
\320\275
'nh2
7: aspartame
Scheme 2. Anic and Enichem's commercial synthesis of aspartame G) using catalytic asymmetric hydro-
hydrogenation.
[H+)-dialkyl tartrate]
8: (S>glycldol
OH
[H-Hialkyi tartrate]
9: 0?>glycldol
[L-(+)-dialkyl tartrate]
10: fS>methylglycidol
Scheme 3. The ARCO Chemical Company's commercial synthesis of the glycidolsusing the Sharpless
asymmetric epoxidation reaction.
*-BuOOH,
D-(-)-diethyl tartrate
H
(Sharpless asymmetric epoxidation) 13
CrO3\302\2532pyr.
1. \320\240\320\2303\320\240=\320\241\320\235\320\241\320\2352\320\241\320\2352\320\241\320\235(\320\241\320\235\320\267J
(Wittig reaction)
2. H2
Scheme 4. The Sharpless asymmetric epoxidation in the J.T. Baker Company's commercial synthesis of
GR,8S)-disparlure A5).
348 22 Menthol
CO,*
N2CHCO2Et,
CO2H
\320\233/-\320\230
CO2Na
\320\230^\320\275
CO2H
20: imipenem
Scheme 5. The Sumitomo Chemical Company's catalytic asymmetric synthesis of ethyl (+)-A S)-2,2-
dimethylcyclopropanecarboxylate A8), an intermediate in Merck's commercial synthesis of cilastatin A9).
(+)-DIOP-Co (cat.),
THF, 60 \302\260C
B3%)
NEt2
21: diethylnerylamine 22 23
{ca. 32%\320\265\320\265)
(+)-DIOP-Co (cat.)
(95%)
24: cyclohexylgeranylamine 25
D6% \320\265\320\265)
FT (Sj-BINAP-Rh(l)
^1
NEt2
(Z)-26
(E)-2B (R&29
E>BINAP fR>BINAP
(Noyori era/.N9
Sol \302\251
V
30
* = enantlomerically
pure BINAP ligand
Sol = solvent
ligand exchange
(-Sol)
Sol
/5-hydride elimination
s-trans
imlnium-RhH
\321\217
complex
suprafacial transfer
of H from Rh to C-3
Scheme 8. Catalytic cycle for the BINAP-Rh(i)-catalyzed asymmetric isomerization of allylic amines.
352 22 Menthol
1. (S>BINAP-Rh(l) (cat.)
(asymmetric isomerization) \342\200\236CHO
CH2=CHMgCI,THF
38 37
1. PCI3
2. NaOAc
3. aq. NaOH
4. fractional distillation
OH
fS>BINAP-Ru(li) (cat), H2
4OH (asymmetric
39 hydrogenation) 40
(98% \320\265\320\265) (96% de; 98% \320\265\320\265)
G/?:7S=99:1)
a-tocopherol (vitamin E)
1. fS>BINAP-Rh(l)(cat.)
(asymmetric isomerization)
hydrogenation
carbonyl ene
reaction
1: (-)-menthol 43: isopulegol 36:(R>citronellal
enamine
hydrolysis
V
asymmetric
teiomerlzation NEt2
Isomerization
Et2NH <J=
NEt2
The stage is now set for the crucial catalytic asymmetric isomer- 47
NEt2
\320\273-BuLi(cat.), NEtj
(thermal Et2NH
cracking) (telomerization)
-r
46: C-pinene 45: myrcene 47 35: diethyl-
geranylamine
\302\256
[Rh((S>BINAP)(COD)] CIO4Q(cat.),
100\302\260C(ca. 100%)
(asymmetric isomerization)
H2)Ni
(hydrogenatlon)
Scheme 12. The Takasago process for the asymmetric synthesis of (-)-menthol A).
than the same substance obtained from its natural source! Indeed,
the enantiomeric purity of natural (i?)-citronellal is at best 80%. On
the basis of well-established
precedent,72 it was anticipated all
along that the methyl-bearing C-3 stereocenter in citronellal would
guide the stereochemicalcourseof a carbonyl ene cyclization74 to
give the isomericisopulegolmolecule D3).Gratifyingly, treatment
22.4 Conclusion
CR,R;-Et-DuPHOS-Rh(l)
@.1 mol%),
EtO2C
X. OAc
H2, MeOH, 25 \320\241
\320\273..
(catalytic asymmetric (99% \320\265\320\265)
hydrogenation)
(BurkN
(S>BINAP-Ru(OCOCH3J
@.5 mol%),
CO2H CO2H
H2, MeOH A00%)
MeO (catalytic asymmetric MeO
hydrogenation) naproxen
(an anti-inflammatory
agent) (92%yield; 97% \320\265\320\265)
(Noyoriefa/.O
f-BuMe2Si0 f-BuMe2Si0
BINAP-Ru(ll) H H
\320\236\320\235
@.2 mol%), H2,
NH MeOH -NH
(96-100%yield)
(catalytic
asymmetric a
hydrogenation)
(Noyoriefa/.)8
CR>tolBINAP fS>tolBINAP
B\320\257,
\320\227\320\257) BS, 3S)
DET, Ti(O/-PrL,
)\302\273-
f-BuOOH, CH2CI2,
4 A mol. sieves, - 20 \302\260\320\241
(Sharpless asymmetric epoxidation) ?leld;
(Sharpless et a/.14;seealso
Chapter 19)
L-(+)-DET,
Ti(O*-PrL)
\342\204\226\302\273
f-BuOOH, CH2Ci2,
geranlol 4 A mol. sieves, - 20 \302\260C
catalyst D mol%),
NaOCI(aq.) *-
CH2CI2
d;
(Jacobsen epoxidation) $*%ylel
et a/.)
15
(Jacobsen
MeO MeO
Ru(OCOCH3J[fff>BINAP]
@.5-1mol%), H2, EtOH/CH2CI2,
NCOCH3
MeO MeO
OMe
23 \302\260C
OMe
A00% yield)
(catalytic asymmetric
OMe hydrogenatlon) OMe
(Noyori ef a/.)9 (>99.5% \320\265\320\265)
(S>BINAP-Ru(ll), H2
*\342\200\242
\"OH OH
geraniol ffl>citronellol
(S>BINAP-Ru(ll), H2
H2, fff>BINAP-RuCI2
(substrate:catalyst = 2000:1), \320\276\320\275
\320\276
19-30 \302\260C
(99%
\320\234\320\265\320\236\320\235,
\320\276\320\274\320\265 yield) \320\220\320\233 OMe
(catalytic asymmetric
hydrogenation) (99% \320\265\320\265)
(Noyori et a/.I1
(84% yield;
96% \320\265\320\265)
(Pfaltz eta/.I3
OSIMezf-Bu
A.2 mol%)
(catalytic asymmetric conjugate reduction)
io
catalyst B.5 moi%),
pyridine W-oxlde,
(Katsukiefa/.I6
\302\251
Ph Ph
catalyst
=
\302\251OAc
R = Ph
C-face
\"HO OH\"
NW AD-mlx-C
Ri H
f-BuOH/H2OA:1)
0\302\260C
SW SE
\\
AD-mix-a
HO OH
\"HO OH\" (Sharpless asymmetric
a-face dlhydroxylatlon)
A mol%)
CN
Ph R = C(CH3JOH
...CO2*Bu
= + N2CHC02f-Bu H'>/V\"c\302\2602*-Bu+Phv
CICH2CH2CI H
cyclopropanatlon)
(91% yield;
et al.) >99% \320\265\320\265)
(Evans
f?>cinnamyl alcohol
(catalytic asymmetric (91%yield;
cyclopropanatlon) 75% \320\265\320\265)
NHSO2C6H4-O-NO2 ,21.
(Kobayashiefa/.)'
chiral ligand =
Cu(l)OTf (S ),
chlral ilgand F mol%),
+ Phl=NTs _______________ Ph.... /\\ ,,.H
Ph\"
H CO2Ph
(catalytic asymmetric
(97% \320\265\320\265)
azirklination)
(Evans efa/.I9a-22
H-
Ci N N= Ci
Ci Ci
OBn
BH3*THFA.0equlv.),
Ph
\342\200\242\302\246Ph
acetophenone oxime fSJ-1-phenylethylamlne
O-benzyl ether
(90% \320\265\320\265)
.24
derived (Itsuno era/.)'
E>valine
oxazaborolidine
@.25 equlv.)
E>cat.
\\ E-10 mol%),
\302\246 BH \302\273-
A. \342\200\242ftoluene
(Corey et al.J5
(SJ-cat.= /S>oxazaborolidine
=
(Corey era/.J5
fflj-cat. = \342\204\226>oxazaborolldine =
NH2
B mol%),
Et2Zn
toluene, 0 \302\260C
(catalytic asymmetric (96%yield;
carbonyl addition) 49%\320\265\320\265)
,27
(Oguniefa/.)
\320\275
\320\275\320\276
(-)-DAIB B mol%),
\302\273~
Et2Zn
toluene, \320\236
\320\241
H-DAIB =
(-)-3-exo-(dimethylamino)-
isoborneol
Me2BBr, -78 C,
Ph'\342\200\224==;\342\200\224Snn-Bu3 \302\273\302\253\302\246
Ph\342\200\224==\342\200\224BMe2
toluene
oxazaborolidlne
29
(Corey and Cimprlch) catalyst
\320\276\320\275 OBMe2
HCI/MeOH,
A
^\342\200\242\342\200\242\342\200\242\342\200\242\321\201^\320\261\320\235\321\206
-78 23 \302\260C
-\302\273 H
Ph Ph
yield;
;%ee)
\320\275\320\262
EtzZn
\"ZnEt
(hydroboration)
(-)-DAIB
\320\236
(catalytic asymmetric
carbonyladdition)
Zn-chelated
catalyet
R1
aq. NH4CI
\320\275\320\276\320\275 H *OZnEt
G9-98% \320\265\320\265)
and
30
(Oppolzer Radlnov)
\320\235\320\236
fff>muscone
32
(Oppolzer and Radinov)
,OMe
v-
\320\276 Ho-
B0 mol%),
A *
FT
\320\273:
'H X\320\274; -78 \302\260C,
C2H5CN; then
H3O\302\251
F7-100 yield;
(catalytic asymmetric 86-93% \320\265\320\265)
Mukalyama-aldol reaction)
,34
(Corey era/.)
R = C6H5, c-C6Hu, \320\237-\320\2413\320\2357,2-furyl
(SMace of the aldehyde
R1 = C6H5, \320\233-\320\2414\320\2359 carbonylis shielded)
Ts = SO2C6H4-p-CH3
fS>oxazaborolldlne
OSiMe3 B0 mol%), Me3SiO, H TFA
(Corey ef a/.)
,34
A00% yield;
82% \320\265\320\265)
\320\220. THF
OMe Et2O,-10\302\260C OMe OMe
ef a/.)
35
(Carrelra
HOjC-y M
\320\275
(S>(-)-proline
C mol%), CH3CN
(Hajos-Wlechert
reaction)
-'CO\302\251
(catalytic asymmetric
enamine-aldol)
-H2O H2O
\320\276\320\275
OAiCI2
CHO
F9% yield)
2. TFA
Me3Si0
n-C3F7
E8% \320\265\320\265)
\320\236 \320\236
chlral llgand A0 mol%),
TiCi2(O/-PrJ,4
A mol. sieves, Me
NO
(catalytic asymmetric
Dlels-Alder) endo-adduct (94% \320\265\320\265)
(endo.exo = 87:3)
(Narasakaefa/.L0
Ph
vPh
\320\273
A0 mol%),
4 A mol. sieves,
toluene/petroleum ether
(catalytic asymmetric G0% yield; >95% \320\265\320\265)
Intramolecular Dlels-Alder)
(Narasakaefa/.L1
BH3\302\273THF,
\302\253
CH2CI2I
\320\236\320\235
\"OMe -40 \302\260\320\241 -OMe \320\276\320\275\321\201
A0mol%)
(catalytic asymmetric
intramolecular DIels-Alder)
(84% yield)
CHO
42
(Yamamotoefa/.)'
NSO2CF3
Ai
Bno Me
Bn = CH2Ph
(catalytic asymmetric
Diels-Alder)
BnO BnO
BnO
catalyst E mol%),
*-
I \302\246y CH2CI2, -78 \302\260C
(83% yield)
Bn = CH2Ph
(catalytic asymmetric
Diels-Alder)
BnO
CHO
Br
(exo)endo = 95:5)
OSi*-Pr3
0Si/-Pr3 \320\275 \320\275
I
SO2C6H4-p-Me
CHO B5 mol%),
Y CH2Ci2AolueneA:1), OHC
-78 \320\241
(83% yield)
(catalytic as
asymmetric
Diels-Alder)
ricaiaiyiic
(97% \320\265\320\265)
(exo-diastereomer
not detected)
(Corey et a/.L5
casslol
y\\H
Ci/j\\Ci
A0 mol%),
(catalytic asymmetric
Diels-Alder) endo-adduct (80% \320\265\320\265)
,46
(Coreyera/.) (endo:exo = 97:3)
/
Ph
,/
A0 mol%),
AgSbF6 B0 mol%),CH2CI2,
-80 \320\241
(84% yield)
Me
chiral llgand A0 mol%),
Cu(OTfJ (8 )
CH2CI2,-15\302\260C
(85% yield)
(catalytic asymmetric
Diels-Alder) endo-adduct (97% \320\265\320\265)
(endo:exo = 96:4)
(Evans el a/.L8
Cu(OTfJ (8 ),
CH2CI2,-45 \320\241
(85% yield)
OBR
Et3N, f-Pr2NEt,
i o
toluene/ CH2CI2,
hexane, -78 \302\260C
u
\302\24678
\302\260C
Phh P
Ph
-20 \302\260C
H -20 \302\260C
ArO2SN N
i 4 ^
\320\222
Ar Ar
Br
I q
Ph fS,S>R*2BBr
}\342\200\224\320\236
A stoichlometric
Ph
amount of fS,S>R2BBr
W
is employed
Ar Ar
(enantfoselective (enantioselectlve
Ireland-Claisen Ireland-Claisen
rearrangement) rearrangement)
H
\320\276
Jss\\
R2BO R ,B0 H
\320\276
\320\275\320\276' HO
(erythro) (threo)
(96% \320\265\320\265) (>97% \320\265\320\265)
yield; 88%
(catalytic asymmetric (88% \320\265\320\265)
ene reaction)
(Yamamotoefa/.M0'51
Ph
^ MeLI-LiBr, E mol%)
Et2O + LiBr
Me2N(CH2KNMe2
B.0 equiv.),PhCH2Br,
toluene, -45 \320\241
(catalytic asymmetric
enolate alkylation)
(Kogaefa/.) ,53
.OPIv
Pd2(dbaK(9mol%),
(fl)-BINAPA1 l%) steps
.OPIv
1,2-dichloroethane, H
f-BuOH G6% yield)
(86% \320\265\320\265)
catalyst A0 mol%), OH
THF, -40 \302\260C,
163 h
HON _____ Me.
\342\200\236 + anti-adduct
14
NO2
{catalytic asymmetric
Henry reaction) (97% \320\265\320\265) (9.6 :1)
,55
(Shlbaaakl etal.)
H2, Pd-C,
EtOH
OH
:
Me
NH2
f/ireo-dlhydrosphingosine
References
1. (a) Morrison, J.D.; Mosher, H.S. Asymmetric Organic 6. Burk, M. J. J. Am. Chem. Soc. 1991,113,8518.
Reactions, 2nd ed., American Chemical Society: 7. (a) Ohta, \320\242.;
Takaya, H.; Kitamura, M.; Nagai, K.;
Washington, D.C., 1976; (b) Nogradi, M. Stereoselec- Noyori, R. J. Org. Chem. 1987, 52, 3174; (b)
tive Synthesis, 2nd ed., VCH Publishers: Weinheim, Takaya, H.; Ohta, \320\242.; Mashima, K.; Noyori, R. Pure
New York, 1995; (c) Eliel, E.; Wilen, S.H. Stereo- & Appl. Chem. 1990, 62, 1135.
Stereochemistry of Organic Compounds, John Wiley & 8. Kitamura, M.; Nagai, K.; Hsiao, Y; Noyori, R. Tet-
Sons: New York, 1994. Tetrahedron Lett. 1990, 31, 549.
2. (a) Eisenbraun, G.H.; Schorno, K. S.;
E.J.; Adolphen, 9. (a) Noyori, R.; Ohta, M.; Hsiao, Y.; Kitamura, M.;
Morris, Chem. 1971, 36, 414;(b) Allen,
R.N. J. Org. Ohta, \320\242.; Takaya, H. J. Am. Chem. Soc. 1986, 108,
S.D.; Schnepp, O. J. Chem. Phys. 1973, 59, 4547; (c) 7117; (b) Kitamura, M.; Hsiao, Y; Noyori, R.;
Jacques, J.; Collet, A.; Wilen, S.H. Enantiomers, Takaya, H. Tetrahedron Lett. 1987, 28, 4829; (c)
Racemates and Resolutions, John Wiley & Sons: New Kitamura, M.; Hsiao, Y; Ohta, M.; Tsukamoto, M.;
York, 1981, p. 329. Ohta, \320\242.; Takaya, H.; Noyori, R. J. Org. Chem. 1994,
3. (a) Andersen, K.K. Tetrahedron Lett. 1962, 93; (b) 59, 297.
Andersen, K.K.; Gaffield, W; Papanikolaou, N.E.; 10. Takaya, H.; Ohta, \320\242.;
Sayo, N.; Kumobayashi, H.;
Foley, J.W.; Perkins, R.I. J. Am. Chem. Soc. 1964, Akutagawa, S.; Inoue, S.; Kasahara, I.; Noyori, R.
56, 5637; (c) Sharpless, K.B.; Klunder, J.M. J. Org. J. Am. Chem. Soc. 1987,109, 1596.
Chem. 1987,52, 2598; (d) Drabowicz, J.; Bujnicki, 11. (a) Noyori, R.; Ohkama, \320\242.; Kitamura, M.; Takaya,
\320\222.;
Mikolajczyk, M. ibid. 1982, 47, 3325. H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. J.
4. (a) Kagan, H. B. Bull. Soc. Chim. Fr. 1988, 846; Am. Chem. Soc. 1987, 109, 5856; (b) Kitamura, M.;
(b) Scott, J.W. Top. Stereochem. 1989, /9, 209; (c) Ohkama, T; Inoue, S.; Sayo,N.; Kumobayashi, H.;
Crosby, J. Tetrahedron 1991, 47, 4789; (d) Akuta- Akutagawa, S.; Ohta, \320\242.; Takaya, H.; Noyori, R. ibid.
gawa, S. In Organic Synthesis in Japan, Past, Pre- 1988, 7/0, 629;(c) Mashima, K.; Kusano, K.; Ohta,
Present, and Future, Tokyo Kagaku Dozin: Tokyo, 1992, \320\242.;
Noyori, R.; Takaya, H. J. Chem. Soc, Chem.
p. 75. Commun. 1989, 1208; (d) Ohkuma, \320\242.; Kitamura,
5. For some excellentmonographs and reviews that deal M.; Noyori, R. Tetrahedron Lett. 1990, 31, 5509; (e)
with catalytic asymmetric synthesis, see: (a) Asym- Kitamura, M.; Tokunaga, M.; Ohkuma, T; Noyori, R.
Asymmetric Synthesis, Morrison, J. D., Ed., Academic ibid. 1991, 32, 4163; (f) Kitamura, M.; Tokunaga,
Press: New York, 1985, Vol. 5; (b) Bosnich, B. Asym- M.; Ohkuma, \320\242.;
Noyori, R. Org. Synth. 1993, 71, 1.
Asymmetric Catalysis, Martinus Nijhoff: Dordrecht, 1986; 12. Kitamura, M.; Ohkuma, \320\242.;
Takaya, H.; Noyori, R.
(c) Catalytic Asymmetric Synthesis, Ojima, I., Ed., Tetrahedron Lett. 1988, 29, 1555.
VCH Publishers: Weinheim, New York, 1993; 13. (a) Leutenegger, U.; Madin, A.; Pfaltz, A. Angew.
(d) Noyori, R. Asymmetric Catalysis in Organic Chem. Int. Ed. Engl. 1989, 28, 60; (b) Pfaltz, A. In
Synthesis, John Wiley & Sons: New York, 1994; (e) Modern Synthetic Methods, Springer-Verlag: Berlin,
Kagan, H. B. In
Organometallic
Comprehensive Heidelberg, 1989, Vol. 5, p. 199.
Chemistry, Wilkinson, G.; Stone, F.G.A.; Abel, E.W., 14.(a) Katsuki, \320\242.; Sharpless, K.B. J. Am. Chem. Soc.
Eds., Pergamon Press: Oxford, New York, 1982, Vol. 102,
1980, 5974; For excellent reviews of the Sharp-
8, Ch. 53, p. 463; (f) Asymmetric Synthesis - Meeting Sharplessasymmetric epoxidation reaction, see: (b) Rossi-
the Challenge, Chem. Br. 1989, 25 C); (g) Brunner, ter, B.E. In Asymmetric Synthesis, Morrison, J. D.,
H. Top. Stereochem. 1988, 18, 129; (h) Brunner, H. Ed., Academic Press: New York, 1985, Vol. 5, p. 193;
Synthesis 1988, 645; (i) Brown, J.M.; Davies, S.G. (c) Finn, M.G.; Sharpless, K.B. In Asymmetric
Nature (London) 1989, 342, 631; (j) Noyori, R. Synthesis, Morrison, J. D., Ed., AcademicPress:New
Chem. Rev. 1989, 18, 187; (k) Evans,
Soc. D.A. York, 1985, Vol. 5, p. 247; (d) Johnson, R. A.; Sharp-
Science (Washington, D.C.) 1988, 240, 420; A) Sharpless, K.B. In Comprehensive Organic Synthesis,
Ojima, I.; Clos, N.; Bastos, \320\241
Tetrahedron 1989, 45, Trost, B.M.; Fleming, I., Eds., Pergamon Press: New
6901; (m) Blystone, S.L. Chem. Rev. 1989, 59, 1663; York, 1991, Vol. 7, p. 389; (e) Johnson, R. A.; Sharp-
(n) Noyori, R.; Kitamura, M. In Modern Synthetic Sharpless, K.B. In Catalytic Asymmetric Synthesis,
Methods, Springer-Verlag: Berlin, 1989, Vol. 5, p. 115; Ojima, I., Ed., VCH Publishers: Weinheim, New
(o) Noyori, R. Science (Washington, D.C.) 1990, York, 1993, p. 103;(f) Pfenniger, A. Synthesis 1986,
248, 1194;(p) Seebach, D. Angew. Chem. Int. Ed. 89; (g) Katsuki, Martin,
\320\242.; V. S. Org. React. (N. Y.),
Engl. 1990, 29, 1320; (q) Tomioka, K. Synthesis in press.
1990, 541; (r) Noyori, R. CHEMTECH 1992, 22, 360; 15. (a) Zhang, W.; Loebach, J.L.; Wilson, S.R.; Jacob-
(s) Chem. Rev. 1992, 92 E); (t) Sharpless,K.B. J.
sen, E.N. Am. Chem. Soc. 1990, 112, 2801; (b)
Tetrahedron 1994, 50, 4235; (u) Noyori, R. ibid. Zhang, W.; Jacobsen, E.N. J. Org. Chem. 1991,56,
1994, 50, 4259; (v) Kagan, H.B.; Fiaud, J.-C. Top. 2296; (c) Jacobsen, E.N.; Zhang, W.; Muci, A.R.;
Stereochem.1978,/0, 175. Ecker, J.R.; Deng, L. J. Am. Chem. Soc. 1991, 113,
References 377
25. (a) Corey, E.J.; Bakshi, R.K.; Shibata, S. J. Am. 3108;(k) Agami, Chim. Fr. 1988, 499.
Bull
\320\241 Soc.
Chem. Soc. 1987,109,5551; (b) Corey, E. J. Pure & 37. (a) Hashimoto, S.; Komeshima, N.; Koga, K. J.
Appl. Chem. 1990, 62, 1209; (c) For a review of Chem. Soc, Chem. Commun. 1979, 437; (b) Take-
asymmetric synthesis using chiral oxazaborolidines, mura, H.; Komeshima, N.; Takahashi, I.; Hashimoto,
see: Wallbaum, S.; Martens, J. Tetrahedron: S.; Ikota, N.; Tomioka, K.; Koga, K. Tetrahedron
Asymmetry 1992, 3, 1475;seealso (d) Mathre, D. J.; Lett. 1987, 28, 5687.
378 22 Menthol
38.For reviews of catalytic asymmetric Diels-Alder 53. Imai, M.; Hagihara, A.; Kawasaki, H.; Manabe, K.;
reactions,see:(a)Kagan, H. \320\222.;
Riant, O. Chem. Rev. Koga, K. J. Am. Chem. Soc. 1994,116,8829.
1992, 92, 1007;(b) Narasaka, K. Synthesis 1991, 1; 54.Kondo, K.; Sodeoka, M.; Mori, M.; Shibasaki, M.
(c) Togni, A.; Venanzi, L. M. Angew. Chem. Int. Ed. Tetrahedron Lett. 1993, 34, 4219.
Engl. 1994, 33, 497; (d) Pindur, U.; Lutz, G.; Otto, 55.Sasai, H.; Tokunga, Watanabe,
\320\242.; S.; Suzuki, \320\242.;
C. Chem.Rev. 1993, 93, 741; (e) Deloux, L.; Sreb- Itoh, N.; Shibasaki, M. J. Org. Chem. 1995, in press.
nik, M. ibid. 1993, 93, 763; (f) Oh, \320\242.;
Reilly, M. 56. For some excellent discussions on enzymes in
Org. Prep. Proced. Int. 1994, 131. organic synthesis, see (a) Wong, C.-H.; Whitesides,
39. (a) Bednarski, M.; Maring, C; Danishefsky, S. Tetra- G. M. In Enzymes in Synthetic
Organic Chemistry,
Tetrahedron Lett. 1983, 24, 3451; (b) Danishefsky, S.J.; Tetrahedron Organic Chemistry Series, Pergamon
DeNinno, M. P. Angew. Chem. Int. Ed. Engl. 1987, Press: Oxford,New York, 1994, Vol. 12; (b) Wong,
26, 15. C.-H.; Halcomb, R.L.; Ichikawa, Y; Kajimoto, T.
40. (a) Narasaka, K.; Iwasawa, N.; Inoue, M.; Yamada, Angew. Chem. Int. Ed. Engl. 1995, 34, 412; (c)
Nakashima,
\320\242.; M.; Sugimori, J. J. Am. Chem. Soc. Enzyme Catalysis in Organic Synthesis - A Com-
1989, 111, 5340; (b) Narasaka, K. Pure & Appl. Comprehensive Handbook, Drauz, K.; Waldmann, H.,
Chem. 1992,64, 1889;(c)Narasaka, K. In Organic Eds., VCH Publishers: Weinheim, New York, 1995.
Synthesis in Japan, Past, Present, and Future, 57. (a) Knowles, W.S.; Sabacky, M.J.; Vineyard, B.D.;
Tokyo Kogaku Dozin: Tokyo, 1992, p. 283. Weinkauff, D.J. J. Am. Chem. Soc. 1975, 97, 2567;
41.(a) Iwasawa, N.; Sugimori, J.; Kawase, Y.; Narasaka, K. (b) Knowles, W.S. Ace. Chem. Res. 1983, K, 106;
Chem. Lett. 1989, 1947;(b) Narasaka, K.; Saitou, M.; (c) Knowles, W. S. J. Chem. Educ. 1986,63, 222.
Iwasawa, N. Tetrahedron:Asymmetry 1991, 2, 1305. 58.(a) Osborn, J. A.; Jardine, F.H.; Young, J.F.; Wilkin-
42. Furuta, K.; Kanematsu, A.; Yamamoto, H.; Takaoka, Wilkinson,G. J. Chem. Soc. A 1966, 1711; (b) Brown,
S. Tetrahedron Lett. 1989, 30, 7231. J.M. Angew. Chem. Int. Ed. Engl. 1987, 26, 190.
43.(a) Corey, E.J.; Imwinkelried, R.; Pikul, S.; Xiang, 59.Gao, Y; Hanson, R.M.; Klunder,- J.M.; \320\232\320\276, S.Y.;
Y.B. J. Am. Chem. Soc. 1989,111,5493; (b) Corey, Masamune, H.; Sharpless, \320\232. J. Am. Chem. Soc.
\320\222.
E.J.; Imai, N.; Pikul, S. Tetrahedron Lett. 1991, 32, 1987, 109, 5765.
7517;(c) Corey, E.J.; Sarshar, S.; Bordner, J. J. Am. 60.For an excellent review of synthetic applications of
Chem. Soc. 1992, 114, 7938; (d) Corey,E.J.; Sar- nonracemic glycidol
2,3-epoxy alcohols,
and related
Sarshar, S.; Lee, D.-H. ibid. 1994, 116, 12089. see: Hanson, R.M. Chem. Rev. 1991, 9/, 437.
44. (a) Corey, E.J.; Loh, T.-P. J. Am. Chem. Soc. 1991, 61. Ladner, W.E.; Whitesides, G.M. J. Am. Chem. Soc.
113, 8966; (b) Corey,E.J.; Loh, T.-R; Roper, T.D.; 1984,106,7250.
Azimioara, M.D.; Noe, M.C.ibid. 1992, 114, 8290. 62. Rossiter, B.E.; Katsuki, \320\242.;
Sharpless, J.
\320\222.
\320\232. Am.
45. Corey, E.J.; Guzman-Perez, A.; Loh, T.-P. J. Am. Chem. Soc. 1981, 103, 464.
Chem. Soc. 1994, 116,3611. 63.(a) Nozaki, H.; S.; Takaya, H.; Noyori,
Moriuti, R.
46. Corey, E.J.; Imai, N.; Zhang, H.-Y. J. Am Chem. Tetrahedron 1966, 5239; (b) Nozaki,
Lett. H.;
Soc. 1991, 113, 728. Takaya, H.; Moriuti, S.; Noyori, R. Tetrahedron
47. Corey, E.J.; Ishihara, K. Tetrahedron Lett. 1992,33, 1968, 24, 3655; (c) Bogdanovic, B. Angew. Chem.
6807. Int. Ed. Engl. 1973, 12, 954.
48.(a) Evans, D.A.; Miller,S.L; Lectka, T. J. Am. 64. Aratani, T. Pure & Appl. Chem. 1985,57, 1839.
Chem. Soc. 1993, 115, 6460; (b) Evans, D.A.; 65.(a) Otsuka, S.; Tani, K. Synthesis 1991, 665; (b)
Lectka, Miller,
\320\242.; S.J. Tetrahedron Lett. 1993, 34, Otsuka, S.; Tani, K. In Asymmetric Synthesis, Morri-
7027; (c) Evans, D.A.; Murry, J.A.; von Matt, P.; Morrison, J. D., Ed., Academic Press: New York, 1985,
Norcross, R.D.; Miller, S.J. Angew. Chem. Int. Ed. Vol. 5, Ch. 6; (c) Kumobayashi, H.; Akutagawa, S.;
Engl. 1995, 34, 798. Otsuka, S. J. Am. Chem. Soc. 1978, 100, 3949.
49.(a) Corey, E.J.; Lee, D.-H. J. Am. Chem. Soc. 1991, 66. (a) Kagan, H.B.; Dang, T.-P. J. Am. Chem. Soc.
113, 4026; (b) Corey, E.J.; Roberts, B.E.; Dixon, 1972, 94, 6429; (b) Kagan, H.B. In Asymmetric
B.R. ibid. 1995, 117, 193. Synthesis, Morrison, J. D., Ed.,Academic Press: New
50.Maruoka, K.; Hoshino, Y.; Shirasaka, \320\242.;
Yamamoto, York, 1983, Vol. 2, p. 1; for discussions of the value
H. Tetrahedron Lett. 1988, 29, 3967. of \320\241\320\263
symmetry in asymmetric synthesis, see: (c)
51.For reviews of catalytic asymmetric ene reactions, Noyori, R.; Takaya, H. Chem. Scr. 1985,25, NS83;
see:(a) Mikami, K.; Shimizu, M. Chem. Rev. 1992, (d) Whitesell, J.K. Chem. Rev. 1989, 89, 1581;(e)
92, 1021; (b) Mikami, K.; Terada, M.; Narisawa, S.; Rosini, C; Franzini, L.; Raffaelli, A.; Salvador!,P.
Nakai, T. Synlett 1992, 255. Synthesis 1992, 503.
52. (a) Mikami, K.; Terada,M.; Nakai, T. J. Am. Chem. 67. Tani, K.; Yamagata, Otsuka,
\320\242.; S.; Akutagawa, S.;
Soc. 1989, 111,1940;(b) Mikami, K.; Terada, M.; Kumobayashi, H.; Taketomi, \320\242.;
Takaya, H.; Miya-
Nakai, T. ibid. 1990, 112, 3949; (c) Mikami, K.; Nar- shita, A.; Noyori, R. J. Chem. Soc, Chem. Commun.
Narisawa, S.; Shimizu, M.; Terada, M. ibid. 1992, 114, 1982, 600.
6566.
References 379
Noyori, R.; Otsuka, S. J. Am. Chem. Soc. 1984, 106, Katagiri, Okazaki,
\320\242.; Oketa,
\320\242.; Y.; Kumobayashi,
5208; (b) Tani, K.; Yamagata, Tatsuno,
\320\242.; Y; Yama- H.; Akutagawa, S. Tetrahedron Lett. 1985, 26, 5153.
Yamagata, Y; Tomita, K.; Akutagawa, S.; Kumobayashi, 72.Nakatani, Y; Kawashima, K. Synthesis 1978, 147.
H.; Otsuka, S. Angew. Chem. Int. Ed. Engl. 1985, 73. (a) Takabe, K.; Katagiri, Tanaka,
\320\242.; J. Tetrahedron
24, 217; (c) Inoue, S.; Takaya, H.; Tani, K.; Otsuka, Lett. 1972, 4009; (b) Takabe, K.; Katagiri, \320\242.;
1: hirsutene 2: \320\2249A2)-\321\201\320\260\321\200\320\277\320\26511\320\265\320\277\320\265
D.RCurran A986)
Hirsutene and
A9A2)-Capnellene
23.1 Introduction
The central activity of organic is the construction of the
synthesis
carbon-carbonbond.For this purpose, of reaction pro-
a number
processes have been developed, many of which feature the union of
carbon nucleophiles (e.g. organometallic reagents) with carbon
electrophiles (e. g. alkyl halides, alkyl sulfonates, epoxides, cyclic
sulfates, carbonyl derivatives, and electrophilicolefins).Carbon-
carbon bond constructions in the laboratory and in nature are, in
fact, accomplishedpredominantly by polar reaction processes. In
this regard, the centralroleof the carbonyl group as an electrophile
and as an activator for the generationof nucleophilic enolate ions is
particularly noteworthy. But in addition to polar processes, there
are many nonpolar reactions that are indispensable as methods for
carbon-carbonbond formation in organic synthesis. These include
pericyclic reactions (i.e. electrocyclizations, sigmatropic rearrange-
rearrangements, and cycloadditions), photochemical reactions, and free radi-
radical reactions.1
ft-Bu3SnH, 6-exo-trig
1
radical
PhCO3f-Bu,
/iv F2%) cyclization
n-Bu3SnH
\320\276 \320\276
9: copacamphene 8: sativene 7 6
F:7 / 3:2)
Scheme 1. Radical cyclization strategy for the synthesis of sativene (8) and copacamphene (9)by
Bakuzis and coworkers.
n-Bu3SnH,
AIBN (cat.),
PCl5, CCI4
F4%) cyclohexane,
reflux, /iv
6-exo-trig n-Bu3SnH
radical cyclization
n-Bu3SnH
F7%)
A5:16/3:7)
AIBN = 2,2-azobisisobutyronltrile = X
n-Bu3SnH,
AIBN (cat.), P-CH3C6H4SO2H,
>
cyclohexane, CH3CN/H2O (92%)
reflux, /iv G2%)
Me3Si
Me3Si (protodesilylation)
[HN=NH] (diimide)
(92%)
i \320\236
15: dihydroagarofuran
(>95% diastereoselectivity)
Scheme 2. Buchi's radical cyclization strategy for the synthesis of dihydroagarofuran A5).
In an effort to
identify a more stereoselective route to dihydro-
dihydroagarofuran A5), trimethylsilylated alkyne 17 was utilized as a sub-
substrate for radical cyclization (Scheme 2). Treatment of 17 with a
CO2Me
\320\234\320\265\320\2362\320\241, \320\241\320\2362\320\234\320\265
\320\234\320\265\320\2362\320\241 ,CO2Me
\320\234\320\265\320\2362\320\241,
22 21
25: norseychellanone 24
(85:15 mixture of
stereoisomers in
favor of 25)
Scheme 4. Stork's vinyl radical cyclization strategy for the synthesis of norseychellanone B5).
386 23 Hirsutene and \320\2249<12)-\320\241\320\260\321\200\320\277\320\26511\320\265\320\277\320\265
n-Bu3SnH,
AIBN (cat.), 5-exo-trig n-Bu3SnH
\302\273
ir-Bu3SnH,
AIBN (cat.),
\302\273
PhH, reflux
od G5%)
28 29
Vinyl radical formation by intramolecular addition
of a carbon-centeredradical to an alkyne
radical cyclization
15-exo-dig
5-exo-trig
\302\253
radical
cyclization
30
1. Na, THF/NH3(I),
Cl -78 \302\260C
(98%)
2. PCC, CH2CI2
\342\200\242
3. DBU, THF, 25 \302\260C
E0% for 2 steps)
OEt
Ph3SnSnPh3,
(CH3KC-N=C:,
PhH, /iv E8%)
\320\236
34 35
Et OEt
-(CH3KC\302\253
37
EtO
OEt
OEt OEt
\320\273
140 \302\260C
n-Bu3SnH
(neat) CsHt
43 (Brook rearrangement) 42 41
Pd(OAcJ,CH3CN,
25 \320\241
E8% from 38)
(Saegusa oxidation)
OEt
1. fS>BINAL-H, THF, -100 \302\260C
(89%)
(Noyori asymmetric reduction)
2. aq. HCimiF,25\302\260C
(98%)
3.
h
TBSO ho\" ho\" h
THF, 25 \302\260C
F2%)
45: (+)-PGF2a
(Wittig reaction)
CO2f-Bu
57 (seeScheme 10), prepared by an interesting sequence starting
from meta-toluic acid E4) (see 54 \342\200\224\302\273
55 \342\200\224\302\273 can
56 \342\200\224\302\273
57), be con-
converted to the highly functionalized perhydroindane 58 through an
Hg(OAcJl NaBH(OMeK,
\302\273
AcOH
) CH2CI2
E8% from 46)
\320\235\320\264\320\236\320\224\321\201
A
OAc
46 47
it
^-elimination
\320\236
-Hg\302\260
5-exo-trig
radical cyclization
H
\302\246\302\246- \320\275 -t- |49|
\342\200\236OMe
OMe
(91%)
CO2H
/>Bu3SnH,
AIBN (cat.), H3O\302\256(90%)
CO2f-Bu
n-Bu3SnH
Scheme 10. Intramolecular free radical conjugate addition in Hart's synthesis of perhydroindane 58.
PhH, 85 \302\260C
D5%) OH
F-exo-trlg
radical cyclization)
60: deoxyalliacolide 61: alliacolide
n-Bu3SnH,AIBN,
\342\200\242
PhH, 85 \302\260C
(95%) OMe
F-exo-trig
radical cyclization)
Scheme 11. Intramolecular free radical conjugate addition in Pattenden's synthesis of alliacolide F1).
\320\276
I
N\342\200\224Br
\320\255
/V-bromosuccinimide B.0 equiv.),
OH CH2CI2, 0 \302\260C
(83%) AIBN (cat.),
PhH, reflux
(88%)
Trialkyltingroups E to a carbon-centered
radical are readily eliminated
(-n-Bu3Sn.)
p-ellminatlon
(\302\261)-69:(\302\261)-perhydro- 68
histrionicotoxin (obtained as a
singlestereoisomer)
PhS
PhS PhS,
n-Bu3SnH,
AIBN (cat.), 5-exo-trlg
NSO2Ph
NSO2Ph \342\200\242 NSO2Ph
PhH, 80 \302\260C radical
(95%) cyclizatlon
(-PhS.)
^-elimination
OH
OMe
NSO2Ph
(+)-CC-1065
MeO
n-Bu3SnH, AIBN, PhH,
SPh
130 \320\241
(sealed tube) C5%)
72 73
Ts = p-CH3C6H4SO2 S-exo-trlg
radical cyclization
MeO
SPh
74
-Me -Me
Scheme 14. Tandem radical bicyclization-f rag mentation in Parker's synthesis of intermediate 76 enroute
to codeine G7) and morphine G8).
396 23 Hirsutene and A9A2>-Capne!lene
MeO
5-exo-trig radical cyclization. event creates a new carbon-
This
centered radical 74 which then participates in a 6-endo-trig cycli-
cyclization with the pendant styryl double bond to give benzylic radical
75. Finally, spontaneous ^-elimination of PhS* occurs, affording
SPh
key intermediate 76 C5 % yield). Two rings, a critical quaternan
,\321\201\320\275\320\276
NO2 [4+2]
X f
(Diels-Alder) Amberlyst A-21
resin (basic),
25 \302\260C
F2%)
79: isoprene 80: nitroethylene
/j-Bu3SnH, AIBN
PhH, 80 \302\260C
E2%)
(tandem radical cyclizations)
(\302\261)-84:(+)-A2-8-epicedrene
PhSeCI
\320\275\320\276 (phenylselenolactonization)
PhSe H
85 86
\"CO2Me
c/s-Fused bicyclic radical 87 is A0equiv.),
on
stereoselectively
the convex face
trapped Ph3SnH C.0 equiv.),
by methyl acrylate PhCH3 @.18 M in 86),
110\302\260CG0%)
intermolecular
t
radical trapping
\320\234\320\265\320\236,\320\241
87
MeO,
During the course of Danishefsky's elegant synthesis of the
erythrina. alkaloid (\302\261)-3-demethoxyerythratidinone (93) (see
MeO SePh Scheme 17), it was found that organoselenide 90, prepared by
reductive alkylation of amine 89, can be converted to allylic gem-
inal acetoxystannane 91 in two straightforward steps.38 This tactic
AcO Snn-Bu3
is noteworthy because radical cyclization of 91, with concomitant
91
fragmentation, furnishes enol acetate 92 regiospecifically,thereby
allowing a controlled introduction of the requisite enone double
MeO.
bond in the natural product (see 92 \342\200\224>
(\302\261)-93).
A novel organoselenide radical precursor is the key intermediate in
MeO
convergent syntheses of the tunicamycin antibiotics (e. g. 97) by
A. G. Myers and his group at the California Institute of Technology
OAc
(see Scheme 18).39 In this elegant work, two functionalized sectors are
92
united through a mixed-silaketal (see intermediate 94), a group that
NBOC
initiator triethylborane brings about a 1-endo-trig ring closure. Fluo-
Fluoride-induced cleavage of the silaketal then furnishes a 7.5:1 mixture of
\320\262\320\276\320\274\320\276
C-5' epimersin favor of 96. This radical cyclization establishesthe
C5'-C6' bond and the C-5' stereocenter of the tunicamycins. The pref-
preferential formation of 96 is consistent with the hydrogen-bonded tran-
OH transition structure 95. The silicon bridge brings the carbon-centered radi-
H,C- radical and the carbon-carbon double bond into proximity, and the
CH,
indicated hydrogen bond stabilizes transition structure 95; the desired
TBSO
configuration at C-5' emergesfrom this arrangement. Incidentally, if
95 the radical cyclization of 94 is conducted in a protic solvent such as
methanol, compound 96 is obtained with significantly diminished
stereoselectivity observation supportsthe hypothesis
A.6:1). This that
transition state hydrogen bonding is crucial to the desired stereochemi-
cal outcome. The total synthesis of (+)-tunicamycin V (97) can be
achieved in four additional steps.
The reactivity of free radicals, heteroatom-centered radicalsin
particular, can be exploited to accomplish the formidable task of
functionalizing unactivated hydrocarbons. In the early 1960s, Sir
Homolytic cleavage DerekBarton, a pioneer in the development of free radicalreactions
for use in organic synthesis, described a valuable photochemical
O=N-;-O
reaction which comprises the general processes shown in Scheme
\320\237\320\233' J9 4i,42 jfcs reaction, known as the Barton reaction, is based on
99 the premisethat photolysis of nitrite ester 99, derived from the
reaction of alcohol 98 with nitrosyl chloride, furnishes a highly
reactive oxygen-centered radical 100. If such a species possesses
an accessible E-carbon-hydrogen bond, then intramolecular hydro-
hydrogen atom abstraction can take place via a six-memberedtransition
state to give a less reactive carbon-centeredradical 101. Nitrosoal-
N\342\200\224OH cohol 102 can then be formed through the combination of 101 with
HO
the nitric oxide that was liberated in the photolysis step. It will be
noted that intermediate 102 can tautomerize to oxime 103, a con-
103 convenient precursor for an aldehyde (see 103\342\200\224\302\273104).
Barton devised this interesting photoinitiated method for func-
functionalizing unactivated carbon\342\200\224hydrogen bonds in response to a
23.1 Introduction 399
MeO MeO
NaBH3CN,
THF/MeOHA:1)
(reductive aikyiation)
1. n-Bu3SnLi,Et2O,-78\302\260C
2. Ac2O, 4-DMAP, CH2CI2, Et3N
(83% overall)
MeO MeO
n-Bu3SnH,
AIBN (cat.),
MeO i MeO SePh
PhH, reflux
F5%)
AcO Snn-Bu3
5-exo-trig
radical cyclizatton
MeO MeO
AcO OAc
Snn-Bu3
92
'1. MeLi.THF
2. PhSeCI, -78 \302\260C
MeO. 3. NalO4, H2O^HF
F4% overall)
MeO
(\302\261)-93:(\302\261)-3-demethoxyerythratidinone
CH
CH3
\302\2733C^ f
SePh
\320\276
BOMO
|
CbzHN --V^-\342\200\224\\ \320\275
OH OH n-Bu3SnH, Et3B,
AcHN
61
PhCH3, 0 \302\260C
94
CH, NBOC
BOMO,
1. 7-endo-trig \320\276\320\275
radical cyclization
2. KF\302\2732H2O, MeOH H3C
(silaketal cleavage) \320\223 ^\320\241\320\235\320\267
\320\2753\321\201
\320\267\320\241 I
TBSO
95
\320\275\320\276
BOMO.
CbzHN
4 steps
96
G.5:1 mixture of C-5'epimers
from which pure 96 was obtained
in 60% yield)
TBS - Sif-BuMe2
Cbz = C(O)OCH2C6H5
BOM = CH2OCH2C6H5
BOC = C(O)OC(CH3K
97: (+)-tunicamycln V
Homolytic cleavage
CINO
\"V H-atom
I (nitrosyl chloride)
abstraction \"U
98 100 101
NO
(nitric oxide)
very difficult problem that emerged in the steroid field. In 1954,the \320\275\320\276
q ,OH
CINO (excess),
pyr., 25 \302\260C
OAc
H-atom abstraction
107
OAc
tautomerization
\320\276\320\275 OAc
\320\275\320\276
o% \320\275\320\276
9
,\320\276\320\275
OH O\342\200\224N=O \320\276\320\275
1. hv, n-hexane, 25 \302\260C
2. APrOH, reflux
R1
2,4,6-CI3C6H2OC(S)CI,
pyr., W-hydroxy-
succinimide (cat.),
PhCH3, 80 \302\260C
[X = 2,4,6-CI3C6H2O]
R2-^
[X = C6F5O] [X = PhO]
\342\200\242
H
1. NaH, CS2
lm2CS, THF, reflux
s I
2. Mel n1
R
^ [X = SMe]
\342\200\224N 118
w
n-Bu3SnH,
PhCH3,reflux
\342\200\242
Snn-Bu3
S\342\200\224Snn-Bu3
S V
x
119
S\342\200\224Snn-Bu3
n-Bu3SnH
\342\200\242Snn-Bu3 +
R* \"H o^-x
120 121
CO2
125
(thiohydroxamate ester)
PhCH3,
or
\320\224 hv
S R
126
Scheme 23. Barton's thiohydroxamate ester chemistry: synthesis of alkyl pyridyl sulfides A27).
406 23 Hirsuteneand A9<12>-Capnellene
from the reaction of an activated carboxylic acid derivative, such as
acid chloride-123, with the commercially available sodium salt of
./V-hydroxypyridine-2-thione A24). If a solution of 125 in toluene
is simply heated to reflux or irradiated with a tungsten lamp, an
alkyl pyridyl sulfide of the type 127 can be producedin excellent
yields. In this transformation, an alkyl radical (R*) formed by ther-
molytic or photolytic decomposition of thiohydroxamateester 125
attacks the thiocarbonyl sulfur atom of 125 to give a new radical
intermediate 126. Concerted or stepwise fragmentation of 126 then
results in the formation of CO2, the alkylpyridyl sulfide 127, and
an alkyl radical (R*) which is available for reaction with another
molecule of 125. The formation of a strong carbon-oxygen n bond
PhH, or hv,
\320\224
/j-Bu3SnH or s\342\200\224x
f-BuSH
125
X = n-BUqSn or f-BuS
\342\200\242X
+ -*-
H\342\200\224R CO2
128
R\342\200\224Cl
R\342\200\224SePh -* R\342\200\224SPh
125
02
or f-BuSH
R\342\200\224H R\342\200\224OH
Scheme 25. Barton's thiohydroxamate ester chemistry: use of neutral molecule radical traps.
quinane natural products derive from various sources and are classi- H H
classified according to
ring fusion as linear, angular, or propellane(see )-1: (\302\261)-hirsutene
CO,
5-exo-trig
radical cyclization
130
\320\275 \320\275
\320\275 III
5-exo-dlg
=>
radical
\320\275 \320\275 cyclization
1: hirsutene
5-exo-trig
radical
cyclization
C-Cbond 134
formation
OTBS
1. NaBH4, CeCI3
OAc A
(Luche reduction) LDA, THF, -78 \302\260C;
(selenoxlde THPO
syn-elimination)
142 THPO
136
(Sn2'-antilactone opening)
1. PPTS,\320\225\320\256\320\235
2. LiAIH4(ca.
64% overall)
1. Me3Si ^ Li I, 1. (CF3SO2JO,
(LOequiv.), \320\240\320\243-.
THF, 0 \302\260C
I CH2CI2, -10 \302\260C OH
.^
\"*2. CsF 2. n-Bu4NI,
G8% overall) PhH, reflux
F4% overall)
PhSe tion to give bicyclic lactone 141. In practice, unsaturated silyl ester
140 is converted directly to 141 with phenylselenenyl chloride.36
Oxidation of selenide 141 to the corresponding selenoxide by
hydrogen peroxide with concomitant syn elimination provides vinyl
H
lactone 136 F2% overallyield from ally lie acetate 138).
141
After considerable experimentation, it was found that the action
of two equivalents of lithium naphthalenide on neopentyl bromide
142 in cold (-78 \302\260C)THF produces, through reductive lithiation,
the corresponding organolithiumreagent.Sequential treatment of
the latter species with CuBr\302\273SMe2 complex and vinyl lactone 136
then affords carboxylic acid 143 in variable yields ranging from 50
\320\235
to 75%. It is noteworthy that 143 is produced as a single regio-
136 in situ generated
and stereoisomer. The organocuprate reagent
reactswith the less hindered convex face of 136 in the Sn2' lactone
opening.60 This crucial transformation creates a key carbon-carbon
bond, introducesnecessaryfunctionality, and establishes the requi-
requisite trans relationship between and right-hand side chains.
the left-
From mws-3,5-disubstituted cyclopentene 143, the pivotal tan-
tandem radical cyclization precursor 134 can be constructed in
straightforward fashion. After acid-catalyzed solvolysis of the THP
ether in 143, lithium aluminum hydride reduction of the carboxyl
terminus affords diol 144 in ca. 64% overall yield. When the latter
is exposed to several equivalents of trifluoromethanesulfonic
(tri-
flic) anhydride and pyridine in CH2CI2 at -10 \302\260C,a ditriflate is pro-
produced. When a solution of this substance in benzene is treated with
excess tetra-n-butylammonium iodide and heated to reflux, diiodide
145is formed in 64% overall yield. Although both iodine-bearing
carbons in 145 could conceivably undergo nucleophilic attack in
the presence of a reactivenucleophile, the neopentyl iodine-bearing
carbon is considerably more hindered than the other. Consequently,
the prospects for effecting a selective displacementof the less hin-
hindered iodide with an acetylide nucleophile seemed very favorable.
132
5-exo-dig
radical
cyclization
n-Bu3SnH
Baeyer-Villiger acid-catalyzed
oxidation rearrangement
MeMgBr,
CuBr*SMe2,
THF, -20 \302\260C
(iodolactonization)
i
(Sn2'-antilactone opening)
. MeSO2CI
2. Nal
3. =\342\200\224Li\302\273H2N(CH2JNH2,
DMSO, 25 \320\241
CO2Me
1. MeMgBr (excess)
*2. Me3SiBr
(90% overall)
155 154
n-Bu3SnH
-2: (\302\261)-\320\2249A2)-\321\201\320\260\321\200\320\277\320\26511\320\265\320\277\320\265
158
23.4 Conclusion
many of characteristics
the of radical reactions and stimulated
References
1. Hart, D. J. Science (Washington, D. C.) 1984223,883. 15. Stork, G.; Sher, P.M.; Chen, H.-L. J. Am. Chem.
2. (a) Mayo, F.R. J. Chem. Educ. 1986, 63, 97; (b) Soc. 1986, 108, 6384.
Walling, C. ibid. 1986, 63, 99; (c) Walling, Chem.
\320\241 16. (a) Brook, A.G. Ace. Chem. Res. 1974, 7, 77; (b)
Br. 1987, 23, 767. Matsuda, Sato,
\320\242.; S.; Hattori, M.; Izumi, Y. Tetra-
3. (a) Giese,B.Radicals in Organic Synthesis: Forma- Tetrahedron Lett. 1985, 26, 3215.
Formation of Carbon\342\200\224Carbon Bonds, Pergamon Press: 17. Ito, Y; Hirao, \320\242.;
Saegusa, T. J. Org. Chem. 1978,
New York, 1986; (b) Ramaiah, M. Tetrahedron 1987, 43, 1011.
43, 3541;(c) Curran, D.P. Synthesis 1988, 417 (Part 18. (a) Noyori, R.; Tomino, I.; Tanimoto, Y.; Nishizawa,
1); 489 (Part 2); (d) Jasperse, C.P.; Curran, D.P; M. J. Am. Chem. Soc. 1984, 106,6709;(b) Noyori,
Fevig, T.L. Chem. Rev. 1991, 91, 1237;(e)Curran, R.; Tomino, I.; Yamada, M.; Nishizawa, M. ibid.
D. P. In Comprehensive Organic Synthesis, Trost, 1984, 106,6717.
B.M.; Fleming, I., Eds., Pergamon Press; New York, 19. (a) Giese,\320\222.; Heuck, K. Chem. Ber. 1979, 112,3759;
1991, Vol. 4, pp. 715, 779; (f) Walling, C. (b) Giese,G.;Heuck, K. Tetrahedron Lett. 1980, 21,
Tetrahedron 1985, 41, 3887; (g) Motherwell, W.E.; 1829;(c)Giese, \320\222.; Heuck, K. Chem. Ber. 1981, 114,
Crich, D. Best Synthetic Methods, Free Radical 1572;(d) Giese, \320\222.;Horler, H.; Zwick, W. Tetrahe-
Chain Reactions in Organic Synthesis, Academic Tetrahedron Lett. 1982, 23, 931; (e) Giese, B. Angew.
Press: London, 1991; (h) Dowd, P.; Zhang, W. Chem. Chem. Int. Ed. Engl. 1985, 24, 553; (f) For a review
Rev. 1993, 93, 2091; (i) Iqbal, J.; Bhatia, \320\222.;
Nayyar, of radical reactions of organomercury compounds,
N.K. ibid. 1994, 94, 519; (j) Braun, M. In Organic see: Barluenga, J.; Yus, M. Chem. Rev. 1988, 88, 487.
Synthesis Highlights, Mulzer, J.; Altenbach, H.-J.; 20. Danishefsky, S.J.; Chackalamannil, S.; Uang, B.-J.
Braun, M.; Krohn, K.; Reissig, H.-U., VCH Publish- J. Org. Chem. 1982, 47, 2231.
Publishers:
Weinheim, New York, 1991, p. 126; (k) Curran, 21. Hart, D.J.; Chuang, C.-P. J. Org. Chem. 1983,48,
D.P.; Porter, N. A.; Giese, B. Stereochemistry of 1782.
Radical Reactions - Concepts,Guidelines,and Syn- 22. The elegant contributions of the Hart group in the
Synthetic Applications, VCH Publishers: Weinheim, alkaloid field are also noteworthy, see: (a) Burnett,
New York, 1996. D.A.; Choi, J.-K.; Hart, D.J.; Tsai, Y.-M. J. Am.
4. Bakuzis, P.; Campos, O.O.S.; Bakuzis, M. L.F. Chem. Soc. 1984,106,8201; (b) Hart, D.J.; Tsai,
J. Org. Chem. 1976,41, 3261. Y.-M. ibid. 1984, 106, 8209; (c) Choi, J.-K.; Hart,
5. Buchi, G.; Wuest, H. J. Org. Chem.1979,44, 546. D.J. Tetrahedron 1985, 41, 3959; (d) Dener, J.M.;
6. For an excellent review of substrate-directed chemical Hart, D.J.; Ramesh, S. J. Org. Chem. 1988, 53,
reactions, see: Hoveyda, A.H.; Evans, D.A.; Fu, 6022.
G.C. Chem. Rev. 1993, 93, 1307. 23. (a) Ladlow, M.; Pattenden, G. Tetrahedron Lett.
7. (a) Stork, G.; Baine, N.H. J. Am. Chem. Soc. 1982, 1985, 26, 4413; (b) Ladlow, M.; Pattenden, G.
104, 2321; (b) Stork, G. In Current Trends in J. Chem. Soc, Perkin Trans. 1 1988, 1107.
Organic Synthesis, Nozaki, H., Ed., Pergamon Press: 24. Giese,B.Angew. Chem. Int. Ed. Engl. 1983, 22, 753.
Oxford, 1983, p. 359. 25. (a) Keck, G.E.; Yates, J.B. J. Org. Chem. 1982,47,
8. Fessenden, R.W.; Schuler, R.H. J. Chem. Phys. 3590; (b) Keck, G.E.; Enholm, E.J.; Yates, J.B.;
19\302\253, 39, 2147. Wiley, M.R. Tetrahedron 1985, 41, 4079.
9. Stork, G.; Baine, N.H. Tetrahedron Lett. 1985, 26, 26.(a) Boger, D.L.; Coleman, R. S. J. Am. Chem. Soc.
5927. 1988, 110, 4796; (b) Boger, D.L.; Ishizaki, \320\242.;
10. The studies of B. Fraser-Reid are noteworthy, see: Wysocki, R.J., Jr.; Munk, S.A. ibid. 1989, 111,
(a) Fraser-Reid, \320\222.;Vite, G.D.; Yeung, B.-W. A.; 6461;(c) Boger, D.L.; Wysocki, R.J., Jr.; Ishizaki, T.
Tsang, R. Tetrahedron Lett. 1988, 29, 1645; (b) ibid. 1990, 112, 5230.
Tsang,R.; Fraser-Reid, B. J. Am. Chem. Soc. 1986, 27. The Boger group has also made important contribu-
108,2116;(c) Tsang, R.; Fraser-Reid, B. ibid. 1986, contributionsto the development of acyl radical reactions,
108, 8102;(d) Tsang, R.; Dickson, J.K., Jr.; \320\240\320\260\320\272, \320\235.; see: (a) Boger, D.L.; Mathvink, R. J. J. Am. Chem.
Walton, R.; Fraser-Reid, B. ibid. 1987, 109, 3484. Soc. 1990, 112, 4003; (b) Boger, D.L.; Mathvink,
11.(a) Stork, G.; Mook, R., Jr. J. Am. Chem. Soc. 1983, R.J. ibid. 1990, 112, 4008; (c) Boger, D.L.; Math-
105, 3720; (b) Stork, G.; Mook, R., Jr.; Biller, S.A.; Mathvink, R. J. J. Org. Chem. 1992,57, 1429.
Rychnovsky, S.D. ibid. 1983, 105, 3741. 28.Ueno, Y; Chino, K.; Okawara, M. TetrahedronLett.
12. Stork, G.; Sher, P.M. J. Am. Chem. Soc. 1983, 105, 1982, 23, 2575.
6765. 29. (a) Parker, K. A.; Fokas, D. J. Am. Chem. Soc. 1992,
13.For an excellent review of tandem vicinal difunc- 114, 9688; see also:(b) Parker, K.A.; Spero, D.M.;
tionalizations, see: Chapdelaine, M.J.; Hulce, M. Inman, K.C. Tetrahedron Lett. 1986, 27, 2833;
Org. React. (N. Y.) 1990, 38, 225. (c) Parker, K.A.; Spero, D.M.; Van Epp, J. J. Org.
14. Stork, G.; Sher, P. M. J. Am. Chem. Soc. 1986, 108, 303. Chem. 1988,53, 4628.
418 23 Hirsutene and A9<12>-Capnellene
30. Chen, Y.-J.; Lin, W.-Y. Tetrahedron Lett. 1992, 33, 44. (a) Barton, D.H.R.; Beaton, J.M. J. Am. Chem. Soc.
1749. I960,82, 2641;(b) Barton, D.H.R.; Beaton, J.M.
31.For a review of nitro compounds in organic synthesis, ibid. 1961, 83, 4083.
see: Tamura, R.; Kamimura, A.; Ono, N. Synthesis 45. Barton, D.H.R.; Basu, N.K.; Day, M.J.; Hesse.
1991, 423. R. H.; Pechet, M.M.; Starratt, A.N. J. Chem. Soc,
32.For reviews of the Diels-Alder reaction, see: (a) Perkin Trans. 1 1975, 2243.
Sauer, J. Angew. Chem. Int. Ed. Engl. 1966, 5, 211; 46. Hobbs, P.D.; Magnus, P.D. J. Am. Chem. Soc. 1976.
(b) Sauer, J. Angew. Chem. Int. Ed. Engl.1967, 6, 98, 4594.
16;(c)Martin, J.G.; Hill, R.K. Chem. Rev. 1961, 61, 47. The studies of Burke et al. are also noteworthy, see:
537; (d) Oppolzer, W. In Comprehensive Organic Burke, S.D.; Silks, L.A., III; Strickland, S.M.S.
Synthesis, Trost, B.M.; Fleming, I., Eds., Pergamon Tetrahedron Lett. 1988, 29, 2761.
Press: New York 1991, Vol. 5, p. 315; (e) Carruthers, 48.Barton, D.H.R.; McCombie, S.W. J. Chem. Soc,
W. Tetrahedron Organic Chemistry Series: Cyclo- Perkin Trans. 1 1975, 1574.
addition Reactions in Organic Synthesis, Pergamon 49. (a) Barton, D.H.R.; Motherwell, W.B. Pure & Appl.
Press:New York, 1990, Vol. 8. Chem. 1981, 53, 15; (b) Hartwig, W. Tetrahedron
33. Rosini, G. In Comprehensive Organic Synthesis, 1983, 39, 2609; (c) Barton, D.H.R.; Zard, S.Z.
Trost, B.M.; Fleming, I., Eds., Pergamon Press: New Pure & Appl. Chem. 1986, 58, 675.
York, 1991, Vol. 2, p. 321. 50. (a) Barton, D.H.R.; Tetrahedron
Jaszberenyi, J.Cs.
34. (a) Ono, N.; Miyake, H.; Kamimura, A.; Hamamoto, Lett. 1989, 30, 2619;(b) Robins, M.J.; Wilson, J.S.
I.; Tamura, R.; Kaji, A. 1985, 41, 4013;
Tetrahedron J. Am. Chem. Soc. 1981, 103, 932; (c) Robins, M. J.;
(b) Ono, N.; Fujii, A. Synthesis 1987, 532;
M.; Kaji, Wilson, J.S.; Hansske, F. ibid. 1983, 705, 4059; (d)
(c) Dupuis, J.; Giese, Hartung,
\320\222.; J.; Leising, M.; Prisbe,E.J.; Martin, J. \320\241
Synth. Commun. 1985, /5,
Korth, H.-G.; Sustmann, R. J. Am. Chem. Soc. 1985, 401.
107, 4332; (d) Korth, H.-G.; Sustmann, R.; Dupuis, 51. Barton, D.H.R.; D.; Motherwell, W.B. J.
Crich,
J.; Giese,B. Chem. Ber. 1987, 120, 1197. Chem. Soc, Commun. 1983, 939.
Chem.
35. Hoffmann, H.M.R. Angew. Chem. Int. Ed. Engl. 52. (a) Barton, D.H.R.; Crich, D.; Motherwell, W.B.
1992, 31, 1332. Tetrahedron 1985, 41, 3901; (b) Crich, D. Aldri-
36. Nicolaou, K.C.; Petasis, N. A. Selenium in Natural Aldrichimica Acta 1987, 20, 35.
Products Synthesis, CIS: Philadelphia, 1984. 53. Barton, D.H.R.; Crich, D.; Kretzschmar, G. J. Chem.
37. Burke, S.D.; Fobare, W.F.; Armistead, D.M. J. Org. Soc, Perkin Trans. 1 1986, 39.
Chem. 1982, 47, 3348. 54.(a) Curran, D. P. In Advances in Free Radical Chem-
38. Danishefsky, S.J.; Panek, J.S. J. Am. Chem. Soc. Chemistry, Tanner, D. Ed., JAI Press: Greenwich,
1987, 109, 917. Connecticut, 1990, Vol. 1, pp. 121-158; (b) Curran,
39. (a) Myers, A.G.; Gin, D.Y.; Widdowson, K.L. J. D.P.; Sisko, J.; Yeske, P.E.; Liu, H. Pure & Appl.
Am. Chem. Soc. 1991, 113, 9661; (b) Myers, A.G.; Chem. 1993,65, 1153.
Gin, D.Y.; Rogers, D.H. ibid. 1993, 775, 2036; (c) 55. (a) Curran, D.P.; Rakiewicz, D.M. J. Am. Chem.
Myers, A.G.; Gin, D.Y.; Rogers, D.H. ibid. 1994, Soc. 1985, 707, 1448; (b) Curran, D.P.; Rakiewicz,
116,4691. D.M. Tetrahedron 1985, 41, 3943.
40. For some representative examples of silicon-tethered 56.Curran, D.P.; Chen, M.-H. Tetrahedron Lett. 1985,
radical cyclizations, see: (a) Stork, G.; Kahn, M. J. 26,4991.
Am. Chem. Soc. 1985, 707, 500; (b) Stork, G.; Sofia, 57. For some excellent reviews and discussions, see: (a)
M. J. ibid. 1986, 108,6826;(c) Koreeda, M.; George, Paquette, Top. Curr. Chem. 1979, 79, 41; (b)
L. A.
I. A. ibid. 1986, 708, 8098;(d) Nishiyama, H.; Kita- Paquette, ibid. 1984, 119, 1; (c) Trost,
L. A. B.M.
jima, \320\242.;
Matsumoto, M.; Itoh, K. J. Org. Chem. Chem. Soc. Rev. 1982, 82, 141; (d) Ramaiah, M.
1984, 49, 2298; (e) Crimmins, M.T.; O'Mahoney, R. Synthesis 1984, 529; (e) Paquette, L.A.; Doherty,
ibid. 1989, 54, 1157; (f) Tamao, K.; Maeda, K.; A.M. Polyquinane Chemistry Springer-Verlag:
Yamaguchi, Y J. Am. Chem. Soc. 1989, 777,
\320\237\320\276,
\320\242.; Berlin, 1987.
4984; (g) Tamao, K.; Nagata, K.; Ito, Y; Maeda, K.; 58. Luche, J.-L. J. Am. Chem. Soc. 1978, 700, 2226.
Shiro, M. Synlett 1994, 257. 59. (a) Ireland, R.E.; Mueller, R.H. J. Am. Chem Soc.
41. (a) Barton, D.H.R.; Beaton, J.M.; Geller, L.E.; 1972, 94, 5897; (b) Ireland, R.E.; Mueller, R.H.;
Pechet, M. M. /. Am. Chem. Soc. 1960, 82, 2640; (b) Willard, A.K. ibid. 1976, 98, 2868; (c) Ireland, R.E.
Barton, D. H. R.; Beaton, J.M.; Geller,L.E.; Pechet, Aldrichimica Acta 1988, 27, 59; (d) Ziegler, F.E.
M.M. ibid. 1961, 83, 4076. Chem. Rev. 1988, 88, 1423;(e) Kallmerten, J.; Witt-
42. (a) Barton, D.H.R. Pure & Appl. Chem. 1968,16, 1; man, M.D. Stud. Nat. Prod. Chem. 1989, 3, 233; (f)
(b) Barton, D.H.R. Aldrichimica Ada 1990, 23, 3. Wipf, P. In Comprehensive Organic Synthesis, Trost,
43. Simpson, S. A.; Tait, J.F.; Wettstein, A.; Neher, R.; . B.M.; Fleming, I., Eds., Pergamon Press: New York,
v. Euw, J.; Schindler, O.; Reichstein, T. Helv. Chim. / 1991, Vol. 5, p. 827; (g) Pereira, S.; Srebnik, M.
Acta 1954,37, 1163, 1200. Aldrichimica Acta 1993, 26, 17.
References 419
60. For reviews of Sn2' reactions, see: (a) Magid, R. M. 62.Curran, D.P.; Chen, M.-H.; Leszczweski, D.; Elliott,
Tetrahedron 1980, 36, 1901;(b) Paquette, L. A.; Stir- R.L.; Rakiewicz, D.M. J. Org. Chem. 1986/5/,
J.M.
Stirling, \320\241 ibid. 1992, 48, 7383. 1612.
61. (a) Meinwald, L; Seidel, M.C.; Cadoff, B.C. J. Am. 63.For an review of organocopperreagents and
excellent
Chem. Soc. 1958, 80, 6303; (b) Freeman, P. K.; their see: Lipshutz, B.H.; Sengupta,
reactions, S.
Balls, D.M.; Brown, D.J. J. Org. Chem. 1968, 33, Org. React. (N. Y.) 1992, 41, 135.
2211. 64. Ho, T.-L.Tandem Organic Reactions, John Wiley &
Sons: New York, 1992.
Me. \320\236,
\320\232.\320\241.Nicolaou
A987)
\320\222 and
Amphoteronolide
\320\222
Amphotericin
24.1 Introduction
Amphotericin \320\222
A) and amphoteronolide \320\222
B) are amongst the most
prominent membersof the clinically important polyene macrolide1
family of natural products. Named for their large macrolactone ring and
conjugatedall-trans polyolefinic region, the polyene macrolides com-
comprise one of the most intriguing and challenging areas of natural prod-
products chemistry.. Amphotericin \320\222
A),2 a widely used antifungal agent, is
produced by Streptomyces nodosus and remainsthe only member of
the polyene macrolides whose structure has been established by X-ray
crystallographic analysis.3
With its seven contiguous trans double bonds, macrolactone ring,
numerous stereogenic centers and /?-glycoside, amphotericin \320\222
A) and
its aglycon B) presented a seriouschallengeto the state of the art of
asymmetric synthesis and acyclic stereocontrol. Thus the Nicolaou
group embarkedin the early program directed towards the
1980s on a
total synthesis of these formidable targets. In orderto acquire a more inti-
intimate familiarity with the chemistry of amphotericin \320\222 A) and to facili-
facilitate the final stages of a projected total synthesis, studies were first
undertaken which included the derivatization and degradation of ampho-
A L and the preparation of its aglycon,amphoteronolide \320\222
amphotericin \320\222 B).5
amphotericin \320\222
A), failed to produce the intact aglycon owing to
the high stability of the aminosugar, and to the high sensitivity of
the aglycon towards strongly acidic conditions.In order to circum-
circumventthese difficulties, a new method for deglycosidationapplicable
to amphotericin \320\222
A) was devised based on oxidative removal of
the carbohydrate unit under neutral conditions. Scheme2 outlines
the mechanistic rationale upon which this novel reactionis based.It
was anticipated that the polyolefinic system of an amphotericin \320\222
OR,
Me...
Me2C(OMeJ,
CSA (cat.),
MeOH. 25 \320\241
Me
F6%) OR
RONHAc
l
\320\236,,\320\276
...Me H'abstraction ..Me .C6 \320\275
@...C6
' \342\200\242
RO S^^O RO RO
NHAc NHAc
1. (i-cleavage
-HBr
2. e\" transfer
RO
\320\275\320\276
\320\276.
...Me
R0...
4 OR
NHAc
VII VI :X = (\320\260):
\\-\320\274\320\265N CMe]
;[(\320\254): IV
N
Me
TBSO,
\320\276\320\275
9ab 1. p-NO2C6H4COCI,
4-DMAP, CH2CI2,
0 25 \302\260C
-\302\273
2. O3, MeOH/CH2CI2,
-78 \302\260C;
then Ph3P,
-78 25 \302\260C
-\302\273
OR1 OMe
TBSO,
11a
amphoteronolide \320\222
B) and demonstrated the potential of intermedi-
9ab
intermediates as precursors to amphotericin \320\222
A).
24.2 Retrosynthetic Analysis and Strategy 425
The body of chemistry described above for amphotericin \320\222
A)
allowed, for the first time, the preparation of a series of novel de-
derivatives of this polyene macrolide antibiotic and set the stage for a
total synthesis of this target molecule. Below we unfold the adven-
adventure that led to the accomplishment of this goal.910
Me'
Ketophosphonate-aldehyda
condenaation (Horner-Wadeworth-
Emmonsreaction)
Eatar bond formation
OMe
Me. .OTBS
COOMe
Phoaphonate-aldehyde
condenaation; ring
\"11 Horner-Wadsworth-Emmons;
^
closure
hydrogenation 0TBS
^
\320\275\320\276^ ^ jj./ JL ^ \320\273\320\230\321\207
,otbs
'COOMe
Phosphonate-aldahyde Phoephonate-aldehyde
condensation condensation
Me.. ,OTHP
otbs
0^,0
tbso
15 16 17 18
K2CO3,
18-crown-6,
TBSO'
PhCH3, 70 \302\260C
(80% yield) ^
'-otbs
HO'
22
<? ^|\320\230
\320\276\320\275
\320\276\320\275
\320\276\320\275 \320\236\320\235
\320\236\320\235
\320\236\320\235
21\320\260 21\320\254
or or
\320\276\320\275
\320\267
\320\236\320\235 HO
IT fl
\320\2616 OTBS
17 18
OH
OH
Me... \320\267 \320\233.\320\236\320\235
I
HO^3gJ OH
\320\236\320\235 OH OH
''Me '6-r \320\223^\321\201\320\276\320\263\320\275
Me1\"\0234s5
|ie
1, 2 OR
tbso,
19
2\320\241.,. 0\320\235 1.
(EtOKCH, AcOH, 0 LiAIH4, THF, 0 \302\260C
OEt
PhCH3, reflux 2. BnBr, NaH, THF, )\342\200\224OEt
EtO2C
\320\275 0->65\302\260C
PCIS, CH2CI2, |
0 \302\260C
(86%)
Ph\"^O
OCHO
K2CO3, MeOH,
BnO \302\253
25 \320\241
(88%)
23
Me2CuLi, Et2O,
1-78 -> -40 \302\260C
28 29 30 31
\320\236\320\236
n-Bu2BOTf, \320\224^
1\320\246
/-Pr2NEt, f \\? G2%)
CH2CI2 Me f~\\
Me Ph
32
SPh 1. LiBH4,THF,
-40 ^ -30 \"\320\241
1. AcOH-THF-H2O, 2. *-BuCOCI, \321\200\321\203\320\263.,
45 \302\260C -^ 25 \"\320\241
\320\236
'I G2%)
\"Me \342\200\242
2. PhSSPh, n-Bu3P
Me'\"' 0 ->25\302\260C
(95%) X\"\"
Me\" > 2,6-lutIdine, CH2CI2, Me--
^ -^ 25 \"\320\241
\320\236
OCOf-Bu OCOfrBu
(87% overall)
35 34
T>-\"
1. Raney Nl, EtOH, 25 \302\260C
(98%)
2. DHP, CSA(cat.),CH2CI2, 0 \302\260C
(96%)
3. Dlbal-H, CH2CI2, -78 \302\260C
(98%)
Me,.. .OTHP
TBSO
PCC, NaOAc,
\302\273-
hyde 31 and sets the stage for a crucial carbon-carbon bond form-
forming reaction.
It is instructive to note that the C34-C35 bond (amphotericin
numbering) in key intermediate 16 (Scheme7) could, in principle,
be conveniently constructed through an aldol condensation. The
execution of an Evans asymmetric aldol reaction17 at this stage of
the synthesis would be particularly productive, for it could secure
the stereochemical relationships at C-34 and C-35. In the event,
exposureof aldehyde 31 to the (Z)-boron enolate derived from oxa-
Ph
1. 1. CH2=CHMgBr, Cul
Et2AIC=CCH2OSi*-BuPh2,
hexane/toluene, -78 -> 0 \302\260C 2. NaH, PhCH2Br
\302\273.
2. NaH, PhCH2Br, THF, 3. O3,-78 \302\260C;
then Me2S
0 -> 25 \302\260C
3. TBAF, THF, 0 -> 25 \302\260C ph3p Et2oc
4. Ph3P=CHCO2Et
G0% overall) 39
G2%overall)
Dlbal-H (93%)
Et2O, 0 \302\260C
38 40
PhCH(OMe),, CSA(cat),
PhH, 25 \302\260C
(80%)
DMSO,
SO3\302\253pyr., Et3N,
TBSO
\"CH2CI2, 25 \302\260C
(94%)
42
SO3*pyc, DMSO,
3. PhOC(S)CI, pyr.,
OH HO
3. PhOC(S)CI,
pyr.,
4-DMAP (cat.), 4-DMAP (cat),
CH2CI2 20a: (+)-xylose 20b: (-)-xylose CH2CI2
4. n-Bu3SnH, AIBN 4. n-Bu3SnH, AIBN 42b
(cat.), PhCH3, 80 \302\260C (cat.), PhCH3, 80 \302\260C
(83% overall)
OBn
HO 1. Sla2BH, Bn\302\260
THF, 0 \302\260C;
BnO
then H2O2, NaOH , III then
-^ JlaH;
OTBS
2. f-BuMe2SICI, Imld., CSA (cat.), I Dk a
\342\200\242
DMF 0 _>25 \302\260C OH OH \320\240\320\237\320\267\320\240=\320\241\320\2352,
50
(84% overall)
49 48
F7-70%)
NalO4, RuO4 (cat.),
CH3CN-CCI4-H2O;
I then CH2N2 G6% overall)
MeO
(MeOJP(O)CH2LI,
*,
OTBS THF, -78 0 \302\260C
-\302\273
V (96%)
51
Scheme 9. Preparation of key building blocks 17 and 18: The carbohydrate approach.
434 24 Amphoteronolide B and Amphotericin \320\222
\302\273. \302\273\302\246
t-BuOOH,Ti(OAPrL,
- 20 \302\260C
CH2CI2,
70-90% yield
90% \320\265\320\265
\320\263
'\302\246?.'\342\200\242
IX
H\342\200\224-M
J \\ 1. Sharpless
\320\263\320\226
\320\236 \320\220\320\225
-*
reduction
XIV XIII
reiterate
\320\275\"\321\202-\320\274 hoi XIII. An important reason why epoxy alcohols are so useful as
\320\262^\302\260 synthetic intermediates is that they are amenable to a variety of
T , \320\276> selective transformations.20 For example, it is known action
that the
of Red-Al on a 2,3-epoxyalcoholsuch as XIII (-M) can accomplish
a regioselective (OH-directed)reductive cleavage of the C2-O
bond to give a 1,3-diol (see XIV; R2, R3 = H).21-22 It is proposed
that the free hydroxyl group of the epoxy alcoholreacts with Red-
Al [NaAlH2(OCH2CH2OMeJ] to give an aluminate, and that an
1. KH, PhCH2Br,
THF, 0 -> 25 \302\260C 1. Me2C(OMeJ,
2. TBAF, THF, CSA (cat.), 25 \320\241
OTPS 2. H2, Pd-C,
0 -> 25 \302\260C CH2CI2, 25 \"C
3. (-BuPh2SiCI,imid., , - .
3. SO3-pyr., DMSO, H0 ^BuOCO \"O OH
DMF, 25 \302\260C
CH2CI2, Et3N, 25 \320\241 4. Dibai-H, CH2Cl2/hexane,
-78 \302\260C
(83% overall) 5ga
G2% overall)
1. Red-Al, THF, 25 \302\260C
2. f-BuCOCI, pyr.,
4-DMAP (cat.), 25 \302\260C
1. Dibal-H, CH2Clj/ G5% overall)
hexane, -78 \302\260C
2. (-BuCOCI,\321\200\321\203\320\263.,
\320\241
\320\236 (-)-DET,
)
3. f-BuPlbSICI, imid., Ti(O*-Pr).,
DMF, 25 \320\241 (-BuOOH,
4. Dlbal-\320\235,
CH2C12/ CH2Ci2. -20 \302\260C
53a hexane, -78 \302\260C 54a 55a
F0%)
F8% overall) TPS = SiPh2(-Bu
1. (COCIfe, DMSO, CH2CI2,-78 \320\241; TBS SIMe2(-Bu
then Et3N
2. Ph3P=CHCO2Me, PhH
G5% overall)
(-)-OET, Ti(O/-PrL,
(-BuOOH, CH2CI2, (-BuOOH, CH2CI2,
52a
-23 \302\260C
G5%) -23 \302\260C
1. Dibal-H, \320\241\320\235\320\263\320\241\320\243
hexane, -78 \302\260C
(+)-DET, Ti(OH>rL, 2. (-BuCOCI,pyr., 0 \302\260C
OTPS OH ch2ci2,
/-\320\262\320\270\320\276\320\276\320\275, 3. (-BuPh2SICi,imid., CO2Me
-20 \302\260C DMF, 25 \320\241
4. Dibal-H, \320\241\320\2352\320\2411\320\263/
55b 54b hexane, -78 \320\241 53b
Scheme 11. Preparation of key building blocks 17 and 18: The SAE approach.
stereoselectivity.
The synthetic strategy for the construction of ketophosphonate
carboxylic acid 14 was designedon the basis of the retrosynthetic
analysis presented in Scheme 13. Subtarget 14 could, in principle,
be derived from 61 by appropriate functional group interchange
and introduction of a Ci unit carrying the phosphonate functional-
With
functionality. the focus on the phosphonate-aldehyde condensation as
the potential coupling reaction, the following steps were devised.
The tetrahydropyran system in 61 can be dismantled by rupture
of the indicated bond, providing vinyl sulfide 62. The design of
this key intermediate allows the possibility of regioselective ring
closure to 61, and provides a convenient site for molecular sim-
1. \320\2465|,LDA, THF,
-78 0 X
-\302\246
tbso.
\302\273-
2. DibBl-H
Me'\"
3. MnO2
16 (86% overall)
1- THF,-78 ~~> 0 X
LDA,
\320\243\320\271|,
OTBS \320\236\342\204\242
OMe OMe
,-Ph
...\320\236.
(MeOJP^.-v Cyclization
II I I
I \320\236
\320\236
14 I
C-Cbond
formation Phosphonate-aldehyde
condensation
Otps
BnO. BnO.
0^-0 SMe
63
functional
\320\237 group
I \\ manipulations
Horner-Wadsworth-Emmons
reaction 17 18
64
14, the HWE coupling reaction provides a most effective and mild
solution to the task of constructing the key C6-C7 bond. Saturation
440 24 Amphoteronolide B and Amphotericin \320\222
\320\276
\320\222\320\277\320\236 \320\270
(\320\234\320\265\320\236J\320\240.
otbs
18
1. PPTS,CH2CI2 (cycllzation)
2. NBS, CH2CI2-MeOH, 0 \302\260C
imid., DMF, 45 \320\241
2. Dibal-H, CH2CI2, -78 \320\241
Ph 3. PDC, DMF, 25 \320\241
\342\200\242\"
N 4. CH2N2, Et2O, 0 \302\260C
E4% overall)
(-BuOCO
66a: R1, R2 = acetonide, R3 = H a: R\\ R2 = acetonide, R \302\246\302\246
: Sif-BuMe2
66b: R1 = H, R2, R3 = acetonide b: R1 = Slf-BuMe2, R2, R3 i acetonide
AcO
2. *-BuMe2SiOTf, .__ .\320\276\320\275
2,6-lutldine, CH2CI2,
0 \320\241
F1% overall)
69ab
AcO
and selective hydrolysis of the J-lactone function in 69ab with
aqueous lithium hydroxide in THE This hydrolytic lactone-opening
reaction furnishes a free hydroxyl group at one end of the point of
69ab
cleavage and a carboxyl group at the other. Esterification of the lat-
latter function with diazomethane (CH2N2) produces a hydroxy
methyl ester, which can be converted to a bis(methylester)through
sequential oxidation (PDC, DMF) and esterification (\320\241\320\235\320\263^)-
reac-
HO2C
...otbs
reactions. The terminal acetate ester can then be cleaved with basic
Me..
tbso
Me''
OMe
TBSO,
Me'
12ab
K2CO3,18-crown-6, WOMefe
PhCH3,65 \302\260C
or
S^ \320\236
DBU, LiCI, CH3CN, 25 \302\260C G0%)
OMe OMe
1\" \"^\320\243-
.OTBS Me,
MeOH
\" HO,
2. CSA,
C02Me
r
\320\276\320\275
2: (+)-amphoteronolide \320\222
amphotericin \320\222
A) and its derivatives; (b) the presence of the basic
nitrogen in the carbohydrate unit; and (c) the requirement for a /?-
glycoside bond in a 1,2-cis relationship with the C-2 hydroxyl
group of the carbohydrate fragment. It should be noted that the last
OMe
Me..
TBS
\320\236
TBSO
a-glycoside bond
. HS(CH2KSH, Et3N
Me
TBS
\320\236
2. Ac2O, 4-DMAP
73 74
\321\203
lMe
catalVst
Y Y V
.Me
ketone reduction
Y Y
XVII XX
Scheme 17. Strategy for the stereocontrolled introduction of the mycosamine residue.
446 24 AmphoteronolideB and Amphotericin \320\222
75 76
NaN3,
15-crown-5
(83%)
1. Ac2O,H2SO4(cat.),0 ->25\302\260C
..OMe 2. CI2CHOMe, ZnCI2 (cat.), CH2CI2
'
TBSO\" 'OAc 3. HgBr2,CaCO3, TBSO\" Y
\"Y' \"OAc
,Ji3 CH3CN/H2O (9:1); then silica gel
4. NaH, CI3CCN, CH2CI2, 0 \302\260C
F5% overall)
\342\204\242
?\320\234\320\265 OMe
NaBH4,MeOH, OTBS
Me.. -> 25 \302\260\320\241\320\274\320\265-
\320\236
C02Me
\302\273-\320\276
82 81: \320\245
= \320\236\320\220\321\201,
Y= H
\320\236^
83: X = Y = \320\236\320\235
\320\235,
N,
1. MeOH, 50 \302\260C
HF\302\253pyr.,
1. f-BuMe2SIOTf,
2. HS(CH2KSH, Et3N
2,6-lutidine,
CH2CI2
(azlde reduction) 2. HS(CH2KSH, Et3N
3. Ac2O,CH2CI2
overall) 3. Ac2O, 4-DMAP, CH2CI2
G9% overall)
OR1
OMe
Me Me..
84 \320\275\320\276\" TBSON
1. \320\234\320\265\320\236\320\235,
CSA, I
25 \302\260\320\241
(80% overall)
\320\234\320\265\320\236\320\235/\320\2352\320\236,
\321\202
\320\276\320\275 OMe
\320\276\320\275
Me, .OTBS
\320\234\320\265--^
85
1: (+)-amphotericin \320\222 HONH2
o-jS-t^-otbs
24.4 Conclusion
References
1. For reviews on this subject, see: (a) Macrolide Anti- Daines, R.A.; Chakraborty, \320\242.\320\232.;
Ogawa, Y. ibid.
Antibiotics, Chemistry, Biology and Practice, Omura, 1988, 110, 4685; (c) Nicolaou, K.C.; Daines, R.A.;
S., Ed., Academic Press: New York, 1984; (b) Ryley, Ogawa, Y; Chakraborty, ibid.
\320\232.
\320\242. 1988, 110, 4696.
J. F.; Wilson, R.G.; Gravestock, M.B.; Poyser, J. P. 11. For reviews of methods for constructing macrolac-
Adv. Pharmacol. Chemother. 1981, 18,49; (c) Ham- tones, see: (a) Nicolaou, \320\232. Tetrahedron
\320\241 1977, 33,
Hammond, S.M. Prog. Med. Chem. 1977, 14, 105; 683; (b) Back,T.G.ibid. 1977, 33, 3041; (c) Masa-
Tereshin, I. M. Polyene Antibiotics - Present G. S.; Corcoran, J.W. Angew. Chem.
(d) mune, S.; Bates,
and Future, University of Tokyo: Tokyo, 1976; (e) Int. Ed. Engl. 1977, 16, 585; (d) Paterson, I.; Man-
Hamilton-Miller, J. M.T. Bacteriol. Rev. 1973, 37, suri, M.M. Tetrahedron 1985, 41, 3569.
166. 12. Nicolaou, K.C.; Seitz, S.P.; Pavia, M.R. J. Am.
2. Vandeputte, J.; Wachtel, J.L.; Stiller, E.T. Antibiot. Chem. Soc 1982, 104, 2030.
Ann. 1956, 587. 13. For reviews, see: (a) Wadsworth, W. S., Jr. Org.
3. (a) Mechlinski, W.; Schaffner, \320\241
P.; Ganis, P.; Avita- React. (N.Y.) 1977, 25, 73; (b) Maryanoff, B.E.;
bile, G. Tetrahedron Lett. 1970, 3873; (b) Ganis, P.; Reitz, A.B. Chem. Rev. 1989, 89, 863.
Avitabile, G.; Mechlinski, W.; Schaffner, \320\241 P. J. Am. 14. For excellent discussionsof the use of optically
Chem. Soc. 1971,93, 4560. active starting materials in synthesis, see: (a) Hanes-
4. (a) Nicolaou, K. C; Chakraborty, \320\242. Daines,
\320\232.; R. A.; sian, S. The Total Synthesis of Natural Products.
Simpkins, N. S. J. Chem. Soc, Chem. Commun. The Chiron Approach, Pergamon Press: New York,
1986, 413; (b) Nicolaou, K.C.; Chakraborty, \320\242.\320\232.; 1983; (b) Scott, J.W. In Asymmetric Synthesis, Mor-
Ogawa, Y.; Daines, R. A.; Simpkins, N.S.; Furst, Morrison, J. D.; Scott, J. W., Eds., Academic Press: San
G. T. J. Am. Chem. Soc. 1988, 110, 4660. Diego, 1984, Vol. 4, p. 1.
5. Nicolaou, K.C.; Chakraborty, Daines,
\320\242.\320\232.; R.A.; 15. (a) Katsuki, T; Sharpless, K.B. J. Am. Chem. Soc.
Ogawa, Y J. Chem. Soc, Chem. Commun. 1987, 1980, 102, 5974; For excellent reviews of the Sharp-
686. See also 4b. less asymmetric epoxidation reaction, see: (b) Rossi-
6. (a) Mechlinski, W.; Schaffner, \320\241. J. Antibiot.
\320\240. 1972, ter, B.E. In Asymmetric Synthesis, Morrison, J.D.,
25, 256; (b) Pandey, R.C.; Rinehart, K.L., Jr. ibid. Ed., Academic Press: New York, 1985, Vol. 5, p. 193;
1977, 30, 158. (c) Finn, M.G.; Sharpless, K.B. In Asymmetric
7. The complexity of this molecular framework pre- Synthesis, Morrison, J. D., Ed., Academic Press:New
prevented MM2 calculations from being carried out. York, 1985, Vol. 5, p. 247; (d) Johnson, R.A.; Sharp-
8. Gonella, N.C.; Nakanishi, K.; Martin, V.S.; Sharp- Sharpless, K.B. In Comprehensive Organic Synthesis,
less, K.B. /. Am. Chem. Soc. 1982, 104, 3775. Trost, B.M.; Fleming, I., Eds., Pergamon Press: New
9. (a) Nicolaou, K.C.; Daines, R. A.; Uenishi, J.; Li, York, 1991, Vol. 7, p. 389; (e) Johnson, R.A.; Sharp-
W. S.; Papahatjis, D. P.; Chakraborty, J. Am.
\320\242.\320\232.
Sharpless, K.B. In Catalytic Asymmetric Synthesis,
Chem. Soc. 1987, 109, 2205; (b) Nicolaou, K.C.; Ojima, I., Ed., VCH: Weinheim, New York, 1993,
Daines, R.A.; Chakraborty, ibid.
\320\242.\320\232. 1987, 109, p. 103; (f) Pfenniger, A. Synthesis 1986, 89; (g) Kat-
2208; (c) Nicolaou, K.C.; Chakraborty, \320\242.\320\232.; Martin,
Katsuki, \320\242.; V. S. Org. React. (N. Y.), in press.
Daines, R. A.; Simpkins, N. S. J. Chem. Soc, Chem. 16. Nicolaou, K.C.; Papahatjis, D. P.; Claremon, D.A.;
Commun. 1986, 413; (d) Nicolaou, K.C.; Daines, Magolda, R.L.; Dolle, R.E. J. Org. Chem. 1985, 50,
R. A.; Chakraborty, \320\242.\320\232.;
Ogawa, Y J. Am. Chem. 1440.
Soc. 1987,709,2821. 17.(a) Evans, D.A.; Bartroli, J.; Shih, T.L. J. Am.
10.(a) Nicolaou, K.C.; Daines, R.A.; Uenishi, J.; Li, Chem. Soc. 1981, 103,2127;(b) Evans, D.A.; Nel-
W.S.; Papahatjis, D.P.; Chakraborty, J. Am.
\320\242.\320\232. Nelson, J.V.; Vogel, E.; Taber, T.R. ibid. 1981, 103,
Chem. Soc. 1988, 110, 4672; (b) Nicolaou, K.C.: 3099; (c) Evans, D.A.; Takacs, J.M.; McGee,L.R.;
450 24 Amphoteronolide B and Amphotericin \320\222
Ennis, M.D.; Mathre, D.J.; Bartroli, J. Pure & Appi 23. Blanchette, M.A.; Choy, W.; Davis, J.T.; Essenfeld,
Chem. 1981, 53, 1109;(d) Evans, D.A.; Nelson, A. P.; Masamune, S.; Roush, W.R.; Sakai, T. Tetra-
J.V.; Taber, T.R. Top.Stereochem. 1982, 13, 1; (e) Tetrahedron Lett. 1984, 25, 2183.
Evans, D. A. Aldrichimica Ada 1982, 15, 23. 24. For the utilization of the acetate group in controlling
18.For previous selective formation of benzylidene ace- stereochemistry in glycosidation reactions, see: Paul-
tals, see: (a) Sinclair, H.B. Carbohydr. Res. 1969, sen, H. Angew. Chem. Int. 1982, 21, 155
Ed. Engl.
12, 150;(b) Ziegler, F.E.; Gilligan, P. J.; Chakraborty, and references cited therein. For some recent applica-
U.R. Tetrahedron Lett. 1979, 20, 3371; (c) Schubert, applications, see: (a) Dolle, R. E.; Nicolaou, \320\232. /. Am.
\320\241
Welzel,
\320\242.; P. Angew. Chem. Int. Ed. Engl. 1982, 21, Chem. Soc. 1985, 107, 1695; (b) Nicolaou, K.C.;
137. Randall, J.L.; Furst, G.T. ibid. 1986, 108, 5556;
19. (a) S. Heterocycles
Masamune, 1984, 21, 107; (b) (c) Nicolaou, K.C.; Caulfield, T.J.; Kataoka, H.;
Masamune, Choy, W.; Petersen, J. S.; Sita;
S.; L.R. Stylianides, N. A. ibid. 1990, 112, 3693.
Angew. Chem. Int. Ed. Engl. 1985, 24, 1. 25. (a) Schmidt, R. R. Angew. Chem. Int. Ed. Engl.
20. (a) Sharpless, Behrens, K.B.;
C.H.; Katsuki, Lee,
\320\242.; 1986, 25, 212 and references cited therein; (b)
A.W.M.; Martin, V.S.; Takatani, M.; Viti, S.M.; Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503;
Walker, F.J.; Woodard, S.S. Pure & Appl. Chem. (c) Nicolaou, K. C; Bockovich, N.J. In Bioorganic
1983,55, 589; (b) Behrens, C.H.; Sharpless, K.B. Chemistry: Carbohydrates, Rogers, R. E., Ed.,
Aldrichimica Ada 1983,16,67;(c) Behrens, C.H.; Oxford University Press: New York, 1996, Vol. 3,
S.Y.;
\320\232\320\276, Sharpless, K.B.; Walker, F.J. /. Org. Ch. 4.
Chem. 1985, 50, 5687; (d) Behrens, \320\241.
\320\235.;
Sharpless, 26. Eby, R.; Webster, K.T.; Schuerch, \320\241
Carbohydr.
K.B. ibid. 1985,50,5696. Res. 1984, 129, 111.
21. (a) Minami, N.; S.S.;
\320\232\320\276, Kishi, Y. /. Am. Chem. 27. For a separate synthesis of 19-dehydroamphoterono-
Soc. 1982, 104, 1109;(b) Ma, P.; Martin, V.S.; Masa- lide B, see: Kennedy, Abiko, A.; Takemasa,
R. M.;
Masamune, S.; Sharpless, K.B.; Viti, S.M. J. Org. Chem. Okumoto,
\320\242.; M.; Masamune, S. Tetrahedron Lett.
1982, 47, 1378;(c) Finan, J.M.; Kishi, Y. Tetra- 1988,451.
Tetrahedron Lett. 1982, 23, 2719; (d) Viti, S.M. ibid. 28. For some more recent degradation studies on ampho-
1982, 23, 4541; (e) Mubarak, A.M.; Brown, D.M. amphotericin B, see: Driver, M.J.; MacLachlan,W. S.; Mac-
J. Chem. Soc, Trans. 1 1982, 809; (f) Masa-
Perkin Pherson, D.T.; Readshaw, S.A. /. Chem. Soc,
Masamune, Choy,
S.; W. Aldrichimica Ada 1982,75, 47. Chem. Commun. 1990, 636.
22. For an excellent review of substrate-directed chemi-
chemicalreactions, see: Hoveyda, A. H.; Evans, D. A.;
Fu, G.C. Chem. Rev. 1993, 93, 1307.
E.J.Corey A988)
\320\222
Ginkgolide
25.1 Introduction
tions.9
In addition to its obvious architectural complexity,ginkgolide\320\222
A) is also very complex from the stereochemical point of view. Of
the
twenty carbon atoms contained within ginkgolide B, eleven are
asymmetrically substituted. Rings A and E are sites of an unusually
heavy concentration of asymmetry; all five carbon atoms in the
A-ring of ginkgolide\320\222 are tetrahedral and unsymmetrically substi-
substituted, and the same is true for the four carbon atoms of ring E.
Moreover, the B-ring of 1 accommodates a consecutive chain of
four stereogenic centers, two of which are quaternary.
The ten-butyl group attached to ring \320\222
of ginkgolide \320\222
A) is a
highly unusual structural feature. In fact, before 1967there was no
precedent for the presence of a terr-butyl group in natural pro-
products.4 A subtle and brilliant feature of Corey's designis the early
introduction of this substituent. The dispositionof the B-ringtert-
butyl group is used to control the formation of three stereogenic
centers. The key features of Corey's synthesis of ginkgolide \320\222
A)
are outlined retrosynthetically in Scheme 1.
Me\"
1: ginkgolide \320\222
MeO
Oxidation A^- 8
\320\233\320\276 \320\276
\320\276
Z4?
\320\275 epoxidation )'\\ \\J--H
.f-Bu -f-Bu \320\2631 i 2r\\/X....wu
\320\2471
\320\275
\" \302\246\320\233
o' Ring closure
10
MeO. MeO.
hydroxylation f-Bu
\302\246 4
Intramolecular
ketene-olefin \320\276
1J
cyclo-
[2\321\2042]
addition
17 MeO.
C-Cbond V*c
\320\276\320\274\320\265
Meo^ formation
f-Bu f-Bu
MeO. reducing rotational freedom of the tether linking the two reacting
groups (see intermediate 14). Of course, the unsaturation between
positions 1 and 2 also provides for the eventual elaboration of ring
and
\320\241 the secondary hydroxyl group at C-l in ginkgolide B.
OMe
OMe
1. f-Bu2Cu(CN)Li2,
'0Me Et2O,-78->-45
\302\260C
19
G5%)
F5% from
18)
TiCI4 CH2CI2,
-78 \302\260C
G6
- 84%) 21 (80%) 16
(80%)
(86%)
G5%)
\320\236\320\234\320\265 dition takes place to give, after silylation of the enolate oxygen atom
\320\236\320\234\320\265
with trimethylsilyl chloride, intermediate 20. This straightforward
reaction sequenceaccomplishes
the introduction of the requisite
tert-butyl substituent at C-8 and the formation of a latent nucleo-
appreciably electron rich, and it is likely that one or both of these sites
would compete with the cyclobutanone ring for reaction with
mCPBA. Fortunately, the desired oxidation could be achievedwith
a nucleophilic oxidant. Treatment of 13 with triphenylmethyl
(trityl) hydroperoxide and sodium hydroxide in acetone at -30 \302\260C
furnishes intermediate 23, exclusively, in a yield of 86 %. It is note-
noteworthy that the use of less bulky oxidants, such as basic hydrogen
peroxide, led to the formation of a 1:1 mixture of regioisomericy-
lactones.
To create a setting favorable for the formation of the E-ring of
ginkgolideB, it is first necessary to modify the reactivity potential
of ring F in 23. Exposure of a solution of 23 in methylene chloride
to 1,3-propanedithiol and titanium(iv) chloride at 0\302\260Cresults in the
formation of dithiane 24 in quantitative yield. Oxidation of the pri-
primary alcohol with PDC in the presence of acetic acid gives alde-
aldehyde 25 in a yield of 75 %.
When a solution of 25 in a 1:1 mixture of methanol and methy-
methylene chloride is exposed to periodic acid, the dithiane group
is cleaved oxidatively to give, after treatment of the crude prod-
product with camphorsulfonic acid (CSA) in methanol, bisacetal 12 as a
2:1 mixture of C-12 anomers in a yield of 80% (Scheme3).
Although the conversion of 12 into 10 could be carriedout on the MeO. MeO.
mixture of anomers, it was found to be more convenient to carry
isomer forward separately. When with lithium OMe
each 12 is treated
diethylamide, the methine hydrogen adjacent to the lactone carbo-
nyl is removed as a proton to give an enolate which is then oxidized
in a completely diastereoselective fashion with Davis's oxaziridine18
to afford 11. 11
460
25 Ginkgolide\320\222
\320\223)
1. \320\235\320\2564,
-30 -> 23 \302\260\320\241
-30->23\302\260C \"\"\\ \320\234\320\265\320\236.
>-S \342\200\2240 \320\241\320\2352\320\24112, \320\243\"
\320\234\320\265\320\236\320\235,
\\*><^L.. H2O (trace)
(trace) . 1 1.
\320\236\320\234\320\265
LiNEt2)THF
.^\320\262u -25->0\302\260\320\241
2. CSA, \320\234\320\265\320\236\320\235
2. Ph
(80%)
PhO2S
CSA, G5o/o
CH2CI2 I from 12)
H. OMe
1. Zn, AcOH
2.
PDC,CH2CI2
rigidity to the tether linking the two reacting groups; (b) it labil-
izes the two allylic carbon-hydrogen bonds at C-3 so that this
carbon can be functionalized; and (c) it provides a suitable plat-
platform upon which requisite functionality can be introduced. When
intermediate 10 is irradiated in the presence of ZV-bromosuccini-
mide, a 6:3:1 mixture of allylic bromides 27, and 28) is
B6,
produced in a combined yield of 80%. Treatment of this mixture
with 10 \320\274 AgNC>3 in acetonitrile gives enone 31, a product
formed from dibromide 28, and the two regioisomeric allylic
nitrate esters 29 and 30. After separation and characterization, the
two allylic nitrate esters 29 and 30 could be converted indepen-
independently into the same allylic alcohol and then into enone 31
through the sequence of reactions illustrated in Scheme 3. From
intermediate 10, this sequenceof reactionsfurnishes enone 31 in a
yield of 50 %.
During the planning stages of this synthesis, the task of achiev-
achieving an allylic oxidation of intermediate 10 was probably not
Ph3COOH, o . Me
\320\275 \320\275 f-BuO
BnMe3Ni-PrO, :>* L-\320\243
...f-Bu 2\320\223V^X-.f-Bu
THF,-10\302\260C; 8
F8%)
CSA,
<92%)
\320\241\320\231\320\223\320\24112
TBSOTf,
TBSOTf, o^ .H0-,,HW...H
2,6-lutidine,
f-Bu ..
\302\253O
-f-Bu
CH3CN
32
l2, CaCO3, TBS = Slf-BuMe2
MeOH
(lactol oxidation)
HO
f-Bu
35
[34:35 = 1:2]
25.4 Conclusion
References
York, 1991, Vol. 3, p. 89. Angew. Chem. Int. Ed. Engl. 1992, 31, 665.
9. Corey, E.J. Chem. Soc. Rev. 1988, 17, 111. 20. Soon after the disclosure of the total synthesis of (\302\261)-
10.Corey, E.J.; Cheng, X.-M. The Logic of Chemical gingkolide B, (see ref. 8a) Coreyreported a concise,
Synthesis, John Wiley & Sons: New York, 1989. enantioselective synthesis of tetracyclic lactone 23,
11. (a) Ireland, R.E.; Willard, A. K. Tetrahedron Lett. see: Corey, E. J.; Gavai, A. V. Tetrahedron Lett.
1975, 3975; (b) Ireland, R.E.; Mueller, R.H.; Wil- 1988, 29, 3201. Thus, in principle, gingkolide \320\222
Willard, A.K. J. Am. Chem. Soc. 1976,98, 2868; (c) could be synthesized in its naturally occurring enan-
Ireland, R.E.; Wipf, P.; Armstrong, J.D., III /. Org. tiomeric form.
Chem. 1991,56, 650;(d) Wipf, P. In Comprehensive
Organic Synthesis, Trost, B. M.; Fleming, I., Eds.,Per-
gamon Press: New York, 1991, Vol. 5, p. 827.
CO2Me
1: methyl homoseco-
dsphniphyllate
C.H.HeathcockA988)
Methyl Homosecodaphniphyllate
26.1 Introduction
The oriental tree, Yuzuriha (Daphniphyllum macropodum), is the
BnO BnCL
CO2Me
BnO..
aza-Prins
1: methyl homoseco-
homosecodaphniphyllate
OBn
\342\200\236OBn
OBn
^
\320\236
OBn,
AcOH,
70 \302\260C -H ,\302\251
1
(96%)
CO2Me
1. CrO3, H2SO4,
H2O, (CH3JCO
2. MeOH, H2SO4
(89%)
(+)-methyl
(\302\261)-1: homoseco-
homosecodaphniphyllate
26.4 Conclusion
References
1. (a) Sasaki, K.; Hirata, Y. J. Chem. Soc. \320\222
1971, 1565; 6. (a) Tietze, L. F.; Beifuss, U. Angew. Chem. Int. Ed.
(b) Toda, M.; Hirata, Y.; Yamamura, S. Tetrahedron Engl. 1993, 32, 131;(b) Ho, T.-L. Tandem Organic
1972, 28, 1477. Reactions, John Wiley & Sons: New York, 1992.
2. Rugged, R.B.; Hansen, M.M.; Heathcock, C.H. 7. For some excellent reviews, see: (a) Johnson, W. S.
J. Am. Chem. Soc. 1988, 110, 8734. Angew. Chem. Int. Ed. Engl. 1976, 75, 9; (b) John-
3. For an insightful and entertaining account of this and Johnson,W. S. Bioorg. Chem. 1976, 5, 51.
related work, see: Heathcock, C.H. Angew. Chem. Int. 8. Trost, B.M. Science (Washington, D. C.) 1991,254,
Ed. Engl. 1992, 31, 665. 1471.
4. Corey, E.J.; Cheng, X.-M. The Logic of Chemical 9. (a) Johnson, W. S.; Weidhaup, K.; Brady, S.F.; Olson,
Synthesis, John Wiley & Sons: New York, 1989. G.L. /. Am. Chem. Soc. 1968, 90, 5277; (b) John-
5. For examples of Diels-Alder reactions involving Johnson, W.S.; Wiedhaup, K.; Brady, S.F.; Olson,G.L.
2-azadienes, see: (a) Boger, D.L.; Weinreb, S.M. In ibid. 1974, 96, 3979.
Hetero Diels-Alder Methodology in Organic Synthe- 10. Chapdelaine, M.J.; Hulce, M. Org. React. (N.Y.)
Synthesis,Academic Press: San Diego, 1987, p. 255; (b) 1990, 38, 225.
Boger, D. L. Tetrahedron 1983, 39, 2869.
?v \320\236\320\235
27
Me
1:
S. J. Danishefsky A990)
indollzomycin
Indolizomycin
27.1 Introduction
In Japan, the interesting discovery was made that the union, by pro-
protoplast fusion, of two inactive Streptomyces strains, Streptomyces
tenjimariensisNM16 and Streptomyces grisline NP1-1, afforded a
particularly active clone (termed SK2-52) that produces the antibi-
antibiotic indolizomycin this novel strategy for generating
A).1 Although
an antibiotic-producing clone from inactive parental strains does
not reveal origin of 1, it has stimulated
the genetic some interesting
proposals.2 For example, it is tempting to entertain the hypothesis
that the biosynthesis of indolizomycin features one or more
enzymes that have arisen from recombinant genes. On the other
hand, the daughter strain, SK2-52, may possess the appropriate
mechanism(s) to express silent genesalready present in one of the
parents. The unusual structure of indolizomycin is likely due, in no
Me'
small part, to its unconventional lineage.
It was on the basis of spectroscopic data and an X-ray crystallo-
graphic analysis of 3
compound (see Scheme 1) that the constitu-
constitutionof the
indolizomycin molecule was revealed. Although the
neutral conditions.
472 27 Indolizomycin
Me
1: indolizomycin
> Julia
Me Me TEOC
coupling
CHO
Me3Si
Me
Me
TEOC=
1: indolizomycin
\320\276 OH
Wharton
fragmentation
TEOC I TEOC
1
\"aza-Roblnson
annulatlon\"
vinylogous
McCiuskey \320\236
fragmentation
TEOC
4
11
MeO2C
14 13 12
\320\236\320\272
Ph3P
,\320\241\320\236\320\263\320\234\320\265
PhH,
15 0 ->25 \302\260C
-N2
14 \320\236
MeO2C MeO2C
16
-
Ph3P=O
1. NaBH4, ,SiMe3
MeOH, -10 \302\260C MeO2C
*
2. HC. MeOH, TiCI4, CH2CI2,
MeO2C \320\234\320\265\320\236\320\263\320\241.
13 17 18
1
Lawesson's
s\342\200\224p -OMe
Lawesson's
I I
reagent
reagent MeO p\342\200\224s (85%yield
from 13)
II
s
1. 1 NNaOH-MeOH
* MeO2C
2. \302\260
12 N-methylmorpholine 19
3. CH2N2, Et2O
G7% overall)
Rh(OAcJ,
12 20 21
HS
23 22
W-2 Raney Ni,
(CH3JCO
,, F6% from 12)
MeO
NaBH4,
\302\273\302\273
11 24 .1
C0%from 11)
MeO
vinylogous
t
McCluskey
fragmentation
Me3Si
) \342\200\224
\320\236\320\235
30% H2O2,
NaOH-MeOH
(97% yield)
TEOC
-N-\320\275
TEOC
25
H2NNH2,MeOH,
AcOH,25 \302\260C
E2% yield) J
OH
-N2
AcO
Wharton
H
fragmentation
TEOC
mCPBA, CH2CI2,
0 \302\260C
(84% yield)
OTBS OTBS
TBSOTf, 1. O3)NaHCO3,
Et3N, \320\241\320\2352\320\2411\320\260, CH2CI2-MeOH
0 \302\260C
(95%) 2. MeOCH=PPh3
(80% overall)
TEOC
TBS = Sif-BuMe2
28 \320\276\320\274\320\265
Ph3P
TEOC F9% yield)
r
CHO Oo OMe
radical may be operative.14 You will note that this outcome would
not have been possible had the precursor epoxy ketones differed in
configuration at C-8a.
A digression is in order at this stage. From the pioneering work
of Henbest and Wilson,15 it is known that cyclic allylic alcohols
such 31 (see Scheme6) can be diastereoselectively
as 29 and
epoxidized with peroxybenzoic acid or m^ta-chloroperoxybenzoic
acid (mCPBA) to give the corresponding cw-epoxy alcohol diaster-
eomers,compounds 30 and 32, respectively. In these peracid oxida-
oxidations, it is currently believed that a pseudo-equatorial hydroxyl
group directs the stereochemical course of the epoxidationevent
(see 31 \342\200\224>32,
Scheme 6).16 Interestingly, exposure of medium-ring
allylic alcohol 33 to the same oxidant results in the stereoselective
formation of trans-epoxy alcohol 34.17The preferred transition
state conformation for the epoxidation of 2-cycloocten-l-olC3)
with mCPBA is characterized by an equatorially oriented hydro-
hydrogen-bonded complex. In this arrangement, which is favored on
mCPBA
(diastereoselectivity: 10:1)
OH
f-Bu f-Bu
31 32
(diastereoselectivity: 24:1)
mCPBA
33 34
(diastereoselectivity: >99:1)
OTBS
OTBS
o^ /
SO,Ph
Li
1. THF, -78 \302\260C
2. Ac2O
TEOC
SO2Ph
CHO
5% Na-Hg I
G7% from 6) I
OTBS
1. 1 NHIO4,THF
\302\253
2. TPAP, CH2CI2,
25 \302\260C
G4% overall)
Me3Si
TBAF, THF
B9% yield)
Me,Si
27.4 Conclusion
References
1. (a) Gomi, S.; Ikeda, D.; Nakamura, H.; Naganawa, (b) Por of intramolecular
a review reactions of N-
H.; Yamashita, R; Hotta, K.; Kondo, S.; Okami, Y.; acyliminium ions, see: Speckamp,W.N.; Hiemstra, H.
Umezawa, H.; Iitaka, Y /. Antibiot. 1984, 37, 1491; Tetrahedron 1985, 41, 4367.
(b) Yamashita, R; Hotta, K.; Kurasawa, S.; Okami, 11.(a) Sheibye, S.; Pederson, B.S.; Lawesson, S.-O.
Y; Umezawa, H. ibid. 1985, 38, 58. Bull. Soc. Chim. Belg. 1978, 87, 229; (b) For a
2. (a) Kim, G.; Chu-Moyer, M.Y.; Danishefsky, S.J. review on the use of Lawesson's reagent, see: Cava,
/. Am. Chem. Soc. 1990, 112,2003; (b)-Kim, G.; M.; Levinson, M. I. Tetrahedron 1985, 41, 5061.
Chu-Moyer, M.Y; Danishefsky, S.J.; Schulte, G. K. 12.(a) Fang, P.G.; Prato, M.; Kim, G.; Danishefsky, S.J.
ibid. 1993, 115,30. Tetrahedron Lett. 1989, 30, 3625; (b) Fang, P.G.;
3. (a) Julia, M.; Paris, J.-M. Tetrahedron Lett. 1973, Feigelson, G.B.; Danishefsky, S.J. ibid. 1989,30,
4833; (b) Kocienski, P. PhosphorousSulfur 1985, 2743; (c) Fang, F.G.; Danishefsky, S.J. ibid. 1989,
24, 97; (c) Kocienski, P.; Lythgoe, Waterhouse,
\320\222.; I. 30, 2747.
J. Chem. Soc, Perkin Trans. 1 1980, 1045. 13.Meerwein, H.; Borner, P.; Fuchs, O.; Sasse, H.J.;
4. Wharton, P.S.; Bohlen, D.H. /. Org. Chem. 1961, Schrodt, H.; Spille, J. Chem. Ber. 1956,89, 2060.
26, 3615. 14.Stork, G.; Williard, P.G. / Am. Chem. Soc. 1977,
5. (a) Bergmann, R. D.; Ginsburg, D.; Pappo,R. Org. 99, 7067.
React. (N. Y.) 1959, 10, 179; (b) Oare,D.A.; Heath- 15.Henbest, H.B.; Wilson, R. A.L. / Chem. Soc. 1957,
cock, C.H. Top. Stereochem. 1989, 19, 227; (c) 1958.
Ihara, M.; Pukumoto, K. Angew. Chem. Int. Ed. 16. For an excellent review of substrate-directed chemi-
Engl. 1993, 32, 1010. chemicalreactions, Hoveyda, A.H.; Rvans,
see: D.A.;
6. (a) Hobson, J.D.; McCluskey, J.G. /. Chem. Soc. Fu, G.C. Chem. Rev. 1993, 93, 1307.
1967,2015;(b) Por a review of amine dealkylations, 17. Itoh, Jitsukawa,
\320\242.; K.; Kaneda, K.; Teranishi, S.
see: Cooley, J.H.; Rvain, R.J. Synthesis 1989, 1. J. Am. Chem. Soc. 1979,101, 159.
7. (a) Roth, M; Dubs, P.; Gotschi, R.; Rschenmoser,A. 18. (a) Rousseau, G.; Le Perchec, P.; Conia, J.M.
Helv. Chim. Ada 1971, 54, 710;(b) Eschenmoser, A. Synthesis 1978, 67; (b) Rousseau, G.; Le Perchec, P.;
Pure & Appl. Chem. 1969, 20, 1;(c) Rschenmoser, Conia,J.M. Tetrahedron Lett. 1977, 45; (c) Rous-
A. Q. Rev. Chem. Soc. 1970, 24, 366; (d) For a Rousseau, G.; Le Perchec, P.; Conia, J.M. ibid. 1977,
review, see: Shiosaki, K. In Comprehensive Organic 2517;(d) Huet, F; Lechevallier, A.; Conia, J.M.
Synthesis, Trost, B.M.; Fleming, I., Eds., Pergamon ibid. 1977,2521.
Press: New York, 1991, Vol. 2, p. 865. 19. (a) Foote, C.S. Ace. Chem. Res. 1968, 1, 104;(b)
8. (a) McCoy, L. L. J. Am. Chem. Soc. 1958,80, 6568; Kearns, D. R. Chem. Rev. 1971, 71, 395.
(b) Majchrzak, M.W.; Kotelko, A.; Lambert, J.B. 20. Greene, T.W.; Wuts, P. G. M. Protective Groups in
Synthesis 1983, 469. Organic Synthesis, 2nd ed., John Wiley & Sons:
9. Garcia, J.; Vilarrasa, J.; Bordas, X.; Banaszek, A. New York, 1991.
Tetrahedron Lett. 1986, 27, 639. 21. (a) Griffith, W.P.; Ley, S. V. Aldrichimica Ada 1990,
10. (a) Hiemstra, H.; Speckamp, W. N. In Comprehensive 23, 13; (b) Ley, S.V.; Norman, J.; Griffith, W.P.;
Organic Synthesis, Trost, B.M.; Fleming, I., Eds., Marsden, S.P. Synthesis 1994, 639.
Pergamon Press: New York, 1991, Vol. 2, p. 1047;
1: cytovaricin D. A. EvuTIS A990)
Cytovaricin
28.1 Introduction
During the course of studies which were carriedout to assess the stabi-
stability of cytovaricin under a variety of reaction conditions, it was
discovered that the lactol portion of the natural product undergoes
facile and irreversible dehydration to UV-active dienol ether 2
under mildly acidic conditions (see Scheme 1). It is likely that the
OH
1: cytovaricin
to postpone its introduction to the final step of the synthesis. Retro- OTES
Retrosynthetic disassembly of the sensitive lactol of cytovaricin A)
furnishes the reduced and protected intermediate 3 as a potential
precursor (see Scheme 2). In the synthetic direction, selective
deprotection and oxidation of the C-17 secondary hydroxyl group
to the corresponding ketone, followed by a final deprotection step,
would complete the synthesis of cytovaricin. At the outset, it was
recognized that cytovaricin presents several viable options for
Secoacid4 is derived
macrocyclization.16 from retrosynthetic scis-
scission of the O-Cl bond, and could conceivably be induced to Mopmb
otbs OTES
synthetic direction, a
\342\200\236O
undergo, in the macrolactonization reaction.
OTES
Alternatively, retrosynthetic cleavage of the C2-C3 double bond Julia olefination
4: seco acid
affords seco aldehyde 5 and introduces the interesting possibility of
achieving macrocyclization through an intramolecular Horner- P(O)OR2
OTES
HO Me f-Bu
Me
I HO.
Me OCH2OCH2CCI3
DEIPSO H Me'
Me 15CHO Me
TESO_, MeO
PhO2S
Asymmetric \342\200\224
Carbonyi addition \342\200\224\342\200\224\302\246
OTES
Me Me
Glycosidation
' MeO
functional group
manipulations
Asymmetric aldol
/
/OTES
\320\236
Asymmetric
OBn
24
A.
-Ph
20
bonyl would then accomplish the introduction of the third and final
stereogenic center in 12. The executionof this elegant and conver-
convergentstrategy is described below.
1. LiOOH.THF,
H2O, 0 \302\260C
= [(CH3KSi]2NNa 2. UAIH4,THF-
NaHMDS
TBS = Sif-BuMe2 Et2O, 0 25 \302\260C
-\302\273
OTBS Me
Ph
Me
\\
NaHMDS NaHMDS
[TSi [TS1
ONa ONa
H L Me L
Me 0 \302\260C
\320\241\320\2352\320\24112, Me
2. Ph
Me
21
20 29
-78 \302\260C;
then H2OZ
1. AcOH, n-Bu3B, THF,
(92%) 25 0
LIBH4,
\302\260C; \302\260C;
H2O2 G1% overall)
2. ^Pr\320\267SiCI, 4-DMAP,
CH2CI2, 25 \302\260C
1. n-Bu3SnH,
PhCH3, 25 \302\260C Me I Me Me
2. Me2C(OMeJ, 31 30
F7% from
p-TsOH (cat), 30)
25 \302\260C
Me Me
1. n-Bu4NF\302\2733H2O,
TIPSO OO THF, 0 \302\260C
4M 2. (COCIfe, DMSO,
CH2CI2,-78 \302\260C;
Et3N, -78 -30
-\302\273 \302\260C
(98% overall)
CH2CI2,
25 \302\260C
Me. Me
1. H2,5%Pd/C,
\320\234\320\265^\320\274\320\265
\320\236 \320\236
EtOAc
\320\274\320\265\321\207
2. MeLi, Et2O-THF,
-78 \302\260C
Me Me
L
33
c+ \320\273
tToU t\\ of*
U v I
I
(Ofc/O
Me \320\274\320\265 Me Me
TMSCi, NH2NMe2,
0 \320\236
?
Me^^32^^30SV^4^' CHzCi2, 0 25 \302\260C
-\302\273
26 Me
Me (99%) Me
16 14
Ph- between
coordination the C-28 carbonyl oxygen and the Lewis acidic boron
Me atom provides sufficient activation of the C-28 carbonyl for a
29 reduction with lithium borohydride. Iodohydration19 of the C31-
C32 double bond in 30, followed sequentially by reductive cleav-
Me Me
cleavage of the carbon-iodine bond with tri-n-butyltin hydride and for-
TIPSO OH TIPSO 0 0 formation of the acetonide ring, affords intermediate 32 in an overall
Me
yield of 67 %. The iodohydration reaction exhibits impressive dia-
stereoselectivity (96:4) and accomplishesthe introduction of the
Me Me Me
third and final stereocenter present in intermediate 14. A straight-
30 32 straightforward two-step sequence of reactions accomplishes the formation
of aldehyde 18 which undergoes homologation to 17 through a
a
Me \320\236 Me \320\236
1-
CH2CI2, 0 \302\260C OPMB
\302\273
2. \320\236 Me
21 34
OPMB
22 1. AIMe3, MeONHMe'HCI,
(91%
-78 then H2O2, 0 THF, 0 \302\260C
\302\260C; \302\260C overall) 2. Et3SICI, imidazole, DMF
(87%)
\320\276 OTES
TES = SiEt3
PMB = CH2C6H4-p-OCH3
Me Me
15
~32^~^30>
2.[T?l,-45\302\260C(90%)
Me
Me,. Me.
Me
M\342\200\224
Et2f-PrSICI, Imidazole, H3 M\342\200\224
Me
H oi
CH2CI2,0 -\302\27325\302\260C , 'MBO-^X^L-^SIA
(98%) H\342\200\224\\*^\\
21
h3j\302\260; |
\320\236 \320\276
Me DEIPS = SI/-PrEt2 Me
36 35
Sml2 @.1 eq),
(98%) /^PrOH A 0 eq.),THF
I
'
Me. Me.
1. BrCH2OCH2CCI3,
DEIPSO\" H proton sponge, CH3CN, DEIPSO'''^1 H
^| t
0 ->25 \302\260C
\320\2234-\320\234\320\265 h-^ \320\241~\321\202\342\200\224Me
0 17 H \320\276
2. DDQ, H2O, CH2CI2,
PMBO
5 -* 25 \302\260C
37 9
(87% overall)
OPMB triethylsilyl ether would occur to give a triol wherein the structural
prerequisites for a spiroketalization reaction are satisfied.In the
OTBS
DEIPSO1* > \320\275
,e \320\276
1. /\302\273-Bu2BOTf, Et3N, CH2CI2, Me
\320\235-\320\233\024\342\200\224
M -78->0\302\260C OTBS \320\236\320\235
\320\275 \320\236
2-
-\320\230
Me Ph 3. MeONHMe\302\253HCI,
\320\220\320\226\320\2653,
8 THF, 0 \302\260C
OMe 38
(85% overall)
1. CI3CC(NH)(OPMB),
CF3SO3H,CCI4-C6H12,
25 \302\260C G1% overall)
2. Dlbal-H, THF,-78 \302\260C
Me
i
Me^^ OCH2OCH2CCI3
DEIPSO
OCH2OCH2CCI3
OPMB
6: spiroketal subunit
\320\247\320\273
21 30 1. .Me3AI, MeONHMe'HCI,
24 THF, 0 \302\260C (92%
-78 then
\302\260C; H2O2
2. 2-lithlopropene, Et2O- overall)
THF, -78 \302\260C
(87%)
f-Bu f-Bu f-Bu
/f-Bu
^Si4 1. Et2BOMe,
o's(o 1. Ca,NH3(l),THF, THF-MeOH, OH
Me
44 43
1. TESOTf, Et3N,
CH2CI2, 0 \320\241
2. O3, MeOH-CH2CI2, G3%
-78 \302\260C;
Me2S, -78 -> 25 overall)
\302\260C
3. DDQ, CH2C!2> H2O,
Me 10 \302\260C
>Bu
SL
\342\200\242*-Bu
OMe
Me' Ac2O, pyr., CH2CI2
AcO OTES
PMBO
OH (99%) 'OMe
Me
49
OMe
44
Ph3CCIO4,
PhCH3,
-20 \302\260C
Temperature pVa 1
-20 \302\260C 13
-3\302\260C 41
\302\260
-20 -> -3 \320\241
OTES
50a
a \342\200\242
chelation-
PhS
52
1. n-BuLi, THF,-40 \302\260C;
Et3SiOTf, -40->-10 \302\260C
(93%overall) 2. OsO4 (cat), NMO, H2O,
THF, (CH3JCO,25 \302\260C
\320\274\320\265
\320\275\320\276.
f-Bu
\320\275\320\276
PhO2S
OTES
7: polyol glycoside subunit
stereogenic center at C-9 controls the emergence of a new stereo- 6: spiroketal subunit
aldehyde 5, all efforts were devoted to the development of the macro- 5: seco aldehyde
macrolactonization option.
a HO Me TESO4 Me
\\ .' f-Bu 1. DMSO, f-Bu
V
\320\275\320\276^ /
\320\276 (COCIJ,
3
4
1
1
Sl\342\200\224f-Bu
1
CH2CI2,-78 \302\260C;
Et3N, -f-Bu
JL \320\236
-78 -30 \302\260C
\321\207>
Me^N^
2. Et3SiOTf, TESO.. J. MeO
TESO.. J-.,
-^\"ot^-Me i \342\200\224
\302\246ES 2,6-lutidine,
\\\302\273\302\273-*~-a\342\200\224-O ^ f | CO
\\n \320\274--\342\200\224p^***-i
\320\233
|\302\273Me L\302\273Me
2>
\321\207/\\/%10 H
PhOjS1^4
PhO2s^^^TES OTES
(87% overall)
7: polyol glycoside subunit 53
(EtOJPOCH2CO2TMS,
n-BuLI, THF, 25 \302\260C;
then (93%)
0.1 N NaHSO4 \\ r
TESO Me
f-Bu
HO .
^^V
\320\243 Y-'-Bu
\320\236 JL .o
Me*^>r
MeO
TESO..
J..o. \302\246^\302\246Oj^VMe
PhO2S/V
s/\\^vio H
OTES
54
TESO Me
Me OCH2OCH2CCI3
DEIPSO \320\275\"O
Me CHO AV\342\200\224Me
TBSO
PhO2S
OPMB
Me
OTBS
\342\200\242Me
OTES
OTES
4: seco acid
Scheme 11. Synthesisof intermediate 54 (a) and coupling of Intermediates 6 and 54 (b).
28.3 Total Synthesis 505
4-DMAP*HCI,
4-DMAP, DCC,
OTBS ~\\\302\260OT! OTES CHCI3,61 \302\260C
4: secoacid
Me
HRpyr,
G4%) pyr., THF,
OTES
25 \302\260C
Me
^'^^N
M
H
?7o ^ /0H
OH 14
H / >*\\Q Me JL,
H
\\ J [
H
J17 HO4^_y^\"OH
|OH
OH H
1: (-)-cytovaricin
JJOPMB
sulfone. When the mixture of /?-acetoxy sulfones is exposedto a large
OTBS \342\200\236O OTES excess of pulverized 6 % sodium amalgam, reductive elimination of
Julia olefination
OTES the acetoxy sulfone to the requisite trans double bond (C14-C15)
4: secoacid
of
and.cleavage the C-21 B,2,2-trichloroethoxy)methoxy protecting
group both take place to afford the desired seco acid 4 in an overall
yield of 66%.
We have reached a critical stage in the synthesis. Through a
Julia-Lythgoe trans olefination reaction,17 two intermediates repre-
representing the \"left- and right-hand\" sectors of cytovaricin have been
joined to give the key macrolactonization substrate, secoacid 4.
OTES
Gratifyingly, in situ activation of the C-l carboxyl group in 4 using
Keek's carbodiimide macrocyclization methodology33 is attended
by smooth internal esterification of the C-21 equatorial hydroxyl
1: cytovaricin
28.4 Conclusion
References
1. (a) Corey, E.J.; Trybulski, E.J.; Melvin, L.S., Jr.; (c) Ferensimycin B: Evans. D.A.; Polniaszek, R.P.;
Nicolaou, \320\232.
\320\241;Secrist, J.A.; Lett, R.; Sheldrake, DeVries, K.M.; Guinn, D.E.; Mathre, D.J. ibid.
P.W.; Falck, J.R.; Brunelle, D.J.; Haslanger, M.F.; 1991, 113, 7613; (d) (+)-A83543A(Lepicidin) Agly-
Kim, S.; Yoo, S. J. Am. Chem. Soc. 1978, 100, 4618; con: Evans, D.A.; Black, W.C ibid. 1992, 114,
(b) Corey, E.J.; Kim, S.; Yoo, S.; Nicolaou, K.C.; 2260; (e) (+)-Calyculin A: Evans, D.A.; Gage,J.R.;
Melvin, L.S., Jr.; Brunelle, D.J.; Falck, J. R.; Try- Leighton, J.L. ibid. 1992, 114, 9434; (f) Macbecin I:
Trybulski, E. J.; Lett, R.; Sheldrake, P.W. ibid. 1978, 100, Evans, D. A.; Miller, S.J.; Ennis, M.D.; Ornstein,
4620; (c) Corey,E. J.; Hopkins, P. \320\222.;
Kim, S.; Yoo, S.; PL. J. Org. Chem. 1992, 57, 1067; (g) Lonomycin
Nambiar, K.P.; Falck, J.R. ibid. 1979, 101,7131. A: Evans, D. A.; Ratz, A.M.; Huff, B.E.; Sheppard,
2. (a) Woodward, R. B. et al. J. Am. Chem. Soc. 1981, G.S. J. Am. Chem. Soc. 1995, 117, 3448.
103, 3210; (b) Woodward, R.B. et al. ibid. 1981, 103, 10.Evans, D. A.; Kaldor, S.W.; Jones, \320\242.\320\232.; Clardy, J.;
3213; (c) Woodward, R.B. et al. ibid. 1981. 103,3215. Stout, T.J. J. Am. Chem. Soc. 1990, 112, 7001.
3. (a) Stork, G.; Rychnovsky, S.D. J. Am. Chem. Soc. 11.Kihara, \320\242.; Kusakabe, H.; Nakamura, G.; Sakurai, \320\242.;
1987, 109, 1564, 1565;(b) Stork, G.; Rychnovsky, Isono, K. J. Antibiot. 1981, 34. 1073.
S.D. Pure & Appl. Chem. 1986, 58, 767. 12.Sakurai, \320\242.;Kihara, \320\242.;Isono, K. Ada Crystallogr.
4. For some insightful discussions, see: (a) Danishefsky, Sen \320\2411983, 39, 295.
S.J. Aldrichimica Ada 1986, 19, 59; (b) Sharpless, 13. Kihara, Isono,
\320\242.; K. J. Antibiot. 1983, 36, 1236.
K.B. Chem. Scr. 1985, 25, NS71. 14.Perron, F.; Albizati, K.F. Chem. Rev. 1989, 89, 1617.
5. (a) Evans, D.A.; Nelson, J.V.; Vogel, E.; Taber, T.R. 15. Greene, T.W.; Wuts, P. G. M. Protective Groups in
J. Am. Chem. Soc. 1981, 103, 3099; (b) Evans, D.A.; Organic Synthesis, 2nd ed., John Wiley & Sons:
Takacs, J.M.; McGee, L.R.; Ennis, M.D.; Mathre, New York, 1991
D.J.; Bartroli, J. Pure & Appl. Chem. 1981, 53, 1109; 16.(a) Paterson, I.; Mansuri, M.M. Tetrahedron 1985,
(c) Evans, D.A.; Nelson, J. V.; Taber. T.R. Top. 41, 3569; (b) Nicolaou, K.C ibid. 1977. 33, 683; (c)
Stereochem.1982, 13, 1; (d) Evans, D. A. Aldrichi- Masamune, S.; Bates, G. S.; Corcoran, J. W. Angew.
Acta
Aldrichimica 1982, 15, 23. Chem. Int. Ed. Engl. 1977, 16, 585; (d) Back, T.G.
6. (a) Masamune, S.; Ali, Sk.A.; Snitman, D. L.; Garvey, Tetrahedron 1977, 33, 3041.
D.S. Angew. Chem. Int. Ed. Engl. 1980. 19, 557; (b) 17. (a) Julia, M.; Paris, J.-M. Tetrahedron Lett. 1973,4833;
Masamune, S.; Choy, W.; Kerdesky, F. A. J.; Imperiali, (b)Kocienski,P. Phosphorous Sulfur 1985, 24, 97.
B. J. Am. Chem. Soc. 1981, 103, 1566; (c) Masa- 18. (a) Cram, D.J.; Kopecky, K.R. J. Am. Chem. Soc.
Masamune, S.; Hirama, M.; Mori, S.; Ali, Sk.A.; Garvey, 1959, 81, 2748; (b) Cram, D.J.; Wilson, D.R. ibid.
D.S. ibid. 1981, 103, 1568; (d) Masamune, S.; Kaiho, 1963, 85, 1245; (c) Eliel, E. L. In Asymmetric Synthe-
\320\242.;
Garvey, D.S. ibid. 1982, 104, 5521; (e) Masa- Morrison,
Synthesis, J. D., Ed., AcademicPress:New York,
Masamune, S.; Lu, L.D.-L.; Jackson, W.P.; Kaiho, \320\242.; 1983, Vol. 2, p. 125;(d) For a review, see: Reetz, M.T.
Toyoda, T. ibid. 1982, 104, 5523;(f) Masamune, S.; Angew. Chem. Int. Ed. Engl. 1984, 23, 556; (e) Mul-
Ellingboc, J.W.; Choy, W.; ibid. 1982, 104, 5526; (g) zer, J. In Organic Synthesis Highlights, Mulzer, J.;
Masamune, S.; Imperiali, \320\222.; Garvey, D.S. ibid. 1982, Altenbach, H.-J.; Braun. M.; Krohn, K.; Reissig,
104, 5528; (h) Masamune, S.; Choy, W.; Petersen, H.-LJ.,VCH Publishers: Weinhcim, New York, 1991,
J. S.; Sita, L. R. Angew. Chem. In!. Ed. Engl. 1985, p. 3; (f) Still, W.C; McDonald, J.H., HI Tetradedron
24, 1; (i) Masamune, S. Heterocycles 1984, 21, 107. Lett. 1980, 21, 1031; (g) Still, W.C; Schneider, J.A.
7. (a)'Heathcock,C.H.;White, C.T. J. Am. Chem. Soc. ibid. 1980,2/. 1035.
1979,101,7076; (b) Heathcock, C.H.; Pirrung, M.C.; 19.(a) Chamberlin, A.R.; Mulholland, R.L., Jr. Tetra-
Buse, \320\241\320\242.;
Hagen, J.R; Young, S. D.; Sohn, J. E. ibid. Tetrahedron 1984, 40. 2297; (b) Chamberlin, A.R.; Mul-
1979, 101, 7077; (c) Heathcock, C.H.; Pirrung, M.C.; Mulholland, R.L., Jr.; Kahn, S.D.; Hehre, W.J. J. Am.
Lampe, J.; Buse, \320\241\320\242.; Young, S.D. J. Org. Chem. Chem. Soc. 1987,109,672.
1981,46, 2290; (d) Heathcock, C.H. In Comprehen- 20. (a) Basha, A.; Lipton, M.; Weinreb, S. M. Tetra-
Carbanion
Comprehensive Chemistry, Durst, \320\242.;
Buncel, E., Eds.. Tetrahedron Lett. 1977, 4171; (b) Levin, J.I.; Turos, E.;
Elsevier: Amsterdam, 1983, Vol. 2, p. 177; (e) Heath- Weinreb, S:M. Synth. Commun. 1982, 12, 989.
cock, C.H. In Asymmetric Synthesis, Morrison, J.D., 21.Collin, J.; Namy, J.L.; Kagan, H.B. Nouv. J. Chim.
Ed., Academic Press: New York, 1984, Vol. 3, p. Ill; 1986. 10, 229.
(f) Heathcock, \320\241 Aldrichimica
\320\235. A eta 1990. 23, 99. 22. For some excellent reviews of the utility of samarium
8. Mukaiyama, T. Org. React. (TV. Y.) 1982, 28, 203. diiodide in organic synthesis, see: (a) Molander,
9. For some other selected synthetic achievements by the G.A. Chem. Rev. 1992, 92, 29; (b) Soderquist, J.A.
Evans group, see: (a) X-206:Evans, D. A.; Bender, Aldrichimica Ada 1991, 24, 15.
S.L.; Morris, J. J. Am. Chem. Soc. 1988, 110,2506; 23.Wilds, A.L. Org. React. (N. Y.) 1944, 2, 178.
(b) Ionomycin: Evans, DA.; Dow, R.L.; Shih. T. L.; 24. For a review, see: Tidwell, T.T. Org. React. (N. Y.)
Takacs, J.M.; Zahler, R. ibid. 1990, 112. 5290: 1990, 39, 297.
508 28 Cytovaricin
MeO
1: gilvocarcin M 2: gilvocarcin V
K. Suzuki A992, 1994)
Gilvocarcin M and
Gilvocarcin V
29.1 Introduction
Pd-catalyzed coupling
OBn
10
triflate \320\237
formation
OBn
OBn
H ..OBn
.OBn
AcO
HO OBn Me
\320\275\320\276
OBn
13 12 C-glycosylation
OBn
11
,\302\260Bn The two building blocks for the synthesis, compounds 12 and 13,
OBn
Me are both readily available.Benzyl protected D-fucofuranosyl acetate
-O
AcO
A2) can be preparedvia a known protocol,12 and the iodoresorcin-
ol derivative 13 can be synthesized in short order from commer-
12 OBn commercially available resorcinol monobenzoate A4) (see Scheme 2). The
latter compound is an ideal starting material because the two oxy-
oxygens are already differentiated. The reaction sequence employedto
achieve the conversion of 14 to 13 is very straightforward and does
not warrant any special comment. It is, however, instructive to
address the important role that the iodine atom will play in this
synthesis; although the iodine atom in compound 13 is not
expressed in the gilvocarcins, it will, at a later stage, permit the
0Bz 0H
1. DHP,PPTS (cat.), OTHP
1. CH3OCH2Ci, *-Pr2NEt, CH2CI2,25 \302\260C
CH2CI2,reflux A00%) (95%)
OBn
OBn
OBn
OBn
a or b, AgCIO4,
AcO -O
HO CH2CI2,4 A mol.
a-11
OBn
a: Cp2HfCI2,7'=-20oC, SlMeCI2
(a:p/8.2:1) (86%)
19 Tf2O, /-Pr2NEt,
CH2CI2,-78 \302\260C
T=-10\302\260C,(a:p/26:1)
(99%)
(86%)
OBn
\320\273-BuLI,THF,
OBn
OBn
Diets-Alder
\\
Me
MeO OBn MeO OBn MeO OBn
5, \320\236
J-Pr2NEt,
.OBn 4-DMAP, OBn
Me
THF, D
\320\223
HO
25 \302\260C
(91%)
(Ph3PJPdCI2 B6 mol %)
NaOAc, DMA, 125 \320\241
(90%)l%) I
MeO OH
DMA = Me2NCOCH3 | MeO OBn
MeO
MeO
H2,10%Pd-C,
MeOH-THF,25 \302\260C
(90%) Me
1: (-)-gilvocarcin OBn
M 20
a-11 OBn
highly stereoselective and completely regioselective coupling of
compounds 12 and 13, providing a 26:1 ratio of stereoisomeric gly-
.OBn cosides in favor of the desired a-11 (86 % yield).
Me
OBn Although the stereo- and regioselective attachment of the carbo-
carbohydrate sector to compound 13 constitutes a significant achieve-
much concern. You will note that the D-fucose sugar ring in a-11
Cp2HfCl2-AgCiO4,
+ )k> (RO)n-
(RO)n -c\342\200\224\\
CH2CI2, 4 A mol.
sieves, -78\302\260C
X = F or OAc -78 -> -20 \302\260C
(O -> C-glycoside
rearrangement)
(RO)n\"
/
\320\275.
i\342\200\224Me
\320\236\320\235
furanoside
\320\235\302\251,\320\224
21
pyranoside
naphthols.13
Acid chloride 5, prepared in two straightforward steps from the
known benzylic alcohol 64e (see Scheme 6). reacts smoothly with
OBn
naphthol 4 to give ester 3 in 91 % yield (see Scheme 3). With an
516 29 Gilvocarcin M and Gilvocarcin V
MeO MeO
(COC!J,
DMF (cat.),
n-Bu4NMn04, pyr.
)
CH2CI2
MeO OBn
appropriately placed iodine atom, intermediate 3 seems poised for a
MeO
Pd-mediated cyclization reaction.411 Indeed, treatment of 3 with
bis(triphenylphosphine)palladium(ii) chloride (Ph3PJPdCl2 B6 mol
%) and sodium acetate C equiv.) in
A'.A'-dimethylacetamide (DMA)
at 125 effects
\302\260C the crucial intramolecular biaryl coupling and
affords tetracycle 20 in 90% yield (see Scheme3). Finally, hydro-
genolysis of the four benzyl groups furnishes (-)-gilvocarcin M A)
MeO OBn
in 90 % yield. The synthetic material was found to be identical in
27 (95% overall)
MeO OBn
\342\200\242OBn
Et2O ), 25 \302\260C .A^Jk^^
Me
(83%) I II
HO \302\260
\320\276\320\274\320\276\320\274 OBn
28
OBn
(Ph3PJPdCI2 B7 mo!%),
NaOCOC(CH3K, DMA,
80 \302\260C
F5%)
1. H2, RaneyNI,
MeO Meu
EtOH-Et2O, 25 \302\260C
PAc
Me 2. Ac2O,4-DMAP,
pyr., 25 \302\260C
F8% overall)
MOMO MOMO
OAc OBn
30 29
-78-> -10\302\260C
1. Me3SIBr, CH2CI2, (94%)
2. o-NO2C6H4SeCN, n-Bu3P, THF, 25 \302\260C
MeO OAc
MeO
ArSe
OAc
2: (-)-gilvocarcln
V
nol accomplishes the cleavage of all four acetate esters and gives
(-)-gilvocarcin V B) in 71 % yield.
29.4 Conclusion
dependent \320\236
\342\200\224\302\273
C-glycoside rearrangement, and, in the context of
the gilvocarcin synthesis, it accomplishes a contrasteric aryl C-gly-
gilvocarcin synthesis showcases the utility
C-glycosylation. This of the
novel Cp2HfCl2-AgClO4 aryl C-glycosylation promoter.
The annulation of ring \320\222
through a regioselective benzyne-furan
[4+2] cycloaddition reaction (see 9+10-\302\273 4, Scheme 3) is also
noteworthy. This elegant tandem transformation17 includes three
distinct reactions. Subjection of iodotriflate 10 to a halogen-lithium
exchange reaction produces the highly reactive benzyne 8, which
subsequently participates in a facile and regioselective Diels-Alder
reaction with 2-methoxyfuran (9). The intermediacy of [4+2]
adduct 7 is transitory, for it suffers C-O bond cleavage in situ and
undergoes conversion to naphthol 4. Through its free hydroxyl
group, naphthol 4 can be conveniently linked to suitably
functionalized D-ring acylating agents. And then, in an exceedingly
simple and striking maneuver, the crucial bond joining aromatic
rings and
\320\222 D can be fashioned through a Martin-type Pd-mediated
cyclization reaction.411 A virtue of Suzuki's convergent gilvocarcin
synthesis strategy
is that it seems ideally suited for the elaboration
of D ring modified analogs.
520 29 Gilvocarcin M and Gilvocarcin V
References
1. Hacksell, U.; Daves, G.D., Jr. Prog. Med. Chem. V.M.; Carney, P.G.; Olvey, K.M.; Lytle, CD.
1985, 22, 1. Photochem. Photobiol. 1990, 57, 477; (x) Eguchi,
2. For isolation and structure determination of the gilvo- Li, H.-Y;
\320\242.; Kazami, J.; Kakinuma, K.; Otake, N. J.
carcins, see: (a) Hatano, K.; Higashide, E.; Shibata, Antibiot. 1990, 43, 1077; (y) Knobler, R.M.; Radl-
M.; Kameda, Y.; Horii, S.; Mizuno, K. Agric. Biol. wimmer, F.B.; Lane, M. J. Nucleic Acids Res. 1992,
Chem. 1980, 44, 1157;(b) Horii, S.; Fukase, H.; 20, 4553; (z) Kikuchi, O.; Eguchi, Kakinuma,
\320\242.; K.;
Mizuta, E.; Hatano, K.; Mizuno, K. Chem. Pharm. Koezuka, Y; Shindo, K.; Otake, N. J. Antibiot. 1993,
Bull. 1980, 28, 3601; (c) Nakano, H.; Matsuda, Y.; 46, 985.
Ito, K.; Ohkubo, S.; Morimoto, M.; Tomita, F. 4. For total syntheses of
defucogilvocarcins, see: (a)
J. Antibiot. 1981, 34, 266; (d) Takahashi, K.; Yoshida, Findlay, J.A.; Daljeet,A.; Murray, P.J.; Rej, R.N.
M.; Tomita, F; Shirahata, K. ibid. 1981, 34, 271; (e) Can.]. Chem. 1987, 65, 427; (b) Macdonald, S.J.F.;
Hirayama, N.; Takahashi, K.; Shirahata, K.; Ohashi, McKenzie, T.C; Hassen, W.D. J. Chem. Soc,
Y.; Sasada, Y. Bull. Chem. Soc. Jpn. 1981,54, 1338; Chem. Commun. 1987, 1528; (c) McKenzie, T.C;
(f) Balitz, D.M.; O'Herron, F.A.; Bush, J.; Vyas, Hassen, W; Macdonald, S.J. F. Tetrahedron Lett.
D.M.; Nettleton, D.E.; Grulich, R.E.; Bradner, W.T.; 1987, 28, 5435; (d) Patten, A.D.; Nguyen, N.H.;
Doyle, T.W.; Arnold, E.; Clardy, J. J. Antibiot. 1981, Danishefsky, S.J. J. Org. Chem. 1988, 53, 1003;(e)
54, 1544; (g) Jain, T.C.; Simolike, G.C.; Jackman, Jung, M.E.; Jung, YH. Tetrahedron Lett. 1988, 29,
L.M. Tetrahedron 1983, 39, 599; (h) Frolova, V.I.; 2517;(f) McGee, L.R.; Confalone, P.N. J. Org.
Kuzovkov, A.D.; Chernyshev, A.I. Antibiotiki Chem. 1988, 53, 3695; (g) Hart, D.J.; Merriman,
(Moscow) 1984,29, 329. G.H. Tetrahedron Lett. 1989, 30, 5093; (h) Desh-
3. For studies on the biological activity of the gilvocar- pande, P.P.; Martin, O.R. ibid. 1990, 31, 6313; (i)
cins, see: (a) Morimoto, M.; Okubo, S.; Tomita, F.; Parker, K.A.; Coburn, A. J. Org. Chem. 1991, 56,
\320\241
Comprehensive Organic Synthesis, Trost, B.M.; Organic Chemistry, ACS Monograph 186: Washing-
Fleming, I., Eds., Pergamon Press: New York, 1991, D. C, 1990.
Washington,
Vol. 4, p. 483. 16. Grieco, P.A.; Gilman, S.; Nishizawa, M. J. Org.
12.Kinoshita, Miwa,
\320\242.; T. Carbohydr. Res. 1985, 143, Chem. 1976, 41, 1485.
249. 17. (a) Tietze,L.F; Beifuss, U. Angew. Chem. Int. Ed.
13.(a) Matsumoto, \320\242.;
Hosoya, Katsuki,
\320\242.; M.; Suzuki, Eng. 1993, 32, 131; (b) Hoffmann, H.M.R. ibid.
K. Tetrahedron Lett. 1991, 32, 6735; see also: (b) 1992, 31, 1332;(\321\201) T.-L.
\320\235\320\276, Tandem Organic Reac-
Giles, R.G.F.; Hughes, \320\220.
\320\222.;Sargent, M.V. ./. Reactions, John Wiley & Sons: New York, 1992.
Chem. Soc, Perkin Trans. 1 1991, 1581.
Me
Me-7\"-O-7
\320\235\320\236-
\320\234\320\265\320\236
Calicheamicin y\\
30.1 Introduction
The story of calicheamicin y\\ A), the most prominent member of
the enediyne class of natural products, began in the early 1980s,
when a touring scientist collected chalky rocks (caliche in Greek)
from a site near a Texas highway. Contained within these rocks
were bacteria (Micromonospora echinospora ssp calichensis)
which, when grown in laboratory cultures, produced calicheamicin
y\\ A) along with a series of related compounds. The phenomenally
high potency of calicheamicin y\\ A) against tumor cells provided
the impetus for its structural elucidation,' thereby revealing the sin-
sinister weaponry used by the organism against its enemies.Calichea-
micin'sstructure was completely unprecedented at the time of its
discovery.It is composedof three main domains: A) the enediyne
segment (\"molecularwarhead\;") B) the trisulfide moiety (\"trigger-
device\;")
(\"triggering and C) the oligosaccharide chain (\"recognition
device\"or \"delivery system\.") The molecular structure of calichea-
calicheamicin \321\203
i A) is a masterful piece of moleculardesignby nature. To
appreciate its sophistication and beauty one has only to look at its
mechanism of action (see Scheme1) which involves: (a) activation
by a nucleophilic attack upon the trisulfide triggering device; (b)
intramolecular conjugate addition of the generated thiolate nucleo-
phile to the enone functionality; and (c) a Bergmancycloaromatiza-
tion reaction2 to form a highly reactive 1,4-benzenoid diradical,
which attacks DNA, causinglethal double-strand cuts to the genetic
material and conversionof the diradical to a benzenoid system. In
engineering this ingeniousmolecularassembly, nature made use of
the Bergman reaction2 (Scheme2) and fine-tuned its reactivity by a
series of clever moves and devices, including: (a) lowering the
524 30 Calicheamiciny\\
NHCO2Me
Sugar Sugar
SSSMe
1: calicheamicin y1l
O2
DNA damage
Scheme 1. Proposed
mechanism of action of calicheamicin y\\ A).
V 200 \302\260C
(? 2[H\302\253]
f1/2
= 30 \320\262
framework; and (c) installing in its structure an allylic double bond with
the binding affinity of the molecule to its target, DNA.4 All told,
calicheamicin y\\ A) is a highly sophisticated molecule that displays
extraordinary efficiency in seeking and destroying DNA, thus in-
Me \320\236
0Me
\320\234\320\265-\320\223-0-7
\320\234\320\265\320\22307
Glycosidation
\320\235\320\236\342\200\224\320\235^\320\247
I \320\234\320\265-^_
MeO
MeO
MeO
1: calicheamicin/\321\202'
Me \320\236
NHCO2Me
OR HO\302\273..!
\320\275\320\276
\320\236\320\235 \320\234\320\265\320\236
MeSSS
6: oiigosaccharide 7: calicheamicinone
Me 0
Me
Me
NHCO2Me
NH
Et3Si0...,\\ \320\230
0SiEt3
FMOC
0Me J6\342\200\224^
CCI3
MeO Me^^N^\302\2607
OSiEt3 MeO
products before.
A few more comments regarding the fascinating mode of action
of this remarkable moleculeare in order here. Withrespect to cali-
calicheamicin's potent DNA-cleaving properties, the oligosaccharide
domain, the trans the a,/?-unsaturated ketone, and
allylic trisulfide,
the conjugated l,5-diyn-3-ene moiety all participate in a remarkable
cascade of reactions leading to the production of a highly reactive
and short-lived species that is lethal to the genetic material (see
Scheme1).In the presence of double-stranded DNA, the oligosac-
oligosaccharide domain of the intact natural product anchors the molecule
528 30 Calicheamiciny\\
NHCOjHe
discrete trisulfide cleavage products ultimately converge upon the
same dihydrothiophene intermediate 3 via different reaction paths
and at different rates.
Although our group had previously described syntheses of both
Sugar
domains of calicheamicin\321\203\321\2147\320\260-\320\234,\320\265
each in its naturally occurring
stereochemical form, projections regarding the compatibility of the
numerous functional groups in 1 with the final stages of the syn-
synthesis led to the definition of intermediates 8 and 9 as suitable sur-
surrogates for the
oligosaccharide and aglycon sectors of the natural
this synthesis because they represent the best balance between sta-
OSiEt3 MeO
Trlchloroacetimidate
formation
Glycosidation Me \320\236
NB
OMe FMOC
Cl
Et
Me... ^O^,\302\253.O
OSiEt3
NB =
OMe OSif-BuMe2
10 11
FMOC= [3,3] sigmatropic \320\237
rearrangement \320\230
fmoc
\320\276\320\274\320\265
'j18
Me
1^ ^4^ ^,CO2Me Me
\"OAc
OSiEt3
-f HO-^^OMe
OMe OMe ^Oxime ether formation
12 13
C-O bond formation
Mitsunobu
reaction
NB NH2
0Me FMOC
I
OMe
^0
\320\234\320\265\342\200\236
\320\236
HO Me2f-BuSi0
y\302\260
\320\236 19 20 16 15
Cl
Glycosidation
OH f-BuMe2Si0
21: D-fucose 22: L-serine 17 Cl 18: W-hydroxy-
methyl ester phthalimide
strategy for the synthesis of aglycon 9 was far from straightfor- Et,SIO.,..\\ || _
From
straightforward. the beginning, all efforts were devoted to the develop-
developmentof an aglycon synthesis strategy that was both diastereo- and
enantioselective. In the event that 9 could be prepared in enantio- Carbonyl addition
NPhth 0. .0
Et3Si0....\\_ L= Et3Si0
o o. .o
HO AcO Et3SIO
SiMe3
/ OMEM
/It
Me3Si Carbonyl addition Me,Si H
28 27 /// Wittig
reaction
26
25
II Oxime formation
\320\223\320\233 \320\223\320\233
\320\276 \320\276 OMEM
I \320\275 1
OMEM 1 OMEM
30 Nitrile oxlde-olefin 31 32
[3+2] cycloaddition
Asymmetric OMEM
allylboration
OMEM
HO
36: tetronic acid 35 34 33
worth noting.
534 30 Calicheamicln
favor of the closed lactol form 35, the open-chain hydroxy alde-
33
aldehyde tautomer is quite electrophilic and can be interceptedby 34.
bridge, to the C-4 sulfur atom of ring B; and one of its oxygen
atoms is joined, through an a-glycosidic bond, to a monosaccharide
derived from L-rhamnose. The degree of difficulty associated with
the synthesis of an aromatic nucleusthat accommodates six contig-
contiguous substituentscan be significant. Nonetheless, calicheamicin's
hexasubstituted aromatic nucleus conceals a subtle element of sym-
symmetry, and this recognition led to the development of a concisesyn-
synthetic route. Scheme 6 illustrates the synthesis of the hexasubsti-
aromatic
hexasubstituted C-ring intermediate 13.
Treatment of commercially available and symmetrical 3,4,5-tri-
methoxytoluene C7) with iodine, periodic acid, and acetic acid
under the conditions of Suzuki19 results in the formation of symmet-
symmetricaldiiodide 38 in 93 % yield. Although only one of these newly
introduced iodine atoms is present in intermediate 13, both play an
important role in this synthesis. Selective monodemethylation of 38
with boron trichloride furnishes phenol 39 in 53 % yield together
with 13% of a regioisomer. Evidently, one of the Lewis-basic
iodine substituents coordinates with the Lewis-acidic boron
trichloride and directs the cleavage of the adjacent methyl ether
OMe (93%)
37
MeOCOCI,
-78->-40X
(87%)
Me,.
Ac2O, Et3N, PhSH, SnCI4,
1
4-DMAP (cat.), OAc CH2CI2, 0 \302\260C oac
\320\276\320\275 \320\241\320\235\320\233.0-25-\320\241 OAc <93%>
42: L-rhamnose 43 44
1. K2CO3 (cat.), THF, MeOH, 25 \302\260C
A00%)
2. n-Bu2Sn0, MeOH, \320\224;
then CsF, Mel, DMF,
0 -\302\27325\302\260C
G7%)
1. Ac2O, Et3N,
4-DMAP (cat.),
Ci3CCN Me \320\236 CH2CI2,25
\302\260C
M
Me
(excess), A00%)
Me 4 \320\220
BF3K>Et2,
Me,. \302\246\320\241\320\2362\320\234\320\265
mO|_ sieves,
\320\276\320\274\320\265
CH2Ci2, -50 \302\260C
1. K2CO3(cat.),
25 \302\260\320\241
(93%)'
\\ Et3SIOTf,
2,6-lutidine,
OMe (90%)
49
1. Dibal-H, CH2CI2,
-78\302\260C
(83%)
2. PDC, CH2Ci2,
25 \302\260C
(80%)
Me 0
j \320\270
CHO
1. KMnO4,(CH3JCO, Cl
H2O,25\302\260CG5%)
Me,, 'OMe
2. (COCiJ,25\302\260C OMe
(-100%) W
Et3!3iO^ \"OSIEt3
OMe
10
HOAr
date function in 12 to give the transient acetoxonium ion 47, which
Me,. \320\241
subsequently reacts with phenol 13 in a stereoselective fashion. It
is important to note that the configuration of the anomeric carbon
in 12 is immaterial to the stereochemical course of the glycosida-
OMe
tion step; both anomers of 12 couplestereoselectively with 13 to
give a-glycoside 48.
47
At this point in the synthesis, it is necessary to exchange hydrox-
yl protecting groups for protecting groups compatible with sub-
subsequent stages of the synthesis. Thus, solvolysis of the acetate
OMe (see Scheme 9). The primary amino group of 22 can be alkylated in
49 a straightforward manner by treatment with acetaldehyde, followed
by reduction of the intermediate imine sodium
with borohydride
Me (see The
22\342\200\224\302\27351). primary hydroxyl and secondary amino groups
^CHO in 51 are affixed to adjacent carbon atoms. By virtue of this close
spatial relationship, it seemed reasonable to expect that the simulta-
4
\320\233 s^4 4OMe simultaneous protection of these two functions in the form of an oxazolidi-
Me,,.
OMe none ring could be achieved. Indeed, treatment of 51 with 1,1'-car-
XX bonyldiimidazole in
refluxing acetonitrile, followed by partial
OSiEt3 reduction of the methoxycarbonyl function with one equivalent of
OMe
50
Dibal-H provides oxazolidinone aldehyde52.
With a heteroatom-bearing stereogenic center in the a-position,
aldehyde be expectedto react with carbon nucleophiles in
52 might
a diastereoselective manner. Although achiral organic nucleophiles
will add to the aldehyde carbonyl of 52, they do not discriminate
between the two diastereotopic faces of the carbonyl. On the other
hand, Brown's diisopinocampheylallylborane, allyl-B(dIpcJ,17b a
Mev\302\260>^ OMe useful
asymmetric allylating reagent, reacts in a completely dia-
,^J, OSiEt3 diastereoselective fashion with 52 to give allylic alcohol 53 after
Et3N' \320\234\320\262\320\241\320\235\320\236,
MeO
1. lm2C=O,CH3CN, Et
2 h
\320\224, G8%) OHC
HO
J NaBH4, 0 \302\260C
F4%) HO 2. Dibai-H, CH2CI2,
-78 \302\260C
22: L-serine methyl 51 52
ester hydrochloride
allyl-B(dlpcJ, THF, -78 \302\260C
E7% overall)
Amberlyst-15
OMe OMe
Et (ion-exchange Et 1. Ag2O, Mel, DMF, ?H Et
resin), MeOH, 40 \302\260C
N
(
'25\302\260c<94%1 2. O3 (excess), \320\236
MeO \"OMe
\320\220\320\240\020 MeOH,-78\302\260C;
then Me2S
55 54 53
(86% overall)
1. NaOH, MeOH, H2O, \320\224
(96%)
2. HCI, MeOH, Et2O, 25 \320\241
(95%)
23,
Et2NSF3,
OMe H 1- K2CO3, FMOC-CI, OMe FMOC
4Amol.
A
! I THF, H20,0 \302\260C
group for the E-ring amino function seemed ideal. Although it was
potentially too labile, this concern was outweighed by the need for
a protecting group that could beeasily removed in the final stages
OMe H of the synthesis. While the use of the FMOC protecting group
proved to be a good choice, it had the drawback that slow rotation
4Et
about the C-N bond afforded a mixture of rotational isomers and
complicated the NMR spectra; the best spectra were obtained in
\320\220\321\2012\320\236,
4-DMAP (cat.),
OH (99%)
21: D-fucose
1. 0 \302\260\320\241
\320\235\320\222\320\263-\320\220\321\201\320\236\320\235,
CH2Ci2-Ac2O,
2 o-NO2C6H4CH2OH, Ag2CO3,
4 A moi. sieves, CH2CI2, 25 \320\241
NB = oN02C6H4CH2
OMe FMOC
AgCIO4, SnCi2,
\302\273>
Et
4 \320\233
mol. sieves,
THF, -78 -> -15\302\260C
20
OMe FMOC
I
n-Bu2SnO, MeOH,
reflux; then Br2,
FMOC
\321\200\320\234\320\265
David-Thieffry procedure.25 This interesting regioselective trans-
transformation entails the formation of a stannylene ketal which is sub-
62 63
NBS, BaCO3,
AIBN (cat.),
CCi4, A
1. n-Bu3SnH,
Ar AIBN (cat.),
Zn(BH4J, \302\2534^0 ...0 O>. ...O^ ^Ar
PhHA Br
NH4Ci, T T PhH'A
Y
* \320\276
\320\236 2. DMSO, (COCIJ, BzO
Et2O, 0\302\260C
OSif-BuMe2 OSif-BuMe2
Je^780
66 65 -78 25 \302\260C
-\302\273 64
HO\342\200\224
\342\204\242OC
f OMe
+ 4V \320\233
A
f-BuMe2SIO
15
\320\223 OMe
MeN 0. xo
Mev_Ov
TTaJ
'0
| \320\222
[ T
^^ HO
''\320\236
I
f-BuMe2Si0
.A.
Ar
68
7-BuMe2Si0
the acyl migration reaction (see 66\342\200\224> 17a, Scheme 12), undergoes
conversion to the unwanted /Mactol isomer. On the other hand,
treatment of enone 65 with zinc borohydride in diethyl ether at
0\302\260Cfurnishes 17 as a 6:1 to 8:1 mixture of a- and \320\224-lactols in
favor of the desired a-isomer (see Scheme12).Apparently, when
ether is used as the solvent for the reduction, the configuration of
the anomeric position can be more easily preserved. Incidentally,
ammonium chloride is added to the reaction mixture to inhibit silyl
group migration. With the stereochemistry of lactol 17 well pre-
preserved (a:/? ca. 6:1 to 8:1), the ratio of the /?-glycoside 67 formed
in the Mitsunobu glycosidation can be increasedto between 5:1
and 7:1, with an overall yield of 53-56% from enone 65 (see
Scheme12).The completion of the synthesis of B-ring intermediate
15 only requires cleavage of the phthalimide function, a task easily
achieved by treatment of 67 with hydrazine A00% yield).
With key intermediates 15 and 16 in hand, we are now in a posi-
position to address their union and the elaboration of imidazolethio-
carboxylate 14 (see Scheme13).You will note that compounds 15
and 16 possesscomplementary sites of reactivity. It was anticipated
that the free amino function in 15 could be induced to converge
upon the electrophilic ketone carbonyl in 16 under sufficiently mild
conditionsto give, after loss of a water molecule, a functionalized
tricyclic oxime ether. Indeed, exposure of a mixture of compounds
15 and 16 in benzene at 25 \302\260Cto a catalytic amount of pyridinium
/>ara-toluenesulfonate (PPTS) results in the formation of oxime
ether 68. This convergent coupling reaction furnishes a single
oxime stereoisomer; although a particular geometrical isomer is illu-
illustrated in Scheme 13, this assignment was not confirmed. Quantita-
Quantitativetriethylsilylation of the free hydroxyl group in 68 with triethyl-
silyl triflate, followed sequentially by reductive cleavageof the fi-
firing benzoate with Dibal-H and acylation of the liberated hydroxyl
group with lj'-thiocarbonyldiimidazole, completes the synthesis of
key intermediate is noteworthy
14. that It
the FMOC protecting
group is not cleaved at
point along the path from 68 to 14.
any
A critical stage in the synthesis of the oligosaccharide domain of
calicheamicin y\\ A) has been reached. Having retraced the
sequences of reactions that have culminated in the synthesis of key
intermediate 14, we are in a position to address the crucial [3,3]
sigmatropic rearrangement (see Scheme 14). Although Ferrier's
demonstration that allylic xanthates can be induced to undergo
[3,3] sigmatropic provides important
rearrangements precedent for
this type of transformation,28 the [3,3] sigmatropic rearrangement
of an allylic imidazolethiocarboxylatesystem containing a silyl \342\204\242O
0Me
enol ether had, to the best of our knowledge, not been previously Me,
demonstrated.Nevertheless,on the basis of some successful model
studies,7d a good deal of confidence invested in the sosr-
was proposition \320\276
converted into the S-bound isomer 70 via a [3,3] sigmatropic rearran- \320\236
OSit-BuMe2
rearrangement. Indeed, when a solution of 14 in toluene is heated to reflux 70
546 30 Calicheamicin y\\
NB
0Me\" FMOC
Me
OSiEt3
,-BuMe2S,O
14
JPI1CH3,
\320\224(82%)
69: PG = Sif-BuMe2
I [3,3] sigmatropic
I rearrangement
\302\253\320\262
\320\276\320\274\320\265
4Et
Me
N' T 'O\" \"O
OSiEt3
OSU-BuMe2
70
NaSMe,
EtSH, CH2CI2,
0 \302\260C
(95%)
NB FMOC
Me \320\236
MeY\302\260yo
OSiEt3
T
OSiN3uMe2
OMe 10
4-DMAP, CH2CI2,
0\302\260CG8%) NB
Et
Me
Me \320\276
\320\234\320\265
72
Me 0
i JL 1.1
Me
w \320\236
*^. \302\273j
_--^\\^ \320\236
t. NH
\"OMe Et3SiO-^^T^
FMOC ? -4
OMe
Me-T^oy Me^
CCI3
Et3SiO\342\200\224'Tl
MeO MeO
OSiEt3 8
fmoc
\320\276\320\274\320\265 for about 45 minutes, the desired rearrangement takes place
smoothly, giving 70 in 82 % yield. In one productive step, the sul-
sulfur atom at position 4 of ring is
\320\222 introduced stereospecifically and
the necessary deoxygenation at position 2 is achieved. Cleavage of
the imidazolethiocarboxylate with sodium methanethiolate in the
presence of ethanethiol provides thiol 11 in nearly quantitative
yield. Multigram quantities of trisaccharide 11 can be preparedby
the reaction sequences described.
Although it is likely that the electron-rich aromatic ring in com-
PhH, \320\224
F0%) -78\302\260C(84%)
\320\275\320\276
36: tetronic 73 35
acid
flpcfeBOMe
sec-BuLi, THF,
-78 \302\260C MEMO\342\200\224-Lij -78^25\302\260C f
OMEM
74 75 34
OMEM 1. f-BuMe2S!CI,imid.,
CH2CI2,25
\302\260C
TBSO
2. PhCOCI, pyr.,
4-DMAP (cat), CH2CI2,
25 \302\260C
77 33
1. TBAF,
AcOH, THF,
50 X (88% from 33)
2. (COCIJ,DMSO,
-78 X; Et3N, -60 -> 25 X;
then NH2OH*HCI,
NaOAc, EtOH-H2O B:1), 25 X
OMEM
32
OMEM
aldehyde derived through oxidation of the primary alcohol in 33.
Although a selective oxidation of the primary alcohol in 33 can be
performed, the production of a five-membered lactol and/or lactone
cannot be avoided. It is, therefore, necessary to protect the second-
hydroxyl
secondary group so that the desired oxidation can be achieved.
33
Selective silylation of the primary hydroxyl group in 33 with tert-
butyldimethylsilyl chloride, followed by benzoylation of the sec-
OMEM secondary hydroxyl, furnishes intermediate 77. The desired primary
alcohol can then be produced by cleavage of the terr-butyldi-
methylsilyl ether with TBAF buffered with acetic acid. Although
this three-step diprotection-deprotection sequencemay seem circu-
circuitous, the yield for each step is essentially 100%,and there is no
77
need for chromatographic purification of intermediates. With the
secondary hydroxyl group suitably protected in the form of a
benzoate ester, the desired oxidation can be effected by the Swern
procedure.29For convenience, addition of hydroxylamine hydro-
chloride to the Swern mixture during workup results in the forma-
formation of as a single geometricalisomer(geometry
aldoxime 32 not
determined) overall in an
yield of 88 % from diol 33.
The intramolecular cycloaddition of a nitrile oxide (a 1,3-dipole)
to an alkene is ideally suited for the regio- and stereocontrolled
synthesis of fused polycyclic isoxazolines.16 The simultaneous
creation of two new rings and the synthetic versatility of the isoxa-
zoline substructure contribute significantly to the popularity of this
cycloaddition process in organic synthesis. In spite of its high
degree of functionalization, aldoxime 32 was regarded as a viable
substrate for an intramolecular 1,3-dipolar cycloaddition reaction.
Indeed, treatment of 32 (see Scheme 17) with sodium hypochlorite
OMEM
\320\275\320\276 NaOCI,
nitrile oxide-olefin
[3+2] cycloaddition
OMEM
Bzo BzO'
\320\236 OBz
OMEM
30 80
E1%) B0%)
Scheme 17. Construction of aglycon 9: intramolecular nitrile oxide-olefin cycloaddition of intermediate 31.
30.3 Total Synthesis 551
at 0 results
\302\260C in the formation of two fused bicyclic isoxazolines,
30 and 78, in 65% overall yield C0:78 ca. 3.5:1)together with
20 % of acyclic unsaturated ester 80. It is presumed that the action
of sodium hypochlorite on 32 generates,through the intermediacy
of an a-chloroaldoxime, unsaturated nitrile oxide 31. This substance
is not isolated; once formed, it readily participates in the desired
1,3-dipolar cycloaddition reaction to give a ca. 3.5:1 diastereomeric
mixture of isoxazolines30 and 78. Unsaturated ester 80 presumably
arises from the decomposition of nitrile oxide 31, a process that is
NaOMe (cat.),
MeOH, 0 \320\241 CrO3, H2SO4,
Li\342\200\224C=C-SiMe3
82 F9%)
THF, -78 then
\302\260C; Ac2O, -78 -\302\27325\302\260C
\320\223\320\233
(COCIJ, DMSO,
AcO \302\253
Ph3P=CHCO2Me,
AcO AcO
PhCH3,90\302\260C
(84%)
1. K2CO3,
Me3S Me3Si
CO2Me MeOH-CH2CI2,
o\302\260c
2. Et3SIOTf,
2,6-lutidine,
CH2CI2,0 \302\260C
(86% overall)
A.5equlv.),
Pd(PPh3L (cat.), Cul (cat.), \320\222\320\2678\320\256
n-BuNH2, PhH,0\302\260C(91%)
1. Mo(CO)e,
\320\276. CH3CN-H2OE:1),
80 \302\260C
(82%)
Et3SiO.
2. K2CO3,
MeOH-THFB:1),
0 \302\260C
(92%)
NPhth NPhth
NPhth MsCI, pyr., SiO2,
4-DMAP (cat.), Et3SlO.... pyr., PhH, Et3SiO....
\342\200\224
ch2ci2, \320\276
\302\260c 25 \302\260C
=\342\200\224^
92
1. MeNHNH2, PhH, 25 \320\241
(99%)
triphosgene = 2. triphosgene, pyr.,
CH2CI2,25 \302\260C;
then pyr.,
MeOH (excess), 0 \302\260C
(82%)
\320\263\320\273 \320\223\\
NHCO2Me 1- Dibal-H,
CH2CI2,
-78 \302\260C
-*
2. NaBH4
(excess),
MeOH,0 \302\260C
(84% overall)
93
s-trans enal
conformer Me4
Scheme 20. The intramolecular carbonyl addition reaction used by Danishefsky and coworkersto
constructa 10-membered
ring enediyne system.
556 30 Calicheamicin
HO
synthesis of both domains of calicheamicin y\\, each with the correct
94 absolute stereochemistry and in a form suitable for further advance.
We are now in a position to describe the union of key intermediates
8 and 9 (see Scheme 21).
It will be recalled that the retrosynthetic analysis outlined in
Me \320\236
NHCO2Me
Me
NH
\320\236' \"OMe
\321\203 OS!Et3
\342\204\242<*
OMe CCI3
Mf^J
\"^isiEt3 MeO
BzO
8
(P:a ca. 1:2)
BF3\302\273OEt2, CH2CI2,
-40 \302\260C
G6% from
lactol precursor of
8, Scheme15)
Me \320\236
NHCO2Me
OSiEt, MeO
95: : R
R = Si
= SiEt3 D0%) Et3Si0Tf,
-\302\253-, ^Pr2NEt,
96: R = HC6%) 1
CH2CI2, 0 \302\260C
(99%)
1. Dibal-H, CH2CI2,
-78\302\260C(91%)
2. Ph3P, DEAD, AcSH,
THF, 0 \302\260C
(96%)
\320\236
Me \320\236 NHCO2Me
OSiEt3 MeO
97
OSiEt3 MeO
97
MeO
98
B:1 mixture of C-4 epimers in favor of 98)
1. Et3SiOTf, A-Pr2NEt,
CH2Ci2, 0 \302\260C;
then
AcOH (excess), EtOAc-H2O B00:1),
25 \302\260C
G5%)
2. Dlbal-H, CH2CI2,-90 \320\241
\320\236
Me \320\236 NHCO2Me
1
OMe
\320\234\320\265-\320\223-071
Et3SiO\342\200\224\320\241^\320\223~\320\247
MeO Me
OSIEt3
MeO
99
Me \320\236
MeO
99
NSSMe
100
CH2CI2,0 -\302\273
25 \302\260\320\241
E7% overall)
Et3SiO
OSiEt3
MeO
101
HF\302\253pyr.,THF-CH2CI2 E:1),
0 -> 25 \302\260C
(90%)
Me \320\236
\320\236\320\235
102
\320\276
NHCO2Me
OMe
Me-r-071
\320\275\320\276\342\200\224^7\342\200\224/
MeO
\320\276\320\275
102
1. TsOH\302\273H2O,
THF-H2O E0:1),
25 \302\260C
F9%)
2. Et2NH-THF-H2O E:25:1),
25 \302\260C
(90%)
HO.,
MeSSS
Me \320\236
Me
\320\236' -\320\236\320\234\320\265
\320\276\320\275
\321\203
\320\236\320\234\320\265
\320\234\320\265-\320\223-0-7
\320\275\320\276\342\200\224*T-f Me.
\320\234\320\265\320\236
\320\236\320\235 MeO
1: (-)-calicheamicin yi
30.4 Conclusion
synthesis of the natural product, and (b) the design and synthesisof
nonnatural analogs that might also exhibit useful antitumor activity.
With respect to the latter endeavor, many nonnatural enediyne-con-
taining molecules have already been synthesized and have been
found to exhibit significant DNA-cleaving propertiesand potential
in cancer chemotherapy.6-39 On the other hand, progress with
respect to the former endeavor has, understandably, been much
slower. In addition to the total synthesis described in this chapter,
the Danishefsky group has also discloseda successful total synthe-
synthesis.36 It would not be fair to view these two syntheses as isolated
achievements, for both have been influenced, in important ways, by
the efforts and accomplishmentsof others in the field, and even by
each other.
References 563
References
1. (a) Lee, M.D.; Dunne, T.S.; Siegel, M.M.; Chang, Ed. Engl. 1986, 25, 212; (e) Toshima, K.; Tatsuta, K.
C.C.; Morton, G.O.; Borders, D. B. J. Am. Chem. Chem. Rev. 1993, 93, 1503;(f) Krohn, K. In Organic
Soc. 1987, 109, 3464; (b) Lee, M.D.;Dunne, T.S.; Synthesis Highlights, Mulzer, J.; Altenbach, H.-J.;
Chang, C.C.; Ellestad, G.A.; Siegel,M.M.;Morton, Braun, M.; Krohn, K.; Reissig, H.-U. VCH Publish-
G.O.; McGahren, W.J.; Borders, D.B. ibid. 1987, Publishers:
Weinheim, New York, 1991, p. 277.
109,3466; (c) Lee, M.D.; Dunne, T.S.; Chang, C.C.; 9. Myers, A.G.; Cohen, S.B.; Kwon, B.M. J. Am.
Siegel, M.M.; Morton, G.O.; Ellestad, G.A.; McGah- Chem. Soc. 1994, 116, 1255.
W.J.;
McGahren, Borders, D.B. ibid. 1992, 114,985. 10.Grundler, G.; Schmidt, R.R. Carbohydr. Res. 1985,
2. (a) Bergman, R. G. Ace. Chem. Res. 1973,6, 25; (b) 135,203.
Jones, R.R.; Bergman, R.G. J. Am. Chem. Soc. 1972, 11. Capon, B. Q. Rev. Chem. Soc. 1964,18,45.
94, 660; (c) Lockhart, T.P.; Bergman, R.G. ibid. 1981, 12. Stephens, R.D.; Castro, C.E. J. Org. Chem. 1963,
103, 4091;(d) Darby, N.; Kim, C.U.; Salaun, J.A.; 28, 3313.
Shelton, K.W.; Takada, S.; Masamune, S. J. Chem. 13. Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahe-
Soc, Chem. Commun. 1971, 1516; (e) Wong, TetrahedronLett. 1975, 4467.
H.N.C.; Sondheimer, F. Tetrahedron Lett. 1980, 21, 14. (a) Ratovelomanana, V.; Linstrumelle, G. Tetrahe-
217;(f) Nicolaou, \320\232. Chem.
\320\241 Br. 1994, 30, 33. TetrahedronLett. 1981, 22, 315; (b) Guillerm, D.; Linstru-
3. (a) Zein, N.; Sinha, A.M.; McGahren, W.J.; Ellestad, Linstrumelle,G. ibid. 1985, 26, 3811.
G.A. Science (Washington, D.C.) 1988, 240, 1198; 15.Corey, E. J.; Cheng, X.-M. The Logic of Chemical
(b) Zein, N.; Poncin, M.; Nilakantan, R.; Ellestad, Synthesis, John Wiley & Sons: New York, 1989.
G.A. ibid. 1989, 244, 697; (c) Zein, N.; McGahren, 16. For excellent reviews of intramolecular nitrile oxide
W.J.; Morton, G.O.; Ashcroft, J.; Ellestad, G.A. cycloaddition reactions, see (a) Caramella, P.; Griin-
J. Am. Chem. Soc. 1989, ///, 6888; (d) Walker, S.; anger, P. In 1,3-Dipolar Cycloaddition Chemistry,
Landovitz, R.; Ding, W.-D.; Ellestad, G. A.; Kahne, D. Padwa, A., Ed., Wiley-Interscience: New York, 1984,
Proc. Nat. Acad. Sci. U.S.A.1992,89, 4608. Vol. 1, pp. 291-392; (b) Padwa, A. Angew. Chem.
4. Hawley, R.C.; Kiessling, L. L.; Schreiber, S.L. Proc. Int. Ed. Engl. 1916, 15, 123; (c) Oppolzer, W. ibid.
Natl. Acad. Sci. U.S.A. 1989, 56, 1105. 1977, 16, 10.
5. (a) De Voss, J.J.; Townsend, \320\241 A.; Ding, W.-D.; Mor- 17. (a) Brown, H.C.; Jadhav, P. K.; Bhat, K.S. J. Am.
Morton, G.O.; Ellestad, G.A.; Zein, N.; Tabor, \320\220.
\320\222.; Chem. Soc. 1988, 110, 1535;(b) Jadhav, P. K.; Bhat,
Schreiber, S.L. J. Am. Chem. Soc. 1990, 112,9669; K.S.; Perumal, Brown,
\320\242.; H.C. J. Org. Chem. 1986,
(b) Hangeland, J.J.; De Voss, J.J.; Heath, J. A.; Town- 5/, 432.
send, \320\241
A.; Ding, W.-D.; Ashcroft, J.S.; Ellestad, 18. For reviews of ring-chain isomeric transformations,
G.A. ibid. 1992, 114,9200. see: (a) Valters, R. Russ. Chem. Rev. (Engl. Transl.)
6. For a review, see: Nicolaou, \320\232. Dai, W.-M. Angew.
\320\241; 1974,43, 665; (b) Valter, R.E. ibid. 1973, 42, 464.
Chem. Int. Ed.,Engl. 1991, 30, 1387. 19.Suzuki, H. Org. Synth. 1971, 5/, 94.
7. (a) Nicolaou, k.C; Groneberg, R. D.; Miyazaki, \320\242.; 20. Nagashima, N.; Ohno, M. Chem. Lett. 1987, 141.
Stylianides, N.A.; Schulze, T.J.; Stahl, W. J. Am. 21.Evans, D.A.; Nelson, J.V.; Vogel, E.; Taber, T.R.
Chem. Soc. 1990,112, 8193; (b) Smith, A.L.; Hwang, J. Am. Chem. Soc. 1981, 103, 3099.
C.-K.; Pitsinos, E.; Scarlato, G.R.; Nicolaou, K.C. 22. Carpino, L.A.; Han, G. Y. J. Org. Chem. 1972, 37,
ibid. 1992, 114, 3134; (c) Nicolaou, K.C; Hummel, 3404.
C.W.; Pitsinos, E.N.; Nakada, M.; Smith, A.L.; Shi- 23. Card, P.J. J. Carbohydr. Chem. 1985, 4, 451.
bayama, K.; Saimoto, H. ibid. 1992, 114, 10082;(d) 24. (a) Mukaiyama, Murai,
\320\242.; Y; Shoda, S. Chem. Lett.
Groneberg, R. D.; Miyazaki, \320\242.; Stylianides, N. A.; 1981,431;(b) Nicolaou, K.C; Dolle, R.E.; Papahat-
Schulze, T.J.; Stahl, W.; Schreiner, E. P.; Suzuki, \320\242.; jis, D.P.; Randall, J.L. J. Am. Chem. Soc. 1984, 106,
Iwabuchi, Y.; Smith, A.L.; Nicolaou, K.C. ibid. 1993, 4189.
115, 7593; (e) Smith, A.L.; Pitsinos, E.N.; Hwang, 25. David, S.; Thieffry, A. J. Chem. Soc, Perkin Trans. 1
C.-K.; Mizuno, Y.; Saimoto, H.; Scarlato, G.R.; 1979, 1568.
Suzuki, Nicolaou,
\320\242.; K.C. ibid. 1993, 115, 7612; (f) 26. Halcomb,R. L.; Danishefsky, S.J. J. Am. Chem. Soc.
Nicolaou, K.C; Hummel, C.W.; Nakada, M.; Shi- 1989,111,6661.
bayama, K.; Pitsinos, E. N.; Saimoto, H.; Mizuno, Y; 27.Hanessian, S. Carbohydr. Res. 1966, 2, 86.
Baldenius, K.-U.; Smith, A.L. ibid. 1993,//5, 7625; 28. (a) Ferrier, R. J.; Vethaviyasar, N. J. Chem. Soc,
(g) Nicolaou, K.C. Angew. Chem. Int. Ed. Engl. Chem. Commun. 1970, 1385; (b) Nakai, Ari-
\320\242.;
31. Nitta,M.; Kobayashi, T. J. Chem. Soc, Chem. 36. Hitchcock, S.A.; Boyer, S.H.; Chu-Moyer, M. Y;
Commun. 1982, 877. Olson, S.H.; Danishefsky, S.J. Angew. Chem. Int.
32. (a) Paz Cabal, M.; Coleman, R. S.; Danishefsky, S.J. Ed. Engl. 1994, 33, 858.
J. Am. Chem. Soc. 1990, 112,3253; (b) Haseltine, 37. Magnus, P.; Lewis, R.\320\242.;Bennett, F. J. Chem. Soc,
J.N.; Paz Cabal, M.; Mantlo, N.B.; Iwasawa, N.; Chem. Commun. 1989, 916.
Yamashita, D.S.; Coleman, R.S.; Danishefsky, S.J.; 38. (a) Harpp, D.N.; Ash, D.K. Int.]. Sulfur Chem. Part
Schulte, G.K. ibid. 1991, 113,3850. A 1971, /, 57; (b) Sullivan, \320\220.
\320\222.;
Boustany, K. ibid.
33. Kende, A.S.; Smith, A.
\320\241 Tetrahedron Lett. 1988, 1971, /, 207;(c) Harpp, D.N.; Ash, D.K. ibid. 1971,
29,4217. /,211.
34. Eschenmoser, A. Q. Rev. Chem. Soc. 1970,24, 380. 39. Nicolaou, K.C.; Smith, A.L.; Yue, E.W. Proc. Natl.
35. (a) Nicolaou, K. C; Schreiner, E. P.;Stahl, W. Angew. Acad. Sci. U.S.A. 1993, 90, 5881.
Chem. Int. Ed. Engl. 1991, 30, 585; (b) Nicolaou,
K. C; Schreiner, E.P.; Iwabuchi, Y.; Suzuki, T. ibid.
1992, 31, 340; (c) Halcomb, R.L.; Boyer, S.H.;
Danishefsky, S.J. ibid. 1992,31,338.
lite
Me OMe Me Me
\320\232.\320\241Nicolaou
1: rapamycin A993)
Rapamycin
31.1 Introduction
address the efforts that culminated in the first total synthesis of this
Pd(O) |
base\302\273HX
base
R1 = aryl or vinyl (Heckreaction)
X = I or Br
-PPh3
Pd(PPh3L ^ Pd(PPh3b
-PPh
reductive elimination
base
H-Pd(PPh3fe-X
F
syn p-hydride elimination
alkene insertion
H Pd(PPh3bX R1 Pd(PPh3feX
rotation
Pd(OAcJ, n-Bu4NBr,
Pd-C, sulfur,
xylene, 150 \302\260C
ring furnishes a
8, compound that can then be transformed into
(-)-morphine (9) in a few straightforward steps. Interestingly, when OMe
the modified substrate 10 is subjectedto a nearly identical reaction,
pentacycle 12 is produced in 56% yield.I6b This productive trans-
OBn
transformation is initiated by an intramolecular Heck insertion to form
the tetracyclic \321\217-allylpalladium intermediate 11; pentacycle 12, DBS\342\200\224N
which possesses the complete skeletonof the opium alkaloids, is
then revealed after an intramolecular nucleophilic attack by the free
phenolic hydroxyl group on the electrophilic \321\217-allylpalladium
DBS Pd(OCOCF3J(PPh3J
A0 mol%), pempidine,
*
PhCH3,120\302\260CF0%)
DBS\342\200\224N
.OMe
MeN DBS\342\200\224N
9: (-)-morphine
OMe
MeO,C Pd(OCOCF3J(PPh3J
B0 mol%), pempidine,
PhCH3,120\302\260CE6%)
MeO2C\342\200\224N
10 11
MeN MeO2C\342\200\224N
9: (-)-morphine 12
Sequential Heck
reaction
\320\275\320\2762\321\201
Pd(OAcJA0mol%),
Ph3P B0 OTBS
Ag2CO3,THF, 65
H
TBS = Sif-BuMe2
17
intramolecular
Heck insertion
\320\223\320\233
p-hydride intramolecular \\
elimination Heck insertion
H (ca. 83%)
OTBS OTBS
20 18
(producedas a
single stereoisomer)
Scheme 4. Overman's sequential Heck cyclization approach to the synthesisof the scopadulcic acids.
17 additional steps.18b
Sequential Heck couplings also figure prominently in an interest-
of the three-component <x
variant
interesting coupling strategy for prostaglan-
prostaglandin
synthesis. Indeed, Larock and Lee disclosed, in 1991, an TBSO
appealing synthesis of the versatile prostaglandin precursor25 (see
Scheme 5) based on a one-pot, palladium-mediated union of three
alkenes.19 In the crucial trimolecular coupling event, chiral allylic
alcohol 21, ethyl vinyl ether, and l-octen-3-one are simply com-
combined in the presence of Pd(OAcJ, NaOAc, and a catalytic amount
572 31 Rapamycin
OEt
OEt
PdX
\320\275\320\276 A
Pd(OAcJA.5equiv.),
EtOCH=CH2Dequiv.), intramolecular
OEt OEt
/5-hydride elimination
s PdX
- HPdX
G2% yield) Me
<X
TBSO
24
Pd(dbaJ cO2Me
@.1 mol equiv.),
trifurylphosphine
@.4 mol equiv.),
AcOH,110\302\260C
E0% yield)
27
suprafacial palladium-ene
cyclizatlon
intramolecular
Heck insertion
intramolecular
Heckinsertion
30 31
that
conformation enforces proximity of the metal center and the vinyl
group. Tetracycle 31 is finally
revealed after /?-hydride elimination
of 30 E0% yield).
The electrophilic character of the palladium atom in the com-
complexes formed by oxidative addition of aryl halides and alkenyl
halidesto palladium(o) complexes can be exploited in useful ways.
For example, Piers and Marais demonstrated that keto iodo alkene
32 can be converted to bicyclic keto alkene 35 in one pot21 (see Me
Scheme 7). In this interesting methylenecyclopentane annulation
method, it is presumed that intermediate 33, produced by sequential
oxidative addition and deprotonation reactions, undergoes conver- 35
574 31 Rapamycin
Pd(PPh3L@.2equiv.),
THF; then f-BuOK,
I THF/f-BuOH PdL2l
intramolecular nucieophilic
substitution
reductive elimination
35 34
Pd(OAcJ E
K2CO3, n-Bu4NCI,
DMF, 60 \302\260C
G9%)
H \320\275
37
intramolecular
Heck insertion
syn [1-hydride
Me
(\302\261)-40:(\302\261)-dehydrotubifoline 39 38
OMe OMe
.OMe ,OMe
Pd(PPh3L(cat.),Et3N,
MeO. MeO. NCO2Me
CH3CN, 80 \302\260C
(93%)
/
\320\276\320\275
.\320\276\320\275
\320\236\320\235\320\241\320\223
(\302\261)-43:(+)-FR-900482
OTBS
OTBS Pd(OAcJ C ),
cyclohexene, (R)-B\\NAP,
i\302\251
Ag2CO3,1-methyl-2-pyrrol-
idinone, 40 \302\260C
G0% yield)
44
TBS= Sif-BuMe2 16-electron Pd complex
45
alkene
insertion
syn p-hydride
*
elimination
.OTBS
CI2Pd-0?>BINAP
Ag3PO4, CaCO3,
1-methyl-2-pyrrolidinone,
60 \302\260C,
h F7% yield)
84
44
OTf
Pd(OAcJA.7mol%),
fS>BINAP B.1 mol%),
OTf
e
n-Bu4NOAc, DMSO, 20 \320\241
alkene
insertion
nucleophilic attack upon the
OAc less hindered carbon of
eiectrophiliccomplex 50
Me
Me
51
Pd(PPh3L C mol%),
Et3N B equiv.), Et\302\2602CN
>
CH3CN, reflux G6%)
52 53
mately affording 53; four new C-C bonds and four carbocyclic
rings are created in this impressive \"zipper\" polycyclization pro-
process.
N N
f
Ph Ph
BBEDA F mol%).
TBSO' Pd(OAcJ E TBSO
CI(CH2)aCI, 50 \302\260C OTMS
A00%yleid)
55
BBEDA = N,W-b/s-(benzyiidene)ethylenediamine
TBS = Sif-BuMea
TMS = SiMe3
PdIVLnH Pd'v
reductive
elimination
TBSO
TBSO
-tfr, \320\232
OTMS
OTMS
57 56
(metallacyclopentene)
HPdOAc
R \302\246
(alkyne hydropalladation)
59 60
intramolecular
carbopalladation
p-hydride elimination
PdOAc
(- HPdOAc)
62 61
\320\236
dba =
Ph
TBS = Sif-BuMe2 I intramolecular
carbopalladation
PdOAc
p-hydride H intramolecular
elimination PdOAc
carbopalladation
t
(- HPdOAc)
TBSO
66
\320\236\320\234\320\265
MeO
(dbaKPd2\302\253CHCI3 B.5
Ph3Sb A0 mol%),AcOH,
PhH, 50 \302\260C
G7% yield)
PhO2S
PhO2S
69
Pd(OAcJ,
P(O/-PrK,
THF.A
(92%)
ring closure
73 72
AK \320\241\320\270
\320\236 \320\247
74
(Ph3PJPdCI2(cat.),
R1-X + HC=CR2 R1C=CR2
Cul (cat.), Et2NH, 25 \320\241
R1 = aryl, vinyl, or
HC=CR2
Cul (cat.), Et2NH
Et2NH2CI
R2C=C\342\200\224C=CR2
R1C=CR2
F
reductive elimination
Et2NH2X HC=CR2
THPO,
75 76
77
1. p-TsOH,EtOH
2. Lindlar catalyst, H2
3. LiOH
1. Cl Cl MeO
SIMe3
4SIMe3
Cl
PhO
Pd(OAcJ (cat.),
Ph3P, Cul (cat.),
n-BuNH2(88%)
83
Scheme 21. The Sonogashira coupling reaction in Nicolaou's dynemicin A model study.
586 31 Rapamycin
Pd(PPh3L B ),
Cul B0 mol%), PhCH3,
25 \302\260C
B5%)
MeO MeO
Me
__ (transannular Dlels-Alder)
OMe OMe
86 85
BY2
/>ydfObOfaffon
R\342\200\224C=CH HBY2 > r
87
BY2
hydroboration f-BuLi
R\342\200\224C=CX HBY, \302\246+~ R
X ' (configuratlonal
(gu BY
89
90 teomerlzation)
teomerlzation)
X = halogen
Y2 = disiamyl =
or
Y2 = catechol =
Pd(PPh3L
Br' A mol%),
NaOEt, EtOH,
PhH, 80 \302\260C
(Z>93 (88%) (E,Z\342\204\226
(>98%
(Suzuki coupling)
stereolsomeric
purity)
Pd(PPh3L
C mol%),
NaOEt, EtOH,
PhH, 80 \302\260C
fZ>93
D9%) fZ,Z>96
(Suzuki coupling) (>98%
stereoisomeric
purity)
Ph
catecholborane BrwPh
(hydroboration) Pd(PPh3L
A mol%),
97 98 NaOEt, EtOH, 99
PhH, 80 \302\260C
(87%)
(>98%
stereoisomeric
(Suzuki coupling) purity)
Pd(PPh3L OEt
(cat.), 4\302\251
NaOH, (99%)
THF (91%)
Pd@) (cat.),
NaOR2 or NaOH,
PhH, \320\224
R\342\200\224X 'V\\
BY,
R\342\200\224X
oxldative addition
R2ONa
NaX
Br Pd(PPh3L,
NaOEt, (Suzuki
(ZJ-ViS PhH, reflux coupling)
(82%)
106: bombykol
\320\223\320\233
Me
-Vi
dlsiamylborane 109
108
,\302\251
H3O'
Me
Me
end
111: trisporol \320\222
benzyl ether
OTBS
Pd(PPh3L(cat.),
\342\200\236COjMe
TIOH E5%)
(Suzuki
OTBS coupling)
Me
112 113 TBS = Sif-\320\222\320\270\320\234\320\265\320\263
OTBS
COjMe .COjMe
n-Bu4NF
Me
Pd(PPh3L B0 mol%),
4 N aq. NaOH, PhH,
. \321\201
reflux C2%)
\\_f
f
Me
R\342\200\224R1
D X R\342\200\224X
^
L2Pd\302\260
reductive elimination *nW n/ oxidative addition
/ \\
L L
I
R\342\200\224Pd\342\200\224L R\342\200\224Pd\342\200\224X
I
L- R1\342\200\224Sn(R2K
trans -> els >^T transmetalation
isomerlzatlon I
1 4
R_pd_R
\320\222
O
R\342\200\224X + R1\342\200\224Sn(R2K 1*- +
R\342\200\224C\342\200\224R1 X\342\200\224Sn(R2K
CO
R\342\200\224\320\241\342\200\224R1
fl i
R\342\200\224C\342\200\224Pd\342\200\224X
\320\241
X Sn(R2K R1\342\200\224Sn(R2K
transmetalation
SiMe3
OTf
1. LDA Me3Sn
Pd(PPh3LA.6mol%),
LiCI A00% yield)
(regloselectlvity: 95:5)
SiMe3
118
,SiMe3
2. PhNTf2 Pd(PPh3L(i.6mol%),
UCI (90%yield)
120 122
via thermodynamic
etiolate (regioselectivity:97:3)
Scheme32.
Stille couplings of regioselectively generated enol triflates with a vinyistannane.
\320\276
123
SnrhBu3
1. L-Selectride
LiCu
G3%) (93%)
2. PhNTf2
\\_\320\243~
\321\202\321\216.
125
Pd(PPh3L(cat.),
I LiCI G5%)
Me' Me
127: pleraplysillin-1
OTBS \320\236 Bn
Pd2(dbaK, CdCI2,
(/-PrJNEt, (Stille
/V-methylpyrrolidinone, coupling)
129 40 \302\260C
F5%)
Snn-Bu3
128 TBS = Sif-BuMe2
TES =
SiEt3
TIPS = S\342\204\226Pr3
Bn =
CH2Ph
Et...
Bn
Scheme 34. The Stille reaction in Evans's synthesis of (+)-A83543A (lepicidin)aglycon A31).
otbs
Me..
Pd(PPh3L (cat.),
132 133
Me....
Me \320\236
135: (+)-jatrophone
Scheme 35. The Stille reaction in Wiemer and Han's synthesis of (+)-jatrophoneA35).
31.1 Introduction 597
OTf
Pd(PPh3L
THF, reflux (82%)
''CO2Me
Me (intramolecular
Stiila coupling)
136 137
method (see Scheme 37). This efficient ring closure is just one in
by J. E. Baldwin and
\320\236
of many examples disclosed his group at Snn-Bu3
\"Pd\302\260\"
(cat.),
PhCH3,100 \302\260C,
3 atm. CO G0%)
(intramolecular
Stille coupling)
139
Snn-Bu*
25 \302\260C
(80%)
142:fS>zearalenone 141
Me \320\236
(\302\261)-144: (\302\261)-ep/-jatrophone
xyl group attached to C-14. Although the macrolide has the poten-
potential for ring-chain tautomerism, rapamycin exhibits a large equili-
equilibrium preference for the closed hemiketal form in both solution and Me OMe Me
coupling with the less hindered vinyl iodide grouping in 145 (i.e.
Ester bond formation
at C-21). The resulting C-18 vinyl iodide/C-19 vinylstannane
would then be poised for an intramolecular Stille coupling to give
rapamycin. This \"stitching cyclization\" strategy would thus be
applied to a fully deprotected seco substrate 145, and, if successful,
would represent a new approach to the construction of polyene
macrolides. 145
Of all the bonds contained within intermediate 145, the O-Cl
ester and N-C8 amide bonds are among the most logical sites for
retrosynthetic disassembly. Retrosynthetic simplification of 145 by
cleavageof these two bonds furnishes, after some functional group
and oxidation state adjustments, fragments 147, 148, and 149. In 146
Stille
couplings
OMe
Me OMe Me Me
1: rapamycin
,Snn-Bu3
19 Ester bond formation
If
20
146 OMe
Me...
''OH
Me OMe Me Me
145
Me OH
TIPS = Si/-Pr3
f-BOC = f-BuOCO
N^COOH PUB = p-MeOC6H4CH2
f-BOC
TPS = Sif-BuPh2
MeO OTIPS \320\236
\320\236\320\235
147 148
TIPS
OMe
Me Me OMe Me Me
149
It is worth
pointing out that the stereochemistry of intermediate Epoxide
147 at and C-10 is inconsequentialsinceboth
C-9 positions will opening
philic iodine.67
A
retrosynthetic analysis of fragment 152 can be completed \320\276
through cleavage of the C16-C17 bond in enone 155, the projected 155
precursor of epoxide 152. This retrosynthetic maneuver furnishes
intermediates 156 and 157 as potential building blocks. In the for-
forward sense, acylation of a vinyl metal species derived from 156 PMBO
with Weinreb amide 157 could accomplish the construction of
enone 155. Iodide153,on the other hand, can be traced retro-
retrosynthetically to
commercially the available, optically active build-
buildingblock methyl (S)-(+)-3-hydroxy-2-methylpropionate A54). aldol
Compound 149, the host of twelve stereogenic centers, a trisub- 158 Asymmetric
reaction
stituted cyclohexane ring, a trans trisubstituted double bond, and
numerous differentiated atoms, is very complex. Its consti-
oxygen
constitution is, however, to two very productive retrosynthetic
amenable PMBO OTBS
MeO OTIPS HO I O
Epoxide
opening
\320\276\320\275
VOM>
Me
Me3Si
I OPMB
153
Vinyllithlum Me
addition
to carbonyl
154: methyl f>()
Mel hydroxy-2-methyl-
13
propionate
18 /
\320\276
155
u
Me Me
Me3Si
\320\236 \320\236
156 157
Me Me OMe Me Me Me \302\253\320\247^--
Me Me \320\261\320\274\320\265 \"\"otps
Asymmetric aldol
15B reaction
\320\236 OTPS
\320\236 9 otbs
\321\200\320\274\320\262\320\276
go \320\236\320\234\320\265
N
Me
T
H OMe Me
Me \"\302\246*p(\302\260H\302\260Etb
\302\246\302\246
Me Ph h. M
161 162 165 169 170
OH OH OH OH OTBS
^\302\246^Asymmetric Me2N
Me Me OH OH OH Me crotylboration 171
163: (+)-B-cftro- 164: D-mannitol 166
Eschenmoser -Claisen
nellene
rearrangement
.OMe
(+\320\230\320\240\320\2412\320\222.,
OTBS
167 168
PMB =
p-MeOC6H4CH2
PG = Si^Pr3
TPS = Sif-BuPh2 172
TBS = \320\262^\320\222\320\234
\320\224
OMe OMe
<^
OTBS \"\342\200\242OTBS
9>
OBn OH
175 174 173
Horner-Wadsworth-Emmons; from oxazolidinone 160 (see 209+160\342\200\224> 210, Scheme 51). On the
double bond reduction
basis of substantial precedent, there was good reason to believe that
such a
coupling would exhibit excellent syn diastereoselectivity
OMe and that the norephedrine-derived chiral auxiliary would define the
3S absolute stereochemistry at carbons 34 and 35. After it has served
M its purpose as a stereocontrollingdevice, the chiral auxiliary in
Me
\\
aldol adduct 210 (Scheme would have 51)
to be reductively
160
cleaved. Further reduction of the resulting hydroxy methyl group
could furnish the requisite C-35 methyl group.
A similar Evans
asymmetric aldol/reduction sequence could also
PMBO
serve well in a synthesis of fragment 158. Compounds161 and
\320\276
162 thus emerge as potential precursors to 158. In theory, building
blocks 161 and 162 could be procured in optically active form
t from commercially available and enantiomerically pure (+)-/?-citro-
Me
Me| \320\276\320\274\320\265
nellene A63) and D-mannitol A64), respectively(seeScheme 42).
Asymmetric
158 reaction
aldol A valuable feature of the Ni'VC^'-mediated Nozaki-Takai-
Hiyama-Kishicouplingof vinyl iodides and aldehydes is that the
31.3.1 147and
Synthesis of Intermediates 158-160
156 157
iodine-lithium exchange reaction, generating the putative organo-
metallic species. Now, when a cold (-78 \302\260C)solution of the newly
formed vinyllithium reagent is exposed to Weinreb amide 157, the
Me3Si
desired C-acylation reaction takes place and enone 155 is produced
in 70 % yield.
With an oxygen-bearing stereocenter in proximity to the C-16
ketone carbonyl in 155, the prospects for achieving a diastereose- 155
lectiveketone reduction seemed favorable. From the work of Mori
and Suzuki, it was known that similarly constituted ketones are
amenable to /?-chelation-controlled reductionswith lithium alumi-
608 31 Rapamycin
num hydride, provided that a suitable Lewis acid such as lithium
Me Me
176:1-trimethylsllyl-
*cat) 177 (81% from 176) 156
propyne
Me
155
-100->0\302\260C;then |152J,
-30 -> 0 \302\260C S\0211\"
(88%)
180
1. ^Pr3SIOTf,
2,6-lutidlne,
0 \302\260C
CH2CI2, (98%)
2. W-iodosuccinimide,
THF, 25 \302\260C
(97%)
fl.,Me bond
60\302\260 Me3Sl...
(
rotation H cie\"cio
h H Cie-C10
\320\241 \320\222 A
hyperconjugatlve
stabilization ofji-cation
TIPS = Sif-\320\240\320\263\320\267
18 i : 12 PMB = j>MeOC6H4CH2
MeO OTIPS OPMB
181
of
construction the C9-C10 bond by an aldol reaction could be made (see
Scheme 44). To this end, oxidative cleavageof the /?ara-methoxy-
1. DDQ, CH2Ci2-H2OA9:1),
25 \302\260C
(94%)
18 i i 12 18 i i \302\253 II
2. (COCIJ, DMSO, CH2CI2,
MeO OTIPS OPMB MeO OTIPS \320\236
-> 0 C; then Et3N
\342\200\24278 (98%)
181 150
.OMe
Me Me OH Me Me
147 182
Ph
I IT
\320\242\320\223 2. 10%Pd-C, H2, rVV
EtOH/EtOAcA:1) OH OH OMe
A00%)
Ph
183:1,3,4,6-di-O-benzyiidene- 184
D-mannitol
f-BuPh2SiCI, imidazole,
DMF, 25 \320\241
(95%)
I TPS = Sif-BuPh2 I
162 185
ll^J silyl chloride B.2 equiv.) and imidazole D.5 equiv.) A84\342\200\224\302\273185).
j Finally, oxidative cleavage of the vicinal diol 185 with lead tetra-
\320\276\320\274\320\265 acetate furnishes aldehyde 162 in 90% yield.
1S2 An equally straightforward sequencecan be used to fashion N-
acyloxazolidinone 161 from commercially available (+)-/?-citronel-
lene A63) (see Scheme 46). Although 163 possesses two oxidiz-
able sites of unsaturation, the trisubstituted olefin is more electron
rich and thus more susceptible to oxidation by an electron deficient
oxidant than the monosubstituted olefin. A selective epoxidation of
the trisubstituted olefin in 163 can indeed be brought about with
meta-chloroperoxybenzoic acid (mCPBA). Acid-catalyzed hydroly-
of
hydrolysis the newly formed oxirane ring then furnishes vicinal diol
186. Sodium periodate induced oxidative cleavage of 186, fol-
followed by Jones oxidation of the resulting aldehyde, providesunsa-
turated carboxylic acid 187 in good overall yield. This four-step
conversionof (+)-/?-citronellene
A63) to carboxylic acid 187 was
developed by D.R.Williamset al.,76 and it can be conducted easily
without the isolation and purification of intermediates. On treat-
treatment with pivaloyl chloride and triethylamine, carboxylic acid 187
is converted to a mixed pivalOate anhydride, a reactive acylating
agent that combines smoothly with the lithiated oxazolidinone
derived from (lS,2/?)-norephedrine to give iV-acyloxazolidinone
161 (90% overall yield).
\320\276\320\275
1. \320\250\320\241\320\240\320\222\320\220,
\320\274\320\265 \302\260\320\241
\320\241\320\2352\320\24112,25 I Me
2. \320\235\320\241\320\2564, 25 \302\260\320\241 i
\320\235\320\263\320\236\320\257\320\235\320\240, \321\200-~\320\234\320\265
Me Me Me \320\236\320\235
(\320\241\320\2353)\320\267\320\241\320\241\320\236\320\2411,
Et3N, EtaO, -78 -> 0 \302\260C
(mixed anhydride
formation); then
A
M
Me Ph
(90%)
Scheme 161.
46. Synthesis of /V-acyloxazolidinone
31.3 Total Synthesis 613
Ph
\320\276
C24-C21
then 30% H2O2G3%;>98%
diastereoselectivity)
Evans asymmetric
aldol reaction
\320\276\320\275
otps ?H OTPS
LiBH4, H20/Et20,
0 -> 25 \302\260C,
(98%)
189
2. p-anisaldehyde dimethyl
Me ecetal, CSA(cat.),CH2CI2,
25 \302\260C
(97%)
190
Dlbal-H, CH2CI2,
-78 -> 25 \302\260C
(96%)
OMe
(COCIJ,
DMSO,
CH2CI2, PMBO OH
-78 \302\260C;
then Et3N,
-78 -> 0 \302\260C
(97%)
Me Me OMe
(+Hpc
OH OTBS
30% H2O2 TBSO
OH
G5%
Me from 193)
166
(>9S%enentiomeric
excess)
1. NaN(SIMe3J, PMBBr, THF/DMF B:1),
0 \302\260C
(90%)
2. O3, CHjCla/MeOH/pyridine E:5:1),
-78\302\260C;
then Me2S, -78 -\302\27325\302\260C
(80%)
CH2CI2, 25\302\260CA00%)
Me
194
\321\217-BuLi,THF, -78 -20
-\302\273 \302\260C;
then Mel, -20 -> 0 \302\260C
(98%)
PMBO OTBS
25 Me. PMBO OTBS
CfeZrHCI, \302\260C;
165
...ph
\321\2030
Me
197 Li, THF,
E mol%) f-BuOH,
\320\236
Br Br
BH3*SMe2,
THF, reflux (95%)
-15\302\260C(99%) OH OH
OMe OMe
LDA, THF, -78 X; Pd(OAcJ, CH3CN,
m \302\273
then MeoSICI,
\320\276\321\202\320\275\321\207 otbs 50 X (83% from 174) OTBS
-78->25X
\320\236 OTMS \320\236
LiBH4, CeCI3*7H2O,
THF/MeOHA:1),
-78 X (95%)
Eschenmoser - .OMe
MeO_ OMe
Clalsen
rearrangement
OTBS
Me2N OTBS xylenes,
reflux (98%) \320\276\320\275
171 173
o-NO2C6H4SeCN,
OMe
n-Bu3P, THF, 25 X; OMe MeOH/CH2CI2, OMe
-78 X; then
0TBS then30%H2O2, 0TBS OTBS
THF, 25 X (88%)
Me2S,
-78 -* 25 X
204 170
(88%)
cally pure phosphonate 169. Compounds 169 and 170 can in fact
be joined efficiently under the mild reaction conditions shown in
Scheme50 to give a,/?-unsaturated imide 206 (96 % yield). The use
31.3 Total Synthesis 619
LICI,
0\320\234\320\265 *-Pr2NEt, OMe
(An
\320\273*+ CH3CN, 25 \302\260\320\241
(96%) VJ
P(OMOEt),
\"OTBS 'OTBS
Ph' Me (Horner-Wadsworth- pi/ \320\274\320\265
169 170 Emmons) 206
(Ph3PKRhCI @.05equiv.), I
Et3SIH, 50 \302\260C
2. f-BuPh2SiCI, imidazole,
Me \342\200\242OTPS
DMF, 25 from 'OTBS
\320\241
G5% 206) ph\"' Me
160 207
DMSO, 25 \302\260C
(83%)
(Nozakl-Takai-Hlyama-
Klshl reaction)
PMBO OH PMBO
1. *-Pr3SlOTf,2,6-lutidine,
CH2CI2,0 \320\241
(98%)
Me Me OMe Me Me
2. HRpyridlne, THF, 25 \302\260C
(97%)
208
3. (COClfe, DMSO, CH2CI2, -78\302\260C;
then Et3N, -78 -\302\273-10\302\260C
(97%) B:1 mixture of diastereoisomers
In favor of 208)
OMe
42
Me
'OTPS
209 160
TIPS
PMBO
1. LiBH4,H2O, Et2O, 21
0 -\302\27325\302\260C
(98%)
2. p-TsCIA.2equlv.),
Et3N, 4-DMAP (cat.),
CH2CI2, 25 \302\260C
(91%)
3. LiEt3BH, THF, 0 -\302\273
25 \302\260C
(91%)
Me Me OMe Me
149
N COOH
TIPS f-BOC
PMBO PMBO OH
148: W-BOC-L-pipecoiic
OMe acid
Me Me OMe Me Me
-OTPS
149
A,3-diisopropylcarbodiimide),
/-Pr2NEt, 4-pyrrolidlnopyrldine,
CH2CI2, -20 \302\260C
(85%)
f-BOC
-TIPS
PMBO \320\236 PMBO \320\236
CHl3, CrCi2,
Me Me OMe Me Me THF/dioxaneD:1),
25 \302\260C
(94%)
212
f-BOC = f-BuOCO
PMB = p-MeOC6H4CH2
TIPS = Si/-Pr3 OMe
TPS = Sif-BuPh2
Me Me OMe
OTPS
213
(>20:1stereoselectivlty)
OMe
1. DDQ, \320\241\320\235\320\2411\321\215/\320\2352\320\236
1 25 \302\260C
Me Ml OMe A9:1), (98%)
2 ^i^^g^m^
213 2,6-lutldlne B0 equlv.),
then
CH2CI2,0 \302\260C; silica
gei, CH2CI2,25 \302\260C
(94%)
\320\246471.
N
1,3-dlisopropyl-
OH carbodllmlde,
1-hydroxy- CH2CI2,0 then
\302\260C; [214
benzotriazole, 0\302\260C(95%)
147
(COCIJ, DMSO,
CH2CI2,-78 \302\260C;
then Et3N,
-78 -^ 0 \302\260C
''OTPS
Me OMe Me Me TES
215
TIPS = SIM>r3
f-BOC = f-BuOCO
PMB =
p-MeOCeH4CH2
TPS =
TES = SIEt3
OMe Me Me TES
216
product.
\"OTPS
Me OMe Me Me TES
216 TIPSO,
Me
\"OTPS
Me OMe Me Me
217
Me.., OMe
Me OMe Me Me
145
31.4 Conclusion
n-Bu-iSn
Snn-Bu3
146
Me OMe Me Me
145
Me OMe Me Me
218
Me
\320\274 1 \320\275
\320\275\320\276
. / v
\320\236
If
Me..
\320\273 \320\236\320\235
|
II
\320\247\320\234\320\265
^-\320\276\320\275
1 1 :
Me OMe Me Me
1: (-)-rapamycin
References
1. Isolation: (a) Vezina, C; Kudelski, A.; Sehgal, S.N. (f) Tsuji, J. Organic Synthesis with Palladium Com-
/. Antibiot. 1975, 28, 111; (b) Sehgal, S.N.; Baker, Compounds, Springer: Berlin, 1980; (g) Heck, R.F. In
H.; Vezina, ibid.
\320\241 1975, 28, 727. Comprehensive Organic Synthesis, Trost, B.M.;
2. Structure: (a) Swindells, D.C.N.; White, P.S.; Find- Fleming, I., Eds., Pergamon Press: New York, 1991,
lay, J. A. Can. Chem. J.
1978, 56, 2491; (b) Findlay, Vol.4, p. 833; (h) Hegedus, L.S. In Organometallics
J. A.; Radics, L. ibid. 1980, 58, 579. in Synthesis, Schlosser, M., Ed., Wiley: Chichester,
3. (a) Rosen, M. K.; Schreiber, S.L. Chem. Int.
Angew. United Kingdom, 1994, p. 383.
Ed. Engl. 1992, 31, 384; (b) Schreiber, S. L. Science 12.(a) de Meijere, A.; Meyer, F E. Angew. Chem. Int.
(Washington, D. C.) 1991, 251, 283; (c) Schreiber, Ed. Engl. 1994, 33, 2379; (b) Mulzer, J.; Altenbach,
S.L.; Liu, J.; Albers, M.W.; Karmacharya, R.; Koh, H.-J.; Braun, M.; Krohn, K.; Reissig, H.-U. Organic
E.; Martin, P.K.; Rosen, M.K.; Standaert, R.F.; Synthesis Highlights, VCH Publishers: Weinheim,
Wandless, T. J. Transplant. Proc. 1991,23, 2839. New York, 1991, pp. 174-180.
4. Snyder, S.H.; Sabatini, D.M. Nature Medicine, 13. Fuji, K. Chem.Rev. 1993, 93, 2037.
1995, /, 32. 14. (a) Bumagin, N. A.; More, P. G.; Beletskaya, I.P. /.
5. (a) Nicolaou, K.C.; Chakraborty, \320\242.\320\232.;
Piscopio, Organomet. Chem. 1989, 371, 397; Casalnuovo, (b)
A. D.; Minowa, N.; Bertinato, P. / Am. Chem. Soc. A.L.; Calabrese, J.C /. Am. Chem. Soc. 112,
199\320\233,
1993, 115,4419; (b) Piscopio, A.D.; Minowa, N.; 4324; (c) Genet, J. P.; Blart, E.;
Savignac, M. Synlett
Chakraborty, Koide,
\320\242.\320\232.; K.; Bertinato, P.; Nico- 1992, 715; (d) Jeffery, T. Tetrahedron Lett. 1994, 35,
Nicolaou, K.C. J. Chem. Soc, Chem. Commun. 1993, 3051.
617; (c) Nicolaou, K.C; Bertinato, P.; Piscopio, 15.Reiser, O.; Reichow, S.; de Meijere, A. Angew.
A.D.; Chakraborty, Minowa,
\320\242.\320\232.; N. ibid. 1993, Chem. Int. Ed. Engl. 1987, 26, 127.7.
619. 16. (a) Overman, L. E.; Abelman, M.M.; D.J.;
Kucera,
6. Romo, D.; Meyer, S.D.; Johnson, D. D.; Schreiber, Tran, V.D.; Ricca,D.J. Pure & Appl. Chem. 1992,
S. L. /. Am. Chem.Soc. 1993,115,7906. 64, 1813;(b) Overman, L.E. ibid. 1994, 66, 1423;
7. Hayward, Yohannes,
\320\241\320\234.; D.; Danishefsky, S.J. J. (c) Madin, A.; Overman, L.E. Tetrahedron Lett.
Am. Chem. Soc. 1993, 7/5, 9345. 1992, 33, 4859.
8. Smith, \320\220. Ill;
\320\222., Condon, S.M.; McCauley, J.A.; 17. Hong, C.Y.; Kado, N.; Overman, L.E. /. Am. Chem.
Leazer,J.L.,Jr.;Leahy, J.W.; Maleczka, R.E., Jr. J. Soc. 1993, 115, 11028.
Am. Chem. Soc. 1995, 117, 5407. 18.(a) Overman, L.E.; Ricca, D.J.; Tran, YD. J. Am.
9. For reviews of methods for constructing macrolac- Chem. Soc. 1993, 115, 2042; (b) Kucera, D.J.;
tones, see: (a) Nicolaou, K.C. Tetrahedron 1977, 33, O'Connor, S. J.; Overman, L.E. J. Org. Chem. 1993,
683; (b) Back, T.G. ibid. 1977, 33, 3041; (c) Masa- 58, 5304.
mune, S.; Bates, Corcoran, J. W. Angew.
G.S.; 19. (a) Larock, R.C; Lee, N.H. J. Am. Chem. Soc.
Chem. Int. Ed. Engl. 1977, 16, 585; (d) Paterson, I.; 1991, 113, 7815;(b) Larock,R.C; Lee,N.H. Org. /.
Mansuri, M.M. Tetrahedron 1985, 41, 3569. Chem. 1991, 56, 6253.
10. (a) Comprehensive Organometallic Chemistry, 20. (a) Oppolzer,W.; De Vita, R.J. J. Org. Chem. 1991,
Wilkinson, G.; Stone, F.G.A; Abel, E.W., Eds., 56, 6256; (b) Oppolzer, W. Pure & Appl. Chem.
Pergamon Press: Oxford, 1982; (b) Green, M.L.H.; 1990, 62, 1941;(c)Oppolzer, W ibid. 1988, 60, 39;
Davies, S. G. Philos.Trans. R. Soc. London A 1988, (d) Tietze,L.F; Beifuss, U. Angew. Chem. Int. Ed.
326, 501;(c) Collman, J.P.; Hegedus, L.S.; Norton, Engl. 1993,52, 131.
J.R.; Finke, R. G. Principles and Applications of 21. Piers, E.; Marais, /.
P. \320\241 Org. Chem. 1990, 55,
Organotransition Metal Chemistry, University 3454.
Science Books: Mill Valley, California, 1987; (d) 22. Rawal, V.H.; Michoud, C; Monestel, R.F. J. Am.
Hegedus, L. S. Transition Metals in the Synthesis of Chem. Soc. 1993, 115, 3030.
Complex Organic Molecules, University Science 23. (a) Jeffery, T. J. Chem. Soc, Chem. Commun. 1984,
Books: Mill Valley, California, 1994; (e) Harrington, 1287; (b) Jeffery, T. Tetrahedron Lett. 1985, 26,
P. J. Metals
Transition in Total Synthesis, Wiley: 2667;(c)Jeffery, T. Synthesis 1987, 70.
New 1990; (f) Pearson, A.J. Synlett
York, 1990, 10; 24. (a) McClure, K.F.; Danishefsky, S.J. J. Am. Chem.
(g) Seebach, D. Angew. Chem. Int. Ed. Engl 1990, Soc. 1993, 115, 6094; (b) Schkeryantz, J.M.;
29, 1320. Danishefsky, S.J. ibid. 1995, 117, 4722; (c) See also:
11.(a) Heck, /. Am. Chem. Soc. 1968,90, 5518;
R.F. Masters, J. J.; Jung, D. K.; Bornmann, W. G.;
(b) Heck, R.F. Ace. Chem. Res. 1979, 12, 146; (c) Danishefsky, S.J.; de Gala, S. Tetrahedron Lett.
Heck, R.F. Org. React. (N.Y.) 1982, 27, 345; (d) 1993, 34, 7253.
Hegedus, L.S. Tetrahedron 1984, 40, 2415; (e) 25. (a) Sato, Y; Sodeoka,M.; Shibasaki, M. J. Org.
Heck, R.F. Palladium Reagents in Organic Syn- Chem. 1989, 54, 4738; (b) Sato, Y; Sodeoka, M.:
Syntheses, Academic Press: New York, 1985, p. 179; Shibasaki, M. Chem. Lett. 1990, 1953; (c) Kage-
References 629
Future, Tokyo Kagaku Dozin: Tokyo, 1992, p. 355. Japan, Past, Present, and Future, Tokyo Kagaku
26. (a) Zhang, Y.; Negishi, E. /. Am. Chem. Soc 1989, Dozin: Tokyo, 1992, p. 441, (f) Miyaura, N.;
111, 3454; (b) Negishi, E. Pure Appl. Chem. 1992, Yamada, K.; Suginome, H.; Suzuki, A. J. Am. Chem.
64, 323; (c) Zhang, Y; Wu, G.; Agnel, G.; Negishi, Soc. 1985, 107, 972; (g) Miyaura, N.; Ishiyama, \320\242.;
E. /. Am. Chem. Soc. 1990, 112, 8590. Sasaki, H.; Ishikawa, M.; Satoh, M.; Suzuki, A. ibid.
27. (a) Trost, B.M. Angew. Chem. Int. Ed. Engl. 1995, 1989, 111,314.
34, 259; (b) Trost, B.M. Science (Washington, 44.(a) Miyaura, N.; Suginome, H. Tetrahedron Lett.
D.C.) 1991, 254, 1471; (c) Trost, B.M. Pure & 1983, 24, 1527; (b) Miyaura, N.; Suginome, H.;
Appl. Chem. 1992, 64, 315;(d) Trost, B.M. ibid. Suzuki, A. Tetrahedron 1983, 39, 3271.
1994, 66, 2007; (e) Trost, B.M. Ace. Chem. Res. 45. Uenishi, J.; Beau, J.-M.; Armstrong, R.W.; Kishi, Y
1990, 23, 34. /. Am. Chem. Soc. 1987, 4756. 109,
28. Trost, B.M.; Jebaratnam, D.J. Tetrahedron Lett. 46. Nicolaou, K.C.; Ramphal, J.Y.; Palazon, J. M.; Spa-
1987,28, 1611. nevello, R. A. Angew. Chem. Int. Ed. Engl. 1989, 28,
29. Trost, B.M.; Lee, D.C; Rise, F. Tetrahedron Lett. 587.
1989,50,651. 47. Miyaura, N.; Suginome, H.; Suzuki, A. Tetrahedron
30. Trost, B.M.; Shi, Y. J. Am. Chem. Soc. 1991,113,701. Lett. 1984,25,761.
31. See reference 27a, p. 272. 48. (a) Stille, J. K. Pure & Appl. Chem. 1985,57, 1771;
32. Trost, B.M. Angew. Chem. Int. Ed. Engl. 1989, 28, (b) Stille, J. K. Angew. Chem. Int. Ed. Engl. 1986,
1173. 25, 508; (c) Mitchell, T.N. Synthesis 1992, 803.
33.Trost, B.M.; Hane, J.T.; Metz, P. Tetrahedron Lett. 49. (a) Scott, W.J.; Crisp, G.T.; Stille, J.K. J. Am.
1986, 27, 5695. Chem. Soc. 1984,106,4630; (b) Crisp, G.T.; Scott,
34. Stephens, R.D.; Castro, C.E. J. Org. Chem. 1963, W.J.; Stille, J.K. ibid. 1984, 106, 7500; (c) Ritter, K.
28,3313. Synthesis 1993, 735.
35. Burdon, J.; P.L.; March,
\320\241\320\276\320\265, C.R.; Tatlow, J.C. 50. (a) Scott, W.J.; McMurry, J.E. Ace. Chem. Res.
Chem. Commun. 1967, 1259. 1988, 21, 47; (b) McMurry, J.E.; Scott, W.J. Tetra-
36. (a) Sonogashira, K.; Tohda, Y; Hagihara, N. Tetrahe- Tetrahedron Lett. 1983, 24, 979.
Lett.
Tetrahedron 1975, 4467; (b) Sonogashira, K. In Com- 51. d'Angelo, J. Tetrahedron 1976, 32, 2979.
Comprehensive Organic Synthesis, Trost, B.M.; Fleming, 52. (a) Ireland, R.E.; Mueller, R.H.; Willard, A.K. J.
I., Eds., Pergamon Press: New York, 1991, Vol. 3, Am. Chem. Soc. 1976,98, 2868; (b) Ireland, R.E.;
p. 521. Wipf, P.; Armstrong, J.D., III J. Org. Chem. 1991,
37. (a) Cassar, L. J. Organomet. Chem. 1975,93, 253; 56, 650; (c) Evans, D. A. In Asymmetric Synthesis,
(b) Dieck, H.A.; Heck, F.R. ibid. 1975, 93, 259; (c) Morrison, J. D., Ed., Academic Press: New York,
Ratovelomana, V.; Linstrumelle, G. Synth. Commun. 1984, Vol. 3, p. 1, (d) Heathcock, C.H. In Asym-
1981, 77,917. Asymmetric Synthesis, Morrison, J. D., Ed., Academic
38. (a) Nicolaou, Ladduwahetty, T; Taffer,
K.C.; I.M.; Press: New York, 1984, Vol. 3, p. 111.
Zipkin, Synthesis 1986, 344; (b) Nicolaou,
R.E. 53. Krafft, M.E.; Holton, R.A. Tetrahedron Lett. 1983,
K.C.; Ramphal, J.Y; Petasis, N.A.; Serhan, C.N. 24, 1345.
Angew. Chem. Int. Ed. Engl. 1991, 30, 1100. 54. (a) House, H. O. Modern Synthetic Reactions, 2nd
39. For reviews of the chemistry and biology of the ene- ed., Benjamin/Cummings: Menlo Park, California,
diyne anticancer antibiotics, see: (a) Nicolaou, \320\232.
\320\241; 1972; (b) Stork, G.; Rosen, P.; Goldman, N.;
Dai, W.-M. Angew. Chem. Int. Ed. Engl. 1991, 30, Coombs, R. V.; Tsuji, J. /. Am. Chem. Soc. 1965,87,
1387; (b) Nicolaou, K.C.; Smith, A. L. Ace. Chem. 275; (c) Caine, D. Org. React. (N. Y.) 1976. 23, 1.
Res. 1992,25, 497; (c) Nicolaou, K.C.; Smith. A.L.; 55. Evans, D.A.; Black, W.C. J. Am. Chem. Soc. 1992,
Yue, E.W. Proc. Natl. Acad. Sci. U.S.A. 1993,90, 114, 2260.
5881. 56. Han, Q.; Wiemer, D.F. J. Am. Chem. Soc. 1992, 114,
40. (a) Magnus, P.; Carter, P. A. J. Am. Chem. Soc. 1988, 7692.
110, 1626;(b) Magnus, P.; Lewis, R.T.; Huffman, 57. (a) Piers, E.; Friesen, R.W.; Keay, B.A. J. Chem.
hC.ibid. 1988,110,6921. Soc, Chem. Commun. 1985, 809, (b) Piers, E.; Frie-
41. (a) Nicolaou, C.-K.; Smith, A.L.;
K.C.;
Hwang, Keay, B.A. Tetrahedron 1991, 47, 4555.
Friesen, R.W.;
59. Kalivretenos, A.; Stille, J.K.; Hegedus, L.S. J. Org. 72. (a) Wick, A.E.; Felix, D.; Steen, K.; Eschenmoser, A.
merten, J.; Wittman, M. D. Stud. Nat. Prod. Chem. 91. Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc,
1989,3, 233; (g) Wipf, P. In Comprehensive Organic 1986, 108,7408.
Synthesis, Trost, B.M.; Fleming, I., Eds., Pergamon 92. Greene,T.W.; Wuts, P.G.M. Protective Groups in
Press: New York, 1991, Vol. 5, p. 827. Organic Synthesis, John Wiley & Sons: New York,
88. (a) Grieco,P. A.; Gilman, S.; Nishizawa, M. J. Org. 1991, p. 329.
Chem. 1976, 41, 1485; (b) Nicolaou, K.C.; Petasis, 93. Shair, M.D.; Yoon, Danishefsky,
\320\242.; S.J. J. Org.
N.A. Selenium in Natural Products Synthesis, CIS: Chem. 1994,59, 3755.
Philadelphia, 1984. 94. Takahashi, Sakamoto,
\320\242.; Y; Yamada, H.; Usui, S.;
89. Blanchette, M.A.; Choy, W.; Davis, J.T.; Essenfeld, Fukazawa, Y. Angew. Chem. Int. Ed. Engl. 1995, 34,
A. P.; Masamune, S.;Roush, W.R.; Sakai, T. Tetra- 1345.
Tetrahedron Lett. 1984, 25, 2183. 95. Shair, M.D.; Yoon, \320\242.;
Danishefsky, S.J. Angew.
90. VanRheenen, V.; Kelly, R.C.; Cha, D. Y. Tetrahedron Chem. Int. Ed. Engl. 1995, 34. 1721.
Lett. 1976, 1973.
\320\276\320\275 \320\276\320\275
1: paeoniflorin 2: paeoniflorigenin
E.J.Corey A993)
Paeoniflorigenin and
Paeoniflorin
32.1 Introduction
The root of the Chinese peony, Paeonia lactiflora, is the source of
a structurally novel monoterpene that bears the name paeoniflorin
A).1 Paeoniflorin exhibits sedative, anticoagulant, and anti-inflam-
anti-inflammatoryactivity, and it occupies an important place in traditional
Chinese medicine.2 The structure of 1 is very complex. Its strained,
cagelike pinane framework is highly oxygenated and contains
numerous stereogenic centers. In fact, with the exception of the
/?-glucose sugar and benzoate ester moieties, six of the remaining
ten carbon atoms are tetrahedral and unsymmetrically substituted
and one is quaternary. In this chapter, we address the elegant sub-
strate'-stereocontrolledtotal synthesis of paeoniflorin A) and its
aglycon, (\302\261)-paeoniflorigenin [(\302\261)-2], by E.J.Corey and his group
at Harvard.3 The general features of Corey's synthesis of paeoni-
paeoniflorin and of paeoniflorigenin are presented in Scheme 1.
\320\275
\"
BzO'
HO-
Me
\320\276\320\275 OH
1: paeoniflorin 2: paeoniflorigenin
OTIPS
Me Epoxide opening
\320\236
\320\257
.Me
Me
Me Birch Me
reduction
OTIPS > H OTIPS
NC
\302\246-v\\ OTIPS OTIPS
9 11
\320\276 Carbo-
lactonlzation -I-
Chlorination \320\276
OH
\302\253or
\320\276
10
Me
Corey's synthesis of paeoniflorigenin B) commenceswith a Birch
reduction6 of the triisopropylsilyl ether of meta-cresol A1) to
give intermediate 9, the substrate for the crucial carbolactoniza-
\342\200\242OTIPS tion reaction (see Scheme 2). It is interesting to note that inter-
NC
intermediate 9 already contains seven out of a total of ten carbon
atoms that constitute the pinane carbon frameworks of 2 and 1,
\320\236
and it provides a suitable platform which
upon the remaining
8
three carbon atoms can be introduced. On the basis of some en-
base encouraging precedents established previously by the Corey group,7
it was projected that intermediate 9 could serve as a substrate for
NC
OH
Me Me
10
Li, NH3(I), Mn3O(OAcODequiv.),
OTIPS
// \320\225\320\256\320\235 KOAc, MeCN, 25 \302\260C
0TIPS OTIPS
D8%)
Oibal-H /nCPBA
C equiv.), C equiv.)
OTIPS H OTIPS
/
\320\241\320\2352\320\24112,-78\302\260\320\241
\320\241|\342\200\236
\320\276 NaHCO3,
CH2CI2, 25 \302\260C
G8%) NC
(81%)
Me
\320\235\320\236 Me
\320\276.
\320\240\320\241\320\241,
TMSOTf (excess), ( )
\320\276'
4 mo1-
\320\220 sieves, \\
\320\276-
-OTIPS \302\273-
\320\275-Vl-f-OTIPS *> H-V|-( \302\246\302\246OTIPS
CH2CI2, -78 \302\260C
25\302\260CA00%)
Cl-yU.O
C5%) NC NC
H
slow addition
1. TMSCN (excess), of Sml2
CH2CI2,415h G equiv.),
TMSO-Tj=fKMe 2-
\342\204\242
Dibal-H \320\275\320\276 THF, -45 \302\260C,
rvn B equiv.),
OTIpS
CH2CI2,-78OC,
15 0.5 h
G1% overall)
1. Dlbal-H
B equiv.),
CH2CI2,-78\302\260C BzO
1N HCI-THF
A:100), 6
0\302\260C, h
A00%)
OP(OMeJ
OBn
17
Pd(OHJ/C, A00%)
MeOH,2h I
HF-CH3CN A:9), 25 10
\302\260C, h
(92%)
19
32.4 Conclusion
produces a \321\201\320\271-fused
bicyclic y-lactone. The folded molecular fra-
framework of this substance is distinguished by a hindered concave
face and a relatively unhindered convex face. This useful property
was exploited by Corey for the purpose of achieving a completely
diastereoselective oxidation reaction (see 7\342\200\224>12,Scheme 2). The
Smb-induced cyclization reaction is also noteworthy. This reduc-
reductive cyclization reaction is remarkably efficient and constitutes an
elegant example of a samarium Barbier reaction; it accomplishes
the formation of a key carbon-carbon bond and completes the
synthesis of the strained molecularskeletonof paeoniflorin.13
References
1. (a) Aimi, N.; Inaba, M.; Watanabe, M.; Shibata, S. 6. (a) Kaiser, E.M. Synthesis 1972, 391; (b) Harvey,
Tetrahedron 1969, 25, 1825;(b) Kaneda, M.; Iitaka, R.G. ibid. 1970, 161; (c) Birch, A. J.; Subba Rao, G.
Y.; Shibata, S. ibid. 1972, 28, 4309. Adv. Org. Chem. 1972, 8, 1; (d) Caine, D. Org.
2. Tang, W.; Eisenbrand, G. Chinese Drugs of Plant React. (TV. Y.) 1976, 23, 1.
Origin: Chemistry, Pharmacology, and Use in Tradi- 7. (a) Corey, E.J.; Gross, A.W. Tetrahedron Lett. 1985,
Traditional and Modern Medicine, Springer-Verlag: Berlin, 26, 4291; (b) Corey, E.J.; Ghosh, A. Chem. Lett.
Heidelberg, 1992, p. 703. 1987, 223.
3. Corey, E.J.; Wu,.Y.-J.J. Am. Chem. Soc. 1993, 115, 8. For an insightful discussion, see: Woodward, R.B.;
8871. Bader, F.E.; Bickel, H.; Frey, A.J.; Kierstead, R.W.
4. (a) Kagan, H.B.; Namy, J.L. Tetrahedron 1986, 42, Tetrahedron 1958, 2, 1.
6573; (b) Molander, G.A.; Etter, J.B. Tetrahedron 9. (a) Pratt, D.V.; Hopkins, P.B. Tetrahedron Lett.
Lett. 1984, 25, 3281;(c) Molander, G.A.; Etter, J.B. 1987, 28, 3065; (b) Kusuda, K.; Inanaga, J.; Yamagu-
J. Org. Chem. 1986, 5/, 1778;(d) Suginome, H.; chi, M. ibid. 1989, 30, 2945.
Yamada, S. Tetrahedron Lett. 1987, 28, 3963; (e) Lan- 10. (a) Molander, G.A.; McKie, J.A. J. Org. Chem.
noye, G.; Sarnbasivarao, K.; Wehrli, S.; Cook,J.M.; 1991, 56, 4112;(b) Curran, D.P.; Totleben, M.J.
Weiss, U. J. Org. Chem. 1988, 55, 2327; (f) Lannoye, J. Am. Chem. Soc. 1992, 114, 6050; (c) Curran, D.P.;
G.; Cook, J.M. Tetrahedron Lett. 1988, 29, 171; (g) Fevig, T.L.; Jasperse, Totleben,
\320\241\320\240.; M.J. Synlett
Barner, B.A.; Liu, Y.; Rahman A., Md. Tetrahedron 1992, 943.
1989,45,6101. 11.Watanabe, Y.; Nakamoto, C; Ozaki, S. Synlett 1993,
5. For some excellent recent reviews of the utility of 115.
samarium diiodide in organic synthesis, see: (a) 12. For a recent see:
review,Toshima, K.; Tatsuta, K.
Molander, G. A. Chem. Rev. 1992, 92, 29; (b) Soder- Chem. Rev. 93, 1503.
1993,
quist, J. A. Aldrichimica Ada 1991, 24, 15. 13. For another synthesis of paeoniflorin, See: Hata-
keyama, S.; Kawamura, M.; Takano, S. J. Am. Chem.
Soc. 1994,7/6,4081.
L. E. Overman A993)
Strychnine
33.1 Introduction
A most impressive transformation in the biosynthesis of cholesterol
is the enzyme-catalyzed conversion of the squalene oxide molecule
into lanosterol and the related conversion of squaleneoxideinto the
plant triterpenoid dammaradienol (see Scheme 1a in Chapter 6). In
one dramatic step, a complextetracyclic framework possessing no
less than seven stereogenic centers is assembled from a flat poly-
olefin chain.1 128 stereoisomeric substancescould con-
Although
conceivably be produced, only one is formed! In R, Robinson's ele-
gant biomimetic synthesis of (\302\261)-tropinone [(\302\261)-5],2 the combination (+)-5: (+)-tropinone
of succindialdehyde B), methylamine C), and either acetone or a
salt of acetone dicarboxylic acid D) results in the formation of
tropinone through consecutive inter- and intramolecular Mannich
reactions (see Scheme1).These impressive examples illustrate, in
a particularly striking way, the marked increase in molecular com-
complexity that can attend the employment of tandem (or sequential)
transformations.3 A tandem transformation pertains to any sequence
of reaction steps in which several bonds are formed or brokenwith-
without the isolation of any intermediates.33 In addition to their aes-
aesthetic appeal, tandem or sequential transformations can be highly
atom economical.4 In an ideal situation, all of the atoms contained
within a starting material are expressed in some form in the desired
product. In this chapter, we present a beautiful application of a tan-
tandem cationic aza-Cope rearrangement/Mannich cyclization strategy
to an enantioselective synthesisof (-)-strychnine A) by L. E. Over-
Overman and his group at U. \320\241
Irvine.5
Overman's cationic aza-Cope/Mannich strategy is predicatedon
the observation that the presence of a chargedatom in a molecular
642 33 Strychnine
\321\205\320\275\320\276
MeNH2
\321\201\320\275\320\276
3
2: succin-
dialdehyde
Mannich
reaction
Me.
\\
Scheme 2.
The aza-Cope/Mannich reaction takes advantage of the facility
with which a y,S-unsaturated iminium ion, such as 6, participates
in a [3,3] sigmatropic rearrangement to give an isomeric species
which is suitably functionalized for an intramolecular and irrever-
irreversible Mannich cyclization (see intermediate 7). The aza-Coperear-
rearrangement substrate 6 is simply an unsaturated iminium ion
nucleophilic enol
\320\275\320\276
[3,3] -H
0
aza-Cope Mannich N
rearrangement reaction R
R R
3-formylpyrrolidine
6 7 8
Scheme reaction.
2. The aza-Cope/Mannich
33.2 Retrosynthetic Analysis and Strategy 643
Lactone formation
1: strychnine 9: Wieland-Gumlich aldehyde
20
Carboxymethylation;
imine formation;
tautomerization
f-BuO
aza-Cope
rearrangement
f-BuO-'X
\342\200\224\342\200\224
Epoxide //
opening
R2N
Of-Bu
15
TIPSO
Of-Bu Me,Sn
Carbonylative
Stille Of-Bu
coupling
15 16 17
TIPS= SIAPr3
Palladium-catalyzed
coupling
TIPSO
AcO' HO
Of-Bu Of-Bu
20 19
24 25
Carbonate formation
Figure 1. Presumed transition carbodiimide (DCC) and cuprous chlorideon the mixture of anti
state for reduction of C-keto jS-hydroxy esters induces a smooth syn dehydration18 to give, after
ester 21. Only one C-21 epimer chromatographic purification, (?)-butenoate 27 in an overall yield
is shown for clarity. of 89 % from 21. It is noteworthy that this of reac-
simple sequence
reactions permits the construction of the requisite trans C21-C22dou-
double bond (strychnine numbering). Treatment of 27 with excess di-
MeOCOCI, pyr.,
OH ^ OMe
CH2CI2,23\302\260C(97%)
Y
24 22
(91%)
23
NaH, Pd2(dbaKA%),
Ph3PA5%),THF,23\302\260C
,CO2Et
DCC, CuCI, NaCNBH3, TiCI4,
\"
(antl:syn> 20:1)
Dibal-H, CH2CI2,
(98%) -78 \302\260C
HO
TIPSO TIPSO
TIPSCI, tetramethyl-
guanidine, NMP, -10 \302\260C CrO3, H2SO4,
HO F5%) H20,
-5\302\260C
28 20 19
NMP = 1-methyl-2-pyrrolidinone
1. L-Selectride, PhNTf2,
THF, -78 -> 0 \302\260C
2. MeeSn2, Pd(Ph3PLA0%), (80%)
TIPSO
|,Pd2(dbaKB.5%),
Ph3As B2%),
CO,LiCI,NMP, Me3Sn
R,N 70 \302\260C
(80%)
Of-Bu
18
dba:
TIPSO
f-BuOOH, Triton-B,
)
THF,-15\302\260C(91%)
Of-Bu
16
\320\260 W-benzyltrimethyl-
=
\320\242\320\263\320\271\342\200\236
Tnton-B
1. Ph3P=CH2, THF,
ammon|Um hydroxide 0 -> 23 \302\260C
(92%)
2. TBAF, THF,
-15\302\260CA00%)
F3COCHN
1. MsCI, M\302\273r2NEt, CH2CI2,
\302\24623
\302\260C
2. LICI, DMF, 23 \302\260C
3. NH2COCF3, NaH,
Of-Bu DMF, 23 \302\260C Of-Bu
(83% overall)
15 30
f-BuO
f-BuO
(CH2O)n,
Na2SO4, [3,3]
1. LDA,NCCO2Me,
THF, -78 \302\260C
t
2. 5%HCI-MeOH,
reflux
O\342\204\226u
OH
G0% overall)
10
much less hindered a face of the A8>16 double bond. Indeed, when
enone 16 is subjectedto the action of basic tert-butyl hydroperox-
ide at -15 \302\260Cin THF, the A816 enone double bond is oxidizedin a
chemo- and stereoselective fashion to give a,/?-epoxyketone 29 in
91 % yield (see Scheme 5). Wittig methylenation of the ketone car-
carbonyl in 29, followed sequentially by fluoride-induced cleavage of
the C-20 triisopropylsilyl ether, Sn2 displacement of the derived
10%H2SO4>
MeOH, reflux
H H [ H
2. Dibal-H, CH2CI2,-78 \302\260C
G6%)
HO' o
9: Wieland-Gumlich aldehyde
CH2(CO2HJ, Ac2O,
F5%) NaOAc, AcOH, 110 \302\260C
Ac2O
__N
(-)-strychnine
33.4 Conclusion
References
1. (a) Clayton, R.B. Q. Rev. Chem. Soc. 1965,19,168; 8. a) Overman, L. E.; Kakimoto, M. J. Am. Chem. Soc.
(b) Van Tamelen, E.E.; Willet, J.D.; Clayton, R.B.; 1979, 101,1310; b) Overman, L.E.; Kakimoto, M.;
Lord, K.E. J. Am. Chem. Soc. 1966, 88, 4752; (c) Okawara, M. Tetrahedron Lett. 1979, Over-4041; c)
Van Tamelen, E.E. ibid. 1982, 104, 6480;(d) Corey, Overman, L.E.; Kakimoto, M.; Okazaki, M.E.; Meier,
E.J.; Russey, W.E.; Ortiz de Montellano, P.R. ibid. G.P. J. Am. Chem. Soc. 1983, 105, 6622; (d) Over-
1966, 88, 4750; (e) Corey, E.J.; Virgil, S.C. ibid. Overman, L. E.; Mendelson, L. \320\242.;
Jacobsen, E.J. ibid.
1991, 113, 4025; (f) Corey, E.J.; Virgil, S.C; Sar- 1983, 105, 6629.
shar, S. ibid. 1991, 113, 8171; (g) Corey, E.J.; Virgil, 9. Angle, S. R.; Fevig, J. M.; Knight, S. D.; Marquis, Jr.,
S.C; Liu, D.R.; Sarshar, S. ibid. 1992, 114,1524. R.W.; Overman, L.E. J. Am. Chem. Soc. 1993,775,
2. Robinson, R. J. Chem. Soc. 1917, 762. 3966.
3. (a) Tietze, L.R; Beifuss, U. Angew. Chem. Int. Ed. 10. Anet, FA.; Robinson, R. Chem Ind. (London) 1953,
Engl. 1993, 32, 131;(b) Ho, T.L. Tandem Organic 245.
Reactions, John Wiley & Sons: New York, 1992; (c) 11.For a review of methodology for the construction of
Hoffmann, H. M.R. Angew. Chem. Int. Ed. Engl. quaternary carbon centers, see: Martin, S.F. Tetra-
1992,31, 1332. Tetrahedron 1980, 36, 419.
4. Trost, B.M. Science (Washington, D.C.) 1991, 254, 12. Corey, E.J.; Cheng, X.-M. The Logic of Chemical
1471. Synthesis, John Wiley & Sons: New York, 1989.
5. Knight,S. D.; Overman, L. E.; Pairaudeau, G. J. Am. 13. Stille, J.K. Angew. Chem. Int. Ed. Engl. 1986, 25,
Chem. Soc. 1993,115,9293. 508.
6. For excellent recent discussions, see: (a) Overman, 14.Tsuji, J.; Shimizu, I.; Minami, I.; Ohashi, Y. Tetra-
L.E. Ace. Chem. Res. 1992, 25, 352; (b)Overman, Tetrahedron Lett. 1982, 23, 4809.
L.E. Abstracts, 33rd National Organic Symposium, 15. (a) Whitesides, G. M.; Wong, C.-H. Angew. Chem.
June 13-17, Bozeman, Montana, ACS Division of Int. Ed. Engl. 1985, 24, 617;(b) Simon, H.; Bader, J.;
Organic Chemistry, 1993, p. 96; (c) For a general Gunther, H.; Neumann, S.; Thanos, J. ibid. 1985, 24,
review of charge-accelerated[3,3] sigmatropic rear- 539; (c) Jones, J.B. Tetrahedron 1986, 42, 3351; (d)
rearrangements, see: Lutz, R. P. Chem. Rev. 1984, 84, Yamada, H.; Shimizu, S. Angew. Chem. Int. Ed.
205. Engl. 1988, 27, 622; (e) Wong, C.-H. Science
7. a) Seebach,D.; Hidber, A. Chimia 1983, 37, 449; (Washington, D. C.) 1989,244, 1145; (f) Chen, C.S.;
(b) Giese, B. Angew. Chem. Int. Ed. Engl. 1977, J. Angew.
Sih, \320\241 Chem. Int. Ed. Engl. 1989, 28, 695;
16, 125. (g) Klibanov, A.M. Ace. Chem. Res. 1990, 23, 114.
References 653
16. Deardorff, D.R.; Matthews, A.J.; McMeekin, D.S.; 22. Mander, L.N.; Sethi, S.P. Tetrahedron Lett. 1983,
Craney, C.L. Tetrahedron Lett. 1986, 27, 1255. 24, 5425.
17.Anh, N.T.; Eisenstein, O. Nouv. J. Chim. 1977, 23. Edwards, P.N.;Smith, G.F. J. Chem. Soc. 1961, 152.
7,61. 24. (a) Wieland, H.; Gumlich, W. Justus Liebigs Ann.
18. Alexandre, C; Rouessac, F. Bull. Soc. Chim. Fr. Chem. 1932, 494, 191; (b) Wieland, H.; Kaziro, K.
1971, 1837. ibid. 1933, 506, 60; (c) Hymon, J.R.; Schmid, H.;
19. (a) Knapp, S.; Hale, J.J.; Bastos, M; Gibson, F. S. Karrer, P.; Boiler, A.; Els, H.; Fahrni, P.; Furst, A.
Tetrahedron Lett. 1990, 31, 2109; (b) Knapp, S.; Helv. Chim. Ada 1969, 52, 1564.
Hale, J.J.; Bastos, M; Molina, A.; Chen, K.Y. 25.Robinson, R.; Saxton, J.E. J. Chem. Soc. 1952,982.
J. Org. Chem. 1992,57, 6239. 26. Smith, G. F. Alkaloids (Academic Press) 1965, 8,
20. Crisp, G.T.; Scott, W.J. Synthesis 1985, 335. 591.
21.Wulff, W.D.; Peterson, G.A.; Bauta, W.E.; Chan, 27.(a) Woodward, R.B.; Cava, M.P.; Ollis, W.D.;Hun-
K.S.; Faron, K.L.; Gilbertson, S.R.; Kaesler, R.W.; Hunger, A.; Daeniker, H.U.; Schenker, K. J. Am. Chem.
Yang, D.C.; Murray, C.K. J. Org. Chem. 1986, 5/, Soc. 76, 4749; (b) Woodward,
1954, R.B.; Cava,
277. M.P.; Ollis, W.D.; Hunger, A.; Daeniker, H.U.;
Schenker, K. Tetrahedron 1963, 19, 247.
\320\236
\320\220\321\201\320\236
K.C.NicolaouA994)
Taxol
34.1 Introduction
Esterification
McMurry coupling
Although taxol's unique mode of action and potential as an anti-
cancer agent underlie much of the intense interest in this cele-
\320\236 ?h 9
celebrated diterpene, synthetic chemists were most impressed with
Shapiro coupling Inspection of 1 reveals that of the fourteen carbon atoms defining the
1: taxol boundary of the molecule, nine are asymmetric and seven of these
bear some form of oxygenation. Taxol's saturated six-membered
C-ring is the site of an unusually heavy concentration of asymme-
this
asymmetry; imposing substructure contains five contiguous stereogenic
centers,and it supports the unusual and potentially electrophilic
oxetanering.
Interestingly, the stereochemical
challenge that would beset any
synthetic approach and perhaps eclipsed, by the poten-
is matched,
potentially serious problem presented by the central eight-membered
carbocycle.On the basis of unfavorable entropy, bond angle defor-
deformations, and destabilizing transannular interactions, the eight-mem-
eight-membered
ring has traditionally been regarded as one of the most diffi-
difficult to construct,915 and the development of general methods for its
synthesis has received a great deal of attention.913 The powerful
combination of the eight-membered ring and the array of oxy-
oxygenated functionality decorating the periphery of the molecule make
taxol an challenging
extremely target for synthesis.
Not surprisingly, taxol has motivated the development of many
synthetic strategies, and much fascinating science has emerged
from research in this area.2-10 Attracted by the formidable challenge
34.2 Retrosynthetic Analysis and Strategy 657
PhLi
HO
McMurry coupling
Esteriflcation S
\302\246 Oxetane AcO \320\236
\"-
rn
Ph
\" \\
1 AcO\\ /? \320\276\320\275 OTES
\320\276 \320\270
\\ \321\20710V:4, ?\" formation teso. Ph
n
H
OH 1 ^ = esterbona'
V4o
i v\302\260
HO
i \320\275 formation
Oxygenation jBzO
AcO
Shapiro coupling
McMurry
allylic \320\237
coupling 1: taxol
oxidation II
\320\276 i
'
AVi Oxetane
V\302\260 formaffon
5
14: 2-chloroacrylonitrile
TPS = Sif-BuPh2
rearrangement 11
TBS =
Sif-BuMe2
TES = SIEt3
.CO2Et Diels-Alder
\320\223
OH OH
17 16:3-hydroxy-2-pyrone
HO OH
OBn
\320\275\320\276'
.\320\273\320\277\320\273
\320\273\321\210- \320\275
<\320\273\320\273/*
The of hydrazone
synthesis 11 commences with an intermolecu-
lar Diels-Alder reaction between diene 13 and the commercially
available ketene equivalent, 2-chloroacrylonitrile A4) (see Scheme
2).13When these simple starting materials are confined to a sealed
tube and heated at 130\302\260C for three days, crystalline cyclohexene
18 is produced in 85% yield. Interestingly, and perhaps somewhat
surprisingly,18 is the only regioisomer formed in this reaction. On
the basis of the substitution pattern of diene 13, it was anticipated
that 18 ought to be the major product formed in this process. How-
However, considering that the Diels-Alder reaction is susceptible to
steric effects, we were concerned that destabilizing nonbonding
interactions in the transition state leadingto the desired regioisomer
18 might prohibit, or at least hinder its formation. Nonetheless,
34.3 Total Synthesis 661
OAc
OAc Cl
130 \302\260C [4+2]
CN
CN (Diels-Alder)
CN
13 14:2-chloroacrylonitrile
KOH, f-BuOH,
70 \302\260C
F5%)
CH2CI2,25 \302\260C
(85%)
20 19
TBS = Sif-BuMe2
becauserelative
consideredstereospecific stereochemical relation-
EtO2C
PhB(OHb,
PhH, 90 \302\260C,
17 16:3-hydroxy-2-
pyrone
1. TBSOTf,2,6-lutldine,
4-DMAP (cat),
CH2CI2, 0 \302\260C
(89% overall)
22
G6% overall)
OBn
1. LiAIH4, Et2O,
TPSO 25 \302\260C TPSO
>
2. MeO OMe
\"'OTBS
/\\
CSA (cat),
24
23
CH2CI2,25 \302\260C
TPS = SiPhjf-Bu
F6% overall)
\320\225\320\256,\320\241
dimethyl-1,3-propanediol.24In this most productive reaction, which
is based on the brilliant work of Narasaka,25 these two simple
achiral starting materials become linked to the boron atom of phen-
ylboronic acid to give mixed boronate ester 21 after expulsion of
two water molecules. The boron atom thus template and
serves as a
brings the diene and dienophilic components together to enable an
intramolecular Diels-Alder reaction, thereby allowing the regio-
chemical courseof the cycloaddition to be rigorously controlled.
This transformation is among a diverse collection of reactionsthat
are facilitated and controlled through the use of a disposable tether
\320\276
\302\2601\321\207
or atom.26 Interestingly, bicyclo[2.2.2]lactone 15, the expected
product from this reaction, participates in a lactone migration
reaction to give bicyclo[4.3.0]lactone 12. It is noteworthy that
Narasaka's boron template methodology enforces the union of
lithium aluminum
hydride (L1AIH4) unexpectedly affords alcohol
22 in 89 % overall yield. Exposure of 22 to a catalytic amount of
camphorsulfonic acid (CSA) in methanol-CH2Cl2 selectively
12 cleaves one the terf-butyldimethylsilyl ethers, providing a y-lactone
ores ores
\321\217-BuLi,THF, >= 25 \302\260C
-\302\273
\320\236
OTPS
-78 25 \302\260C
-\302\273 (82%)
h\342\200\224Y\"H
NNHSO2Ar \320\275
Si lace
11 25
TBSO TBSO
OTPS . \\ PTPS
ft*?*0*2
OBn
,OBn Su'OOH,
PhH, 25
(87%)
27
KH, HMPA-Et2O,
COCI2, 25 \302\260C
G7%)
TBSO OTPS
\320\276\320\275
\320\275\320\276
OBn I- TBAF
OBn
(excess),
THF, 25 \302\260C
2. TPAP(cat-), Zn-Cu, DME,
\320\236 NMO, CH3CN, 70\320\245B3%)
\320\271/\"\320\276
\320\236 '
JL^ CH2Ci2,25\302\260C
\\>JL-
\302\273 \302\273
G4%overaii) if \\
(\302\261)-29
27
reaction sequence (i.e. coupling, oxidation, reduction) permits the
construction of a key carbon-carbon bond and allows the vicinal
TBSO OTPS oxygens at carbons 1 and 2 to be correctly positioned in space.
OBn As discussed previously, the use of a cyclic protecting group
bridging the vicinal hydroxyls at C-l and C-2 is an important fea-
feature of this synthesis. It was hoped that this device would facilitate
the pending pinacol couplingreactionby conferring conformational
rigidity to the cyclization precursor (see intermediate 7, Scheme 1).
This tactic, together with the discovery that the C-l hydroxy, C-2
benzoatesystem of the natural product can be unveiled in one step
upon treatment of a simple cyclic carbonate with phenyllithium
(see Figure 1), led to the selection of a carbonate as the cyclic pro-
protecting group. Treatment of a solution of diol 27 in HMPA-Et2O at
25 \302\260C
with potassium hydride and phosgene results in the formation
of carbonate 28 G7 % yield). Cleavage of both silicon protecting
groups with excess tetra-n-butylammonium fluoride then furnishes
a diol that can be easily oxidized to key intermediate 7 with TPAP-
NMO27 G4 % overall yield).
A critical stage in the synthesis has been reached.The constitu-
of dialdehyde
constitution 7 would seem to lend itself to a reductive carbon-
yl coupling reaction. If feasible, such a process would accomplish
the construction of taxol's strained eight-membered ring, and it was
hoped that carbons 9 and 10 would not, at any stage during the
course of their union, be deprivedof their valuable oxygen atoms. A
Ti\302\260-mediated pinacol coupling, also known as the McMurry cou-
coupling reaction, appeared particularly attractive. It is appropriate at
this point to acknowledge important precedent that encouraged
the selection of this particular cyclization reaction. In 1986, Kende
and his collaborators disclosed a convergent synthesis of a rather
advanced tricyclic taxane triene via a strategy that features a
McMurry coupling reaction.31 Although the yield for the crucial
cyclization step was modest B3 % yield), it was encouraging that
the congested taxane carbonframework could be assembled through
direct closure of the eight-membered B-ring. Moreover, refinements
of and further insights into the McMurry coupling reaction were
34.3 Total Synthesis 667
relationships, all of the chiral intermediates described thus far are racemic.
We were cognizant of the possibility that our racemic synthetic
material couldbe resolvedafter the introduction of an enantiomeri-
cally pure taxol side chain. Nonetheless, the vicinal hydroxyl (\302\261)-29
+ diastereoisomer
1. resoiution
2. K2CO3,MeOH,25 \302\260C
(90%)
(\302\261)-29
(J9
1. Ac2O, 4-DMAP,
CH2Ci2,25 \302\260C
2. TPAP (cat), NMO,
CH3CN, 25 \302\260C 1. HCi,
(88% overaii) MeOH,
H2O, 25 \302\260C
AcO AcO 2. Ac2O,
OBn OBn OBn
BH3\302\273THF, THF, 4-DMAP,
6 0 then
\302\260C; H2O2, CH2Ci2
9 _____
5 aq. NaHCO3 OH
\342\200\242O E5%) overaii)
the a isomer
C-5 was established by conversion to and correlation
with a degradation product. From intermediate 32, the construction
of the oxetane ring only requires a few functional group manipula-
manipulations. Cleavage of the isopropylidene ketal in 32 with HC1 in
methanol, followed by selective acetylation of the primary hydrox-
yl group, furnishes intermediate 33 in 76 % overall yield.
Hydrogenolysis of the C-7 benzyl ether, followed sequentially by
selective triethylsilylation of the newly liberated C-7 hydroxyl and
mesylation of the C-5 secondary hydroxyl, provides compound 34
in 60% overall yield (see 33\342\200\224>34, Scheme 6). On the basis of
Potier's studies,35 it was hoped that the C20 hydroxyl group,
AcO AcO
OTES
1. H2,10%Pd(OHJ-C(cat.),
EtOAc, 25 \302\260C
5
refiux
AcO
OTES
1. Ac2O,4-DMAP,
CH2Ci2, 25 \302\260C
(94%)
1. NaN(SiMe3J,bj AcO
AcO THF, 0 X Ph \320\236
OH
OTES
(86% based on
89% conversion)
HO--
OH
2. HF\302\253pyr.,THF,
25 X (80%) BzO AcO
Bz6
1: (-)-taxoi
OTES derived from cleavage of the C-20 acetate in 34, could be induced
to displace the proximal C-5 mesylate in an intramolecular fashion.
To this end, selective cleavage of the C-20 acetate in 34 can be
brought about with basic methanol at 0\302\260Cto give the desired diol
mesylate. When a solution of the latter substance and excess tetra-
OAc n-butylammonium acetate in butanone is heated to reflux, the
desired intramolecular etherification reaction takes place, with
inversion of configuration at C-5, to give hydroxy oxetane 35 in
72% yield. Despite its hindered nature, the C-4 tertiary hydroxyl
AcO \320\236
OTES
group in 35 can be acetylated smoothly with acetic anhydride and
4-dimethylaminopyridine D-DMAP) to give compound 5 (see
Scheme 1) in 94% yield.
Throughout the course of this synthesis, the five-membered car-
carbonate ring has served several important functions. In addition to
its passive role as a protecting group, the carbonate ring confers
rigidity to pinacol cyclization precursor 7 and forces the two alde-
aldehyde carbonyls into reasonably close proximity; although an exami-
examination of molecular models suggested that this should have a very
favorable effect on the cyclization event, there is certainly room for
improvement in this most crucial stage. It was also anticipated, on
the basis of chemical degradation/reconstitution studies, that the
carbonate ring could also serve as a direct precursorto taxol's C-l
hydroxy and C-2 benzoate functions (see Figure 1). Indeed, treat-
treatment of compoundphenyllithium 5 with fur- at -78 in
\302\260C THF
furnishes, in the desired hydroxybenzoate ester4 (Scheme
80 % yield,
6). It is certainly noteworthy that the other three carbonyl groups
and the oxetane ring are impervious to the action of phenyllithium
AcO
under these conditions. The compatibility of the C-9 keto function,
\320\236
OTES the two acetate esters, and the oxetane ring with this transformation
presumably reflects the highly effective steric shielding that these
References
1. Mann, J. Nature (London) 1994, 367, 594. Vu, P.; Tang, S.; Zhang, P.; Murthi, \320\232. Gentile,
\320\232.;
2. For reviews, see: (a) Kingston, D.G.I.; Molinero, L.N.; Liu, J.H. ibid. 1994, 116, 1599.
A. A.; Rimoldi, J.M. Prog. Chem. Org. Nat. Prod. 8. Masters, J. J.; Link, J.T.; Snyder, L.B.; Young, W.B.;
1993, 61, 1; (b) Nicolaou, K.C.; Dai, W.-M.; Guy, Danishefsky, S. J. Angew. Chem. Int. Ed. Engl. 1995,
R.K. Chem. Int. Ed. Engl.
Angew. 1994, 33, 15. 34, 1723.
3. Wani, M.C.; Taylor, H.L.; Wall, M.E.; Coggon, P.; 9. (a) Illuminati, G.; Mandolini, L. Ace. Chem. Res.
McPhail, A.T. J. Am. Chem. Soc. 1971,93, 2325. 1981, 14, 95; (b) For an excellent review, see: Peta-
4. Schiff, P. \320\222.;
Fant, J.; Horwitz, S.B. Nature (London) sis,N.
A.; Patane, M.A. Tetrahedron 1992, 48, 5757.
1979, 277, 665. 10. S. Org. Prep. Proced. Int. 1991, 23, 465;
(a) Swindell, \320\241
5. Denis,J.-N.;Correa, A.; Greene, A.E. J. Org. Chem. (b) Blechert, S.; Miiller, R.; Beitzel, M. Tetrahedron
1990,55, 1957. 1992, 48,6953.
6. Nicolaou, K.C.; Yang, Z.; Liu, J.J.; Ueno, H.; Nartter- 11. Nicolaou, K.C.; Nantermet, P.G.; Ueno, H.; Guy,
met, P. G.; Guy, R. K.; Claiborne, C.F.; Renaud, J.; R. K. J. Chem. Soc, Chem. Commun. 1994, 295.
Couladouros, E. A.; Paulvannan, K.; Sorensen, E. J. 12. For reviews of the Diels-Alder reaction, see: (a)
Nature (London) 1994, 367, 630. See also: Nicolaou, Sauer, J. Angew. Chem. Int. Ed. Engl. 1966, 5, 211;
K.C.; Guy, R.K. Angew. Chem. Int. Ed. Engl. 1995, 34, (b) Sauer, J. ibid. 1967, 6, 16;(c) Martin, J.G.; Hill,
2079. R.K. Chem. Rev. 1961, 61, 537; (d) Oppolzer,W. In
7. (a) Holton, R.A.; Somoza, C; Kim, H.-B.; Liang, F; Comprehensive Organic Synthesis, Trost, B.M.;
Biediger, R.J.; Boatman, P. D.; Shindo, M.; Smith, Fleming, I., Eds., Pergamon Press: New York, 1991,
C.C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C; Vol. 5, p. 315; (e) Carruthers, W. Tetrahedron
Vu, P.; Tang, S.; Zhang, P.; Murthi, \320\232. Gentile,
\320\232.; Organic Chemistry Series: CycloaddilionReactions
L.N.; Liu, J.H. J. Am. Chem. Soc. 1994, 116, 1597; in OrganicSynthesis, Baldwin, J. E.; Magnus, P. D.,
(b) Holton, Kim, H.-B.; Somoza, C; Liang,
R.A.; E; Eds., Pergamon Press: New York, 1990, Vol. 8; (f)
Biediger, Boatman, P.D.; Shindo,
R.J.; M.; Smith, Kahn, S.D.; Pau, C.F.; Overman, L.E.; Hehre, W.J.
C.C.; Kim, S.; Nadizadeh, H.; Suzuki, Y; Tao, C; J. Am. Chem. Soc. 1986,108,7381.
672 34 \320\242\320\260\321\205\320\276!
23. For an informative review of Diels-Alder cycloaddi- 34. Gerlach, H. Helv. Chim. Acta 1978, 61, 2773.
tions of 2-pyrones, see: Afarinkia, K.; Vinader, V.; 35. Ettouati, L.; Ahond, A.; Poupat, C; Potier, P.
Nelson, T.D.; Posner, G.H. Tetrahedron 1992, 48, Tetrahedron 1991, 47, 9823.
9111. 36. (a) Holton, R.A. Eur. Pat. Appl. EP400.97I, 1990;
24. Nicolaou, K.C.; Liu, J. J.; Hwang, C.-K.; Dai, W.-M.; (b) Holton, R.A. Chem. Abstr. 1991, 114, 164568q;
Guy, R. K. J. Chem. Soc, Chem. Commun. 1992, (c) Ojima, I.; Habus, I.; Zhao, M.; Georg, G.I.; Jaya-
1118. singhe, L.R. J. Org. Chem. 1991, 56, 1681;(d)
25. (a) Narasaka, K.; Shimada, S.; Osoda, K.; Iwasawa, Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park,
N. Synthesis 1991, 1171; (b) Shimada, S.; Osoda, K.; Y.H.; Sun, \320\241\320\234.; Brigaud, T. Tetrahedron 1992, 48,
Narasaka, K. Bull. Chem. Soc.Jpn. 1993,66, 1254. 6985; (e) Ojima, I.; Sun, \320\241\320\234.;
Zucco, M.; Park,
26. For selected examples, see: (a) Tamao, K.; Maeda, Y. H.; Duclos, O.; Kuduk, S. Tetrahedron Lett. 1993,
K.; Yamaguchi, Ito, Y J. Am. Chem. Soc. 1989,
\320\242.; 34, 4149.
\321\201\320\276*\320\275
\320\276\320\275
Zaragozic Acid A /
Squaiestatin SI
35.1 Introduction
HMG CoA
\320\276 reductase
\320\233\320\2451
\320\275\320\276 SCoA \320\275\320\276
other
biomolecules
5: farnesyi pyrophosphate (FPP)
zaragozic squaiene
acid A synthase
\342\200\242.\302\246\342\200\242*v
O(P)
NADPH
squaiene 'H
7: squaiene synthase 6: presquaiene pyrophosphate
squaiene
epoxidase
8: 2,3-oxidosqualene 9: choiesteroi
The search for inhibitors of this pathway began with the first key
regulatory enzyme, HMG CoA reductase. Several clinically useful
inhibitors of HMG CoA reductase now known. One of the most
are
successful, Mevacor, produced by Merck, is one of the pharmaceu-
pharmaceutical
industry's best selling products. However, the problem with
inhibiting a branched biosynthetic pathway at an early point is that
the biosynthesis of other crucial biomolecules may also be inhib-
inhibited. Indeed, there is some evidence that levels of ubiquinone and
the dolichols are affected by some HMG CoA reductase inhibitors.
Consequently,efforts have recently been directed towards finding
inhibitors of squalene synthase, the enzyme controlling the first
step on the route to cholesterol after the FPP branch point.
Medicinal chemistry has frequently drawn inspiration and impor-
important new leads from the examination of natural products, and this
was proven to be the case once more. In 1992, researchers at Merck
and Glaxo announced, almost simultaneously, the independent dis-
discovery of the same new classof natural products from two different
fungi. As a consequence,the same family of natural products has
two names - the
zaragozic acids (MerckL or the squalestatins
(Glaxo).5 A typical member of the family, zaragozic acid A (squa-
lestatin SI) A) was shown to have a tremendous affinity for squa- 1: zaragozicacid A
squalene synthase (K, = 79 for rat
\321\200\320\274 microsomal squalene synthase)
and could even lower serum cholesterol levels in vivo in a popula-
populationof marmosets.6
From a structural standpoint the central tricarboxylic acid \"core\"
is the most interesting portion the zaragozic acids;of
it is common
to all members: the others differ only in the nature of the alkyl side
chain at C-l and the ester side chain at C-6. The core is very heavi-
heavilyoxygenated, quite unprecedented, and offered a significant syn-
synthetic challenge. This,
together with their amazing biological activ-
activity, made the
zaragozic acids exciting targets for synthesis in the
early 1990s. Later in this chapter, we describe the Nicolaou syn-
synthesis of zaragozic acid A A).7 The keynote of this synthesis was
the use of the Sharpless Asymmetric Dihydroxylation (AD) reac-
reaction,8 a process still in its infancy but which promises to be a
powerful tool for the synthesis of complex oxygenated molecules.
In the following sections and before we describe the synthesis
of zaragozic acid A, we give a brief historical introduction to the
dihydroxylation reaction, then describe the development of the
Sharpless AD and someof its recent applications.
1. OsO4 HO OH
2. H2SorNs2SO3
\\ /
/=\\ *- /\342\200\224\\
r' rr reduction
reduction r'
r' r
10 11
(Scheme 12). It was postulated that the olefin (e.g. 12) undergoes a
[3+2] cycloaddition with OSO4 to give the osmate(vi) glycolate
ester 13. The glycolate 13 is stable and can be isolatedand charac-
characterized. Reduction, usually with H2S or Na2SO3, gives the diol 14.
Although this is generally an excellent reaction, the expense
incurred in stoichiometric dihydroxylation reactions has precluded
its use in all but the most crucial situations. One of theseis repre-
represented in Corey's synthesis of the ginkgolide compound, (\302\261)-bi-
lobalide [(\302\261)-17] (see 15-\320\2306, Scheme 4).14
The first OsO4^cooxidant combinationsappear to be the Hof-
mann reagent, OSO4-MCIO3(M = Na, K),10 and later improve-
improvements (M = Ag, Ba) by Braun.15 Although there have been substan-
substantially better methods for some time, these conditions are still
occasionally used in undemanding situations. The other classical
method, Milas's reagent (OSO4-H2O2), is also still used, but over-
oxidation is frequently a problem and yields are sometimeslow.
35.1 Introduction 677
\321\201- \320\276
X OS
/ \\
\302\260v H2Sor \320\235\320\236
\320\236 \320\236
\320\236\320\235
\\\320\223 [3+2] /\302\260
Na2s\302\2603
O
Ocycloaddition \\\342\200\224/ reduction \\ /
12 13 14
Scheme 3. The Criegeemechanism for the osmium tetroxide mediated dihydroxyiation reaction.
OAc OsO4>
pyridine,
15 (+)-17:(\302\261)-bilobalide
18
Scheme 6. Corey's synthesis of gibberellicacid GA3 B2) employing the Upjohn catalytic dihydroxylation
procedure.
OH HO,
1. OsO4A.1 equiv),
PhCH3> 25 8-24
\302\260C, h
2. LiAIH4, Et2O
23 24a 24b
=
3-18% \320\265\320\265
ligand
25
MeO
82% \320\265\320\265
ligand = (85% yield)
83.2% \320\265\320\265
(90% yield)
ona alkaloids, were tried instead. There are a large number of ter-
\320\275
\320\275.
-NH HN-
28@.13equiv),
NMOA.2equiv),
OsO4 @.2%),
acetone-water,
23 0\302\260C,
15h(89%) 24a [94% \320\265\320\265]
The third and very valuable discovery that the new phthalazine
(PHAL) and pyrimidine (PYR) ligand classes C2-35, Figure 2)
30: trloxoosmium(VIII)
L
glycolate
L = chiral ligand
NMM = 4-methyl-
morpholine
Scheme 9. The two catalytic cycles for the Sharpless AD with NMO as a cooxidant.
684 35 ZaragozicAcid A/Squalestatin S1
N N
Et
OMe OMe
Figure 2. Structures of phthalazine C2,33), pyrimidine C4,35), and indoline C6,37) ligands used in the
and K2CO3), and \"AD-mix P\" (the same, but with (DHQDJPHAL
instead of (DHQJPHAL, Figure 2). The formulation is such that
all one has to do is to stir equal amounts of water and ter?-butanol,
1.4 g of AD-mix per mmol of itself at 0 \302\260C
olefin, and the olefin
until the reaction is complete (usually overnight). This straightfor-
straightforward
recipe is beginning to reduce the commonly perceived\"black
art\" of organic chemistry to a nearly embarrassinglevel of simpli-
simplicity.
As discussed in Chapter 19, the concept of reagent control has
revolutionized chemistry in the latter part of the 20th century. By
35,1 Introduction 685
P-face
\"HO OH\"
NW
SW SE
\"HO OH\"
a-face
K2OSO2(OHL>
K3Fe(CNN,
EtO2C K2CO3,MeSO2NH2, EtO2C
OH
f-BuOH-H2OA:1),
25 \302\260C,
12 h
39a 39b
no ligand \342\200\224
0sO4 used \"I 2
ligand = 33 [(DHQDJPHAL]
< 20
= 32
10 1
ligand [(DHQJPHAL]
HO OH
HO,
40: (+)-castanospermine
NMO, acetone,
OPiv H2O (> 95%)
[42a:42bca. 1:1.7]
\320\236\320\235
\320\247\320\236
OAc
\320\275\320\2762\321\201-^.\320\276 Ph
ho2c-V\"
\321\2010*\320\275
\320\276\320\275 OBn \320\236\320\235
\320\236 OPiv
pathway A A
[3+2] l
\320\276*
OsO4
+ H2Sor OH
Na2SO3
L
reduction R
46
[2+2]
k> 1 El chiral ligand
pathway \320\222
^
44: osmaoxetane
Scheme 12. Mechanisticalternatives: [2+2] vs. [3+2] cycloaddition of OsO4 and an olefin.
688 35 Zaragozic Acid A/Squalestatin S1
1. (DHQfePHAL@.5%), \320\236\320\235
\320\236
K2OsO2(OHL @.2%),
OMe
NMOA.45equiv), \320\273\320\275
47 f-BuOH, 25 23
\302\260C, h G2%)
2. recrystallize from PhCH3 48 [99% \320\265\320\265]
1. MeC(OMeK, p-TsOH,
CH2CI2>25 \302\260C,
5 h
2. MeCOBr,CH2CI2,-15\302\260C,
2h F0%, 2 steps)
1. NaN3, DMF, 50 19
\302\260C, h
i
so
25 \302\260C
G4%, 2 steps)
49
OBz OAc
52: taxol
Scheme 13. Sharpless's asymmetric synthesisof the C-13 side chain 51 of taxol E2).
35.1 Introduction 689
72 % yield % \320\265\320\265
after and 99
recrystallization. Although the original
secondary oxidant, NMO, was used instead of \320\232\320\267\320\240\320\265(\320\241\320\234)\320\261-\320\232\320\263\320\241\320\236\320\267,
which resulted in a slightly lower the much
\320\265\320\265, higher concentration
at which the reaction could be run more than compensated. Differ-
- a
Differentiation of the two hydroxyl groups of the diol potential prob-
problem in any application
- can be achieved by forming a mixed
ortho ester which can subsequently be opened regioselectively at
the benzylic positionby bromide ion to give the anti bromo acetate
49 (regioselectivity 6:1). Displacement of the bromide by Sn2
attack of azide with of configuration, followed sequen-
inversion
sequentially by reduction azide to the amine and transacylation
of the
affords acetamide 50. Hydrolysis of the acetamide, benzoylation,
and hydrolysis of the ester then gives the C-13 side chain 51 of
taxol E2) in 23 % overall yield from 47. In this manner, several
moles of 51 can be made through a straightforward, cheap, and
relatively environmentally safe process.
Camptothecin Scheme 14) is an important
E5, anticancer agent.
Researchers at Glaxo32 required large amounts of enantiomerically
applicationof the AD not only illustrates the utility of the AD, but reminds
us that the magic AD-mix powders do not always work the first
time! Starting with 2-methoxypyridine, a seriesof standard manip- 33: (DHQDJPHAL
manipulations provides the enol ether 53. Standard AD with AD-mix P
[which contains (DHQDJPHAL C3) as the chiral ligand] and
MeSChNtb gave a slight preferencefor the desired enantiomer, but
only in 26 % \320\265\320\265.
However, by changing the ligand from
(DHQDJPHAL C3) to (DHQDJPYR C5), the was
\320\265\320\265 increased MeO.
1. (DHQDfePYR,
OMe
K3Fe<CNN,
K2OsO2(OHL>
K2CO3, MeSO2NH2,
1
f-BuOH-H2OA:1),
0 \302\260C,
24 h G0%)
2. l2, CaCO3
\320\236
\320\236\320\235
SS: camptothecin
7: squalene
1. AD-mix a
2. acetonide formation
3. repeatsteps1 and 2
three times
4. aq. HCI-MeCN
G9% overall)
HO i HO i HO i
OH OH OH
56 [100%\320\265\320\265]
K2CO3 C equiv),
. . MeSO2NH2 A equiv), \342\200\236
Me0\320\273\320\220\320\273\342\200\236
0Me
MeO OMe
*.BuOH-H2OA1)
58 0\302\260C,4h 59 [18% \320\265\320\265]
PMBCI, Et3N,
4-DMAP, 23 \302\260C,
3 h (98%)
OMe OMe
same
conditions
as above
(93%)
MeO OMe
61 [>99% \320\265\320\265]
\342\200\224\320\276
63: (-)-ovalicin
Intramolecular
1: zaragozic acid A
= oxygen atom 55 ketalization
p
\320\262\320\277\320\2762\321\201
\\ 4>CO2Bn
\320\275\320\2762\321\201
\320\276\320\275
\320\275\320\276/ \320\276 OAc
HO2C
\320\276\320\275
\\
\321\201\320\276?\320\275\320\235
67 66 ^ Dithiane anion
addition
oxidation
\320\237 state P = protecting group
11 adjustments DTBMS = Sif-Bu2Me
dihydroxylations
OP \321\201
Stille coupling 71 72
now looks rather less intimidating than its ketalized form and more
like a familiar problem of acyclic stereocontrol. Cleavage of the
C1-C7 bond in 66 yields two fragments of approximately equal
size. The C-l alkyl side chain is conveniently excised as the acyl
anion equivalent, dithiane 67, thus providing an excellent opportu-
opportunityfor late-stage convergency. It was also anticipated that the
35.2 Retrosynthetic Analysis and Strategy 693
double bond in 72. This strategy has the advantage that by having
the C-10 carbon atom in 70 at a higher oxidation state, a \"handle\" is
attached otherwise highly
to an symmetrical molecule.
The retrosynthetic analysis described above outlines a triply con-
convergent strategy towards the synthesis of zaragozic acid A A). The
most pleasing aspect of the retrosynthetic strategy is the rapid and
enantioselective manner in which the \"two-dimensional\" molecule
694 35 ZaragozicAcid A/Squalestatin S1
reconstitution degradation
OSEM
HO, OH
74 75
OSEM
OPMB
SEM = CH2OCH2CH2Si(CH3K
PMBO Sn-n-Bu3
76
I
Pd(CH3CNJCI2,
DMF, 22 3 d
\302\260C, G0%)
AD-mix p
pmbo
pmbo^ osem
^osem \"Super\"
A.4g/mm0|dJene)i pmbo^ QH
MeSO2NH2 OSEM
PMBO B.0-3.0equiv), pmbo'
\320\273
*- MeO2C OH
\320\236 24-72
\302\260\320\241,
JJ/\320\261^\320\236\320\234\320\265
h
1
C0%, plus 44%
79 recovered 79) 80 [83%\320\265\320\265]
Scheme 19. Synthesisof aldehyde 68: the Sharpless AD of diene 79 and synthesis of 80.
696 35 Zaragozic Acid A/Squalestatin S1
OMe
80 (Scheme 19). In a subsequentpaper,7d we reported that a num-
number of combinations of protecting groups were surveyed before
\320\237\320\276.
the diastereoselective dihydroxylation.
The next key step, the second dihydroxylation, was deferred
until the lactone 82 had been formed from compound 80 (Scheme 82
20). This tactic would alleviate some of the steric hindrance around
the C3-C4 double bond,and would create a cyclic moleculewhich
was predicted a
to have greater diastereofacialbias. The lactone
can be made by first protecting the diol 80 as the acetonide 81
(88 % yield), followed by oxidative cleavage of the two PMB
groups with DDQ (86 % yield).43 Dihydroxylation of 82 with the
standard Upjohn conditions17 furnishes, not unexpectedly,a quanti- OSEM
A:1:1),0\302\260C, 18h(83%)
c\302\260x
83 82
\\s> 4^
\320\276\320\262\320\277
TPSO \320\276\320\275
\320\276\320\275
\320\275\320\276\342\200\2248
1. TPSCI, imidazole, 4-DMAP, \\ ^CHO
V3_J
4 DMF, 22 \302\260C,
12h(89%)
OSEM OSEM
2. Dess-Martin periodinane, 10 \320\236
CH2CI2,22 C, 24 h (89%)
\302\260x \302\260x
84 85
(97%)
1. CH3N(TMS)COCF3,
ohc ores 100 2h HO\342\200\224,
OH
\302\260C,
:^CO 2. PPTS, CH2CI2-Me0H
*OSEM <10:1). 22 5 min
\302\260c. OSEM
-* .
3. Dess-Martinperiodinane,
CH2CI2, 22 C, 2 h
(97% 3 steps)
87 86
Scheme 20. Synthesis of aldehyde 68: the diastereoselective dihydroxylation of 82 and synthesis of 87.
35.3 Total Synthesis 699
\320\276\320\275\321\201
p\342\204\242s BnO2C Bno2c
*^CO 1. NaCIO2, NaH2PO4,
2-methyl-2-butene,
OSEM
frBuOH-H2OD:1),
22 3 h
\302\260C,
\302\260X \302\260X
2. DCBI, PhCH3,
100 \302\260C,
1 h 88 F0%, 2 steps) 89A6%, 2 steps)
CHO periodinane,
i OH
CH2CI2, 22 \302\260C,
30 mln (93%)
\302\260\302\260X\302\260 \302\260x \302\260X
68 91 90
1. CH3N(TMS)COCF3, 80 \302\260C,
2 h
2. PPTS, CH2CI2-MeOHA0:1),
22 \302\260C,
5 min A00%, 2 steps)
35.3.3 ModelStudies
In total synthesis, model studies are frequently performed on sim-
simpler systems prior to the final assault on the target molecule. In the
92: 2-methyl-1,3-dithiane
synthesis of zaragozicacid A A), 2-methyl-l,3-dithiane (92) was
employed as a simple model for the more elaborate dithiane 67.
ODTBMS
Deprotonation of 92 with \320\270-butyllithium under standard condi-
CS
conditions47 and addition of the aldehyde provides a mixture of two
diastereoisomers, 93 and 94 (Scheme
22), in approximately equal
amounts. One of the diastereoisomers (93) lacks the TMS group, 67
700 35 Zaragozic Acid A/Squalestatin S1
TMSO
OTMS BnO,C HpCO2Bn
BnO2C \342\200\242 BnO2C I
^COB 9H
92
n-BuLI, THF, -40 \302\260C;
BnO2C CO2Bn
95
98 99
HO OH
7/
\342\200\2426
1. LiOH, THF-HZOA:1),
22 \302\260C,
19h(90%)
Scheme 22. Synthesisof model compound 101 via a thermodynamically driven rearrangement of 95.
35.3 Total Synthesis 701
\320\25081\320\255\320\2241\320\256. \320\234\320\265\320\236\320\2639
30 min (87%)
81%
G3%)
(83%, \320\265\320\265)
PMBO
PMBO
AIMe3, n-BuLi, PhCH3,
-20 C, 20 h (89%)
109
1. DDQ, CH2CI2,4\320\224
mol. sieves,
22 \302\260C,
5 h E3%)
2. Dibal-\320\235, CH2CI2,
-78 2 h
22 \302\260C,
\320\275> (81%)
1. (COCIJ,DMSO,CH2CI2 r-,
-78 then
\302\260C; Et3N, /
2 h (98%) 40-
2- THF, 35 \302\260C,
[\320\242\320\223\320\223|.
110
6 h G3%)
1. Dess-Martin 2. Tebbe reagent,
periodinane, THF, 22 X, 1 h (85%)
CH2Ci2,22 \302\260C,3. HSCH2CH2CH2SH,
Tebbe reagent = 20 min (92%) Dibal-H,PhH, 22 C,
20 h F4%)
= Sif-Bu2Me
DDQ, CH2CI2-
H2O B0:1), 22 \302\260C,
ODTBMS OPMB
2. DTBMSOTf,
2,6-lutidine,
4-DMAP, 70 8 h
\302\260C, (87%)
67 113
O3,CH2CI2,
-78\302\260C,
30 S
1. Ph3P=CHCO2Me,
CH2CI2,22 \302\260C,
3 h
B:1),
2. LiOH, MeOH-H2O
!
OH 22 3 h
\302\260C,
B7% overall from 114,
64 92%de) 117
Scheme24.
Synthesis of C-6 acyl side chain 64.
ODTBMS
\320\276
ODTBMS
BnO2C CO2Bn
1.8%HCI-MeOH,
\320\234\320\265\320\236\320\263\320\241
78 \302\260C,
21 h D5%) q | | ODTBMS
\"OH
121 120
HO OH
7'
\302\2466 OH OPMB
CI3CC(OPMB)=NH,
CSA,CH2CI2,22\302\260C
BnO2C
BnO2C min B1%,
45 plus
36% recovered122)
73
1. EDC, \320\246\320\2751,
4-DMAP, CH2CI2,
22 10.5
\302\260C, h D7%, 3:2
HO OH
OPMB mixture of C-6/C-7 esters)
2. TESOTf,pyr., CH2CI2,
22 20
\302\260C, min G9%)
B0:1),
3. DDQ,CH2CI2-H2O
22 1 h
\302\260C, (98%)
73
1. Ac2O,pyr., 4-DMAP,
CH2CI2, 22 4 h
\302\260C, (99%)
2. TBAF, THF, 0 15
\302\260C, min (85%)
10%Pd-C,
1,4-cyclohexadiene,
1,4-dioxsne,
110\302\260C,
2 h E0%)
EDC=
N
H
1-{3-dimethylaminopropyl)-
3-ethylcarbodiimide
hydrochloride scldA
1: (+)-zaragozic
35.4 Conclusion
References
1. American Heart Association. 1991Heart and Stroke 6. Baxter, A.; Fitzgerald, B.J.; Hutson, J.L.; McCarthy,
Facts. American Heart Association, Dallas, 1991. A.D.; Motteram, J.M.; Ross, B.C.; Sapra, M.; Snow-
2. (a) Lipid Research Clinics Program, J. Am. Med. den, Watson, N.S.; Williams, R.J.; Wright,
M.A.; \320\241
Assoc. 1984, 251, 351; (b) Lipid Research Clinics /. Chem. 1992, 267, 11705.
Biol.
Program, ibid. 1984, 251, 365. 7. (a) Nicolaou, K.C.; Nadin, A.; Leresche, J.E.; La
3. Stryer, L. Biochemistry, 3rd ed., W.H. Freeman: New Greca, S.; Tsuri, \320\242.;
Yue, E.W.; Yang. Z. Angew.
York, 1988. Chem. Int. Ed. Engl. 1994, 33, 2187;(b) Nicolaou,
4. Bergstrom, J.D.; Kurtz, M.M.; Rew, D.J.; Amend, K.C.; Nadin, A.; Leresche, J.E.; Yue. E.W.; La
A.M.; Karkas, J.D.; Bostedor, R.G.; Bansal, V.S.; Greca, S. ibid. 1994, 33, 2190; (c) Nicolaou, K.C.;
Dufresne, VanMiddiesworth,
C; F. L.; Hensens. O. D.; Yue, E. W.; Naniwa, Y; De Riccardis, R; Nadin, A.;
Liesch, J.M.; Zink, D.L.; Wilson, K.E.; Onishi, J.; Leresche, J.E.; La Greca, S.; Yang, Z. ibid. 1994, 33,
Milligan, J. A.; Bills, G.; Kaplan, L.; Nallin Omstead, 2184; (d) Nicolaou, K.C.; Yue, E.W.; La Greca,S.;
M.; Jenkins, R.G.: Huang, L.; Meinz, M.S.; Quinn, Nadin, A.; Yang. Z.; Leresche, J.E.; Tsuri, \320\242.;
L.; Burg, R.W.; Kong, Y.L.; Mochales, Mojena, S.; Naniwa, Y; De Riccardis, F. Chem. Eur. J., 1995, 1,
M.; Martin, I.; Pelaez, R; Diez, M.T.; Alberts, A.W. 467.
Proc. Natl. Acad. Sci. U.S.A.1993,90, 80. 8. For a review of the AD, see; Kolb, H.C.; VanNieu-
5. (a) Dawson, M.J.; Farthing, J.E.; Marshall, P.S.; wenhze, M.S.; Sharpless, K.B. Chem. Rev. 1994, 94,
Middleton, R. F; O'Neill,M.J.;Shuttleworth, A.; Stylli, 2483.
C; Tait, R. M.;Taylor. P. M.; Wildman, H. G.; Buss, A. D.; 9. Makowaka, O. Ber. Dtsch. Chem. Ges. 1908, 41,
Langley, D.; Hayes, M.V. J. Antibiot. 1992, 45, 639; 943.
(b) Sidebottom, P. J.; Highcock, R.M.; Lane, S. J.; Proco- 10. For a review of the early literature, see: Schroder, M.
piou, P. A.; Watson, N. S. ibid. 1992,45, 648. Chem. Rev. 1980, 80, 187.
708 35 ZaragozicAcid A/Squalestatin S1
3329. 1994,59,6142.
12.Hofmann, K.A.; Ehrhart, 33. Comins, D.L.; Baevsky, M.F.; Hong,
O.; Schneider, \320\236.\320\222\320\265\320\272 H. /. Am.
Dtsch. Chem. Ges. 1913, 46, 1657. Chem. Soc. 1992,114, 10971.
13.Criegee, R. Justus Liebigs Ann. Chem. 1936, 522, 34. Crispino, G.A.; \320\235\320\276, Sharpless,
\320\240.\320\242.; K.B. Science
75. (Washington, D.C.) 1993,259,64.
14.Corey, E.J.; Su, W.G. J. Am. Chem. Soc. 1987, 109, 35. Corey, E.J.; Dittami, J.P. J. Am. Chem. Soc. 1985,
7534. 107, 256.
15.Braun, G. /. Am. Chem. Soc. 1930,52, 3188. 36. Corey, E. J.; Guzman-Perez, A.; Noe, M. C. /. Am.
16. Sharpless, K.B.; Akashi, K. /. Am. Chem. Soc. 1976, Chem. Soc. 1994, //6, 12109.
98, 1986. 37. Stille, J.K.; Groh, B.L. /. Am. Chem. Soc. 1987,
17. VanRheenen, V.; Kelly, R.C.; Cha, D. Y. Tetrahedron 109, 813.
Lett. 1976,25, 1973. 38. Zhang, H.X.; Guibe, F.; Balavoine, G. /. Org. Chem.
18. Corey, E.J.; Cheng, X.-M. The Logic of OKganic 1990,55, 1857.
Synthesis, John Wiley & Sons: New York, 1989, 39. Shevchuk, M.I.; Tolochko, A.F.; Dombrovskii, A.V.
p. 205. /. Gen.Chem. (Engl. Transl.) 1970, 40, 54.
USSR
19. Minato, M.; Yamamoto, K.; Tsuji, J. /. Org. Chem. 40. The rotational barrier of the C-Ca bond in methyl
1990, 55, 766. acrylate has been calculated to be around 7.4 kcal-
20. Hentges, S.G.; Sharpless, K.B. J. Am. Chem. Soc. mol-1 (Loncharich, R.J.; Schwartz, T.R.; Houk, K.N.
1980, 102, 4263. J. Am. Chem. Soc. 1987, 109, 14).
21.Cleare, M.J.;Hughes, P.C.; Griffith, W.P.; Wright, 41. Hoffmann, R.W. Chem. Rev. 1989, 89, 1841.
M. J. /. Chem. Soc, Dalton Tmns. 1977, 941. 42. Fleming, I. Frontier Orbitals and Organic Chemical
22. Jacobsen, E.N.; Marko, I.; Mungall, W.S.; Schroder, Reactions, Wiley-lnterscience: New York, 1976.
G.; Sharpless, K.B. /. Am. Chem. Soc. 1988, 110, 43. Horita, K.; Yoshioka, \320\242.; Oikawa,
\320\242.; Y;
\320\242\320\260\320\277\320\260\320\272\320\260,-
1968. For a review of ligand-accelerated catalysis, Yonemitsu, O. Tetrahedron 1986, 42, 3021.
see: Berrisford, D.J.; Bolm, C; Sharpless, K.B. 44. (a) Dess,D.B.;Martin, J.C. J. Org. Chem. 1983, 48,
Angew. Chem. Int. Ed. Engl. 1995, 34, 1059. 4155;(b) Dess, D.B.; Martin, J.C. /. Am. Chem.
23. (a) Yamada, Narasaka,
\320\242.; K. Chem. Lett. 1986, 131; Soc. 1991, 113, 7277; (c) Ireland, R.E.; Liu, L.
(b) Tokles, M.; Snyder, Tetrahedron
\320\242.\320\232. Lett. 1986, /. Org. Chem. 1993,58, 2899.
27, 3951; (c) Oishi, Hirama,
\320\242.; M. /. Org. Chem. 45. Bal, B.S.; Childers, W.E.; Pinnick, H.W. Tetra-
1989, 54, 5834; (d) Nakajima, M.; Tomioka, K.; Tetrahedron 1981,37,2091.
Iitaka, Y.; Koga, K. Tetrahedron 1993, 49, 10793; 46. For a discussion of this undeservedly neglected
(e) Corey, P.D.; Virgil, S.; Yuen, P.-W.;
E.J.; Jardine, method of esterification, see: Mathias, L. J. Synthesis
Connell, R.D. J. Am. Chem. Soc. 1989, 111, 9243; 1979, 11,561.
(f) Hanessian, S.; Meffre, P.; Girard, M.; Beaudoin, 47. (a) Seebach, D.; Corey, E.J. /. Org. Chem. 1975, 40,
S.; Sanceau, J.-Y; Bennani, YL. /. Org. Chem. 231; (b) For a recent review on the synthetic uses of
1993,58, 1991. 1,3-dithianes see: Bulman Page, PC; van Niel,
24. Cotton, F. A.; Wilkinson, G. Advanced Inorganic- M.B.; Prodger, J.C. Tetrahedron 1989, 45, 7643.
Chemistry, 5th ed., Wiley-lnterscience:New York, 48. Beauhaire, J.; Ducrot, P.-H.; Malosse, C; Rochat, D.;
1988. Ndiege, I.O.; Otieno, D.O. Tetrahedron Lett. 1995,
25. Wai, J.S.M.; Marko, I.; Svendsen, J.S.; Finn, M.G.; 36, 1043.
Jacobsen, E.N.; Sharpless, K.B. /. Am. Chem. Soc. 49. Still, W.C.; Gennari, \320\241 Tetrahedron Lett. 1983, 24,
1989, 111, 1123. 4405.
26. Sharpless, K.B.; Amberg, W.; Bennani, Y.L.; Cris- 50. (a) Katsuki, \320\242.;
Sharpless, J. Am. Chem. Soc.
K.B.
pino, Hartung, J.; Jeong, K.-S.;Kwong,
G. A.; H.-L.; 1980,102,5974; (b) Gao, Y; Hanson, R.M.; Klun-
Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. der, J.M.; S.Y.;
\320\232\320\276, Masamune, H.; Sharpless, K.B.
Org. Chem. 1992, 57, 2768. ibid. 1987,109,5765.
27. Jones, R. A. Y Physical and Mechanistic Organic 51. For example: Roush, W. R.; Adam, M.A.; Peseckis,
Chemistry, 2nd ed., Cambridge University Press: S.M. Tetrahedron Lett. 1983, 24, 1377.
Cambridge,1984. 52. Pfaltz, A.; Mattenberger, A. Angew. Chem. Suppl.
28. Kim, N.-S.; Choi, J.-R.; Cha, J.K. J. Org. Chem. 1982, 161.
1993, 58, 7096. 53. Nakatsuka, M.; Ragan, J.A.; Sammakia, Smith,
\320\242.;
29. Carreira, E. M; Du Bois, J. J. Am. Chem. Soc. 1994, D.B.; Uehling, D.E.; Schreiber, S.L. /. Am. Chem.
116, 10825. Soc. 1990, 112, 5583.
30. Sharpless, K.B.; Teranishi, A. Y; Backvall, J.-E. /. 54. Mancuso, A.J.; Huang, S.-L.; Swern, D. /. Org.
Am. Chem. Soc. 1977, 99, 3120. Chem. 1978, 43, 2480.
31. Wang, Z.-M.; Kolb, H.C.; Sharpless, K.B. /. Org. 55. Bhide, R. S.; Levinson, B.S.; Sharma, R.B.; Ghosh,
Chem. 1994,59,5104. S.; Salomon, R.G. Tetrahedron Lett. 1986, 27, 671.
References 709
56. Evans, D.A.; Ennis, M.D.; Mathre, D.J. /. Am. 61. (a) Carreira, E.M.; Du Bois, J. J. Am. Chem. Soc.
Chem. Soc. 1982, 104, 1737. 1994, 116, 10825; (b) Carreira, E.M.; Du Bois, J.
57. Oppolzer, W.; Moretti, R.; Thomi, S. Tetrahedron ibid. 1995,117,8106;(c)Evans, D. A.; Barrow, J. C;
Lett. 1989, 30, 5603. Leighton, J.L.; Robichaud, A. J.; Sefkow, M.J. ibid.
58. (a) Enders, D. In Asymmetric Synthesis, Morrison, 1994, 116, 12111; (d) Heathcock, C.H.; Caron, S.;
J. D., Ed., Academic Press: New York, 1984, Vol. 3, Stoermer, D. Presented at the 209th National Meeting
p. 275; (b) Enders, J.; DeKimpe,N.; Kep-
D.; Tiebes, of the American Chemical Society, Anaheim, CA,
pens, M.; Stevens, C; Smagghe, G.; Betz, O. /. Org. April 1995; paper ORGN 170. (e) For a discussion of
Chem. 1993,58,4881. the published syntheses see: Kelly, M.J.; Roberts,
59. (a) Newton, R.F.; Reynolds, D.P.; Finch, M.A.W.; S.M. Nature (London) 1995, 373, 192; Koert, U.
Kelly, D. R.; Roberts, S.M. Tetrahedron Lett. 1979, Angew. Chem. Int. Ed. Engl. 1995, 34, 111.
20, 3981; (b) Newton, R.F.; Reynolds, D.P.; Webb, 62. For a review of the chemistry and biology of the
C.F.; Roberts, S.M. /. Chem. Soc, Perkin Trans. 1 zaragozic acids, see: Nadin, A.; Nicolaou, \320\232.
\320\241
1981, 2055; (c) Ogawa, Y.; Nunomoto, M.; Shiba- Angew. Chem. Int. Ed. Engl. 1996, in press.
saki, M. J. Org. Chem. 1986, 51, 1625. 63. The substantial contributions of Alan Nadin and
60. A particularly convenient method to differentiate the Eddy Yue to the preparation of this chapter are grate-
C-6 C-7 hydroxyl
and groups has recently been gratefully acknowledged.
reported: ref. 61b.
Y. Kishi A994)
1: palytoxin
Palytoxin
36.1 Introduction
vinyl iodides and vinyl boronic acids; and (c) new methods for the
\320\276\320\275
CrCI2, DMF,
\302\273-
CrCI2, DMF,
25 \302\260C
(94%)
Me CrCI2, DMF,
Y 25 \302\260C
(96%)
CrCl2, DMF,
Br 1
25 \302\260C
(86%)
CrCI2, DMF,
25 \302\260C
(81%)
Scheme 1. The chromium(n) chloride-mediated carbonyl addition process of Nozaki, Takai, and Hiyama.
36.1 Introduction 713
multifunctional contexts.
Allylic bromides can also serve as progenitors for nucleophilic
organochromium reagents. An elegant example is found in Still and
Mobilio's synthesis of the 14-membered cembranoid asperdiol D)
(see Scheme 2).7 In the key step, reduction of the carbon-bromine
4: asperdiol
mixture
cleavD:1 of
diastereoisomers (Still and MobllioO
in favor of 3)
\320\241\320\236\320\263\320\234\320\265 \320\241\320\236\320\263\320\234\320\262
CrCI2, THF,
25 \302\260C,
\342\200\242\302\246
4 A mol.
sieves
\320\276\320\275
B5%)
6: dlhydropseudopterolide
Swern oxidation
CO2Mb CO2Me
epimerization
(Paquetteefa/.)8
7: gorgiacerone
(Takaiefa/.I0
DMF, 25 \320\241
D1%)
\320\276\320\275
(Takaiefa/.I0
When cc.p-unsaturated aldehydes are
employed, 1,2-addltlon products are
produced preferentially
CrCI2,NiCI2(cat.), Me ?H
DMF, 25 \"C, TBSO
ultrasound
PivO PivO'
OBn (ca. 70%)
OBn
THF, 25 \302\260C
C4%)
(Beau efa/.I3
(-BuC(O)O *-BuC(O)O
THF, 25 \302\260C
G5%)
(-BuC(O)O ^BuC(O)O
(Nicoiaou etBl.)\"
2 Cr(lll)
X = I, Br, OTf
N1A1) + 2 Cr(ll) Ni(O)
oxidative addition
Cr(lll)
RCHO
(see Takal etal.f addition
carbonyl
OH
\320\276\320\275\321\201
oc(O)t-Bu
(-BuPhjSiO.
(Kishi eta/.)
HO Me
(+)-ophiobolin \320\241
TBSO.
TBSO.
'
\320\275 \320\271\320\275\320\275! \320\275
TBS = Slf-BuMe2
= \320\241\320\2352\320\2416\320\2354-\321\200-\320\236\320\234\320\265
\320\240\320\234\320\222
\320\275\320\276
(Kishi eta/.I
hallchondrln \320\222
\320\236 Me Q Me
\321\201\320\275\320\276 CrCI2, \320\275\320\276...
, Nl(acacJ@.i%) 'ft
\320\275...
DMF F0%)
reagent which then reacts with the aldehyde. The nickel(n) pro-
produced in the oxidative addition step reenters the catalytic cycle.
Numerous applications of the Ni(n)/Cr(ii)-mediated coupling
reaction in total synthesis have already been reported.11 Some of
the more noteworthy examples derive from Kishi's laboratoriesand
played a role in the syntheses of such complex moleculesas
(+)-ophiobolin C16 and halichondrin B17 (see Scheme 5). Another
elegant application can be found in the enantioselective total syn-
syntheses of (+)-brefeldin and
\320\241 4-e/?/-brefeldin \320\241
by Schreiber and
Meyers (see Scheme 5).18
NiCi2/CrCi2 coupling
OH
Amide bond
formation .
>s \320\236Me
NiCI2/CrCI2 Me
coupling \"\"OH
Wlttig reactions;
hydrogenation
Horner-Wadsworth-
Emmona reaction
1: palytoxin
TBS = Slf-BuMe2
PMB = \320\241\320\2352\320\241\320\261\320\2354-\321\200-\320\236\320\234\320\265
Bz = C(O)C6H5
THP
TBS
'otbs
11
formation).
TBS = Sit-BuMe2
PMB = CH2C6H4-p-OMe
Bz = C(O)CeH5
THP
-JO
PPTS = pyrldlnium
p-toluensulfonate
1. PPTS, MeOH/Et2O, 42 \302\260C
OBz
PMBO
TBS ,0PMB
\320\236Me \320\236Me
.opmb
CrCI2, NICI2@.11%),
DMSO/THFA:3),32 \302\260i
1 PMBO
TBS = Slt-BuMe2
F8-82%) TBS
PMB = CH2C6H4-p-OMe
Bz = C(O)C6H5 r < \320\223-\320\223-^-0PMB
\302\260\\
MeO''
MeO'
TBSO CH(SEth
JL ja.
\302\246\302\256@
TEOC-HN
TBSO CH(SEtJ
/
\321\203'\302\273
JJ-0 X N \302\246rosso..
I I l2,NaHCO3,
<^*^ (CH3JCO/H2OA9:1)
'\302\246otbs
0\342\200\224\320\274\320\270
s/ OTBS TBSO''
TEOC-HN OTBS
26
CrCI2,NiCI2@.11%),
dMSO/THFC:1)
OCPh2D-Me0Ph)
.otbs
OTBS
TEOC-HN OTBS
28
LiCH[B(OCH2CH2CH2O)]2-TMEDA,
THF, 0 C; then EtOAc, brine/1 N HCI
OTBS
..otbs
0-
114
115, otbs tbso'' ''otbs .OTBS
/ \321\203
TEOC-HN otbs
29
OTBS
...otbs
iTBS
iTBS
otbs
\320\276\320\276
A:350) at 22 The
\302\260C. overall yield for the deprotection sequence
C1 ^>32)is ca.35%.
The final stages of Kishi's palytoxin synthesis involve the attach-
attachment of the N-acyl vinylogous urea side chain to C-l of palytoxin
carboxylic acid C2), a task that proved quite challenging and
required the development of special methods. Among these, the
most applicable to this synthesis involved the introduction of a side
chain carrying a latent double bond in the form of a phenylselene-
nyl group. Thus, reaction of a mixture of palytoxin carboxylic acid
and palytoxin <5-lactone, easily formed from palytoxin carboxylic
acid by the action of acetic acid, with the Ca-Cf amine 16 (see
Scheme 11) in pyridine at ambient temperature furnishes the corre-
corresponding C-l amide in 36% yield F2% based on recovered paly-
palytoxin carboxylic acid). Oxidation of the phenylselenenyl group by
Davis's (camphorsulfonyl)oxaziridine24 (see (A), Scheme 11) is
accompanied by spontaneous.sy/t-elimination of the resulting selen-
oxide, affording a 3:2 mixture of trans- and cis-N-acyl vinylogous
ureas in 43 % total yield. The major isomer(trans-Aa-b) of this mix-
mixture is palytoxin, and is identical to the authentic natural product.
726 36 Paiytoxin
OTBS
..OTBS
otbs
\342\200\242OTBS
TEOC =
C(O)CH2CH2SiMe3
TBS = Sif-BuMe2
PMB =
CH2C6H4-p-OMe
Bz =
C(O)C6H5
1. LiBH4, EuCi3, MeOH/Et2O A:1)
2. Ac2O, \320\241
\320\236
4-DMAP, \321\200\321\203\320\263.,
, G5-80%)
OTBS
..OTBS
OTBS
TBS
/ Me PMBO., I >0PMB
1 '
PMBO
Y^ 15 ^OPMB
\302\246otbs
Scheme 9. Coupling of key intermediates 24 and 30 and synthesis of fully protected paiytoxin carboxylic
acid 31.
36.3 Total Synthesis 727
OTBS
...otbs
.OTBS
.OTBS
Me
\342\200\242OTBS
\302\246otbs
31
OH
OH
.OH
OH
OH
AcOH
\320\276\320\275
..\320\276\320\275
,\320\276\320\275
'\320\276\320\275
115 \302\253^^
V 'o
\320\276'\321\207\320\276
H2N
A: camphor sulfonyl
oxaziridine
HO
\320\235 \321\214
\320\235
\320\276\320\275
1: palytoxin
Scheme 11. Construction of the /V-acyl vinylogous urea and synthesis of natural palytoxin A).
References 729
36.4 Conclusion
The total of
synthesis palytoxin A) is a landmark scientific
achievement. It not only extended the frontiers of target-oriented
synthesisin terms of the size and complexity of the molecules, but
also led to new discoveries and developments in the areas of syn-
synthetic methodology and conformational analysis. Among the most
useful synthetic developments to emerge from this synthesis
include the refinement of the NiCb/CrCb-mediated coupling reac-
reaction between iodoolefins and aldehydes, the improvements and
modifications of Suzuki's palladium-catalyzed diene synthesis, and
the synthesis of N-acyl vinylogous ureas.
References
1.For reviews of palytoxin, see: (a) Moore,R. E. Prog. 6. Takai, K.; Kimura, K.; Kuroda, \320\242.;Hiyama, \320\242.;
Chem. Org. Nat. Prod. 1985, 48, 81; (b) Hirata, Y.; Nozaki, H. Tetrahedron Lett. 1983, 24, 5281.
Uemura, D.; Ohizumi, Y. Handbook of Natural Tox- 7. Still, W.C.; Mobilio, D. J. Org. Chem. 1983,48,
Toxins, Tu, \320\220. Ed.,
\320\242., Marcel Dekker: New York, 1988, 4785.
Vol. 3, p. 241. 8. Rayner, Astles,
\320\241\320\234.; P.C; Paquette, L.A. J. Am.
2. Murata, M.; Naoki, H.; Matsunaga, S.; Satake, M.; Chem. Soc. 1992, 114, 3926.
Yasumoto, T. J. Am. Chem. Soc.1994,116,7098. 9. (a) Jin, H.; Uenishi, J.; Christ, W.J.; Kishi, Y. J. Am.
3. Uemura, D.; Ueda, K.; Hirata, Y; Naoki, H.; Iwashita, Chem. Soc. 1986,108,5644; (b) Kishi, Y. Pure &
T. Tetrahedron Lett. 1981, 22, 2781. Appl. Chem. 1992, 64, 343.
4. Moore,R.E.;Bartolini, G. /. Am. Chem. Soc. 1981, 10. Takai, K.; Tagashira, M.; Kuroda, \320\242.;
Oshima, K.;
103;2491. Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 1986,
5. (a) Armstrong, Beau, J.-M.; Cheon, S.H.;
R.W.; 108,6048.
Christ, W.J.; H.; Ham, W.-H.; Hawkins,
Fujioka, 11. For reviews of Ni(n)/Cr(n)-mediatedcoupling reac-
L.D.; Jin, H.; Rang, S.H.; Kishi, Y; Martinelli, M.J.; reactions, see: 1992, 248;(b) Sac-
(a) Cintas, P. Synthesis
McWhorter, W.W.,Jr.; Mizuno, M.; Nakata, M.; Stutz, comano, N. A. In Comprehensive
Organic Synthesis,
A.E.; Talamas, F.X.; Taniguchi, M.; Tino, J.A.; Ueda, Trost, B.M.; Fleming, I.; Schreiber, S.L., Eds.,Per-
K.;Uenishi, J.; White, J.B.; Yonaga, M. J. Am. Chem. gamon Press: New York, 1991, Vol. 1, p. 173.
Soc. 1989, 111, 7525; (b) Armstrong, R.W.; Beau, 12. (a) Nicolaou, K. C; Theodorakis, E. A.; Rutjes,
J.-M.; Cheon, S.H.; Christ, W.J.; Fujioka, H.; Ham, F.P.J.T.; Tiebes, J.; Sato, M.; Untersteller, E.; Xiao,
W.-H.; Hawkins, L.D.; Jin, H.; Kang, S.H.; Kishi, Y; X.-Y J. Am. Chem. Soc. 1995, 117, 1171;(b) Nico-
Martinelli, M.J.; McWhorter, W.W.,Jr.; Mizuno, M.; Nicolaou, K.C.; Rutjes, F. P.J.T.; Theodorakis, E.A.;
Nakata, M.; Stutz, A. E.; Talamas, F. X.; Taniguchi, Tiebes,J.; Sato, M.; Untersteller, E. ibid. 1995, 117,
M.; Tino, J.A.; Ueda, K.; Uenishi, J.; White, J.B.; 1173.
Yonaga, M. ibid. 1989, 111, 7530; (c) Suh, E.M.; 13. Crevisy, C; Beau, J.-M. Tetrahedron Lett. 1991, 32,
Kishi, Y ibid. 1994, 116, 11205; (d) Kishi, Y Chem. 3171.
Scr. 1987, 27, 573;(e) Kishi, Y Pure & Appl. Chem. 14.Nicolaou, K.C.; Liu, A.; Zeng, Z.; McComb, S. J.
1989, 61, 313. Am. Chem. Soc. 1992, 114, 9279.
730 36 Palytoxin
15. For a review of vinyl triflate chemistry, see; Ritter, Yamada, K.; Suginome, H.; Suzuki, A. J. Am. Chem.
K. Synthesis 1993, 735. Soc. 1985, 707, 972; (g) Miyaura, N.; Ishiyama, \320\242.;
16. Rowley, M.; Tsukamoto, M.; Kishi, Y. J. Am. Chem. Sasaki, H.; Ishikawa, M.; Satoh, M.; Suzuki, A. ibid.
Soc. 1989,111,2735. 1989, 777,314.
17. Aicher, T.D.; Buszek, K.R.; Fang, F.G.; Forsyth, 21. Uenishi, J.; Beau, J.-M.; Armstrong, R.W.; Kishi, Y.
C.J.; Jung, S.H.; Kishi, Y.; Matelich, M.C.; Scola, J. Am. Chem. Soc. 1987,709,4756.
P.M.; Spero,D.M.;Yoon, S.K. J. Am. Chem. Soc. 22.Matteson, D.S.; Moody, R.J. Organometallics 1982,
1992,114,3162. 7,20.
18.Schreiber, S.L.; Meyers, H.V. J. Am. Chem. Soc. 23. For some excellent reviews, see: (a) Wadsworth,
1988, /70,5198. W.S., Org. React. (TV. Y.) 1977, 25, 73; (b) Mar-
Jr.
19. Tomioka, K.; Oshima, K.; Nozaki,
H.; Takai, H. Tet- yanoff, B.E.; Reitz, A.B. Chem. Rev. 1989, 89, 863.
Tetrahedron Lett. 22, 1605.
1981, 24. (a) Davis, F.A.; Towson, J.C.; Weismiller, M. C; Lai,
20. (a) Suzuki, A. Ace. Chem. Res. 1982, 75, 178;(b) S.; Carroll, P.J. J. Am. Chem. Soc. 1988,770, 8477;
Suzuki, A. Pure & Appl. Chem. 1985,57, 1749;(c) (b) Davis, F. A.; O. D.; Billmers, J.M. Tetra-
Stringer,
Suzuki, A. ibid. 1986, 58, 629; (d) Suzuki, A. ibid. Tetrahedron Lett. 1983, 24, 1213; (c) Davis, F.A.; Chen,
1991, 63, 419; (e) Suzuki, A. Organic Synthesis in B.-C. Chem. Rev. 1992, 92, 919; (d) Davis, F.A.
Japan, Past, Present, and Future, Tokyo Kagaku Pure & Appl. Chem. 1993,65, 633.
Dozin: Tokyo, 1992, p. 441; (f) Miyaura, N.;
K.C.NicolaouA995)
Brevetoxin \320\222
37.1 Introduction
Brevetoxin \320\222
A) is a marine neurotoxin associated with the \"red
tide\" catastrophes that periodically occur along coastal areas around
the world and are responsible for massive killings of fish and other
marine life, as well as human poisoning.14 red tide
The term
describes seawater discoloredby vast blooms of monocellular algae
(phytoplankton), which constitute the base of the marine food chain.
The name derives from the red coloration usually accompanying
such occurrences, although the red tides may often be brown, green,
or even colorless.The story of brevetoxin \320\222
A) may be as old as
1000B.C., for a passage in the Bible mentions an event that some
believe might have been the first recorded incident of a red tide:
\"... and the waters that were in the river were turned to
blood. And the fish that were in the river died; and the river
stank and the Egyptians could not drink of the water of the
same year, a costly red tide catastrophe occurred off the coast of
Japan near the Seto Inland Sea, killing over 500 million dollars
worth of caged yellowtail fish. In another episode, a massive
human poisoning incident was recordedin Canada in 1987, during
which victims complained of vomiting, diarrhea, disorientation, and
abdominal cramps. The incident was later traced to poisoned mus-
mussels from Prince Edward Island where a red tide was in full bloom.
In the same year, another disastrous event linked to red tide phe-
phenomena took place in which 14 humpback whales died suddenly
and unexpectedly in Cape Cod, Massachusetts. In 1991, a bizarre
incident was observed in which hundreds of sick and dying peli-
pelicans were found on the beaches of California near Monterey.
Again, this tragedy was later traced to a red tide occurrence.
A most striking disaster took place off the east coast of the
United States from 1987 to 1988 (right after the humpback whale
episode) in which 760 bottlenose dolphins were found dead along
the beaches stretching from New Jersey to Florida. This poisoning
was traced to red tides caused by blooms of the dinoflagellate
Ptycodiscus brevis Davis (Gymnodynium breve Davis), the alga
responsible for the secretion of brevetoxins, a family of neuro-
neurotoxins. Such incidents provide clear evidence of the dangers to the
marine environment posed by these organisms, whose rapid and
uncontrollable growth has been linked to oceanic pollution by
humans.
Within the brevetoxin family, brevetoxin \320\222
A) occupies a posi-
position of some historical significance, for it was the first member to
be discovered.5 Brevetoxin and
\320\222 its relatives are potent, lipid-
soluble neurotoxins that exert their biological effects by binding to
sodiumchannelsof neurons, keeping them open, thereby causing
depolarization of the cell membrane.Using a combination of spec-
oxygens are syn to each other with the exception of the last one on
ring K, which is anti. Brevetoxin is composed
\320\222 of only carbon,
hydrogen, and oxygen,and is distinguished by twenty-three stereo-
centers, three carbon-carbon double bonds, and two carbonyl
groups. Interestingly, the polycyclic skeleton of brevetoxin B,
which comprises a J-lactone ring, seven tetrahydropyran rings, two
oxepane rings, and a didehydrooxocane ring, is reminiscentof a
ladder, a consequence of the ?ra/\302\253-fusion of the eleven contiguous
ether rings. Although the bis(oxepane) region (see rings D and E in
structure 1) confers some degree of flexibility to the natural prod-
product, brevetoxin is
\320\222 a rather rigid molecule.
37.1 Introduction 733
a. Tetrahydropyran Systems
\320\276\320\275
5-exo cyclization
(preferred)
\302\251
H
path a pathb
the premise that the oxonium ion resulting from protonation of the
epoxide oxygen will seek stabilization by withdrawing electron
OTPS
BnO BnO
TPS = Sif-BuPh2
9 10
Bn =
CH2Ph
Scheme 2. Intramolecular conjugate addition for the construction of tetrahydropyrans affords the
thermodynamically most stable isomer.
b. Didehydrooxocane Systems
EtS
\320\275\320\276
AgNO3, NCS, SiO2,
\302\273
2,6-lutidine, CH3CN,
3 A mol. sieves (92%)
13
\321\201.
Systems
\320\236\321\205\320\265\321\200\320\260\320\277\320\265
molecule until efficient and general strategies for the synthesis of seven-
membered oxacycles could be developed.
One of the more salient and synthetically challenging substruc-
tural features of the brevetoxin molecule
\320\222 is the trans-fused
[5.5.0] bicyclic ring framework, the bis(oxepane) system (see rings
D and E in 1). Careful consideration of this problem ultimately led
to the rather daring, yet very attractive, proposal that it might be
possible to construct a bis(oxepane)system by bridging a macro-
cyclic structure.17 This concept is simple and very appealing
because the formation of one bond would result in the simultaneous
formation of both oxepane rings. According to this proposal, both
oxepane rings could be constructedin a single operation provided
that a bond could be formed between the two sp2-hybridized carbon
atoms of a macrocyclicbis(lactone) A5; X = O) or a macrocyclic \320\276 s
15:X =0
16:X = S
p s
Lawesson's
\320\267\320\254
\320\236 reagent
V 4\302\260 \320\247;
\320\276 s s
15 16 17 18
1. coupling I
coupling
SMe
reductive \320\263 CO
desulfurization
MeS se
20 19
cb CD
\320\275 H
21 22 23
s 7 0
\320\276 H
l4--~s
24
SMe
(99%)
Scheme 5. Bridging macrocycles to form bicycles: the first successful experiments with bis(thiolactone)
24. The terms bis(thiolactone) and dithiolactone are used in this chapter to describecompounds of
type 24 even though such systems are sometimes referred to as dithionolactones or dithioxolactones.
740 37 Brevetoxin \320\222
hv, PhCH3,0.5 h
\321\217
F5%)
hv, PhCH3
(-S2) (90%)
31:dithiatopazine
Ph3P, Ph3P,
PhH, 50 \302\260C PhH, 50 \302\260C
1.NaBH4, ;l1.NaBH4,
EtOH; Mel EtOH; Mel
2. Ac2O,Et3N, 2. Ac2O,Et3N,
4-DMAP 4-DMAP
O3, /n-CPBA,
H2O, CH2CI2
Lawesson's
reagent,
((CH3JNJC=S,
xylene, 160 \302\260C
D7%)
39
1. 2MHCI, 25 \320\241
2. NaH.THF
G6% overall)
46
Et3SiH
Et3SiH,
TMSOTf,
Me XX
*-
Ph
\320\276\320\275
CH2CI2,
47
0 \302\260C
(90%)
Scheme 10. Synthesis of compound49 by the reductive hydroxy ketone cyclization method.
hv, PhCH3,
75 \302\260C
F6%)
(photochemical
dithioester
cyclization)
TMSOTf, Ph2MeSiH,
CH2CI2,0 \302\260C
(88%)
(reductive hydroxy
ketone cyclization)
D:1 mixture of trans and cis
diastereoisomers in favor of trans 28)
=>
53
\321\214 \320\254
55 58 57
Me Me
MeLi, THF, MeS. Ph3SnH,
-78 then
\302\260C; AIBN (cat.),
\320\236
\302\273-
Mel, -78 -> 0 \302\260C PhCH3,110 \302\260C
OBn
Me \320\275
TBSO(CH2LB-thienyl)CuCNLi2,
Et2O,-78->10\302\260C;then
*-
I(CH2LI, pempidine (85% yield)
OBn OBn
OTBS
TBS = Sif-BuMe2
Me~
pempidine =
Me' I Me
Me
OBn OBn
BH3\302\253THF,
THF, 0 \302\260C;
then NaOH,
H2O2
OBn (89% yield) OBn
TBSO TBSO-
n-Bu3SnLi C equiv.),
THF, -78 \302\260C;
(CuOTfJ, pernpid
D5% overall)
lne|
1. n-Bul_i, THF, -78 \302\260C
(tin-lithium exchange)
(
2. (benzyloxy)ethyl triflate,
HMPA, Et3N, THF, -78 \302\260C Snn-Bu3
F5% yield) n-Bu3Sri
BnO OBn
Me
Me
H H H
1: brevetoxin \320\222
Me
Bridging reaction
34 Extension
Me
- \342\200\242 27
\320\275 \320\275 \320\234\320\265
\320\276 \320\270 |\"| \320\276
| >-^.. \320\275
\320\275 \320\275 \320\275 '\320\234\320\265
\\
I \320\222\320\277\302\260\302\273
1: brevetoxin \320\222
\320\234\320\265
Oxygenation
OTPS
Lactonization
Me
Horner-
Wadsworth-
Emmons MeO
Esterification
OPMB 72
BnO^
MeO Me,.
\320\235 \320\235
OTPS
;\320\235
Hydroxy dithioketal H, u\" \\^,o
73 / cyclization
Hydroxy epoxide
cyclization
.6 'H
TBSO
W \320\247
\320\275 H \320\274\320\265\"^ Wittig coupling
75
Hydroxy epoxide Conjugate
cyclization addition
\\ OBn
\342\200\236
EtS H. M-e I HOk X ..OH
Me HO BOMO
H H <Me
78: geraniol 76 ^
Hydroxy epoxide
' 77
TPSO
79: D-mannose
cyclization
37.2.2 StepwiseBis(oxepane)
Synthesis Approach:
The Second-Generation Strategy
Me
Me
1: brevetoxin \320\222
OTPS
\320\275 h h
Photochemical ring closure
OTPS
H Me H
CO2(CH2JSiMe3 TBSO
H H H H H Me
83 84
Me.
Hydroxy dithioketal
Yioketal 0*^4\"
\320\275 \320\276
\" /\"'\"'\"
af/on
cyclization - jJ J /
^ f\\
Me Me Methylenation
Me H 7 \320\276-
H Me \320\275
\320\220
\320\262
\320\235 Me
o*'. o' I I I \", \320\275
\320\275 \320\275 \320\275
Me
\\.) \320\275
Hydroxy epoxide
86
Hydroxy epoxide
cyclization cyclization
OBn
Sharpless \320\275Me
\342\202\254
IV/tt/g
OBn OTPS
(MeOJP<js
TPS = S^BuPh2
TBS =
Sif-BuMe2
Bn =
CH2Ph
OBn
H H
Me 93
Me Me \320\275 Intramolecular
OBn
\320\275
oj ^ = -OBn
conjugate addition
,\342\200\224\\?
^JJT Me
MeO2C
OBn OTPS
Intramolecular
conjugate addition
TBSO
Wittig. , .
\320\273 -
, '\302\260TPS
reaction
K^o-L
\320\275
MeO2C
90
Homer- Wadsworth-
Emmons
OBn
Me
HO. \302\246
OBn
C-glycosidation
91
OH
hon
^\320\220|,\"\320\276\320\275
OBn OH
PivO HO''
79: D-mannose
Me Me H
\320\236\320\235
\320\236\320\235
\320\236\320\235 Me \320\223
TfO^
^^ CHO
^
E
\\~O' I4 'T^^^o
VVS J \\ H H Me
\320\276\320\275
\320\276\320\275
\320\276\320\275 Plv0 : H
Me
99: D-mannitol 97 98
Lactonization
Me Me H
\320\242\320\256.
OBn OBn
H H Me H H Me
H
\302\246. H
\342\200\242.
Me Me
98 100
Hydroboration/
oxidation \342\200\224.
OBn
HO2C Me
102 103 101
Murai coupling
Homologation
W/tt/g coupling; Hydroxy epoxide
hydrogenation
\321\203 cyclization _
.Me Me H Me Me H Me !\320\274\320\265
Ph%-
Me \320\275 \320\235Me
105 epoxide
\342\200\224\342\200\224Hydroxy 106
Lactonization cyclization
104
Carbonyl \\y
addition v
H Me Me Me \320\274\320\265
OH v
J co2Et
I Jv J-'\302\260
\321\200,\320\273\321\201\320\234'\\
\320\275 Wittig coupling H H
109 108 107
HO
OH
HO
110: 2-deoxy-D-ribose
from a good deal of experience with the bis(oxepane) problem, and 1\320\243
this experience provided the foundation for a conservative solution. I H H ;
\320\267
Starting from FG ring system 105, it was hoped that rings E, D, C, 105 \342\200\242^\342\200\224Hydroxyepoxide
cyclization
B, and A could be annulated sequentially and in that order (Scheme
17c).
Keto phosphonate ester 92, revealed by retrosynthetic disassem-
of ring
disassembly A in 87, could conceivably participate in an intramole-
Horner-Wadsworth-Emmons
intramolecular (HWE) reaction36 on treatment
Hydroxy epoxide
with a suitable base (Scheme 17a). If successful, this reaction cyclization
furnish compound 92, the substrate for the A-ring forming HWE reac-
reaction. Retrosynthetic disassembly of the C-ring in compound 93 in
the manner illustrated revealsct,/?-unsaturated hydroxy ester 94 as a
potential precursor(Scheme17b).In the context of 94, the free sec- Intramolecular
conjugate addition
secondary hydroxyl group attached to ring D and the electrophilic
/?-carbon of the unsaturated ester moiety are in proximity. In such a
favorable setting, the alkoxide ion resulting from deprotonation of
the hydroxyl group in 94 would be expectedto take part in a conju-
conjugate addition reaction to give pyran ring C. Under equilibrating
\320\274\320\265\320\276,\321\201
conditions, this base-induced intramolecular conjugate addition Homer- Wadsworth-
reaction would be expectedto afford the desired, more stable Emmons
Me Me H
Continuing with the retrosynthetic analysis, we still face, in 95, a
rather difficult synthetic problem. Compound 95 possesses
a stereo-
higher order organocuprate reagent derived from 103 with enol tri-
triflate 102. The substituted didehydrooxepane thus formed (see 146,
H
Me Me
Scheme 25) could then be subjected to a regio- and diastereoselec-
diastereoselective
hydroboration/oxidation sequence. The hydroboration/oxida-
tion of146, equivalent the of an anti-Markovnikov hydration of the
102 enol ether, would accomplish the introduction of the adjacent
C-14 and C-15 stereogenic centers in 101. The ortho
conspicuous
ester function in compound 103 serves an important purpose; this
trioxabicyclo[2.2.2]octanegroup is a useful protecting group for
the carbonyl of a carboxyl group and is stable to both basic and
103 nucleophilic reagents.38 At some stage after the Murai coupling of
37.2 Retrosynthetic Analysis and Strategy 761
compounds 102 and 103, the ortho ester function can be converted
to an ester with mild aqueous acid and thence to the requisite
carboxyl group with aqueous base.
coupling;
As we have previously witnessed,enol triflate
Wittig
102 can be traced hydrogenation
\321\203
to the corresponding lactone (see 104). In the synthetic direction, .Me Me H
37.3.1 86
Synthesis of the UK Framework
Our enantiospecific synthesisaldehyde 86 commenceswith
of UK
D-mannose G9) (see 18). Peracetylation of 79 under
Scheme stan-
standard conditions affords the corresponding pentaacetate. Of all the
acetoxy functions in D-mannose pentaacetate, the one attached to
1. Ac2O(excess),
pyr., 25 \302\260C
2. allyltrimethyl- OH
silane, BF3\302\253OEt2, H0
_\342\200\236
f-BuPh2SiCI, imid.,
\342\200\242OH ,.OH
TMSOTf, CH3CN, 0 \302\260C DMF, 0 \302\260C;
then
3. NaOMe, 2-methoxypropene,
MeOH, 25 \302\260C CSA (cat.), 0 \302\260C
0H OTPS
G5% overall). (82% yield)
79: D-mannose 112
1. lm2C=S,PhCH3,110 \302\260C
TPS = Sif-BuPh2 F6%
Bn = CH2Ph
2. /T-Bu3SnH, AIBN (cat), overall)
PhCH3,110\302\260C
*CH2CI2,-78\302\260C; 2. MeOH,
\302\260 n-Bu2SnO,
\320\277
H |
then Et3N, 0 \302\260C 60 C; then BnBr,
otps A00% yield) QTps OTPS
115 DMF, 100 \302\260C
G4%) 113
AIMe3,
MgBr2*OEt2,
CH2CI2, -50 \302\260C 1. TBAF.THF,
, F1% yield
of 91) 25 \302\260C
OBn 2. p-TsCI,
OTPS \302\273..l
4-DMAP,
CH2CI2,0 \302\260C
3. NaOMe, MeOH
80 \302\260C
otps F0% overall)
116
(ca. 3:1 mixture of
diastereoisomers in favor of 91)
1. O3, CH2CI2,-78 \302\260C;
then Me2S, Ph3P
2. CH2=CHMgBr, THF, 0
D4% yield of 117)
Scheme 18. Construction of the UK ring system (86): synthesis of intermediate 90.
764 37 Brevetoxin \320\222
OTPS
MeO,C OBn OBn
I H Me
NaH, THF, 25 \302\260C
= MeO2C
TPSO TPSO
| Me OTPS
\320\234\320\265\302\260\320\263\320\241
OTPS Ha OTPS
Dibal-H, CH2CI2,
-78 \302\260C;
then
Ph3P=CHCO2Me
G5% overall)
OBn OBn
G7% overall)
TPS OTPS
118
(ca. 10:1 mixture of epoxide
stereoisomers in favor
of 119)
1. (COCIJ, DMSO,
CH2CI2, -78 \302\260C;
then Et3N
2. Ph3P=CHCO2Me, PhH, 25 \302\260C
3. TBAFA.2equiv.),THF,25\302\260C
,, G5% overall)
.OTPS
BnO
OBn
H Mel
CO2Me
TPS = Sif-BuPh2
Bn = CH2Ph (ring junction substltuents
omitted for clarity)
2. 2-methoxypropene,
CSA (cat.), CH2CI2,25 \302\260C
OTPS
(85% overall) OTPS
121 120
Scheme 19. Construction of the UK ring system (86): synthesis of intermediate 121.
766 37 Brevetoxin \320\222
OTBS 1. f-BuPhjSiCI, OH
H H Mel l
OTPS Et3N, 4-DMAP,
CH2CI2, 25 \302\260C
*
OH
2. f-BuMe2Si0Tf, \320\276
2,6-lutidine, H H
1. CSA, CH2CI2:MeOH
A:1),0\302\260C
G9% 2. TBSCI, imid.,
overall) DMF, 0 \302\260C
3. NMO, TPAP (cat.), CH3CN,25 \302\260C
secondary
remaining compound
hydroxyl, 124 (95% overall yield). Acet-
onide protecting groups can usually be removedunder acidiccon-
conditions, and the one present in 124 is no exception. Treatment
of a solution of in 124
CH2Cl2:MeOH A:1) at 0\302\260C with CSA
768 37 Brevetoxin \320\222
OH
1. Ph3P=CMeCO2Et, (COCIJ,
HO
O. THF,80\302\260C DMSO,
OH \302\273-
\320\275\320\276
2. PhCH(OMe>2, Ph\" CH2CI2,
CSA,CH2CI2, -78\302\260C; H
110: 2-deoxy- 25 \302\260C \320\2569
then Et3N 108
D-ribose (93% overall)
AIMe3,, CH2CI2, -20 \302\260C
I
G5% from
from 109) I
OH
Me Me 1. TMS-imidazole, Me Me
F.OR! CH2CI2, 25 \302\260C OH\\ CO2Et
* Nu
2. Dibal-H, CH2CI2,
-78 \302\260C
(96% overall) Nu
128: R = SiMe3 127
126:
R =
(?)-CH2CHC(Me)CO2Et
(-)-DET, Ti(O/-PrL,
f-BuOOH,
CH2CI2,-25\302\260C
Me Me 1. SO3\302\273pyr., DMSO, 1. TBAF,
I CH2CI2, -78 \302\260C THF, 25 \302\260C
2. Ph3P=CH2, 2. PPTS, L
-
THF, 0 \302\260C Ph
CH2CI2, h-^
H
G3% overall 0 -> 25 \302\260C
H \320\275
Scheme 21. Construction of the FG ring system A05): synthesis of intermediate 131.
37.3 Total Synthesis 769
meric equilibrium that naturally exists between lactol 110 and the
open-chain aldehyde tautomer.44 The terminal aldehydic function of
the latter substanceis electrophilic, and it obligingly participates in
an (?)-stereoselective Wittig reaction with the indicated phosphorus
ylide to give an a,/?-unsaturated ester triol. The presence of three
free hydroxyl groups in the product of the above Wittig reaction
Me Me 1. f-BuMe2SICI, imid., Me Me
OH
DMF, 50 \302\260C \320\276
Me Me Me Me
J 1. Dibal-H, CHZCI2,-78 \302\260C
\321\201 CO2Et
OH
2. mCPBA, CH2CI2, 0 \302\260C
4\\,
H (94% overall)
|Me
TBS
134 133
1. 5O3*pyr.,Et3N, DMSO,
CH2CI2, 0 \302\260C
2. Ph3P=CH2, THF, 0 \302\260C
(81% overall)
Me Me Me Me H
1. TBAF, THF, 25 \302\260C
*\342\200\242
2. PPTS, CH2CI2, 0 -> 25 \302\260C
Ph
(86% overall) H
| H Me
TBS
135 136
1. KH, BnBr, THF, 45 \302\260C
2. 9-BBN, THF, 25 \302\260C;
then NaOH, H2O2,0 \320\241
3. KH, BnBr, THF, 45 \302\260C
G5% overall)
Me Me H Me Me H
CSA (cat.),
MeOH,0 \320\241
(95%)
H H Me
138 137
1. t-BuMe2SiCIB.5 equiv.),
imld., DMF, 50 \320\241
2. CSA, MeOH, 0\302\260C Me Me
3. (COCIJ, DMSO, CH2Ci2,
-78 C; then Et3N
(81% overall)
TBSO^N
H H Me
105
newly formed cis C-C double bond in the presence of 10% Pd/C
139
and a catalytic amount of NaiCCb. Selective acid-induced solvolyt-
ic cleavageof the primary TBS ether then furnishes primary alco-
alcohol 140 (95% yield from 139). Although compound 140 could, in OBn
principle, be oxidized to the corresponding carboxylic acid in one
step, it proved more reliable to effect this functional group transfor- TBSO OBn
transformation in a stepwise fashion. Thus, Swern oxidation of 140 fur-
furnishes an aldehyde which can be oxidizedto the desired carboxylic 140
772 37 Brevetoxin \320\222
Me Me H Me Me H
PPh3 TBSO
THF,0\302\260C(99%) TBSO
1 \" OBn
H H Me H Me
105 139
1. H2,10%Pd/C (cat.),
Na2CO3, EtOAc
2. CSA A equiv.), CH2CI2,
MeOH, 0 \302\260C
2,4,6-Ci3C6H2COCI,
Et3N, THF, 0 \"\320\241;
then 4-DMAP, PhH, 80 \320\241
(90%)
Me Me H
LIN(SiMe3J,
HMPA, THF, -78 'C;
*
then PhNTf2,
OBn
-78 -> 25 \302\260C
(93%)
Scheme 23. Construction of the ABCDEFG ring system (87): synthesis of intermediate 102.
SOBr2, Me \342\200\236.
145
1. BH3\302\253THF,
Me Me THF, 0 DC; Me Me H
H
then NaOH, OBn
H2O2,0 \302\260C
-*
OBn 2. LiOH, OBn
MeOH,H2O
HO2C Me G3%overall) Me
2,4,6-CI3C6H2COCI,
Et3N, THF, 0 \302\260C;
then 4-DMAP, PhH, 80 \320\241
(85%)
OBn
OBn
100-P
1. H2, [lr(COD)(py)P(CyK](PF6),
1. UN(SiMe3J, HMPA,
PhSeBr, THF, -78 \302\260C CH2CI2,25 \302\260C
(80%; 1:1
mixture of diastereoisomers)
2. mCPBA, THF, 25 \302\260C
2. LiOH, MeOH, H2O, 25 \302\260C
A00%)
(91% overall) 3. 2,4,6-CI3C6H2COCI, Et3N, THF;
then 4-DMAP, PhH, 60 \320\241
(90%)
Me Me \320\275
LOf i
LiN(SiMe3J, HMPA, THF,
-78
\342\200\236 then
\302\260C; MeOH OBn
0Bn
(94%)
MeO2C Me
148 149
Scheme 25. Construction of the ABCDEFG ring system (87): synthesis of lactone 100.
37.3 Total Synthesis 775
Me Me H 1. LiN(SiMe3fe,HMPA, Me Me H
-78 .OBn
i THF, \302\260C;
then Tf2NPh, 25 \302\260C
2-
tbsoJ>cho PivO
OBn OBn
100
PivO
150
CrCi2, NiCi2(cat.), 1. KH,
DMF, 25 CS2, Et2O, 25 \302\260C;
\302\260C,
then Mel
ultrasound
2. n-Bu3SnH, AIBN,
(84% overaii)
PhH,80 \302\260C
F0% overaii)
. BH3\302\273THF,
THF, -30 \302\260C;
then NaOH, Me
\320\2752\320\2762,\320\276\302\260\321\201
TbsoJ
2. Et3Si0Tf,
2,6-iutidine, PivO
OBn OBn
CH2Ci2,0\302\260C
G9% yieid)
1.Dibal-H,CH2Ci2,-78\302\260C
2. Dess-Martin periodinane,
CH2CI2,25 \302\260C
3. (MeOJP(O)CH2CO2Me,
KN(SiMe3J,18-crown-6, THF, \320\236
\320\241
(82% overaii)
TBSO TBSO
2. KH, Et2O,
25 \302\260C
OBn 'OBn
(90% overall) CO2Me
153
Scheme 26. Construction of the ABCDEFG ring system (87): synthesis of intermediate 153.
37.3 Total Synthesis 777
Me Me \320\275
OBn
1. (+)-DET,Ti(O/-PrL,
f-BuOOH, CH2CI2,-20 \302\260C H H 'OBn
2. SO3\302\253pyr., DMSO,
154
Et3N, CH2Ci2, 0 \320\241
3. Ph3P=CH2, THF, 0 \302\260C
G9% overall)
Me Me
TBS OBn 1. TBAF, THF, 25 \302\260C
2. PPTS, CH2CI2, 0 \302\260C
3. f-BuMe2Si0Tf, 2,6-lutidine,
CH2CI2,0 \302\260C
H H OBn G6% overall)
155
Me Me
OBn
H Me H
Me
;
Me \"
\320\275
O=
Dess-Martin
=
periodinane
AcO OAc
OBn
Scheme 27. Construction of the ABCDEFG ring system (87): synthesis of intermediate 157.
780 37 Brevetoxin \320\222
Me
\320\234\320\265
1. TBAF, THF, 25 \302\260\320\241
2. BrCH2COCI, \321\200\321\203\320\263.,
H Me H
CH2CI2,0 \302\260\320\241
0'
\320\262 \321\201 D V- 3. 90 \302\260\320\241
(\320\234\320\265\320\236K\320\240,
1 1\342\200\224 \320\235 \320\235 Me
TBSO\"' t t
4 \"\320\276\"\320\247--<\320\275 G3% overaii)
\320\275 \320\275 \320\275 Me OBn
157
Me
, LiCI, OBn
CH3CN, 25 \302\260C
(89% yieid)
Me Me \320\275
1. Dibal-H,
CH2Ci2, -78 \302\260C
OBn 2. (93% overaii)
BF3\302\253OEt2, Et3SiH,
158 CH2Ci2, -10 \302\260C
Me
1. Li, NH3(I),-78\302\260C
2. p-TsCi, pyr.,
CH2Ci2,25 \320\241 OBn
G3% overaii)
(92% overaii)
; Ml s
\320\274\302\253 \320\275
Me ,OTMS
Me \320\275 \320\236,^s
V
0-i/
,0. \320\225 F G
I X
^^<
\320\262
\321\202
\\
\320\276 f
\321\207^
\320\247>'
PPh3
\320\275 \320\275 Me
T\"o' \320\275
\320\235 \320\275 \320\275
87
OTBS
.OTPS
1.n-BuLi, HMPA,
THF, -78 \302\260C
2. PPTS, MeOH, 25 \302\260C OTPS
G5% overall)
H H H
Me
1. PCC, PhH,80\302\260C
2. TBAF, THF, 25 \302\260C
3. Dess-Martin periodinane,
CH2CI2,25 \302\260C
D9% overali)
Me
Et3N, CH2CI2 .
2. 0 overa\")
\302\260C \320\275
HF\302\253pyr., CH2Ci2,
1: (+)-brevetoxin \320\222
H H H
observed in reaction
this (Scheme 29). Compound 85 is then
revealed selective
after acid-induced solvolytic cleavage of the tri-
methylsilyl ether G5 % overall yield). Incidentally, the (Z) stereo-
selectivity observed in the Wittig reaction described above depends
on the use of HMPA.
With the two oxepane rings and the eight six-membered oxa-
cycles in their proper places, the task of assembling the complex
polycyclic framework of brevetoxin \320\222 is reduced to the construc-
of only
construction one C-O bond. At this stage of the synthesis, tension
was high because we had never accomplished the construction of
an intact brevetoxin skeleton.
\320\222 As matters transpired, the decision
to defer the construction of the didehydrooxocane ring to such an
advanced stage in the synthesis proved to be beneficial. Exposure
of compound 85 to the conditions of a hydroxy dithioketal cycliza-
tion accomplishes the desired ring closure to give, after homolytic
reductive cleavage of the ethylthio group with triphenyltin hydride
and AIBN, compound 161 in an overall yield of 85%. It is note-
noteworthy that the Ag+-induced hydroxy dithioketal cyclization and
the subsequent reductive
cleavage of the C-S bond proceed diaster-
37.4 Conclusion
' M. M. H maitotoxin
References 785
References
1. Anderson, D.M. Sci. Am. 1994, 271(8), 62 and refer- 17. (a) Nicolaou, K.C.; Hwang, C.-K.; Duggan, M.E.;
references cited therein. Reddy, \320\232. Marron,
\320\222.; B.E.; McGarry, D.G. J. Am.
Trost, B.M.; Fleming, I., Eds., Pergamon Press: New 63. (a) Nicolaou, K.C.; Hwang, C.-K.; Duggan, M.E.;
York, 1991, Vol. 7, p. 389; (e) Johnson, R.A.; Sharp- Nugiel, D.A.; Abe, Y; Bal Reddy, K.; DeFrees,
\320\222.In
Sharpless, \320\232. Catalytic Asymmetric Synthesis, S.A.; Reddy, D. R.; Awartani, R.A.; Conley, S.R.;
Ojima, I., Ed., VCH Publishers: Weinheim, New Rutjes, F.P.J.T.; Theodorakis, E.A. J. Am. Chem.
York, 1993, p. 103;(f) Pfenniger, A. Synthesis1986, Soc. 1995, 117, 10227; (b) Nicolaou, K.C.; Theo-
89; (g) Katsuki, Martin,
\320\242.; V.S. Org. React. (N. Y), Theodorakis, E.A.; Rutjes, F.P.J.T.; Sato, M.; Tiebes,J.;
in press. Xiao, X.-Y; Hwang, C.-K.; Duggan, M.E.; Yang, Z.;
43. (a) Griffith, W.P.; Ley, S. V. Aldrichimica Acta 1990, Couladouros, E.A.; Sato, F.; Shin, J.; He, H.-M.;
23, 13; (b) Ley, S.V.; Norman, J.; Griffith, W.P.; Bleckman, T. ibid. 1995, 117,10239;(c) Nicolaou,
Marsden, S. P. Synthesis 1994, 639. K.C.; Rutjes, F.P. J.T.; Theodorakis,E.A.; Tiebes, J.;
44. For reviews of ring-chain isomeric transformations, Sato, M.; Untersteller, E. ibid. 1995,117,10252; (d)
see: (a) Valters, R. Russ. Chem. Rev. (Engl. Transl.) For a personal account, see: Nicolaou, \320\241
\320\232. Angew.
1974,43, 665; (b) Valter, R. E. ibid. 1973, 42, 464. Chem. Int. Ed. Engl. 1996, in press.
45.(a) Smith, M.B. Organic Synthesis, McGraw-Hill: 64. Murata, M.; Legrand, A.M.; Ishibashi, Y; Fukui, M.;
San Francisco, 1994, p. 42; (b) Trost, B.M. Science Yasumoto, T. J. Am. Chem. Soc. 1990,112,4380.
(Washington, D. C.) 1985, 227, 908. 65. Satake, M.; Ishida, S.; Yasumoto, Murata,
\320\242.; M.;
46. Cherest, M.; Felkin, H.; Frajerman, C. Tetrahedron Utsumi, H.; Hinomoto, T. J. Am. Chem. Soc. 1995,
Lett. 1971, 12, 379. 117,7019.
47. (a) Bal, B.S.; Childers, W.E., Jr.; Pinnick, H.W.
Tetrahedron 1981, 37, 2091; (b) Hudlicky, M. Oxi-
Author Index
Barclay, A. 655 Danishefsky, S. J. 8, Hoffmann-La Roche 285 Magnus, P. 403, 558, 585
Barton, D. H. R. 6, 10,59, 369, 390, 398f., 471, Hofmann, K. A. 676 Makowaka, O. 675
382, 398, 401, 405, 777 555, 558, 560, 563, 574, Holton, R.A. 594,671 Marais, P. \320\241573
Beckmann, E. 285 671 Horwitz, S.B. 655 Martin, R.
\320\236. 510
Beckwith, A. L. J. 382 Dauben, W. G. 667 Houk, K.N. 196 Marvell, E. N. 333
Olah, G. A. 6, 743 Roush, W.R. 619 Stork, G. 83, 85, 137, Wallach, O. 6
Oppolzer, W. 158, 366, Ruzicka, L. 6 382, 385f., 388,485 Walling, \320\241382
572 Suginome,H. 589 Wani, M. \320\241655
Otsuka, S. 348 S Sumitomo Chemical Watanabe, Y. 639
Overman, L.E. 569,641 Sabatier, P. 6 Company 346 Westley, J. W. 748
Sakabe, N. 453 Suzuki, A. 586, 589 Whalley, W. 333
P Sakurai, H. 319,331 Suzuki, H. 535 Wiechert, R. 368
Parker, K. A. 395 Samuel,E. 115 Suzuki, K. 509 Wiemer, D. F. 595f.
Patemo, E. 317f. Santini, \320\241 333 Suzuki, M. 607 Wilkinson, G. 345
Pattenden, G. 392 f. Sasaki, K. 465 Williams, D. R. 612
Pedersen, J.
\320\241 6 Saxton, J. E. 650 T Wilson, R. A. L. 480
Pelletier, P. J. 21 Schlittler, E. 55 Takabe, K. 355 Windaus, A. 6
Perkin, W.H. 5 Schmidt, R.R. 528,556 Takahashi, T. 150 Wittig, G. 6
Persoons, J.
\320\241 211 Schreiber, S. L. 317,333, Takai, K. 712 Wohler, F. 5
Pfaltz, A. 360, 362 586, 717 Takasago 343 Woodward, R. B. 3, 5 ff.
Piers, E. 573 f., 597 Seebach, D. 293 Takaya, H. 360 9, 13 ff., 21,43, 55, 99,
Pirrung, M. \320\241221 Sharpless,K.B. 10, Tani, K. 348 167, 180, 485
Potier, P. 669 293, 359, 361, 434, Trost, B.M. 10,578 ff.
Prelog, V. 6 677 f. Y
allylic 1,3-strain 192 ff., 208, 242 f., aryl C-glycosides 509,514 baccatin III 657, 688
491 f., 500, 696 aryl C-glycosylation 510, 519 Baeyer-Villiger oxidation 68, 70 f.,
allylic amines L-ascorbic acid 607 76,78, 170f, 176,183,201,
-, asymmetric isomerization 348f. aspartame 345 f. 413f.,455, 459
790 Subject Index
J. T. Baker Company 346 f. Black hypothesis 265, 283 carbon-centered radicals 386 ff.,
Barbier reaction bleach (NaOCl) 534 394, 416
-, intramolecular Sm(n)-mediated N-f-BOC-L-pipecolic acid 601, 620, -, intramolecular conjugate addi-
633,638, 640 622 addition 392
Barton f-BOCprotecting group 624 carbonyl addition 227 ff. 239, 715,
- deoxygenation 760, 777 bombykol 589f. 761
-reaction 398, 40 Iff. boron trichloride 535 -, a-chelation-controlled 17,204,
Barton-McCombiereaction 403 f. (+)-brefeldin \320\241716 f. 230,234, 238 f., 242, 245, 490,
Beckmann 4-ep;-brefeldin 716f.
\320\241 502f.
- fragmentation 126 brevetoxin \320\22210f., 731 ff, -, chromium(II)-mediated 712 f.
- rearrangement 103, 108, 110 -, retrosynthetic analysis 748 ff. -.intramolecular 553, 555f.
benzilic acid rearrangement 600 -, total synthesis 762 carbonyl coupling
benzocyclobutenes 155, 158 ff., bridging reaction 737 ff., 750 ff. -, reductive 666
164 -
bis(thiolactones) 739 f., 784 1,1'^carbonyldiimidazole 254, 258,
/j-benzoquinone 56ff., 318 - dithioesters 784 538, 541
acetal - 752 ene cyclization
benzylidene macrocycles carbonyl
-, reductive cleavage 613 bromoetherification 189, 193, 202 f. -, Lewisacid induced 354,356
benzyne-furan cycloaddition 515, bromolactonization 170ff., 183 carbopalladation 579 f.
519 N-bromosuccinimide 393 f., 536, -, intermolecular 572
Bergman cycloaromatization 17, 542f. -, intramolecular 579 f.
523 f.( 528 5-bromo-o-vanillin 516 -, sequential 580
biaryl coupling Brook rearrangement 389f. carpanone 95 ff.
bicyclo[3.3.0]
system 221 f. 666,677 cassiol 371
bicyclo[4.2.0] system 221 f. f-butyl isocyanide 388 castanospermine 685
bidentate ligands 680 f. catalytic asymmetric reac-
- 681, 684 358-ff.
(DHQJPHAL reactions
- (DHQDJPHAL 681, 684 cage structure 317 f. -, aldol-type reaction 367
- (DHQJPYR 681,684 calicheamicin 10f., 523 ff. -, aziridination 363
y'i
- (DHQDJPYR 681, 684, 689 ^aglycon 525, 527f.,533 -, carbonyl addition 365f.
- (DHQ)IND 681 -,-, total synthesis 548 ff. -, carbonyl reduction 363
- (DHQD)IND 681 -, enediyne system 555 -, conjugate reduction 360
bilobalide 676 f. -, mode of action 523 f., 527, 562 -, cyclopropanation 362
BINAP 349 ff. -, oligosaccharideunit 523, 525 ff., -, Diels-Alderreaction 369 ff.
(fl)-BINAP 576 531, 535 ff. -, enamine-aldol reaction 368
(S)-BINAP 348 -,-, total synthesis 535 ff. -, ene reaction 374
(tf)-BINAP-Rh(I)catalyst 355 -, retrosynthetic analysis 525 ff. -, enolate alkylation 374
(S)-BINAP-Rh(I) catalyst 352, 355 -, total synthesis 535 ff. -, Heck reaction 375
biomimetic cyclizations -, trisulfide moiety 523, 527, 558f. -, Henry reaction 375
-, polyolefinic 83 ff., 92, 470 calicheamicinone 526 f. -, hetero-Diels-Alder reaction 369
biotin 285 ff. (lS)-(-)-camphanic chloride 667 f. -, hydrogenation 358,360
-, retrosynthetic analysis 286 ff. camphor 5 -, hydroxyl-directed Simmons-Smith
-, total synthesis 288 ff. camphorquinone 115 f. reaction 366
Birch reduction 108, 204, 392, (+)-camphorquinone 102 -, intramolecular Diels-Alder
633ff. camptothecin 689 reaction 369 f.
N, W-bis(benzylidene)-ethylene- A9<12>-capnellene 381,407 -, Jacobsenepoxidation 359
diamine 578 f. -, retrosynthetic analysis 409f. -, Katsuki epoxidation 361
bis(oxepane) 737, 744f., 748, 750, -, total synthesis 413 ff. -, Mukaiyama-aldol reaction 367 f.
752, 754 f. 759, 761,784 carbapenem system 249 f. -, oxime ether reduction 363
bis(thiolactone) 740, 750 carbene 250, 254,475, 483 -, Sharpless asymmetric dihydroxyla-
trans-1,2-bis-(tri-\302\253-butyl-stannyl)- carbene insertion 256, 258, 260, tion 361
ethylene 601, 624 262 -, Sharplessepoxidation 359
bislactonization carbolactonization 634, 636, 640 catecholborane 587 f.
-, intramolecular 124 -, Mn(m)-mediated 633 f. cation-\321\217 cyclization 17, 86, 91 f.,
bisquinodimethide 95 ff. carbomacrocyclization 503 466, 470
Subject Index 791
CC-1065 394 Coreyprocedure 243 (r|5-cyclopentadienyl)cobalt
CeCl3-7H2O 618 Corey lactone 68 ff., 72f. dicarbonyl 155 f.
chelate effect 680 Corey-Nicolaou cyclosporins 565
P-chelation-control 607 f. - double activation 168 cyclotrimerization 154 f.
chelidonine 158 - macrolactonization 168 -, cobalt-catalyzed 156,158f., 162,
2-chloroacrylonitrile 71, 75, 660 ff. coronary heart disease 673 164
chloroethyl protecting group 387 corphins 127 D-cymarose 501
chlorophyll 14 corrin 99f., 103, 117, 126, 130f. L-cysteine 285 f.
chlorophyll a 99 f. corrinoids, natural 127 L-cystine dimethyl ether 288f.
cholesterol 674, 689 a-corrnorsterone 109 ff. cytovaricin 11, 485 ff.
chromium(II) chloride 620, 712 f., P-corrnorsterone 101 f., 108 ff. -, dehydration 486
715, 717,721f. corticosterone acetate 401 f. -, retrosynthetic analysis 487 ff.
Diels- Alder reaction 17, 56, 68, 71, 2,2'-dipyridyldisulfide 176 Eschenmoser reagent 784
75,78,102,105,113,124,153 f., disiamylborane 587,590 Eschenmoser coupling
396 f., 658, 660 ff. G/?,8S)-disparlure346 f. -, oxidative 102
-, asymmetric 76 ff. dithiane protecting group 701,704 Eschenmoser sulfide \"contrac-
-, boron-mediated 671 dithiatopazine 740 f. \"contraction102, 117ff., 122, 474, 478
-, intermolecular 153, 510 ff., 519, 1,2-dithietane 741 f. -,alkylative 119
660 dithioester cyclization 742, 745, -, oxidative 119
-.intramolecular 95 ff., 153, 158, 752 Eschenmoser-Claisen rearrange-
160 ff., 265, 267,272, 282, 466, dodecahedrane 12 rearrangement605 ff, 617 f. .
468 ff., 664 l-DOPA 344 f. estrone 153ff.
- of/7-benzoquinone 56 f. DTBMS group 702 ff. -, retrosynthetic analysis 160 ff.
-, transannular 586 -, total synthesis 162 ff.
diethyl 1,3-acetonedicarboxylate E etherification
256, 258 EDC 706 -, intramolecular 59
diethylaminosulfur trifluoride 540 P-effect 610 Evans's asymmetric aldol conden-
diethylgeranylamine 348, 352 ff. electriceel acetylcholinesterase 646 condensation 490, 603, 605 f.
-, enantioselective isomeriza- electrocyclic ring-opening 334ff. Evans's asymmetric aldol reaction
tion 348 -, conrotatory 160,335,340 431,496, 499, 506, 611,613f.,
diethylnerylamine 349 6rc-electrocyclization 620 f.
-, enantioselective isomerization \342\200\224,
disrotatory 568
349 electrocyclizations 266 ff., 275,
(-)-diethyl D-tartrate 427 f., 432, 281,283 farnesyl pyrophosphate 674
434 f. P-elimination 245, 306, 390 ff., Felkin-Anh model 646
(+)-diethyl L-tartrate 427 ff., 434 f. 542,551,600,638 Finkelstein exchange 90, 162,773
dihydroagarofuran 383f. s-cisenal 555 Fischer esterification 78,201,469
dihydropseudopterolide 713, 715 s-trans enal 555 Fischer indole synthesis 25, 27 f.
dihydroquinidine (DHQD) 679 enamides FK-506 600
dihydroquinine (DHQ) 679 -, catalytic asymmetric hydro- FMOCprotecting group 539 f., 542,
f/ireo-dihydrosphingosine 375 genation 345 545, 561
ES,6/?)-dihydroxyeicosatetraenoic enamine 109 FR-900482 574f.
acid 590f. T|3-enamine complex 352 free radical reactions 382
dihydroxylation 60 enantioselective hydrogenation D-fucofuranosyl acetate 512
-, OsO4-mediated 676f. -, Rh-catalyzed 345 D-fucose 510,514,529,531,540
diimide reduction 384 enantioselective isomerization
gorgiacerone 713, 715 321,. 366,458,492, 587 f., 590, isodihydroagarofuran 383
grandisol 403 746, 775 isoprene 396 f.
Grieco o-nitrophenyl-selenenylation hydroboration/oxidation 191 f., 196, isopulegol 354, 357
519,618 321, 758, 760,769,771,775, 777, isoreserpicacid lactone 62
L-gulose 293, 31Iff. -, intermolecular 668 isostrychnic acid 650f.
hydrogen atom abstraction 422 isostrychnine I 22 f., 37 ff.
H -, intramolecular 398, 401 ff. isoxazole 533, 55If.
haemin 5 hydropalladation 578 ff. isoxazolines 534,550 f.
Hajos-Wiechert reaction 368 1-hydroxybenzotriazole 623 f.
halichondrin \320\222716 f. hydroxy dithioketal cycli-
halogen-lithium exchange 516, 616, zation 750 ff., 781,783f. Jacobsen epoxidation 359
773 A2S)-hydroxyeicosatetraenoic jatrophone 598
halogen-metal exchange 536 acid 585 (+)-jatrophone 595 f.
halolactonization 171 hydroxy epoxide cyclization 193, \320\265/\320\273'-jatrophone 598 f.
Harpp reagent 560 f. 751 f., 756, 758 ff. Johnson ortho ester Claisen
Heck cyclization/anion capture -, 6-endo activated 752, 755, rearrangement 87 ff., 137 ff., 190,
process 576 759ff., 769, 778 193, 198f.
Heckreaction 566 ff. hydroxy epoxide-opening 17 Julia coupling 473 f., 481
-.asymmetric 576 f. (+)-P-hydroxyisobutyric acid 232, Julia olefination 487 f.
-, catalytic cycle 567 f. 234 f., 241 Julia-Lythgoe coupling 503, 506
-, domino 576 hydroxy ketones
-, intermolecular 572 -, reductive cyclization 743 ff., \320\232
(-)-ovalicin 690f. -
cyclization 510f., 516 phthaloyl chloride 553 f.
1-oxabisnorpenicillin G 262 - macrocyclizations 581 pinacol coupling 659, 666 f.
oxazaborolidine 80 -
zipper reactions 581 -. Ti(o)-mediated 666
oxazaborolidine catalyst 74 f., palladium-ene cyclization, supra- P-pinene 355f.
364 f., 367, 616 f. facial 572 f. Pinnick oxidation 697
oxazolidinone chiral auxiliary 613 palytoxin 10f., 71 Iff. L-pipecolic acid 601, 620
oxepane 732 f., 742ff., 754, 760, -, retrosynthetic analysis 717 ff. pleraplysillin-1 594 f.
771,784 -, total synthesis 719 ff. PMB trichloroacetimidate 705 f.
oxetane 317, 319,657, 659, 668 ff, palytoxin 8-lactone 725, 728 polycyclization 90, 468, 748
-, annulation 668 palytoxin carboxylic acid 717, 725, polyene macrolideantibiotics 425,
oxidative addition 567, 569, 573 f., 727f. 434, 448
576, 580,583 f., 587, 589, 592 f., partial synthesis 2, 401 polyene macrolides 421
715,717, Paterno-B iichi reaction 318 f., 3 21, polyether antibiotics 185 ff., 230
oxidative dimerization 96 324, 331 polyether ionophore 748
oxidative phenolic coupling 95 ff. Payne rearrangement 299 ff., 308, Bn+l)polyols 434ff.
oxime ether 545 311 potassium permanganate 538
oxy-Coperearrangement 17, 211, Payne rearrangement/epoxide potassium ;<?r?-butylperoxide 218 f.,
213ff.,334f. opening 300 f., 309, 311, 313 338
-.anionic 212 ff., 334 f. Pearlman'scatalyst 740 potassium tri-.sw-butylborohydride
oxy-Cope rearrangement/cyclobutene pcmpidine 569 f., 746 ff. see K-Sclcctride
334
ring opening D-penicillamin hydrochloride 44 ff. presqualene pyrophosphate 674
oxygen-centeredradical 401 penicillin 41 f. primary radical 409
oxylactonization 454 penicillin G 42 prismane 12
oxypalladation, palladium(n)- penicillin V 14, 41 ff. progesterone 83 ff.
induced 572 -, potassium salt 48, 50 -.retrosynthetic analysis 85
ozonolysis 103, 108, 113,115,204, -, retrosynthetic analysis 44 -, total synthesis 88
237^.424 -, total synthesis 45 ff. [3.3.3]propellane 580
penicilloic acid 44 prostaglandin A2 137 ff.
cyclization 570 TPAP/NMO oxidation 664, 666 ff. vinylogous amide 478
- Michael addition/enolate alkylation transamination 496 f. vinylogous amidine 117 ff.
467 transesterification 148,704 vinylogous formamide 553
- radical bicyclization 387, 395, 412 translactonization 169,180,697 vinylogous McCluskey fragmenta-
- radical cyclizationMntermolecular tri-n-butyltin hydride 383 ff., 473
fragmentation f., 477 f., 483
trapping 389 398 ff., 403, 405 f., 409, 412ff., vitamin \320\22212 10 f., 99 f.
- radical cyclizations 397, 407, 542 f., 695 -, C-ring lactam intermediate 115ff.
409 f., 415 tri-n-butyltin radical 382 f., 387, -, cyanobromide intermediate 101 f.,
- Sonogashira cyclization/ 394, 399, 403, 409, 412f., 416 105, 110,112f., 121, 124, 127
Diels-Alder reaction 586 trialkyltin radical 403 -, cyanocorrigenolide intermediate
tandem vicinal difunctionalization triazone protecting group 643, 650 121 ff.
388, 452, 456, 470 trichloroacetimidate glycosidation -, cyclization strategy 115 ff.
target molecules 8 ff. 528,531,537 -, macrocyclization strategy 121 ff,
-, natural products 9 tricyclo[6.3.0.01>6]undecanone
system -, pentacyclenone intermediate 101,
-, designed molecules 12 223 107f., 110
tartaric acid 427 triethylborane 398, 400 -, retrosynthetic analysis 100 ff.
347, 389 f., 424ff., 481, 494, 532, zaragozic acids 675
693, 702, 718f., 750ff., 764 ff., 778 yohimbine 55 (S)-zearalenone 598f.
-, intermolecular 533,551,761,781 Yuzuriha 465 zinc borohydride 545
-.intramolecular 601 zinc bromide 551
-, Schlosser modification 87,90 zipper polycyclizations 578
Woodward-Hoffmann rules 17,102, zaragozic acid A 673 ff., 677 zipper reactions
126,267,269 -, model studies 699 ff. -, palladium-catalyzed 581
-
retrosynthetic analysis 691 Zn-Cu couple 667
X -\302\246
total 694 ff.
synthesis
427 f., 432f. -
(+)-xylose triply convergent strategy 693 f.
(-)-xylose 427f., 432 f. zaragozic acid \320\241686
Get the Best of Organic Synthesis!
New Handbooks New Textbooks
D.P. Curran, N.A. Porter, B. Giese describes the concepts, lines of development
and perspectives of this highly interdisciplinary
Stereochemistry of Radical and burgeoning field of research.
VCH Weinheim
Softcover. DM 68.00
ISBN 3-527-29243-87
With a foreword by J.D. Roberts. VCH Weinheim
CLASSICS IN
This book is avnust fur every synthetic organic chpnist.-Witfi didactic skill and clarity,
\320\232. Nicolaou
\320\241 and Sorcnaen prc.sfciiithe
& J. most remarkableand ingenious total
ISBN 3-527-29231-4
783527\02292318\"